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Abstract 
Resorcyclic acid lactones (RALs) are natural products, with some having been 
shown to be potent inhibitors of several protein kinases and mammalian cell 
proliferation and tumour growth in animals.  LL-Z1640-2 (also known as 5Z-7-
oxo-zeanol or C292) is a cis-enone RAL, isolated in 1978 from fungal broth and 
classified as an anti-protozoal agent.  Later, in 1999, its cytokine releasing 
inhibiting activity was discovered, with subsequent data showing it could 
selectively and irreversibly inhibit transforming growth factor activating kinase-1 
(TAK1) activity at low concentrations.  It is also reported as having significant 
activity versus tumour necrosis factor-alpha (TNF-α) production in cells. 
This thesis documents and describes the work undertaken towards a total 
synthesis of the 14-membered macrocycle, LL-Z1640-2.  The presence of two 
internal bonds and three stereogenic centres poses a challenge synthetically, but 
this has been effectively overcome with the development of a flexible, economic 
and efficient synthesis, beginning from the commercially available starting 
materials, methyl 2,4,6-trihydroxybenzoate and 2-deoxy-D-ribose.   
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LL-Z1640-2 2-Deoxy-D-riboseMethyl 2,4,6-
trihydroxybenzoate  
The original route relied on a Wittig olefination to introduce the E-double bond, 
with moderate selectivity and success.  Later, an improved method was built 
upon, which utilised Grubbs mediated cross-metathesis to form the desired E-
olefin in good yield and selectivity.  Once the entire carbon framework had been 
established via a one-pot oxidation-Grignard adition of the appropriate alkyne 
unit, subsequent transformations enabled the formation of the seco-acid.  This 
very successfully underwent Mitsunobu macrolactonisation, with complete 
inversion of the stereocentre, to afford the macrocyclic lactone.  From this 
intermediate, the desired natural product LL-Z1640-2 could be generated in 
three steps. 
3 
A number of natural products and biologically important compounds contain 
spirocyclic pyran and piperidines ring systems as part of their overall structures.  
In 1996, pinnaic acid and halichlorine were isolated from their respective marine 
natural sources.  It was subsequently shown that they exhibited inhibitory 
activity towards certain biological substances and for this reason they became 
targets for total synthesis.  Characterised by an azaspiro[4.5]decane ring system, 
the difficulty in achieving total syntheses of such compounds is immense.  
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Pinnaic Acid Halichlorine  
The aim of the project was to develop a concise method towards the generation 
of highly functionalised spirocyclic piperidine units.  The regioselective aza-
Achmatowicz oxidative rearrangement was used as the key step to rearrange α-
amino furan building blocks into their respective enones.  Importantly, this 
rearrangement was proven to be viable and to proceed with compounds 
possessing a terminal olefin, with no over-oxidation observed. 
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This thesis also describes the investigation and efforts made into the production 
of more functionalised units, as well as studies into the synthesis of the cores of 
halichlorine and polymaxenolide, again using the aza-Achmatowicz and 
Achmatowicz rearrangement respectively. 
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1  Introduction 
1.1  Macrolides 
Macrolides are a biologically important class of natural products, but for many 
years the synthesis of such compounds posed an insurmountable challenge to 
chemists due to their often complex structures.  Over the last 20-30 years, new 
synthetic methodologies have been pioneered, enabling the total synthesis and 
subsequent biological evaluation of many of these significant natural products.  
The key step in the majority of cases is the formation of the large ring 
(macrocycle) and to date there are several reliable methods to execute this.  
Generally, a macrolide is defined as a molecule containing a large ring lactone in 
its structure,[1] which can be thought of as being derived from seco acids through 
internal esterification (Figure 1).  Additionally, those containing more than one 
ester linkage are also classified as macrolides. 
R O
O
OH
R
OH
O
A B  
Figure 1:  General Structure of Large Ring (Macrocyclic) Lactones (A) and Seco (Hydroxy) 
Acids (B). 
 
A large amount of investigation has been devoted into this class of compounds.  
They have been found to possess significant biological and physiological 
properties and many have the potential to be drug leads.  The macrolide 
antibiotics[2] feature a polysubstituted macrocyclic lactone, within a 12-16 
membered framework.  Examples of this class of antibiotics include 
erythromycin A and B, which both have 14-membered rings and leucomycin A, 
which has a 16-membered ring (Figure 2).  
Suzannah J. Harnor, 2010  21 
 
O
O
OH
HO
O OR''
OR'
OH
1
2
14 O
O
OH
O OR''
OR'
OH
1
2
14
O O
H3C
(H3C)2N
OH
OH
H3C
HO
H3C
R' = D-Desosamine R'' = L-Cladinose
Erythromycin A Erythromycin B
O
OH
CHO
OR
H3CO
OCOCH3
O
Leucomycin A3
O
N
CH3
CH3
HO CH3
O
O
OH
CH3
CH3
OCOCH2CH(CH3)2
R =
 
Figure 2:  Structures of Erythromycin A and B and Leucomycin A3. 
 
There is a wealth of information regarding the different types and classes of 
macrolides, but it is not feasible to document it all within the length of this 
thesis.  Briefly, the polyene macrolide antibiotics[3] possess strong anti-fungal 
activity, the cytochalasans[4] are active metabolites isolated from marine 
microorganisms and exhibit antibiotic, antitumour and cytostatic action, the 
macrodiilides contain within their structure two ester linkages and the 
macrotetrolides have four ester linkages and are antibiotic and ionophoric.  
Alkaloids also can contain macrocyclic lactones and so can be thought of as 
macrolides, for example carpaine[5] has a symmetrical 26-membered ring (Figure 
3).  β-Resorcyclic acid macrolides also exist with many members, but as they are 
the group that LL-Z-1640-2 belongs to they will be discussed in further depth. 
H
N
O
O
N
H
O
O
H3C
CH3
 
Figure 3:  Structure of Carpaine. 
 
1.2 Resorcyclic Acid Lactones 
Resorcyclic acid lactones (RALs) have been known since 1953 when the first 
isolation of radicicol took place from Monocillium nordinii[6] and was termed 
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Monorden.  The isolation of zearalenone,[7] LL-Z1640-2[8a] and hypothemycin[9] 
followed in subsequent years.  Interestingly, the structures that were originally 
proposed for radicicol and hypothemycin were later found to be incorrect.  
When radicicol was isolated from Nectria radicicola[10] in 1964, the correct 
structure was elucidated and radicicol became the given name.  In 2006, 
radicicol was found to be synthesised by fungi associated with a Sonoran desert 
plant.[11]  Initially, the biological activity of early discovered RALs did not attract 
immediate attention and it was only in latter years that they were held in 
greater esteem.   
1.3 Biosynthesis of RALs 
RALs are mycotoxins which are produced by different fungal strains via 
polyketide synthesis (Figure 4).[12]   
O
S CoA
O
O S
O
PKS
HOO
R
OH
HO
O
O
R  
Figure 4:  Biosynthesis of RALs.  The red carbons represent the two-carbon units that are added 
in each reiterative condensation. 
 
PKS's are type I polyketide synthases and are large multidomain enzymes that 
iteratively catalyse the condensation of nine units of malonates or 
thioacetates.[12]  The product of each condensation can then be processed by 
different modules to either reduce or dehydrate the β-ketone.   
The biosynthesis involves two PKSs.  The first assembles the first five acetate 
units, with further processing to arrive at the adequate oxidation state at each 
carbon and the second performs the remaining three condensations without 
carbonyl reduction.  Ketones that are unreduced are highly reactive and take 
part in a cyclisation/aromatisation, the lactone then gets released via a 
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cyclisation module on the second PKS.[13]  The functionality around the RAL 
macrocycle is dependent on the arrangement of modules in the first five 
condensations. 
1.4 Biological Activity of the RALs 
Originally, the properties of RALs did not attract much attention from chemists 
and it wasn't until the early 1990s that interest was renewed, mainly due to the 
selective kinase inhibitory action that some RALs possessed.  
Zearalenone was found to have oestrogen agonistic properties, which were due 
to the direct interaction on the oestrogen receptor in competition with 17-
estradiol.[14]  Interestingly, the macrocycle was able to adopt a conformation 
that mimicked a steroid[15] and these properties further allowed it to be used as 
a bovine growth stimulant. 
Radicicol has been found to be a potent and selective inhibitor of the molecular 
chaperone HSP90.[16,17]  When there is no HSP90 chaperone activity, clients of 
HSP90 are unfunctional and targeted for degradation.  It has been shown through 
co-crystallisation studies that even though radicicol and ATP are not structurally 
similar, radicicol is a competitive ligand for the ATP binding site of HSP90.[18] 
There are some cis-enone RALs which irreversibly inhibit mitogen activated 
protein kinases (MAP kinases) and are competitive with ATP.  The subject of 
protein kinases is vast and an immense amount of wide-ranging studies have 
been carried out in this field.  Due to their importance and their biological 
connections with LL-Z1640-2, the protein kinases will be discussed in further 
depth. 
1.5 Mitogen Activated Protein Kinases (MAP Kinases) 
Protein phosphorylation of amino acids in the human body is catalysed by kinases 
and likewise, dephosphorylation is phosphatase catalysed (Figure 5). 
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Figure 5:  Protein Phosphorylation and Dephosphorylation. 
 
Mitogen activated protein kinases (MAP kinases) belong to the family of kinases 
that are responsible for controlling many cellular events.  Although each has a 
unique character, a number of features are shared by all MAP kinases.  They are 
activated by protein kinase cascades that contain at least two upstream kinases 
(Figure 6).  These upstream kinases are members of the MAP kinase/ERK 
(extracellular signal-regulated kinase) kinase or MEK family.  In order for MAP 
kinases to become highly active, they require tyrosine and threonine 
phosphorylation (catalysed by MEKs).[19,20] 
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Figure 6:  Excerpt from MAP Kinase Cascades.  Reproduced from Elsevier Inc., 2003. 
 
Inhibitors of MAP kinases are interesting as the MAP kinases relay, amplify and 
integrate signals from a range of extracellular stimuli, in so doing regulating a 
cell's response to its environment.  The amplitude of the signal is controlled by 
three sequentially activated kinases, called a phosphorelay system.  Generically, 
a stimulus turns on the activator which phosphorylates the first kinase (MAPKKK) 
which then phosphorylates the second kinase (MAPKK), which in turn 
phosphorylates the third kinase (MAPK) which phosphorylates a cytosolic protein 
or transcription factor.[21]   
There are at least three subfamilies of MAP kinases (ERKs, JNKs and p38 
enzymes), with at least seventeen MAPKKKs, seven MAPKKs and twelve MAPKs.  
Importantly, the specificity of the cascades needs to be regulated.  This is 
achieved by scaffolding proteins which organise and localise the cascades to 
provide a combinatorial arrangement and down stream signal which is unique.[22]  
The MAP kinases are intensely important in regulating cellular responses and it is 
for this reason that they are prime, viable drug targets.  They are also hugely 
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important in determining the functions of specific MAP kinases in complex 
networks. 
Radicicol A (Figure 7) was the first RAL to show inhibitory action towards a 
kinase.  The mode of action is that it accelerates the degradation of specific 
mRNA sequences containing AU-rich elements (AREs).[23,24] 
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Figure 7:  Structures of cis-enone Containing RALs. 
 
Some macrolides contain an α,β-unsaturated ketone in the macrocycle, for 
example the cis-enones which include hypothemycin, radicicol, radicicol A, LL-
783,277 and LL-Z1640-2 (Figure 7).  These cis-enone RALs have been shown to 
inhibit mammalian cell proliferation and tumour growth in animals,[25-27] with 
other reports suggesting that cis-enone RALs inhibit selected protein kinases.[28]  
Researchers at Merck found that LL-783,277 and hypothemycin were potent and 
irreversible inhibitors of MEK1 (4 nM and 15 nM respectively), with the presence 
of their cis-enone being essential for the activity.[29]  The irreversible inhibition 
can be accredited to a Michael addition onto the cis-enone of a cysteine residue 
which is present in the ATP-binding pocket of a subset of kinases (Figure 8).[28]  
LL-Z1640-2 was found to be a potent and irreversible inhibitor of TAK1 (IC50 8.1 
nM).[30] 
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Figure 8:  Proposed Mode of Action of the cis-enone RALs.  LL-783,277 is given as the 
example in this case. 
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1.6 Chemical Synthesis of the RALs 
Constructing natural products synthetically provides challenges, both 
intellectually and practically, which many thrive on in order to discover and 
even invent new chemical reactions and strategies.  Since the syntheses of urea 
and acetic acid in the early 1800's, chemistry has evolved so much that high 
complexity of targets can be achieved.  The macrolides have in general; a large 
macrocyclic ring fused to resorcyclic acid and for many years posed a challenge 
to synthetic chemists due to their complex structures.  Over time, synthesis of 
these compounds has become more prevalent, with some having been 
synthesised and then re-synthesised to utilise new synthetic developments.  As a 
consequence, long-standing, resistant molecules have finally succumbed to total 
synthesis.   
Zearalenone[31] (Figure 9), due to its marked anabolic and uterotrophic activities, 
held great interest and a number of syntheses to this molecule have been 
reported.  Indeed, it was perhaps the first naturally occurring macrolide to be 
synthesised, with the first total synthesis published by chemists at Merck in 
1968.[32] 
O
OH
HO O
O
 
Figure 9:  Structure of Zearalenone. 
 
Leading up to the total synthesis of zearalenone, the Merck group investigated 
whether the macrocyclic ring could be formed by esterification of the seco-acid 
and from this, whether the natural product could be obtained.  In order to test 
their hypothesis, they took natural zearalenone and prepared from it, the seco-
acid derivative, by methylation of both phenolic groups and saponification.  
Preliminary experiments led to the knowledge that zearalenone could be 
obtained from the acyclic precursor by lactonisation followed by protection 
group removal.  With the final stages completed, work began on the 
construction of the fragments which would join to form the seco-acid (Scheme 
1). 
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Scheme 1:  The Merck Synthesis of Zearalenone. 
 
The aliphatic unit was obtained by condensation of 1 with 1-pentenylmagnesium 
bromide 2 followed by exposure to methanolic hydrogen chloride to afford the 
ketal 5, via 3 and 4.  Reductive ozonolysis of the double bond and tosylation of 
the resulting alcohol 6 was followed by displacement of the tosylate with 
bromide ion and heating with triphenylphosphine to give the phosphonium salt 
7.  The aromatic unit, as its sodium salt, was obtained from 2,4-
dimethoxyphthalic anhydride by partial reduction with lithium tri-t-
butoxyaluminium hydride followed by diazomethane to afford the methyl ester 
8, which was then converted to its sodium salt 9. 
The phosphorane 10 and aldehyde 9 in DMSO were condensed to afford the seco-
acid 11 in 55-60% yield.  Cyclisation proceeded using trifluoroacetic anhydride in 
dilute benzene to give 12, which then underwent liberation of the phenolic 
group.  The authors reported that this group was used as a handle to resolve the 
racemate 13 as 2-l-menthoxyacetate 14 gave natural zearalenone 13 after 
removal of the menthoxyacetate and the methyl ether (BBr3). 
1.7  LL-Z1640-2 
LL-Z1640-2 (also known as C292[8b] or 5Z-7-oxo-zeaenol) is a cis-enone resorcyclic 
acid lactone that was first isolated in 1978 as an anti-protozoan agent from the 
culture broth of fungal strain f6024.[8a]  As part of its structure it has a 14-
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membered macrocycle, with two internal double bonds and three stereogenic 
centres (Figure 10). 
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Figure 10:  Structure of LL-Z1640-2 (C292 or 5Z-7-oxo-zeaenol).  The internal double bonds 
and stereogenic centres are highlighted. 
 
1.8 Biological Activity of LL-Z1640-2 
Originally, this compound did not capture a great deal of attention as it held no 
particularly interesting properties; it had no anabolic or oestreogen-like activity.  
However, a major breakthrough came when a screen for TAK1 inhibition 
revealed that this compound had an IC50 of 8.1 nM.
[30]  Conversely, zearalenone 
and radicicol showed no appreciable activity.  The same authors then proceeded 
to show that LL-Z1640-2 was competitive with ATP, as it targeted the ATP-
binding pocket of kinases,[12] as well as being an irreversible inhibitor of a 
specific mitogen activated protein kinase, TAK1.  On topical application to an 
animal model, LL-Z1640-2 was shown to effectively prevent inflammation.[30]   
1.9 Transforming Growth Factor Activating Kinase-1 
(TAK1) 
TAK1 is transforming growth factor activating kinase-1 and is a MAPKKK involved 
in the p38 signalling cascade for proinflammation signals such as cytokines 
(Figure 6 and Figure 11).  LL-Z1640-2 is 50-fold less active against MEK1 (411 
nM), whilst having no inhibitory effect on other MAP kinases, such as ASK1.[33-35]  
This renders this RAL a promising specific inhibitor of TAK1. 
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Figure 11:  Position of TAK1 in a Summary of the Protein Kinase Cascade. 
 
1.10 IC50 
For competition binding assays and functional antagonist assays the most 
common summary measure of the dose-response curve is IC50.  The IC50 is 
defined as the half-maximal inhibitory concentration and it serves to measure 
how much of a particular substance/molecule is needed to inhibit a biological 
process by 50%.  It is commonly used in pharmacological research as a measure 
of antagonist drug potency and is comparable with EC50 for agonists.  This is the 
concentration giving 50% of that compound's maximal response.  The IC50 of a 
compound is calculated by plotting a dose-response curve relating concentration 
of the compound to the activity of the biological process. An example of a dose 
response cure is shown below (Figure 12). 
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Figure 12:  Dose-response Curve. 
 
1.11  Previous Syntheses of LL-Z1640-2 
1.11.1 The First Total Synthesis - Tatsuta 
Tatsuta, Takano, Sato and Nakano published the first total synthesis of LL-Z1640-
2 in 2001[36], beginning from a carbohydrate starting material.  In terms of the 
retrosynthesis (Scheme 2) they visualised the lactone core as originating from 
the Mukaiyama cyclisation[37] of seco-acid 16.  They foresaw that a Tsuji 
hydrogenolysis[38] would enable them to reach the seco-acid.  17 is prepared 
through Sonogashira coupling[39] of 18 and 19.  19 is made from D-ribose 20 – the 
carbohydrate starting material and it was envisioned that the required 
stereochemistry of the two alcohols present in the final product would come 
from this compound. 
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Scheme 2:  Tatsuta's Retrosynthetic Analysis. 
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Tatsuta's synthesis began with D-ribose 20 in which the anomeric hydroxyl was 
protected as a benzyl ether and the resulting triol 21 globally protected as MOM 
ethers to generate 22.  Removal of the benzyl group, followed by reaction of the 
resulting lactol 23 with the lithiated acetylide, afforded diol 24.  Selective 
pivaloylation of diol 24, yielded 25 as a single product.  The authors note that 
only a trace of its diastereoisomer was observed. 
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Scheme 3:  Tatsuta's Synthesis of LL-Z1640-2.  Reagents and Conditions: (a) CSA/BnOH, 80 
oC, 89%; (b) MOMCl, i-Pr2Net, MeCN, 50 oC, 4 h, 85%; (c) H2, Pd(OH)2, EtOH, 3 h, quant.; (d) 
TMS-acetylene, nBuLi, BF3·OEt2, THF, –78 oC → rt; (e) PivCl, pyridine, 0 oC, 1 h, 2 steps 48%. 
 
Following TMS removal, the terminal alkyne 19 was coupled with iodobenzene 
18 under palladium(0) mediated conditions to afford 26 (Scheme 4).  Alkynol 26 
was protected as the ethoxycarbonate 27 and then reduced with Lindlar's 
catalyst to give the desired Z-olefin 17.  Tsuji's hydrogenolysis conditions[38] 
cleanly isomerised the olefin to yield the E-alkene 28. 
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Scheme 4:  Tatsuta's Synthesis of LL-Z1640-2.  Reagents and Conditions: (a) TBAF, AcOH, 
THF, 2 h, quant.; (b) Pd(OAc)2, CuI, PPh3, Et3N, 2 h, 85%; (c) ClCO2Et, pyridine, 0 oC, 1 h, 98%; 
(d) H2, Pd/BaCO3, quinoline, EtOH, 30 min; (e) Pd2(dba)3CHCl3, n-Bu3P, HCOONH4, 1,4-dioxane, 
95 oC, 1 h, 2 steps 96%.  
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Pivaloyl group removal yielded the primary alcohol 29, which was oxidised to 
aldehyde 30.  Treatment of aldehyde 30 with carbon tetrabromide and 
triphenylphosphine proceeded to give the dibromoolefin 31 (Scheme 5). 
MOMO
H3CO
O
OCH3
OMOM
OMOM
OPiv
OMOM a
MOMO
H3CO
O
OCH3
OMOM
OMOM
OH
OMOM b
MOMO
H3CO
O
OCH3
OMOM
OMOM
O
OMOM c
MOMO
H3CO
O
OCH3
OMOM
OMOM
OMOM
Br
Br
28 29
30 31  
Scheme 5:  Tatsuta's Synthesis of LL-Z1640-2.  Reagents and conditions: (a) NaOMe, MeOH, 
50 oC, 3 h, 95%; (b) (COCl)2, DMSO, Et3N, CH2Cl2, –78 oC → rt; (c) PPh3, CBr4, CH2Cl2, 0 oC, 15 
min, 2 steps 85%. 
 
The dibromoolefin 31 was treated with nBuLi and the lithiated acetylide firstly 
produced; was captured with (S)-propylene oxide 32 to afford alcohol 33 
(Scheme 6). 
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Scheme 6:  Tatsuta's Synthesis of LL-Z1640-2.  Reagents and Conditions: (a) nBuLi, BF3·OEt2, 
THF, –78 oC → rt, 45%; (b) H2, Pd/BaCO3, quinoline, AcOEt, 30 min; (c) 2 M, NaOH, MeOH, 1,4-
dioxane, 90 oC. 
 
Lindlar's reduction of alkyne 33 yielded Z-olefin 34.  Saponification of the ester 
gave the seco-acid 16, which was cyclised under Mukaiyama conditions,[37] to 
afford the lactone 36 in 50% yield over 3 steps (Scheme 7).  Removal of the MOM 
protecting groups generated tetraol 37. 
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Scheme 7:  Completion of Tatsuta's Synthesis of LL-Z1640-2.  Reagents and Conditions: (a) 
Et3N, MeCN, 50 oC, 1 h, 3 steps, 47%; (b) 5% HCl-MeOH, 50 oC, 2 h, 76%; (c) Dess-Martin 
periodinane, CH2Cl2, 15 min, 62%. 
 
The final step involved the selective oxidation of the allyl alcohol.  Interestingly, 
the authors reported, after extensive experimentation, that DDQ and Dess-
Martin periodinane were the only reagents found to selectively oxidise the 
alcohol in yields of 20% and 62% respectively.  The authors claimed that ketone 
15 was identical in all respects to the naturally isolated LL-Z1640-2. 
1.11.2 The Second Total Synthesis – Sellès and Lett 
In 2002, the second total synthesis of LL-Z1640-2 was published in two parts by 
Sellès and Lett.[40,41]  The first part focused on the stereospecific convergent 
synthesis of the precursors required for the formation of the 14-membered ring, 
either via intramolecular Suzuki coupling or an intermolecular Suzuki coupling 
followed by a macrolactonisation.[40]  The retrosynthetic analysis (Scheme 8) led 
to three subunits:  the aromatic unit 38 and two enantiopure units 40 and 41.   
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Scheme 8:  Lett's Retrosynthetic Scheme. 
 
The hypothesised approach is flexible and the 14-membered macrocycle can be 
formed either by an intramolecular Suzuki coupling or by a macrolactonisation 
(via acyl activation or Mitsunobu).  The enantiopure units draw from readily 
available starting materials.   The C4'-C5'-diol would come from the regio- and 
stereospecific opening of the epoxide by a carbamate derived from 43.  This 
epoxy alcohol could be obtained through a Sharpless asymmetric epoxidation of 
the trans-disubstituted allylic alcohol. 
Synthesis of the aromatic unit 38 began with 4-methoxysalicyclic acid 46, which 
was selectively protected as the silyl ether 47, then treated with oxalyl chloride 
followed by diethylamine, to generate amide 48 (Scheme 9).   
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Scheme 9:  Lett's Synthesis of LL-Z1640-2.  Reagents and Conditions: (a) TBDMSCl, i-Pr2NEt, 
DMF, rt, 2 h; (b) oxalyl chloride, DMF, CH2Cl2, –10 oC → rt, overnight, then Et2NH, 1 h, rt; (c) 
Et2NAlMe2 from Me3Al and Et2NH, toluene, –60 oC → rt, 45min, then bis-OTBS from 46, reflux, 
overnight; (d) tBuLi, pentane, Et2O, –78 oC, 10 min, then Br2; (e) Me3O+, BF4-, CH2Cl2, rt, overnight, 
then evaporation; (f) aq. satd Na2CO3/MeOH (1/1), rt, 6 h; (g) conc. NaOH:DME (1:1), reflux, 
overnight; (h) TMSOK, DME, reflux, overnight. 
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The presence of the TBS protective group prevented o-metallation at position 3 
of amide 48 by its steric effect and allowed conversion of the amide 48 into the 
methyl ester 51.  The final aromatic unit 38 was obtained using conditions that 
avoided decarboxylation. 
The synthesis of the enantiopure C7'—C10' subunit began with 
ethynyltrimethylsilane 52, which was lithiated and used to open the enantiopure 
(S)-propylene oxide 32.  The free alcohol 53 was protected as the TBS ether 54 
and specific deprotection of the TMS-alkyne using potassium carbonate in 
methanol gave alkyne 55 in a 76% overall yield (Scheme 10).  Hydrozirconation 
with Schwartz' reagent[42] was used to generate the (S)-E-vinyl iodide 56.  
Hydroboration of iodoalkyne 57 with Sia2BH generated the (S)-Z vinyl iodide 58. 
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Scheme 10:  Lett's Synthesis of LL-Z1640-2.  Reagents and Conditions: (a) Et2O, –78 oC, nBuLi, 
30 min, then (S)-propylene oxide 32 and further addition of BF3·OEt2, in 50 min, –78 oC; (b) 
TBDMSCl, imidazole, DMF, rt; (c) K2CO3, MeOH, rt, 5 h; (d) Cp2ZrCl2, LiBHEt3, THF, rt, then 55, rt, 
15 min and I2 in THF; (e) nBuLi, THF, hexane, –78 oC, 15 min, then I2 in THF; (f) Sia2BH, THF, –20 
oC → 0 oC, 3 h then AcOH, 65 oC, 3 h. 
 
Epoxide 65 was obtained in seven steps from 2-butyne-1,4-diol 59 (Scheme 11).  
The authors note that the selective deprotection of TBS ether 63 was best 
carried out using DDQ.   
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Scheme 11:  Lett's Synthesis of LL-Z1640-2.  Reagents and Conditions: (a) Red-Al®, toluene, 
THF, 0 oC–rt, overnight, 81%; (b) NaH, THF, rt, 1 h, then –78 oC, TBDMSCl, 36 h, 74%; (c) MsCl, 
Et3N, CH2Cl2, –10 oC → rt, 30 min; (d) NaI, acetone, rt, 1 h; (e) TMS-alkyne 52, THF, nBuLi, –78 
oC, 30 min, then 45 and HMPA (THF:HMPA = 10:1), rt, 4 h; (f) DDQ, MeCN:H2O (9:1), rt, 2 h; (g) 
Ti(OiPr)4, (+)-DET, anhydrous CH2Cl2, t-BuOOH (~ 3 M in isooctane), –25 oC, overnight.  
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Sharpless asymmetric epoxidation of ene-yne 64 with (+)-DET afforded the 
desired epoxyalcohol 65, as a single enantiomer.  The epoxide 66 was opened in 
the presence of BF3OEt2 to afford carbonate 67 in high yield (Scheme 12).   
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Scheme 12:  Lett's Synthesis of LL-Z1640-2.  Reagents and Conditions: (a) PhNCO, CH2Cl2, 
pyridine, rt, 1 h; (b) BF3·OEt2, Et2O, –20 oC, 2 h, then 1 N H2SO4, rt, overnight; (c) NaOMe, MeOH, 
rt, 8 h, then DOWEX 50 WX8 column eluted with MeOH; (d) TBDMSCl, imidazole, DMF, rt, 1 h; (e) 
2-methoxypropene, TsOH, CH2Cl2, rt, 1 h; (f) nBuLi, hexane, Et2O, –30 oC, 30 min, then TMSCl, –
30 oC → 10 oC, 98%; (g) DDQ, MeCN:H2O (9:1), rt, 2 h, 73%; (h) oxalyl chloride, DMSO, CH2Cl2, –
78 oC, 30 min, then 72, 30 min and Et3N, –78 oC → 0 oC. 
 
Simultaneous hydrolysis of the carbonate and TMS deprotection was achieved 
using sodium methoxide in methanol, to afford triol 68 in 93% yield.  TBS 
protection (→69) and acetonide formation, followed by reprotection of terminal 
alkyne 70 with a TMS group (→71) all proceeded readily.  Once again, DDQ was 
used to bring about the selective deprotection of TBS ether 72.  These 
conditions minimised cleavage of the acetonide and TMS groups.  Finally, the 
alcohol was converted to the aldehyde 73 under standard Swern conditions. 
The synthesis of the C1'—C10' fragment 79 began with the condensation of the 
two enantiopure fragments 58 and 73 to give a 60:40 mixture of the two C6' 
epimeric diastereoisomers 74 (Scheme 13).  Following deprotection of TMS-
alkyne 74, the C6'-OH 75 was protected as the MPM ether 77.  As the 
diastereoisomers were not easily separated, the authors carried forward this 
mixture to the macrocyclisation precursors.   
As pointed out previously, the hypothesised approach was flexible and the 
macrocycle can be formed by one of two methods.  If an intramolecular Suzuki 
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coupling[43] were to be used for the formation of the macrocycle, then precursor 
79 is needed.   TBS ether 77 was deprotected using TBAF in THF and resulting 
alcohol 78 was coupled with benzoic acid 38 with DCC.  The required ester 79 
was obtained in 76% overall yield.  
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Scheme 13:  Lett's Synthesis of LL-Z1640-2.  Reagents and Conditions: (a) Et2O, –78 oC, then 
tBuLi/pentane, 15 min and further addition of 73 in pentane, –78 oC → 0 oC; (b) K2CO3, MeOH, rt, 5 
h; (c) Et2O, CF3SO3H, rt, 4 h; (d) TBAF, THF, rt, 10 h; (e) DCC, DMAP, CH2Cl2, rt, 5 h. 
 
For the alternative Mitsunobu macrolactonisation[44] reaction, precursor 83 was 
required (Scheme 14). 
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Scheme 14:  Lett's Synthesis of LL-Z1640-2.  Reagents and Conditions: (a) Sia2BH, THF, –25 oC 
→ rt, 2 h, then aq. 2 M K3PO4, further addition of that mixture via cannula at rt to a solution of 51 
and 15 mol% [Pd(OAc)2+4TFP] in DME; DME:H2O (~7:1), reflux, 8 h; (b) TBAF, THF, rt, 6 h, 93%; 
(c) 2 N NaOH:MeOH (1:3), reflux, overnight, 71%. 
 
Aryl bromide 38 underwent an intermolecular Suzuki coupling with the 
vinyldisiamylborane, prepared in situ from alkyne 80.  In comparison to the 
previous method, the aromatic hydroxy acid is not used, but rather its precursor, 
the methyl ester 81 is used.  Interestingly, the final methyl ester cleavage 
proved less than straight forward.  This was eventually achieved in 71% yield 
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from 82, using 13 equivalents of 2 N aq. NaOH in methanol under reflux to yield 
83. 
Once both cyclisation precursors were available, the cyclisation reactions were 
attempted.  In the completion of the total synthesis, published as Part 2,[41] the 
authors reported that the 14-membered macrocycle was achieved much more 
efficiently through the use of an intermolecular Suzuki coupling, followed by an 
intramolecular Mitsunobu macrolactonisation (Scheme 8 and Scheme 15). 
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Scheme 15:  Retrosynthetic Analysis for Completion of the Synthesis. 
 
Using a model system 84, the intramolecular Suzuki coupling of 
vinyldisiamylborane (generated in situ) derived from the alkyne 79, was tested 
(Scheme 16).  The best results were observed when acetone was added to 
destroy, in situ, any excess Sia2BH that remained after hydroboration.  Using 
these conditions, the macrolides 85 and 86 were obtained in 9% and 15% 
respectively.  When the same conditions were applied to 87 and 88, no 
corresponding macrolides were seen. 
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Scheme 16:  Lett's Synthesis of LL-Z1640-2.  Reagents and Conditions: Sia2BH, THF, –20 oC → 
rt, 2 h, then addition of acetone and afterwards 2 M aq. K3PO4 at –10 oC → rt, further addition of 
that mixture via cannula to a solution of 4 mol% [Pd(OAc)2+4TFP] in DME, i.e. substrate 0.034 M in 
DME:H2O (~30:1), reflux, 6 h. 
 
The macrolactonisations were far more successful when using the Mitsunobu 
reaction and its associated conditions (Scheme 17).  The transformations were 
all achieved at room temperature, under low dilution (0.007-0.01 M), with yields 
ranging from 64-70%.  In these cases there were no inhibitory factors arising 
from steric interactions or ring strain.  In the case of the macrolactonisation of 
83, this proceeded readily in 67% yield.   
As expected there was complete inversion of configuration at C10', further 
exemplified by comparison of the 1H NMR spectra for product 86, being derived 
from either intramolecular Suzuki coupling or Mitsunobu macolactonisation. 
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Scheme 17:  Lett's Synthesis of LL-Z1640-2.  Reagents and Conditions: hydroxy acid 0.007 M in 
anhydrous toluene, PPh3, DEAD, rt, 15 min. 
 
All that remained was the conversion of 86 into the final target compound 15 
(Scheme 18). 
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Scheme 18:  Lett's Completion of the Synthesis.  Reagents and Conditions: (a) DDQ, 
CH2Cl2:pH 7 buffer (9:1), rt, 30 min, 94%; (b) p-TsOH, MeOH, rt, 4 h, 68%; (c) PCC, 2,5-DMP, 
CH2Cl2, 0 oC, 6 h; (d) Jones' reagent, acetone, 0 oC, 10 min, 35%; (e) p-TsOH, CH2Cl2:MeOH (1:1), 
rt, 3 h, 30 min, 76%. 
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Firstly, MPM ether 86 was deprotected using DDQ in buffered conditions to 
afford the alcohols 94M and 94m (60:40) in 94% yield.  When using a model 
system, the authors were readily able to oxidise the 6'-OH into the corresponding 
enone using activated MnO2 in 70% yield, disappointingly, this could not be 
transferred to the 'real' system.  The mixture of the epimers could not be 
oxidised even when using a large excess of active MnO2 or by DDQ.  An 
alternative was to prepare 95, but even this triol led to complex mixtures on 
oxidation with MnO2.  Fortunately, the authors tried PCC and on reacting 
94M/94m with PCC in the presence of 2,5-dimethylpyrazole they observed a 
clear difference in the reactivity of the diastereoisomers.  The major epimer 
94M was converted quantitatively into the Z-enone 96 in 62% yield after 
chromatography, while the minor epimer 94m was unchanged and isolated in 
23% yield after chromatography.  The pure minor diastereoisomer was reacted 
under Jones' oxidation conditions to form the Z-enone 96 in 35% yield.  Overall 
the Z-enone was isolated in 74% yield from 94 (60:40) mixture.  Surprisingly, 
Swern oxidation of 94M gave the Z-enone 96 in 30% yield after chromatography.  
Finally, the acetonide was cleaved using p-TsOH in a 1:1 mixture of 
dichloromethane:methanol at room temperature, to generate LL-Z1640-2 15 in 
76% yield (20% of 96 also recovered). 
The syntheses presented by these two sets of authors are lengthy, containing 
steps that have needed careful establishment and much optimisation.  At no 
time is there any mention of whether the steps that involve intricate conditions 
are readily reproducible, giving comparable yields.  To their credit the syntheses 
are stereospecific, convergent and flexible.  Indeed, Sellès and Lett go on to 
epoxidise the E7',8'-enone to afford hypothemycin.  Another additional benefit is 
that they are able to carry through their 60:40 mixture of the two 
diastereoisomers 94M/94m, epimeric at C6', through all the steps until the 
oxidation, which is the penultimate step of the synthesis, where they could 
isolate each epimer after chromatography. 
1.11.3 Synthesis of the Aliphatic Subunit from Mannose 
In 2007, Krohn and Shukov published their synthesis of the aliphatic subunit of 
LL-Z1640-2.[45]  This particular synthesis incorporated the Vasella reaction as a 
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key step and the synthesis proceeded via the ring-opening of a 6-iodo-4-deoxy-D-
mannose unit.  The Vasella reaction[46] allows the conversion of halosugars into 
components having a carbonyl group tethered to an olefinic bond.  The Vasella 
reaction is not uncommon and has been incorporated into previous total 
syntheses; of pentenomycin[47] for example. 
The authors hypothesised that mannose could be used to provide two of the 
required stereocentres present in LL-Z1640-2.  Mannose is a simple and 
inexpensive, commercially available compound and as such is an ideal choice as 
a starting material for a total synthesis.  For this particular synthesis, the 
authors prepared two 6-deoxy-6-iodomannose derivatives 100 and 102 from 
methyl-α-D-mannopyranoside 97 (Scheme 19).  This has been documented in 
depth in a previous publication by the same authors.[48]  The alcohols formed 
were then treated with iodine and triphenylphosphine to give 6-iodo sugars 100 
and 102. 
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Scheme 19:  Krohn's Synthesis of LL-Z1640-2.  Reagents and Conditions: (a) i) H3PO2/AIBN, 
Et3N, dioxane, reflux, 90%; ii) p-TsOH, acetone, 90%; (b) Ph3P, I2, rt, 90%. 
 
The iodo sugars 100 and 102 were then treated with activated zinc to initiate 
the Vasella ring-opening.  Reaction of the deoxysugar 100 proceeded smoothly 
and gave aldehyde 103 in good yield using sonication (reaction of the mesylate 
102, under the same conditions, gave a mixture of products, presumably due to 
an interaction of zinc with the mesylate group) (Scheme 20). 
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Scheme 20:  Krohn's Synthesis of LL-Z1640-2.  Reagents and Conditions: (a) activated zinc, i-
PrOH, sonication, 50 oC, 60%; (b) nBuLi, THF, –78 oC, 50%; (c) Py–HF, THF, rt, 73%; (d) MnO2, 
benzene, rt, 80%; (e) (i) nBuLi, I2; (ii) N2(CO2K)2, 50%. 
 
From their retrosynthesis the authors envisaged that the aldehyde could be 
coupled with either acetylene 104 or vinyl iodide 108.  The acetylene unit was 
easily obtained and the Z-vinyl iodide could be accessed from the alkyne 104 
through iodination and then stereoselective diimide reduction.  The vinyl iodide 
and alkyne were each reacted in situ with nBuLi and then these lithium reagents 
reacted with the aldehyde 103.  When the aldehyde 103 and vinyl lithium were 
reacted a complex mixture of products was seen.  Conversely, when the 
aldehyde and lithiated alkyne were reacted a mixture of diastereomeric 
propargyl alcohols 105 was observed (1:2.3 by 1H NMR).  Cleavage of the 
terminal TBS protecting group, followed by selective oxidation of the resulting 
diol 106, afforded ketone 107.  Though not presented in the published paper, 
the authors identify this ketone as a late-stage building block towards 111 
(Scheme 21).  They predict that secondary alcohol 111 can be esterified with 
acid 110, followed by Z-selective reduction of the acetylene.  Ring-closing 
metathesis of 109 would close the macrocycle to produce and finalise the 
synthesis of the required LL-Z1640-2. 
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Scheme 21:  Krohn and Shukov's Proposed Completion of the Synthesis of LL-Z1640-2. 
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The synthetic steps presented in this publication are neat and time efficient.  
The 6-iodo-4-deoxymannose derivative 100 was subjected to the Vasella ring-
opening reaction, affording the δ,ε-hexenal 103.  Coupling of the aldehyde to 
the acetylene is reliable and two subsequent, straightforward steps produces 
propargylic ketone 107. 
1.11.4 Synthesis of the Complete LL-Z1640-2 Framework 
In 2007, Marquez, Henry and Robertson published their fast and efficient, 
convergent synthesis of the complete LL-Z1640-2 framework.[49]  Their 
retrosynthetic analysis (Scheme 22) envisioned cleavage of the ester 
functionality and of the aryl double bond of the macrocyclic ring to produce the 
vinyl benzoic acid 113 and alcohol 115. 
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Scheme 22:  Marquez's Retrosynthetic Analysis. 
 
The commercially available and relatively inexpensive, methyl 2,4,6-
trihydroxybenzoate 114 was used as the starting material for the synthesis of 
the vinyl benzoic acid unit 110 (Scheme 23).  The C4 position was methylated 
selectively through treatment with trimethylsilyl diazomethane to afford diol 
117 in high yield.  Monosilylation of the diol under standard conditions produced 
the TBS silyl ether 118, which was treated with triflic anhydride to yield triflate 
119.  The vinyl unit 120 was synthesised by subjecting the aryl triflate to a Stille 
coupling with vinyltributyltin.  Saponification of the methyl ester 120 proceeded 
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to generate the free benzoic acid 110.  Spontaneous desilylation was also 
observed during this step. 
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Scheme 23:  Marquez's Synthesis Towards LL-Z1640-2.  Reagents and Conditions: (a) TMS–
CH2N2, Et2O, 90%; (b) TBDMSCl, Et3N, CH2Cl2, 80%; (c) Tf2O, pyridine, 100%; (d) vinyltributyltin, 
Pd(PPh3)4, CH2Cl2, 100%; (e) NaOH, 1,4-dioxane, 96%. 
 
(L)-(+)-Diethyl tartrate 116 was used as the starting material for the synthesis of 
the C1'—C10' aliphatic unit (Scheme 24).  The tartrate was protected as the 
dimethyl ketal (→121) and then the diester reduced to the corresponding diol.  
Selective silylation provided TBS ether 122, which then underwent Swern 
oxidation to generate aldehyde 123.  Corey-Fuchs olefination gave alkyne 124, 
which was then alkynated with (S)-propylene oxide 32 under highly activated 
conditions.  This resulted in the formation of internal alkynol 125 as a single 
diastereoisomer, after which silylation gave the bis-TBS silyl ether 126.   
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Scheme 24:  Marquez's Synthesis Towards LL-Z1640-2.  Reagents and Conditions: (a) 2-
Methoxypropene, p-TsOH, CH2Cl2, 97%; (b) i) LiAlH4, THF; ii) NaH, TBDMSCl, THF, 89%; (c) 
Swern, 100%; (d) i) CBr4, PPh3, CH2Cl2; ii) nBuLi, Et2O, 79%; (e) (S)-propylene oxide, nBuLi, 
BF3·OEt2, THF, 76%; (f) TBDMSCl, Et3N, DMAP, CH2Cl2, 97%.   
 
The outstanding steps of the C1'—C10' unit started with the selective deprotection 
of the primary TBS silyl ether, which yielded the primary alcohol 127 (Scheme 
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25).  A one-pot oxidation-allylation progressed to give the homoallylic alcohol 
128 as a 1:1 mixture of diastereoisomers.  At this stage the authors did not 
attempt to control the stereochemistry of allylation as the aim was to access LL-
Z1640-2, as well as its C9' anomer for biological evaluation purposes.  The next 
step was to convert the alkyne unit into the Z-alkene that is present in LL-Z1640-
2.  Attempts at hydrogenation using a Pd/BaSO4 catalyst poisoned with 
quinoline, regrettably led to the over-reduced alkane 129. 
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Scheme 25:  Marquez's Synthesis Towards LL-Z1640-2.  Reagents and Conditions: (a) HF–Pyr, 
Pyridine/THF, 85%; (b) i) (COCl)2, DMSO, Et3N, CH2Cl2, –78 oC → rt; (ii) vinylmagnesium bromide, 
THF, 89%; (c) H2, Pd/BaSO4, quinoline, 99%. 
 
The observed over-reduction prompted an assessment of the synthetic route and 
as a consequence changes were made.  In the modified approach the bis-TBS 
ether 126 was selectively reduced to yield the Z-olefin 131 with complete 
stereocontrol (Scheme 26).  Primary TBS removal (→132), followed by a one-pot 
oxidation-allylation procedure provided the required C1'—C10' fragments 133 of 
LL-Z1640-2 and 9-epi- LL-Z1640-2. 
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Scheme 26:  Marquez's Synthesis Towards LL-Z1640-2.  Reagents and Conditions: (a) H2, 
Pd/BaSO4, quinoline, 100%; (b) HF–pyr/pyridine, 65% + SM; (c) i) (COCl)2, DMSO, Et3N, CH2Cl2, –
78 oC → rt, ii) vinylmagnesium bromide, THF, 96%. 
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In order to introduce the remaining units of the framework, the free alcohol 133 
was protected as the PMB ether and the secondary TBS silyl ether carefully 
removed to afford the secondary alcohol 135 (Scheme 27).  Reaction of alcohol 
135 with vinyl benzoic acid 110 generated the esters 136 and 137 cleanly in 
good yield.  This served to complete the entire frameworks of both LL-Z1640-2 
and 9-epi-LL-Z1640-2 respectively. 
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Scheme 27:  Marquez's Synthesis Towards LL-Z1640-2.  Reagents and conditions: (a) NaH, 
PMBCl, TBAI, THF, 100%; (b) HF–pyr/pyridine, 97%; (c) 110, DCC, 67%. 
 
The authors conclude that their two-directional chain functionalisation synthesis 
is fast, high-yielding and flexible, producing not only the complete framework of 
LL-Z1640-2 but also that of its C9- epimer, 9-epi-LL-Z1640-2.   
1.11.5 The Third Total Synthesis – Winssinger's Modular 
Approach  
In 2007, a third total synthesis of LL-Z1640-2 was published, whereby a modular 
approach was developed.[50]  The authors devised a retrosynthesis (Scheme 28) in 
which the enone would be introduced at a late stage to avoid isomerisation to 
the trans-isomer.   
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Scheme 28:  Winssinger's Retrosynthetic Disconnection of LL-Z1640-2.  Adapted from 
Reference 50. 
  
The cis-alkene would originate from a vinyl lithium addition onto an aldehyde.  
Three fragments, 138, 139 and 140, would be used to construct the main body 
of the structure, the order in which they could be coupled possible by means of 
any permutation.  Despite this the authors needed a starting point and so 
rationally presumed that coupling the two non-aromatic fragments, 138 and 
140, first would allow them to use a fluorinated protecting group for the 
alcohol, facilitating the use of fluorous isolation technology.  A distinct 
advantage of this technique is that multiple components can be tagged and 
taken through a synthesis as a mixture, with fluorous chromatography performed 
at the end to resolve the mixture. 
For the synthesis of the aromatic fragment 143 (Scheme 29), carboxylic acid 141 
was protected with a 2-(trimethylsilyl)ethyl group by esterification with 
2(trimethylsilyl)ethanol.  Selenide 143 was then formed by treatment of ester 
142 with LDA and then coupled with diphenyldiselenide. 
CH3O
H3CO
OH
O CH3O
H3CO
O
O CH3O
H3CO
O
O
SePh
TMSTMS
a b
141 142 143  
Scheme 29:  Winssinger's Synthesis of LL-Z1640-2.  Reagents and Conditions:  (a) Oxalyl 
chloride, DMF, CH2Cl2, 0 oC, 1 h, then 2-(trimethylsilyl)ethanol, Et3N, DMAP, rt, 1 h, 96-98%; (b) 
LDA, diphenyldiselenide, THF, –78 oC, 1 h, 89-91%. 
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Aldehyde 147 was obtained from the ketal-protected deoxyribose 144[51] by 
reduction with lithium aluminium hydride and the crude diol 145 selectively 
silylated on the less sterically hindered alcohol with a TBS protecting group 
(→146).  The remaining alcohol was oxidised using an immobilised version of 
IBX, giving aldehyde 147, which was used without work-up or purification 
(Scheme 30). 
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Scheme 30:  Winssinger's Synthesis of LL-Z1640-2.  Reagents and Conditions:  (a) LiAlH4, 
THF, 0 oC → rt, 2 h, 95%; (b) TBDPSCl, imidazole, DMF, 23 oC, 2 h, 66%; (c) PS-IBX, CH2Cl2, rt, 2 
h, 100%. 
 
The remaining fragment was synthesised beginning from (R)-2-hydroxypentane 
148 with fluorous PMB trichloroacetimidate 149 to afford 150 (Scheme 31).  
Cross-metathesis of alkene 150 with vinyl borolane 151, in the presence of 
Grubbs second generation catalyst, afforded the trans-product 152 in good 
selectivity (>20:1 E:Z).  The vinylborane could be transformed into the cis-vinyl 
bromide 153 through treatment with bromine and sodium methoxide. 
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Scheme 31:  Winssinger's Synthesis of LL-Z1640-2.  Reagents and Conditions:  (a) 149, CSA, 
CH2Cl2, rt, 12 h, 92%; (b) 150, Grubbs second generation catalyst, toluene, 80 oC, 12 h, 92%; (c) 
Br2 (1 M in CH2Cl2), Et2O, –20 oC, 10 min, then NaOMe (1 M in MeOH), –20 oC, 30 min, 89%; (d) 
tBuLi, THF/Et2O, –100 oC, 15 min, then 147, –100 oC, 15 min, 88%; (e) EOMCl, iPr2EtN, TBAI, 
DMF, rt, 12 h, 96%; (f) TBAF, THF, rt, 12 h, 92%; (g) PPh3, I2, imidazole, THF, 0 oC, 1 h, 91%; (h) 
143, LDA, THF/HMPA (10:1), –78 oC, 20 min, 88-91%; (i) H2O2, THF, rt, 2 h, 79-82%; (j) DDQ, 
CH2Cl2/H2O (2:1), rt, 2 h, 70-80%; (k) TBAF, THF, rt, 2 h, 87%. 
 
Transmetallation of the bromide with tBuLi and addition onto the crude 
aldehyde 155 afforded alcohol 154, which was protected as the EOM ether to 
yield 155 as a mixture of diastereoisomers (3:1).  Conversion of the silyl-
protected hydroxyl group into the iodide proceeded smoothly to afford 156, 
which was then alkylated with the aromatic fragment 143.  The resulting 
selenide was oxidised and eliminated to afford 157.  The crude reaction mixture 
was loaded onto a fluorous-silica column to remove the non-fluorous tagged 
components from the desired compound.  The seco-acid 158 was obtained after 
the sequential removal of the PMB and TMSE ester protecting groups. 
The final steps of the synthesis incorporate the key macrolactonisation which 
was accomplished through a Mitsunobu reaction using fluorous-tagged triphenyl 
phosphine and diazodicarboxylate (Scheme 32).  The desired compound 159 was 
gained after a fluorous solid-phase extraction.  The usage of boron trichloride 
enabled the simultaneous deprotection of the EOM and acetonide groups as well 
as the cleavage of the ortho-phenol.  The formed allylic alcohol 95 was 
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selectively oxidised with a polymer-bound IBX to afford LL-Z1640-2 15 after 
filtration. 
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Scheme 32:  Winssinger's Completion of the Synthesis of LL-Z1640-2.  Reagents and 
Conditions:  (a) RFPh3P, RFDEAD, toluene (10 mM), rt, 2 h, 81%; (b) BCl3, CH2Cl2, 0 oC, 15 min, 
86%; (c) PS-IBX, CH2Cl2, rt, 1 h, >90%.  
 
This synthesis is concise and advantageous in its use of fluoro chemistry and 
polymer-bound reagents, enabling the process to be suitable for high-throughout 
synthesis. 
1.12 Inflammation 
Inflammation is the body's immediate response to damage to its tissues and cells 
by pathogens (infection), noxious stimuli (chemicals) or physical injury.  It is 
characterised by redness, swelling, heat and pain in a tissue.[52]   
There are two classifications of inflammation:  acute and chronic.  Acute 
inflammation is a short-term response, resulting in healing.  Leukocytes 
penetrate the damaged region, repairing the tissue.  Chronic inflammation is a 
prolonged response that involves active inflammation, tissue destruction and 
attempts at tissue repair.  The persistency is associated with many chronic 
human conditions, including allergy, cancer, arthritis and autoimmune 
diseases,[52] some of which can be treated with non-steroidal anti-inflammatory 
drugs (NSAIDs).[53] 
In response to damage of body tissues, mast cells release histamine.  Although 
there are other substances involved in the inflammatory response, histamine is 
thought to be responsible for most of the effects.  Histamine acts to increase 
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blood flow to damaged tissues, causing the heat and redness.  It also makes the 
blood capillaries more 'leaky', resulting in fluid oozing out of them and into the 
tissues, causing localised swelling.  The pain associated with inflammation is 
attributed to the stimulation of nerve endings by inflammatory chemicals.   
1.13 Inflammatory Disorders  
1.13.1 Rheumatoid Arthritis 
Rheumatoid arthritis is a non-specific autoimmune disorder, where the immune 
system acts against and damages joints and surrounding soft tissues.  The 
reasons why these autoimmune disorders develop are unclear, but genetic 
factors may play a role.  An autoimmune disorder may primarily affect a specific 
organ or cell type, or may affect various organs.  In the case of arthritis, it is the 
inflammation of a joint, characterised by pain, swelling and stiffness.  The 
arthritis may involve one joint or many and can vary in severity from a mild ache 
and stiffness to severe pain and joint deformity.  Rheumatoid arthritis is the 
most severe type of inflammatory joint disease and as shown in Figure 13, the 
joints most commonly affected are those in the hands, wrists, feet and arms, 
which become extremely stiff, painful and deformed. 
 
Figure 13:  Common Target Sites for Rheumatoid Arthritis.[54] 
 
The symptoms occur most commonly in women but can also arise in younger 
people.  Overall, women are affected two to three times more than men.  The 
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onset of the disease is gradual, with mild fever and aches and pains preceding 
specific joint symptoms, though in some, joint inflammation can develop 
suddenly.  As well as the joint being affected, the structures around the joint 
may also become inflamed, resulting in weakness of the tendons, ligaments and 
surrounding muscles.  The finger joints are the most commonly affected, 
resulting in a weak grip.[55]   
With respect to the pathogenesis of rheumatoid arthritis,[56] monocytes are 
attracted to the affected joint, where they differentiate into macrophages and 
become activated.  In addition to interleukin-1 (IL-1), they also secrete tumour-
necrosis factor (TNF), which increases the expression of adhesion molecules on 
endothelial cells, which recruit more cells to the joint.  IL-1 and TNF induce 
synovial fibroblasts to express cytokines, chemokines and growth factors, which 
contribute to cartilage and bone destruction (Figure 14). 
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Figure 14:  Overview of the Pathogenesis of Rheumatoid Arthritis.[56]  Reproduced with 
permission. 
 
1.13.2 Osteoarthritis 
Osteoarthritis (OA) is a form of arthritis also known as degenerative arthritis and 
is the most common type, resulting from general mechanical stress and ‘wear 
and tear’ on the joints.  It is thought that metabolic and genetic factors may 
also contribute.  It is characterised by degeneration and degradation of the 
cartilage that lines joints which leads to joint space narrowing (JSN), painful 
joint disruption and loss of function or by formation of osteophytes (bony 
outgrowths), which lead to pain and stiffness of the affected joint.[55,57]  It 
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generally evolves in middle age, but it most prevalently troubles the older 
generation, affecting three times as many women as men.  Injury to a joint in 
earlier life can attribute to the development of osteoarthritis.  Osteoarthritis 
causes pain, swelling, creaking and stiffness of one or more joints, the hands, 
hips, knees and spine being most commonly affected as shown in Figure 15. 
 
Figure 15:  Common target sites for Osteoarthritis.[58] 
 
OA involves the entire joint organ, including the subchondral bone, menisci, 
ligaments, muscle, capsule and synovium.  If pain prevents the joint from being 
used regularly, weakness and shrinkage of the muscles surrounding the joint 
results.  The affected joints become enlarged and distorted by osteophytes, 
which are responsible for the characteristic gnarled appearance of hands 
affected by osteoarthritis.   In the United Kingdom, there are an estimated 8.5 
million people affected by OA.[59]  In the United States there are an estimated 
20-40 million people affected; with over 250,000 knee replacements and over 
150,000 hip replacements carried out annually.[57]  Due to improvements in MRI 
imaging, there is an increased understanding of the other tissues in the 
pathophysiology of OA (Figure 16).   
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Figure 16:  Molecular Pathogenesis of Osteoarthritis.  A Schematic representation of key 
pathological events and some of the potential targets considered for disease modification.[57]  
Reproduced with permission. 
 
Traditionally thought of as a non-inflammatory disease, Dr. Abramson and 
colleagues at NYU Medical Centre in the United States have reported that "OA 
cartilage produces inflammatory mediators such as nitric oxide, prostaglandin E2 
and other pro-inflammatory cytokines locally which leads to joint 
deterioration."[57]  There is a general belief that interleukin-1 (IL-1) plays a 
central role in the pathogenesis, with data being retrieved from animal 
susceptibility models, models of IL-1-targeted therapy, genetic association 
studies and elevated IL-1 gene expression in whole blood from patients with 
multi-joint osteoarthritis. 
1.13.3 Crohn's disease 
Inflammatory bowel disease is a general term for chronic inflammatory disorders 
affecting the small and/or large intestine.  Crohn's disease most commonly 
affects those in adolescence and early adulthood and arises due to specific 
conditions – inflammation affecting any part of the gastrointestinal tract from 
the mouth to the anus, causing pain, fever, diarrhoea and loss of weight.  The 
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site of inflammation is most commonly the terminal ileum, which becomes thick 
due to continued chronic inflammation and deep, penetrating ulcers may form.  
The disease tends to be irregular; areas of the intestine that lie between 
diseased areas may appear normal but in fact could be mildly affected.  The 
cause is unknown, but it may arise from an abnormal allergic reaction or 
response to a viral or bacterial agent.  The diagnosis can be determined firstly 
by displayed symptoms of spasmic pain in the abdomen, diarrhoea and sickness, 
followed by a physical examination which could reveal tender abdominal 
swellings.  The disease is chronic and the symptoms fluctuate over years, in 
some cases eventually subsiding.  Many other patients require surgery, whilst 
some remain in normal health with the disease being localised. 
1.13.4 Cancer and Inflammation 
The recognised connection between the development of cancer and 
inflammation has long been known.[60,61]  Long-term inflammation leads to the 
development of dysplasia, an abnormal alteration in a tissue owing to 
abnormality in the function of the component cells, leading to cancer.  
Epidemiological studies estimate that nearly 15% of worldwide cancer cases can 
be related to microbial infections.[62,63]  Further evidence has come from the use 
of NSAIDs in the prevention of spontaneous tumour formation in people with 
familial adenomatous polyposis (FAP), an autosomal dominant genetic 
disorder.[64] 
The formation of reactive oxygen and nitrogen species can occur at the site of 
inflammation. These species have the potential to damage DNA, proteins and 
cell membranes, favouring carcinogenesis.  It is also known that chronic 
inflammation often results in repeated cycles of damage and compensating cell 
proliferation.  As a consequence, the number of cells that are dividing increases 
and therefore there are more cells that are available for DNA damage, 
promoting the growth of malignant cells.[65]  In the article, Why Cancer and 
Inflammation?[66] it is suggested that cancer and inflammation are related by 
epidemiology, histopathology, inflammatory profiles and the efficacy of anti-
inflammatory drugs in prophylaxis.  The association is non-trivial and therefore 
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cannot be reduced to one theory, but lines of evidence show that the 
inflammatory system positively affects tumour development and growth. 
1.14 Tumour Necrosis Factor-alpha (TNF-α) and 
Alzheimer's Disease 
In the brains of those patients with Alzheimer's disease, neuroinflammation with 
over-expression of cytokines is a standard characteristic. Tumour necrosis 
factor-alpha (TNF-alpha or TNF-α) is a proinflammatory cytokine and numerous 
studies have proven it be involved in the pathogenesis of the disease.[67]  Over 
recent years it has become known that excess TNF-alpha plays a pivotal role in 
Alzheimer's disease.[68]  Etanercept, a potent anti-TNF therapeutic, was firstly 
used to treat rheumatoid arthritis, acting by binding to TNF-alpha and blocking 
its interaction with cell surface TNF-alpha receptors.  The result is that the 
effects that excess TNF-alpha exerts are reduced.  The drug has duly been used 
to treat other inflammatory disorders in which TNF-alpha takes part. 
In 2006, in a pilot study, it was reported that treatment with Etanercept was 
effective in the treatment of mild to severe Alzheimer's.[69]  These findings 
encouraged further studies and new, exceptional conclusions were reported in 
2008.[68]  In the study by Tobinick and Gross in 2006,[69] there was noticeable 
clinical improvement in Alzheimer's disease patients within minutes of 
administration of the drug.  It is important to note that a novel method of 
administration was used called perispinal extrathecal into the posterior neck.  
This serves to improve delivery of the drug to the brain via the cerebrospinal 
venous system.  
In the most recently published study,[68] Tobinick and Gross were able to take an 
individual patient with late onset Alzheimer's disease and use cognitive tests to 
evaluate the rapid effect after treatment.  The most obvious sign of an 
improvement came when observing the results of the Montreal cognitive 
assessment.  One day before treatment the patient was unable to complete 
parts of the test; becoming agitated and overwhelmed by his inability to do so.  
His score was seven out of a possible thirty.  Two hours after administration, his 
score increased to fifteen out of thirty and he was able to answer questions with 
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less frustration and perform simple calculations.  Seven weeks and fourteen days 
after receiving his last dose of perispinal Etanercept, his score was fourteen, 
with noticeable improvement in the tasks (Figure 17).   
 
Figure 17:  Tobinick and Gross' Most Definitive Study Results.  The Montreal Congnitive 
Assessment shows rapid and sustained improvement in Visuospatial/Executive function following 
perispinal etabercept administration.  Reproduced from Reference 68 with permission from the 
original publisher (BioMed Central). 
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Tobinick and Gross conclude that TNF-alpha is of critical importance in the 
regulation of synaptic transmission in the brain.  They attribute this to the 
extreme rapidity of the effect and the potency and selectivity of Etanercept as 
an anti-TNF-alpha agent.  Synaptic dysfunction is important in the pathogenesis 
of Alzheimer's disease and TNF-alpha mediates this and the associated cognitive 
and behavioural impairment.  By using Etanercept they can rapidly neutralise 
the excess TNF-alpha and bring it to normal physiological levels, thereby 
alleviating the cognitive difficulties in patients by allowing normal cross-talk 
between regions of the brain.  Clearly this is an intensely significant 
breakthrough in the study of Alzheimer's disease and the results presented can 
be utilised to set up further studies. 
It has been shown that LL-Z1640-2 has significant activity versus TNF-alpha 
production in cells, with an IC50 of 6 nM.
[70]  This leads to the hypothesis that LL-
Z1640-2 could be an antagonist and as such, a possible drug lead for the 
treatment of Alzheimer's disease.  If it can indeed reduce the levels of TNF-
alpha in cells, then this is analogous to the mode of action of Etanercept, proven 
to be successful in improving the cognitive function in patients with Alzheimer's 
disease. 
1.15 Targeting TAK1  
One of the major roles of TAK1 is to mediate some of the intracellular actions of 
proinflammatory cytokines.  When it becomes activated, TAK1 is believed to 
switch on several protein-kinase cascades, including those that activate stress-
activated protein kinase 2a, which is also called p38α, but is more often 
abbreviated to SAPK2a/p38α. 
At the head of three proinflammatory kinase cascades lie TAK1 and its 
associated regulatory subunits TAB1 and TAB2 and the structurally related 
TAB3.[71,72]  In 2003, Cohen and colleagues showed that SAPK2a/p38α exerted 
feedback control on TAK1 via TAB1.[72]  They also discovered that the down 
regulation of TAK1 by SAPK2a/p38α was not just a feedback control device for 
limiting the activation of SAPK2a/p38α, but could also limit the activation of IKK 
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and JNK.  This would synchronise three signalling pathways that play key roles in 
the inflammatory response. 
 
Figure 18:  A representation of the feedback control of TAK1 activity by SAPK2a/p38α, 
highlighting how it implicates the regulation of JNK and NF-κB.[71]  Reproduced with 
permission. 
 
Figure 18A, shows how SAPK2a/p38α downregulates TAK1, via the 
phosphorylation of TAB1.  In Figure 18B, SAPK2a/p38α is inhibited by SB203580, 
which stops the feedback control of TAK1.  This causes the upregulation of the 
JNK and IKK pathways.  These findings and those in associated publications, has 
led to the belief that the downregulation of TAK1 by SAPK2a/p38α may be a 
critical factor for the development of anti-inflammatory drugs.  Presently, there 
are compounds that are more potent than SB 203580, which are undergoing 
clinical trials for the treatment of rheumatoid arthritis and other chronic 
inflammatory diseases.[50,73,74]  Ultimately, it is reasonable to suggest that the 
inhibition of TAK1 activity may be effective in preventing inflammation and 
tissue destruction endorsed by proinflammatory cytokines. 
1.16 Retrosynthetic Analysis 
For this approach towards the total synthesis of LL-Z1640-2, it was important to 
utilise and build upon findings obtained through previous work carried out by 
past members of the Marquez research group.[49]  The retrosynthetic analysis is 
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shown in Scheme 33, highlighting the key disconnections.  A distinct advantage is 
that the synthesis begins from readily available starting materials, which are 
easily handled and manipulated to form the key fragments required for the 
coupling reactions.   
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Scheme 33:  Initial Retrosynthetic Analysis. 
 
An efficient approach was envisaged that would afford the final product 15 from 
the macrolactonisation of seco-acid 160.  No issues were forseen with this type 
of lactonisation, despite it serving to form a large-ring macrocycle.  The 
precedent in the literature for this has already been demonstrated and discussed 
previously in this introduction.[36,41,50]  Seco-acid 160 could result from a series 
of transformations from alkyne 161.  Alkyne 161 is obtained through the 
addition of alkyne 164 to terminal alcohol 162, itself a product of a Wittig 
olefination between aromatic fragment 163 and sugar moiety 144.  It is hoped 
that this choice of reaction would enable to key trans-alkene to be formed in 
high selectivity. 
The aromatic fragment 163 could be synthesised from the readily available 
starting material, methyl 3-oxobutanoate, in five steps, while the sugar moiety 
144 could also be easily prepared in one protection step from 2-deoxy-D-ribose.  
The alkyne unit 164 is available from S-(+)-propylene oxide 32, with the added 
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advantage that the second protection step is carried out on the crude material, 
so discarding the need for any purification on a highly volatile material. 
The proposed route is robust and allows flexibility in the choice of orthogonal 
protecting group on fragments 163 and 164.  Following the Wittig olefination 
and introduction of the alkyne unit, the target compound 15 should be 
accessible in seven steps. 
65 
 
2 Results and Discussion 
2.1 General Information  
For the purposes of the following results and discussion section, the carbon 
atoms in the structure of the final product have been assigned accordingly.  This 
enables the reader to interpret and distinguish between the correct fragments 
and specific parts of the molecule being discussed.  The assignment is 
documented in Figure 19 below. 
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Figure 19:  Structural Assignment of LL-Z1640-2. 
 
2.2 Synthesis of the Aromatic Fragment 
2.2.1 Retrosynthetic Analysis of (3-Acetoxy-5-methoxy-2-
methoxycarbonylbenzyl)-triphenylphosphonium bromide, 165  
The proposed retrosynthetic analysis of (3-acetoxy-5-methoxy-2-
methoxycarbonylbenzyl)-triphenylphosphonium bromide 165 is shown in Scheme 
34.  The salt was thought of as originating from the bromide 166, which in turn 
could originate from the methoxy unit 167.  Methoxy unit 167 is a result of 
acetate protection of phenol 168, itself a product of selective capping of the 
para-hydroxyl of diol 169 with a methyl group.  The diol could be prepared from 
the cyclisation and aromatisation of methyl acetoacetonate 170. 
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Scheme 34:  Retrosynthetic Analysis of the Aromatic Fragment 
 
Thus, the key step in this synthetic strategy is the first reaction, whereby methyl 
acetoacetonate is used to produce the aromatic product.  The next four steps 
after aromatisation were thought to be straightforward and no potential pitfalls 
were envisioned.  
2.2.2 Synthesis of Methyl 2-acetoxy-6-bromomethyl-4-
methoxybenzoate, 166 
The synthesis of the aromatic fragment 166 began with methyl acetoacetonate 
170, which was efficiently converted into the aromatic unit 169 using 
established conditions.[49b]  This reaction proceeded well and resulted in high 
yields. 
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Scheme 35:  Synthesis of the Aromatic Fragment 166.  Reagents and Conditions:  (a) NaH, 
nBuLi, THF, –78 oC → rt–reflux, 16 h, 65%; (b) TMS diazomethane, CHCl3:MeOH, 0 oC, 3 h then rt, 
16 h, 89%; (c) Ac2O, pyridine, DMAP, Et3N, CH2Cl2, 0 oC → rt, 2 h, 97%; (d) 1,3-dibromo-5,5-
dimethylhydantoin, benzoylperoxide, CCl4, reflux, 3.5 h, 95%. 
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The mechanism for this first transformation is worth discussing due to its 
relative complexity (Scheme 36).  Deprotonation of β-ketoester A gives enolate 
B, which can attack the ketone of a second β-ketoester unit.  Treatment of 
intermediate anion C with n-butyllithium removes the acidic hydrogen α to the 
ketone to give D.  Β-elimination of the hydroxyl group of E then gives the 
condensation product F.  Deprotonation then generates enolate G, which upon 
attack onto the adjacent ester gives cyclic hemiacetal intermediate H, which 
then collapses into the tricarbonyl unit I.  Compound J is formed by 
tautomerisation of the 1,3-dione I.     
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Scheme 36:  Mechanism by which Methyl 2,4-dihydroxy-6-methylbenzoate (169) is Formed. 
 
Selective methylation of 169 was achieved in 89% yield with TMS diazomethane 
in a mixture of chloroform and methanol.[49b]  The mechanism is thought to 
proceed as shown in Scheme 37.  TMS diazomethane 171 deprotonates the 
alcohol para to the ester functionality (presumably due to less steric hindrance 
and lack of H-bonding) and methanol attacks the δ+ silicon.  Hydrogen transfers 
from oxygen to diazomethane as silicon leaves.  The phenolic anion then attacks 
the CH3 group, giving product 168 and releasing nitrogen. 
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Scheme 37:  Mechanism of TMS-diazomethane Mediated Methylation. 
 
Protection of the remaining phenol proceeded under standard acetylation 
conditions to afford the fully protected aryl unit 167 in 97% yield.  The final step 
was bromination of the methyl group, which proceeded using 1,3-dibromo-5,5-
dimethylhydantoin to afford 166 in 95% yield.[49b] 
The proposed mechanism is shown in Scheme 38 and the first step is the 
homolytic cleavage of the radical initiator, benzoyl peroxide 172, to give two 
radical units 173.  Radical 173 reacts with aryl unit 167 to generate radical 
174.  This goes on to react with 1,3-dibromo-5,5-dimethylhydantoin 175 to give 
desired product 166 and new radical 176, which can go on to react with a 
second molecule of 167 to form radical 174 and 177.   These react together to 
generate product 166 and new radical 178.  
 
Suzannah J. Harnor, 2010  69 
H3CO
O
OCH3
O
O
H3CO
O
OCH3
O
O
Br
H
H
H
H3CO
O
OCH3
O
O
H
H167 174
O
O
O
O
O
O
x2
O
O NN
O
BrBr
O
166
NN
O
Br
O
NN
O
Br
O
H3CO
O
OCH3
O
O
H
H
H
167
H3CO
O
OCH3
O
H
H174
NHN
O
Br
O
176
176
H3CO
O
OCH3
O
O
Br
166
NHN
O
O
178
175
172 173
173
177
 
Scheme 38:  Radical Bromination of 167. 
  
2.3 Synthesis of the Sugar Fragment  
The synthesis of the carbohydrate unit 144 was previously established[75] and 
began with 2-deoxy-D-ribose 179, which initially was ketal protected (Scheme 
39) using Horton's conditions.[51]  However, their high yields were not 
reproducible, although the ratio of α- and β-anomers matched those reported.  
In Horton's procedure, dimethylformamide is used as the solvent due to the poor 
solubility of 2-deoxy-D-ribose.  This suffices to an extent for those reactions on a 
smaller scale, but as this is one of the initial steps in a total synthesis, the 
reaction calls to be carried out a large scale.  Evidently, using vast volumes of 
DMF is prohibitive, both in terms of its toxicity but also due to the difficulty in 
removing it from the final product.  In due course, it was discovered that 
switching to ethyl acetate as the solvent for the reaction, greatly improved the 
yields.  In addition, ethyl acetate is readily removed under vacuum, 
circumventing any unnecessary decomposition of product.  The protection yield 
was significantly improved when a catalytic amount of pyridinium p-
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toluenesulfonate (PPTS) was used and ethyl acetate was employed as the 
solvent.[75,76]  After purification, the desired ketal protected product 144 was 
isolated in 62% yield. 
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Scheme 39:  Ketal Protection of 2-deoxy-D-ribose.  Reagents and Conditions:  (a) 2-
Methoxypropene, PPTS, EtOAc, –10 oC, 2.5 h then rt, 16 h, 62%. 
 
2.4 Coupling of the Aromatic and Sugar Fragments 
The C1'—C2' olefin present in the target compound possesses the E-configuration 
and whilst there are many ways by which olefins can be formed it is essential in 
this case that the chosen reaction generates an olefin with high E-selectivity. 
2.4.1 Controlling the Geometry of Olefins 
Geometrical isomers of alkenes are different compounds and they often have 
very different biological, chemical and physical properties.  Experimentally they 
pose problems as they can be very difficult to separate by chromatography or 
distillation and as a consequence chemists have discovered and developed 
methods to make olefins as single isomers. 
There are elimination reactions that can be employed to give single geometrical 
isomers as the product and they fall into four main classes: 
 1.  Only one geometrical isomer is possible, for example, in a six-
 membered ring only a cis-double bond can exist. 
 2.  The geometrical isomers are in equilibrium and the more stable 
 E-alkene is formed. 
 3.   The reaction is stereoselective and the E-alkene is formed as the 
 main product by kinetic controls. 
 4.  The reaction is stereospecific and the alkene geometry depends 
 on the  stereochemistry of the starting materials and the 
 mechanism of the reaction. 
 
Most common are reactions that fall into class 3 in the above list.  
Predominantly E-alkenes can be formed by stereoselective elimination reactions.  
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E1 elimination reactions give mainly the E-alkene as the transition state is lower 
in energy than that leading to the Z-alkene.  An example is the treatment of 2-
pentyl bromide with base (Scheme 40), which leads to three times as much E-
alkene as Z-alkene, due to the lower energy of the transition state.   
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Scheme 40:  Stereoselective Formation of E-Alkenes.  Adapted from Reference 119. 
 
2.4.2 Wittig Olefination 
The Wittig reaction is arguably the most important and effective reaction used 
to generate E- and Z-alkenes.[77,78]  The formation of the olefin comes from the 
reaction of aldehydes (fast) and ketones (slow) with the ylide generated from a 
phosphonium salt (Scheme 41). 
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Scheme 41:  General Scheme for the Wittig Olefination 
 
The phosphorus ylide is prepared from a triaryl- or trialkylphosphine and a 
primary or secondary alkyl halide, followed by deprotonation with a suitable 
base.  Depending on the nature of the R substituents, there are three different 
types of ylide: 
Type 1 – "Stabilised" – The alkyl halide has at least one strong electron 
withdrawing group 
Type 2 – "Semi-stabilised" – Have at least one aryl or alkenyl substituents as 
the R groups 
Type 3 – "Unstabilised" – Have only alkyl substituents. 
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The overall geometry of the olefin is dependent on the reactivity of the ylide.  
"Stablilised" ylides give rise to predominantly E-alkenes with aldehydes and are 
not as reactive as "unstabilised" ylides, which give rise mainly to Z-alkenes.  
"Semi-stabilised" ylides generate alkenes with intermediate selectivity. 
Mechanistically, the addition of the ylide B to the carbonyl A is thought to lead 
to a zwitterionic intermediate betaine D, which closes to the four-membered 
cyclic oxaphosphetane E.  If the betaine possesses the cis-configuration the 
reaction from the reactive ylide to the cis-oxaphosphetane, then the major Z-
alkene F is fast.  The reaction to the trans-betaine is slower, but the collapse is 
fast to form the minor E-alkene. 
O
R1 H
PPh3
R2H
PPh3
O
R2
H
H
R1
PPh3
R2
H
OR1
H
PPh3
R2
H
OR1
H
R2 H
HR1
Sy n Z-alkene
A B D E FC
 
Scheme 42:  General Mechanism for the Wittig Reaction. 
 
Improvements have been established to enable better selectivity of the Wittig 
reaction.  In the Schlosser modification of Wittig,[79,80] E-alkenes are made in a 
one-pot synthesis from "unstabilised" ylides and carbonyl compounds.   
Mechanistically (Scheme 43), the addition of the ylide A to the carbonyl 
compound B, at —78 oC, leads to the formation of the cyclic cis-oxaphosphetane 
C.  Cis-oxaphosphetane C is deprotonated with alkyl/aryl lithium to give the cis-
lithiobetaine D.  Treatment of D with phenyllithium generates the cis-β-oxido P-
ylide E, which equilibrates to the trans-β-oxido P-ylide F, which is more 
thermodynamically stable.  The trans-ylide F is then treated with an H+ donor to 
give the pure trans-lithiobetaine G and then with tBuOK to generate the trans-
oxaphosphetane I via the trans-betaine H.  This trans-oxaphosphetane I then 
collapses to the desired E-alkene J. 
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Scheme 43:  Mechanism of the Schlosser Modification of Wittig. 
 
When it came to the coupling of the aromatic fragment and the sugar derivative, 
the choice of method was considered carefully.  It was decided that a Wittig 
olefination using a stabilised ylide would yield the desired double bond 
geometry.  The corresponding Wittig salt 165 was generated in one step from 
the bromide 166 (Scheme 44). 
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Scheme 44:  Generation of the Wittig Salt 165.  Reagents and Conditions:  PPh3, toluene, reflux, 
24 h, 65%. 
 
Triphenylphosphonium salt 165 is a stabilised ylide due to the negative charge 
being stabilised by further conjugation and by the phosphorus atom.  This 
stabilised ylide is not very reactive and as a consequence the reaction progresses 
slowly, via the trans-oxaphosphetane, to generate the E-alkene.  Stabilised 
ylides have been shown to react with lactols efficiently and the concept of 
carrying out Wittig chemistry on lactols is well known.  Wittig approaches and 
reactions of stabilised ylides with lactols have been commonly used to form C-
glycosides[81] and to synthesise lactones[82] and 2-substituted tetrahydrofurans.[83]  
The protected sugar 144 has masked aldehyde character of C1, which is 
exploited under Wittig conditions (Scheme 45).   
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Scheme 45:  Mechanism of Formation of 184. 
 
Reaction of ylide 165 and lactol 144 afforded the desired alkene 184.  However, 
the selectivity was disappointing and as determined by 1H NMR spectroscopy the 
E:Z-ratio was 3:2, matching preliminary results obtained within the group.[49b]  
Unfortunately, the isomers were inseparable and in addition, it was discovered 
that approximately 10% of a deacetylated side-product 185, was also present in 
the inseparable mixture.  The instability of the acetate group to the reaction 
conditions meant that our choice of protection group had to be modified.  In an 
alternative approach, the Wittig olefination reaction was repeated, but on this 
occasion sodium methoxide was added directly to the reaction mixture in order 
to ensure complete cleavage of the acetate protecting group.  The overall yield 
over the 2 steps was determined as 40%.  With diol 185 in hand, the primary 
hydroxyl was protected selectively as its silyl ether 186 in 65% yield.  This then 
enabled the protection of the remaining aryl hydroxyl as the PMB ether 187 in 
excellent 90% yield using standard conditions (Scheme 46). 
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Scheme 46:  Wittig Olefination of 165 and 144.  Reagents and Conditions:  (a) NaH, THF:DMF, 
80 oC, 30 min; (b) NaOMe, rt, 15 min, 40%; (c) TBDMSCl, imidazole, DMF, rt, 3 h, 65%; (d) PMBCl, 
TBAI, K2CO3, DMF, 80 oC, 18 h, 90%. 
 
2.4.3 Horner-Wadsworth-Emmons Olefination 
The Horner-Wadsworth-Emmons olefination[84] is another reaction that can be 
used to generate alkenes with excellent E-selectivity.  In general terms, it is the 
reaction between an aldehyde or ketone and a phosphonate ester (Scheme 47).  
It is important to note that the reaction does not proceed in the case of β-
hydroxy phosphonates as no elimination takes place. 
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Scheme 47:  General Reaction Scheme for the Horner-Wadsworth-Emmons Olefination. 
 
The first step of the mechanism shown in Equation [1], Scheme 48, is the 
formation of the phosphonate carbanion from the phosphonate ester.  The base 
can be nBuLi, NaH or NaOMe for example, which deprotonates the acidic 
hydrogen first, to then allow the addition of the aldehyde or ketone.  The 
addition of the carbanion to the carbonyl can occur syn- or anti-periplanar, to 
form either the trans- (Equation [2]) or cis-oxaphosphetane (Equation [3]) 
intermediate.  The formation of the trans-oxaphosphetane is favoured as the 
bulky substituents are kept as far apart as possible on opposite sides of the ring.  
Elimination gives the E-alkene and is faster than elimination to the Z-alkene by 
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way of the steric crowding in the syn-transition state.  Equilibration of the two 
oxaphosphetane diasteroisomers as a result of the starting material replenishing 
the supply of anti-diasteroisomer, causing the E-alkene to be formed almost 
exclusively.  The E-selectivity is further maximised by increasing the size of the 
alkyl group of the phosphonate.[85] 
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Scheme 48:  General Mechansim for the Horner-Wadsworth-Emmons Olefination. 
 
In an attempt to improve the E-selectivity of the reaction a Horner-Wadsworth-
Emmons olefination was carried out.  This first required the generation of the 
phosphonate ester, which would then be coupled with lactol 144.   
The phosphonate ester was obtained via an Arbuzov (or Michaelis-Arbuzov) 
reaction,[86] whereby the bromide 166 was treated with triethyl phosphite under 
microwave irradiation conditions to obtain phosphonate ester 189 in 58% yield.  
The choice to use microwave chemistry was advantageous in this case as it 
reduced not only the reaction time, but also reduced the safety risk associated 
with heating a reaction to elevated temperature for a prolonged period. 
Mechanistically, nucleophilic attack (SN2) by the phosphorus on the alkyl halide 
of 166 is followed by dealkylation of the trialkoxyphosphonium salt 188 to 
generate phosphonate ester 189 (Scheme 49).   
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Scheme 49:  Mechanism of Formation of 189 via the Arbuzov Reaction. 
 
2.4.4 Microwave Reactions 
Microwave chemistry originated in the 1950s, but only gained prominence in 
1986.[87]  Microwave methodology is the application of microwave irradiation to a 
reaction.  It has become increasingly popular due to benefits such as reaction 
rate acceleration, shorter reaction times, milder reaction conditions and higher 
yields, as well as operational simplicity and lower energy usage.   
Microwaves act as high frequency electric fields and usually will heat polar 
molecules in a solvent or conducting ions in a solid.  With conventional heating 
the walls of the reactor heat quickly, but the core takes a prolonged time to 
achieve the target temperature.  Microwave heating directly targets the 
compounds in the mixture throughout their volume, enabling the advantages 
mentioned above.  The modern microwaves, manufactured by companies such as 
Biotage, are powerful but safe and easy to use, indeed some are even 
automated.  The temperature range is typically 40 to 250 oC, with a pressure 
range of 0-20 bar.  Different vial sizes are available enabling the user to begin 
with milligrams and scale up to grams if necessary.  
With the phosphonate ester 189 in hand, the Horner-Wadsworth-Emmons 
reaction was attempted under conditions published by Schauer and Helquist.[88]  
Helquist's reaction conditions have the advantage of being mild and require a 
tertiary amine base in the presence of a Lewis acid, instead of the strong bases 
originally used.  Helquist's work revealed that zinc(II) triflate is an effective 
promoter of mild Horner-Wadsworth-Emmon reactions with diprotic substances. 
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Scheme 50:  Horner-Wadsworth-Emmons of Phosphonate Ester 189 and Lactol 144.  
Reagents and Conditions:  Zn(OTf)2, DBU, TMEDA, THF, rt, 18 h. 
 
Unfortunately, the HWE coupling under Helquist's optimised conditions gave 
mixed results.  The 1H NMR spectrum showed that 184 was present as a mixture 
of inseparable E- and Z-isomers in low yield, together with the deacetylated 
product 185.  This disappointing result prompted us to pursue the initial Wittig 
olefination approach.  This provided us with a way to carry material forward in 
an attempt to progress with the total synthesis.  The differentially protected 
diol 187 gave us an excellent starting point from which to incorporate the entire 
carbon framework of LL-Z1640-2.  
2.5 Synthesis of the Alkyne Fragment 
2.5.1 Retrosynthetic Analysis of (S)-(-)-tert-butyldimethyl(pent-4-
yn-2-yloxy)silane, 55 
From our original retrosynthesis of LL-Z1640-2, we had realised the importance 
that the alkyne unit to be coupled to the aldehyde had the correct 
stereochemistry already in place.  Literature precedent indicated that this 
would be easily achievable through a straightforward approach (Scheme 51).[89]   
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Scheme 51:  Retrosynthetic Analysis of the Alkyne Fragment 164.  PG equals a suitable 
protecting group. 
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2.5.2 Synthesis of (S)-(-)-tert-butyldimethyl(pent-4-yn-2-
yloxy)silane, 55 
(S)-(+)-Propylene oxide is commercially available, but extremely hazardous and 
particular care is needed when handling this compound.  (S)-(+)-Propylene oxide 
32 can be synthesised from ethyl (S)-lactate 191, according to Golding's 
procedure (Scheme 52).[90]  We chose not to do this, as we were mindful of the 
safety aspects in producing such a compound.  
OH
EtO2C H
CH3
OH
H
CH3HO
OAc
H
CH3Br
O
CH3
H
a cb
191 192 193 32  
Scheme 52:  Golding's Synthesis of (S)-(+)-Propylene oxide.[90]  Reagent and Conditions:  (a) 
LiAlH4; (b) 33% HBr in AcOH; (c) C5H11ONa, C5H11OH. 
 
Commercially sourced (S)-propylene oxide 32 was added to a stirred suspension 
of lithium acetylide ethylenediamine complex to afford the crude alcohol 190 in 
quantitative yield.  In order to maintain our orthogonal protecting group 
strategy, the free alcohol was protected as its TBS silyl ether to generate the 
desired optically pure alkyne fragment 55 in 78% yield. 
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Scheme 53:  Synthesis of the Alkyne Fragment 55.  Reagents and Conditions:  (a) lithium 
acetylide ethylenediamine complex, DMSO, 0 oC → rt, 48 h, 100%; (b) TBDMSCl, imidazole, DMF, 
rt, 16 h, 78%.  
 
2.6 Synthesis of the C1'—C10' Carbon Framework 
2.6.1 Addition of the Alkyne Fragment 
There is literature precedent for the enantioselective synthesis of propargylic 
alcohols by the direct addition of terminal alkynes to aldehydes and this had the 
potential to be exploited in this synthesis. 
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Before Carreira published his conditions,[91,92] the methods available for 
asymmetric synthesis of optically active propargylic alcohols were nucleophilic 
addition of metallated acetylenes to aldehydes or ynone reduction, with both 
the metallated acetylene and ynone requiring prior preparation.  In 2000, 
Carreira published the synthesis of optically active propargylic alcohols 195 (up 
to 99% e.e.) under mild conditions at room temperature using N-
methylephedrine 194 as a chiral additive (Scheme 54).[91]   
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Scheme 54:  Carreira's Synthesis of Propargylic Alcohols Using a Chiral Additive. 
 
The authors initially found that in the presence of Zn(OTf)2 and an amine base, 
terminal acetylenes underwent addition to aldehydes at room temperature in 
good yields.  They hypothesised that a zinc(II) alkynylide was generated in situ, 
comparing it to the reaction of Cu(I) salts and amine bases with terminal 
acetylenes.  With this success, they then went on to use inexpensive, 
commercially available chiral additives as ligands for Zn(II).  In summary, they 
found that N-methylephidrine, an amino alcohol, was the most effective to give 
the optically active adduct. 
The coupling sequence began with protected compound 187 which was 
deprotected using TBAF to generate alcohol 196 in 94% yield (Scheme 55).  
Alcohol 196 was then subjected to standard Swern conditions to produce 
aldehyde 197, confirmed by the strong, characteristic signal in the 1H NMR 
spectrum. 
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a b H
187 196 197  
Scheme 55:  Synthesis of Aldehyde 197.  Reagents and Conditions:  (a) TBAF, THF, 0 oC → rt, 
2 h, 94%; (b) (COCl)2, DMSO, Et3N, CH2Cl2, –78 oC → rt. 
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Unfortunately, this particular aldehyde proved unstable and started 
decomposing almost immediately, rendering it unusable for the addition to the 
alkyne unit.  It also meant that large quantities could not be made and then 
stored for future use.  In order to circumvent this problem, a new method was 
devised.  As part of the new Swern oxidation procedure, triethylamine would be 
added at —78 oC and the reaction mixture allowed to warm to room temperature 
before being stirred for a further 30 minutes.  It was hypothesised that at this 
stage the aldehyde need not be isolated, but rather it could be added directly to 
a second, simultaneously running reaction.  This second reaction would contain 
the other reagents needed for the overall addition reaction (Scheme 56).  The 
freshly prepared aldehyde 197 was added to a mixture of Zn(OTf)2, N-
methylephidrine 194 and alkyne 55.  Unfortunately, despite the reported 
success in the literature, the reaction did not work in our hands.   
PMBO
OCH3
O
H3CO
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PMBO
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O
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H
OHO
196197198
H
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55
 
Scheme 56:  Proposed One-pot Oxidation-Grignard Addition Reaction. 
 
This set-back prompted us to search the literature for alternative procedures.  In 
1999, the anti-selective addition of triisopropoxytitanium acetylide 200 to 
aldehyde 199 was published.  It was reported that this alkyne addition afforded 
the anti-product 201 in 98% yield and as a single diastereoisomer (Scheme 
57).[93]  The improved procedure is analogous to that employed previously 
without success in Scheme 56.  The only major difference was the use of 
chloroisopropoxytitanium (IV).  Unfortunately, the reaction was not successful 
and NMR spectroscopy of the isolated compound showed it not to be the desired 
product.   
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[M] C11H23
BnO
C11H23
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O
OH
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201 202  
Scheme 57:  Addition of Triisopropoxytitanium Acetylide 200 to Chiral Aldehyde 199. 
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2.6.2 One-Pot Oxidation-Alkyne Coupling 
The failure of the alkyne to couple to the aldehyde under titanium or zinc-
promoted conditions drove us to consider an alternative metal counterion during 
the addition process.  It was discovered in our laboratory that treatment of 
alkyne 203 with ethylmagnesium bromide at —78 oC did not proceed to generate 
the expected product.  On its addition to the aldehyde 204, it gave instead the 
ethyl addition product 205 (Scheme 58).[75] 
H3CO
O
O
OHO
H3CO
O
O
OH
O
H
OTBS
OTBS
a
204 205
203
 
Scheme 58:  Addition of Acetylide 203 to Aldehyde 204.  Reagents and Conditions:  (a) 
EtMgBr, THF, –78 oC, 94%. 
  
However, when the alkyne was treated with ethylmagnesium bromide at room 
temperature, the required magnesium acetylide was generated.  Trapping of the 
aldehyde 204 afforded the alkynol product 206 in 88% yield (50:50 mixture of 
diastereoisomers) (Scheme 59).[75] 
H3CO
O
O
OHO
H3CO
O
O
OH
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H
OTBS
OTBS
a
OTBS
203
204 206  
Scheme 59:  Trapping of Acetylide 203 with Aldehyde 204.  Reagents and Conditions:  (a) 
EtMgBr, THF, rt, 88%. 
 
Thus, alkyne 55 was treated with ethylmagnesium bromide at room temperature 
and was then added to crude aldehyde 197.  It was pleasing to see that the 
coupling did take place and the desired product 198 was obtained in 30% yield 
as a mixture of diastereoisomers (Scheme 60).  It is worth pointing out that this 
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yield was for an initial, test-scale reaction and so it is fair to say that some 
material could potentially have been lost during work-up or purification.  TLC 
analysis however proved the reaction to be efficient, with the clean conversion 
of the alcohol to the aldehyde and then to the final product.   
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Scheme 60:  One-Pot Oxidation Alkyne Coupling.  Reagents and Conditions:  (a) EtMgBr, THF, 
rt, 3 h; (b) (COCl)2, DMSO, Et3N, THF, –78 oC → rt; (c) 55, THF, –78 oC → rt, 18 h, 30%. 
 
Though the success of this reaction was appreciated and the gaining of the C1'—
C10' skeleton was welcomed, it was not advantageous to have an inseparable 
mixture of diastereoisomers.  As can be appreciated, the 1H and 13C NMR spectra 
of such a compound is very complex and the ratio of diastereoisomers is not 
determinable.  It can be postulated that a mixture is obtained due to the 
stereocentre α (alpha) to the aldehyde not being sufficient to fully direct the 
addition to the expected face.  From the Felkin-Anh model, the outcome of the 
nucleophilic addition to the carbonyl compound can be predicted.  When the 
large group is placed perpendicular to the carbonyl group, the expected face is 
the addition of the alkyne unit between the two hydrogen atoms (the two small 
groups and the least hindered trajectory).  The syn-product is the expected 
product, while the anti-product is formed when the addition occurs between the 
large group and hydrogen of the aldehyde.  In order to progress forward, the 
situation was reluctantly accepted and it was understood that NMR analysis of 
subsequent compounds would be difficult.  Time was of the essence and we 
knew we could not afford the time at this stage to go back and test further 
enantioselective conditions.   
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2.7 Isomerisation Attempts 
In the preparation of carbon-carbon double bonds, the isomerisation of a 
mixture of Z- and E-olefins to the geometrically pure E-isomer is highly 
significant and valuable.  Over time, radical,[94] photochemical[95] and 
organometallic[96] reagents have been part of the conditions developed to 
isomerise olefins.  Though successful, they are not without their disadvantages.  
Radical and photochemical techniques often require harsh conditions and in a 
number of photochemical reactions the reverse isomerisation is seen.   
Recently, Yu and co-workers[97] prepared E-arylakenes via a mild, palladium(II)-
catalysed isomerisation of Z-arylalkenes (Scheme 61).  The method was limited 
to double bonds conjugated to aromatic systems, but this wasn't a hindrance as 
the double bond to be isomerised in our case is conjugated to an aromatic unit.  
What made the method even more attractive was that the reaction required only 
10% loading of the chosen palladium catalyst, bis(acetonitrile)palladium(II) 
chloride, which is also commercially available and relatively inexpensive.  The 
authors found that cis- and trans-methyl styrenes and styrenes with more bulky 
substituents were converted to the trans-isomer in good yield. 
Ar
R
Ar
R10 mol% PdCl2(MeCN)2
CH2Cl2, r.t.  
Scheme 61:  Yu's Palladium(II)-Catalysed Isomerisation of E-arylalkenes. 
 
In 2007, Jung and colleagues[98] reported their efforts into the development of 
mild and efficient methods for olefin isomerisation, to generate geometrically 
pure E-alkenes using palladium acetate, tributyltinhydride and triethylamine 
(Scheme 62). 
R
R'
R
R'5 mol% Pd(OAc)2, Bu3SnH
Et3N, CH2Cl2, reflux  
Scheme 62:  Jung's Palladium(II)-Catalysed Isomerisation of Olefins. 
 
Jung found his conditions to be general for the isomerisation of Z-alkenes with 
allylic hydrogens and conjugated Z-arylakenes.  The authors found that the 
Suzannah J. Harnor, 2010  85 
nature of the alkene substituents controlled the result of the isomerisation, for 
example, stabilisation by a phenyl group facilitated the reaction.  The authors 
proposed a possible mechanism (Scheme 63) for the isomerisation and postulated 
that the Pd(0), formed by reduction of palladium(II) acetate with 
tributyltinhydride, would serve as an active catalyst for the isomerisation.  The 
oxidative addition of tributyltinhydride to Pd(0) affords the palladium-tin 
complex which undergoes insertion.  The E-olefin is generated following β-H 
elimination and Pd(0) is regenerated from Bu3Sn—Pd—H. 
2Bu3SnH Pd(OAc)2 Pd(0) 2Bu3Sn(OAc) H2
Bu3SnHBu3SnH
Bu3Sn-Pd-H
R
H
R'
H Pd
H SnBu3
R
H H
R'
H
H
Pd
H
R'R
SnBu3
H
R H
R'
insertion
reductive eliminationoxidative addition
β
-H el imination
 
Scheme 63:  Proposed Mechanism of Pd-Catalysed Isomerisation with Bu3SnH.  Adapted 
from Reference 98. 
                     
The fact that the Wittig olefination gave a 3:2 mixture of isomers, presented an 
opportunity for us to attempt an olefin isomerisation.  If successful, the Wittig 
reaction could be scaled up with the knowledge that the E:Z-mixture of isomers 
could be readily isomerised into the geometrically pure E-isomer.  Hence, Jung's 
conditions were tried on a simple model system 185 (Scheme 64).  Due to the 
fact that the isomers were inseparable, it made it difficult to follow the reaction 
by TLC.  To monitor the reaction it became necessary to take an aliquot of 
reaction mixture, allow it to cool, filter it through Celite® to remove the solids 
and concentrate it before running a 1H NMR to observe any isomerisation to the 
E-isomer.  After 45 hours under reflux it became apparent that no further 
isomerisation of the Z-isomer to the E-isomer was occurring so the above work-
up was performed, followed by column purification and analysis by NMR.  
Although not wholly successful, some isomerisation had taken place and from 
the spectra the mixture was now 4.8:2 from 3:2 (E:Z). 
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Scheme 64:  Isomerisation attempts.  Reagents and Conditions:  (a) Pd(OAc)2 (5 mol%), 
Bu3SnH, Et3N, CH2Cl2, reflux, 45 h, 33%; (b)  Pd(OAc)2 (5 mol%), Bu3SnH, Et3N, CHCl3, reflux, 50 
h then rt, 74 h, 54%. 
 
A second test reaction attempt was run, treating alcohol 196 under the same 
conditions, but switching the solvent to chloroform.  Taking into account the 
prolonged reaction time needed for this kind of transformation, on this occasion 
the reaction mixture was heated under reflux for 50 hours and then cooled to 
room temperature, with stirring continued for a further 74 h.  Again the same 
problem of inseparable isomers was encountered, rendering TLC analysis 
ineffective.  The 1H NMR spectrum showed a slight improvement from 1.4:1 to 
2:1 (E:Z).   
The failure of the palladium(II) catalysed isomerisation conditions to generate 
geometrically pure E-olefins meant that we had to seriously rethink our 
synthetic strategy to LL-Z1640-2.  Whilst the Wittig olefination allowed us to 
garner material to test conditions for ensuing reactions in our proposed 
synthesis, it was becoming clear that this particular olefination to form the C1'—
C2' double bond in the trans-configuration was not suitable and another, 
significantly improved method was required. 
2.8 Additional Studies 
2.8.1 Cross-coupling Reactions 
At this point a fellow PhD student in the research group found that a cross-
metathesis between vinylboronic acid pinacol ester 207 and alkene 208 was 
achievable (Scheme 65).[75]  He found that Grubbs first or second generation 
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catalyst afforded alkene 209 in 71% or 73% yield respectively, as a 4:1 separable 
mixture of E:Z-isomers.  Aside from proceeding with the desired Suzuki coupling, 
the success opened up the possibility of using alkene 208 as a partner in other 
Grubbs-mediated cross-metathesis reactions.   
O
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O
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O
O
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O
B
O
a or b
207 208 209  
Scheme 65:  Successful Cross-metathesis of Alkene 208.  Reagents and Conditions:  (a) 
Grubbs second generation catalyst (5 mol%), CH2Cl2, reflux, 13 h, 73%; (b) Grubbs first generation 
catalyst (5 mol%), CH2Cl2, reflux, 13 h, 71%. 
 
My fellow PhD student then went on to investigate the possibility of a cross-
metathesis reaction between aromatic alkene 210 and alkene 208.  Following 
intense screening and optimisation, he found that the best reaction conditions 
were using Hoveyda-Grubbs second generation catalyst, with 30% loading and a 
ratio of 1:2 of aromatic alkene 210 and alkene 208 respectively (Scheme 66).  
The desired heterodimer 186 was obtained as a 9:1 mixture of E:Z.  The 
additional formation of the homodimer could not be prevented and was isolated 
in an amount proportional to the success of formation of the heterodimer. 
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Scheme 66:  Successful Cross-metathesis of Aromatic Alkene 210 and Alkene 208.  
Reagents and Conditions:  (a) Hoveyda-Grubbs second generation (30 mol%), CH2Cl2, reflux, 48 h, 
73%. 
 
My colleague was able to protect the free hydroxyl of 186 as its MOM ether 211 
and remove the silyl ether protecting group to reveal the free alcohol 212 
(Scheme 67), at which stage the isomers became separable.  Due to time 
constraints enforced upon my colleague, the project was left at this stage, but a 
synthetic path of this type is highly attractive and something that would be 
worthwhile pursuing. 
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Scheme 67:  Formation of Free Alcohol 212.  Reagents and Conditions:  (a) bromomethyl methyl 
ether, DIPEA, CH2Cl2, 0 oC → rt, 19 h, 90%; (b) TBAF, THF, rt, 30 min, 100%. 
 
2.8.2 Continuation of the Synthesis Towards LL-Z1640-2 
Taking into account all the investigations carried out towards the total synthesis 
of LL-Z1640-2 thus far, it was necessary to decide on a suitable path to follow.  
It was known from one angle that the Wittig olefination wasn't going to be 
productive in carrying the synthesis forward, due to the difficulties with the 
poor selectivity.  Whilst all the possibilities for producing products with 
excellent E-selectivity had by no means been exhausted, we were now aware of 
the success with Grubbs-mediated cross-metathesis between alkenes 210 and 
208.[75] 
2.9 New Synthetic Route to LL-Z1640-2 
For completeness, it is necessary to highlight the routes that have already been 
established towards aromatic alkene 210 and alkene 208.  They are similar to 
those already described, but in order to present the revised synthesis towards 
LL-Z1640-2 in its entirety they will be discussed further. 
2.9.1 Synthesis of the New Aromatic Fragment, 210 
Aromatic fragment 210 was synthesised following the approach initially 
developed by Dr M. N. Robertson, a fellow member of the research group 
(Scheme 68).[49a,75,98] 
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Scheme 68:  Synthesis of Aromatic Fragment 210.  Reagents and Conditions:  (a) TMS–CH2N2, 
Et2O, 90%; (b) TBDMSCl, Et3N, CH2Cl2, 80%; (c) Tf2O, pyridine, 100%; (d) vinyltributyl tin, 
Pd(PPh3)4, CH2Cl2; (e) TBAF, THF, 0 oC → rt, 2 h; 74% (over 2 steps). 
 
2,4,6-Trihydroxybenzoate 114 was selectively methylated to afford diphenol 
117.  Diol 117 was then mono-protected to generate silyl ether 118.  The 
remaining hydroxyl group was converted to the corresponding triflate 119, under 
carefully controlled conditions.[75]  The triflate was then subjected to Stille 
coupling[99] with vinyltributyltin.  This proceeded in good yield to afford 120, but 
also partially cleaved the silyl ether protecting group, giving phenol 210.  A 
decision was taken to treat the mixture of 120 and 210 with TBAF to deprotect 
fully the TBS group, affording aromatic fragment 210 in 74% yield over two 
steps. 
2.9.2 Synthesis of the Alkene Coupling Fragment, 208 
2-Deoxy-D-ribose 179 was ketal protected using 2-methoxypropene (Section 2.3).  
Wittig olefination of lactol 144 using methyltriphenylphosphonium iodide 
proceeded to give terminal alkene 213 in an acceptable 60% yield.[76]  The 
primary alcohol was protected as its TBS silyl ether in 87% yield under standard 
conditions to give the desired alkene cross-metathesis coupling partner 208. 
OH
O
O
OTBS
O
O
a b c
179 144 213 208
O
OH
O
O
O
OH
OH
OH
 
Scheme 69:  Synthesis of Alkene 208.  Reagents and Conditions:  (a) 2-Methoxypropene, PPTS, 
EtOAc, –10 oC, 2.5 h then rt, 16 h, 62%; (b) (Ph3P-CH3)I, KHMDS, THF, –78 oC → rt, 17 h, 60%; 
(c) TBDMSCl, DMAP, Et3N, CH2Cl2, rt, 18 h, 87%. 
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2.9.3 Olefin Metathesis 
Olefin metathesis is one of the most powerful synthetic methods in organic 
chemistry.  The definition of metathesis is change position, meta meaning 
change and thesis meaning position.  In metathesis reactions double bonds are 
broken and made between carbon atoms in ways that cause atom groups to 
change places.  In the 1950s, Du Pont, Standard Oil and Phillips Petroleum 
reported catalysed metathesis reactions when propene led to ethylene and 2-
butenes on heating with molybdenum.[100] 
Olefin cross-metathesis is the intermolecular mutual exchange of alkylidene (or 
carbene) fragments between two olefins promoted by metal-carbene complexes 
(Scheme 70).[101]  The process is catalytic, typically requiring 1-5 mol% of 
catalyst, with high yields readily achievable. 
R
R
R'
R'
R'
R
R
R'
 
Scheme 70:  General Scheme of Cross-Metathesis.[101] 
 
In 1971, Chauvin and Hérisson published their widely accepted transition metal 
alkene metathesis mechanism (Scheme 71).[102]  The reaction is reversible, but 
the gaseous ethylene produced drives the reaction to completion.  A [2+2] 
cycloaddition between olefin B and a transition metal carbene A forms a 
metallocyclobutane intermediate C.  This collapses in a productive fashion to 
afford the first olefin product D and a new metal alkylidene E.  This metal 
alkylidene can react with a molecule of F via metallocyclobutane G to yield A, 
which re-enters the catalytic cycle. 
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Scheme 71:  Mechanism of Olefin Cross-Metathesis. 
 
In 2005, the Nobel Prize in Chemistry was jointly awarded to Yves Chauvin, 
Robert H. Grubbs and Richard R. Schrock, "for the development of the 
metathesis method in organic synthesis."[103]  They each contributed to the field 
of metathesis in their own way.  To summarise, in 1971 Chauvin explained how 
metatheses reactions function and types of metal compound that act as 
catalysts, in 1990 Schrock was the first to produce an efficient metal-compound 
catalyst for metathesis (Figure 20, 214) and in 1992 Grubbs reported his 
development of a superior ruthenium catalyst (Figure 20, 215) for metathesis.  
Modifications of his catalysts came in 1995 (First Generation) and 1999 (Second 
Generation) (Figure 20, 216 and 217 respectively).  Their research and findings 
combined allowed synthetic methods that were more efficient, simpler to use 
and more environmentally friendly. 
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Figure 20:  Commonly Used Metathesis Catalysts. 
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2.9.4 Coupling of Fragments 210 and 208 
The cross-coupling between the aromatic alkene 210 and alkene 208 was 
attempted using Hoveyda-Grubbs second generation catalyst (Figure 21) under 
the established conditions (Scheme 72).[75] 
N N
Ru
Cl
Cl
O
 
Figure 21:  Hoveyda-Grubbs Second Generation Catalyst. 
 
With a 30 mol% loading of catalyst and a 2:1 ratio of 208 to 210, the desired 
product 186 was obtained in 65% yield after refluxing in the dark for 48 h in 
dichloromethane.  Despite repeated attempts the yield obtained was not quite 
as high as reported previously in the group,[75] though more than acceptable to 
proceed.  The product was still a mixture of E- and Z- isomers, but had vastly 
improved to 9:1 (E:Z), as opposed to 3:2 obtained following the Wittig 
olefination. 
OH
H3CO
O
OCH3
OTBS
O
O
OH
H3CO
O
OCH3 OTBS
O
O
a
210 208 186
 
Scheme 72:  Cross-metathesis of 210 with 208.  Reagents and Conditions:  (a) Hoveyda-Grubbs 
second generation catalyst (30 mol%), CH2Cl2, reflux, 48 h, 65%. 
 
From earlier work, a TBS silyl ether positioned on the aryl ring was found to be 
labile and as such was ruled out as the choice of protecting group for the 
aromatic hydroxyl.  In addition, there was a TBS group already present in the 
molecule which could potentially make the mono-deprotection slightly 
troublesome.  A MOM ether was chosen as the protecting group for the phenolic 
alcohol of coupled product 186.  It was envisaged that the MOM group would 
stay in place throughout the remainder of the synthesis, while its cleavage could 
be performed simultaneously with the acetonide protecting group at the end of 
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the synthesis.  The MOM group was introduced, using MOMBr and Hunig's base,[75] 
generating 211 in 60% yield (Scheme 73).  This lower than expected yield was a 
surprise and it was originally assumed that the MOMBr could also be damaging 
the substrate.  Removal of the TBS group with TBAF generated the free alcohol 
212, which could be used directly in our previously established one-pot alkyne 
coupling reaction. 
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Scheme 73:  Formation of Alcohol 212.  Reagents and Conditions:  (a) MOMBr, DIPEA, CH2Cl2, 
0 oC → rt, 18 h, 60%; (b) TBAF, THF, 0 oC → rt, 1.5 h, 93%.  
 
2.10 Synthesis of the Seco-Acid 
2.10.1 Retrosynthetic Analysis of 2-{(E)-3-[(4S,5S)-5-((Z)-(S-5-
Hydroxy-1-triisopropylsilanyloxy-hex-2-enyl)-2,2-dimethyl-
[1,3]dioxolan-4-yl]-propenyl}-4-methoxy-6-methoxymethylbenzoic 
acid, 218 
As demonstrated in the retrosynthetic analysis shown in Scheme 74, seco-acid 
218 was envisioned as originating from the base-catalysed hydrolysis of ester 
219.   Compound 219 would be the result of PMB deprotection at the terminus 
of the structure.  Z-Alkene 220 can be gained via selective hydrogenation of the 
alkyne 221.  Alkynol 222 comes from the one pot oxidation-acetylide addition of 
212 and 223. 
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Scheme 74:  Retrosynthetic Route to Seco-Acid 218. 
 
2.10.2 Synthesis of 2-{(E)-3-[(4S,5S)-5-((Z)-(S)-5-Hydroxy-1-
triisopropylsilanyloxy-hex-2-enyl)-2,2-dimethyl-[1,3]dioxolan-4-yl]-
propenyl}-4-methoxy-6-methoxymethylbenzoic acid, 218 
Alcohol 212 was subjected to the same one-pot Swern oxidation-Grignard 
acetylide coupling as described previously.  This time it was decided to use an 
alternative protecting group for the hydroxyl group of the alkyne unit.  The 
experiences encountered with cleavage of previous TBS groups under regular 
reaction conditions prompted us to change our strategy with regards to 
orthogonal protection.  It was assumed that the more stable PMB ether would 
withstand the conditions employed in the three reactions up to its cleavage.   
As shown in Scheme 75, lithium acetylide complex was coupled with (S)-(+)-
propylene oxide to afford alcohol 190.  The crude alcohol was then protected as 
the PMB ether to afford alkyne 223 in 40% over two steps. 
H
OH
H
OPMBO
CH3
H
a b
32 190 223  
Scheme 75:  Synthesis of 1-Methoxy-4-((S)-1-methyl-but-3-ynyloxymethyl)-benzene.  
Reagents and Conditions:  (a) lithium acetylide ethylenediamine complex, DMSO, 0 oC → rt, 48 h, 
100%; (b) PMBCl, DMF, 0 oC → rt, 17 h, 40%.  
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Alkyne 223 was treated with ethylmagnesium bromide and the resulting anion 
was added directly to a solution of freshly generated aldehyde 224 in THF.  It 
was pleasing to see that once again the Grignard acetylide had added cleanly to 
the aldehyde, affording 222 in an acceptable 65% yield, as an inseparable 
mixture of diastereoisomers (Scheme 76). 
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Scheme 76:  Synthesis of Seco-Acid 218.  Reagents and Conditions:  (a) (COCl)2, DMSO, Et3N, 
–78 oC → rt; (b) THF, –78 oC → rt, 14 h, 65%; (c) TIPSCl, imidazole, DMF, rt, 24 h, 83% (based on 
starting material consumed); (d) H2, Pd/BaSO4, quinoline, MeOH, rt, 4 h, 85%; (e) DDQ, CH2Cl2, 
pH 7 buffer, rt, 20 h, 79%; (f) 2 N KOH, EtOH, 80 oC, 48 h, 57%. 
 
Having successfully introduced the alkyne unit, a triisopropylsilyl (TIPS) ether 
was chosen as the protection group for the newly created secondary alcohol 
222.  In 1974, Ogilvie and colleagues[104] reported their experiments aimed at 
selective protection and deprotection of OH groups using the TIPS group.  Due to 
its bulk, the isopropyl units of the TIPS group provide steric screening for the 
silicon they are attached to (and the atom to which the silicon is connected),[105] 
but also slow down reactions at silicon compared to TMS or TBDMS groups.   
The TIPS ether was expected to remain in place for the duration of our synthesis 
until its cleavage in readiness for the final oxidation to the ketone.  TIPS is more 
resistant to fluoride than TBS, but can be removed using standard conditions 
such as TBAF, so we didn't foresee any issues with its removal.[106]  Protection of 
secondary alcohol 222 using TIPSCl and imidazole proceeded slowly as expected 
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and did not go to completion despite multiple attempts.  Fortunately, the 
transformation was clean and no other products were formed.  In 2000, a group 
published their findings in the efficient and selective protection of alcohols and 
phenols with TIPSCl/imidazole using microwave irradiation.[105]  The method is 
solventless, so the alcohol 222, imidazole and TIPSCl were added to a dry 
reaction vessel and subjected to microwave irradiation.  The pattern of 
irradiation is shown below in Table 1.   
 Round                      Irradiation Condition  
 
1 
2 
3 
4 
5 
Time (s) 
15 
15 
30 
40 
90 
Power (W) 
300 
300 
400 
400 
400 
Table 1:  Irradiation Conditions for the TIPS Protection of Alcohol 222. 
 
After each irradiation a sample of the reaction mixture was taken and TLC 
analysis performed.  After the second round of irradiation, the desired product 
was observed (run against an authentic sample), with the reaction having 
progressed approximately 30%.  After round three, the reaction had progressed 
further but after round four, the situation had changed.  The reaction had 
progressed further still but there were three visible spots by TLC, starting 
material 222, product 221 and a previously unseen spot.  We continued with 
round five and it was found that the starting material had still not been 
consumed, the formation of the unknown had increased and there was no 
distinct change in the desired product.  It was postulated that proceeding with 
microwave irradiation would have only increased the percentage of the 
unknown, with no guaranteed consumption of alcohol 222.  With these findings 
we reverted back to our standard protection conditions.  
With the fully protected compound 221 in hand we turned our attention to the 
selective hydrogenation of the alkyne to generate the cis-alkene.  Usual 
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palladium catalysts are so effective in promoting the addition of hydrogen to 
both triple and carbon-carbon bonds that the alkene intermediate formed by 
hydrogen addition to an alkyne cannot be isolated.  Lindlar's catalyst[107] is a less 
efficient catalyst and allows the isolation of the intermediate alkene.  The 
addition of hydrogen is syn and the alkene formed has the cis-configuration.  
Hydrogenation of alkyne 222 using Pd/BaSO4 poisoned with lead(II) acetate and 
quinoline under a hydrogen atmosphere generated the Z-olefin 220 in variable 
yields of 77-85%.   
Removal of the PMB protecting group, to generate 219, was successfully 
achieved using DDQ, in a yield of 77%.  However, some problems were 
encountered and on occasion the reaction did not proceed and it was necessary 
to work-up the reaction mixture and repeat the procedure.  For this reason 
attempts were made to remove the PMB ether under different conditions.   
In 2000, Yu and co-workers reported the chemo- and regio-selective cleavage of 
the PMB group at low temperature in the presence of tin(IV) chloride and 
thiophenol.[108]  With the authors statement of the reaction being fast and high 
yielding and with further encouragement from the fact that these conditions had 
been employed successfully already in our group[109] we proceeded to test the 
reagents for the removal of the PMB group of 220.  Unfortunately, 1H NMR of the 
crude residue suggested that the desired product had not been formed and it 
was not deemed fruitful to continue with any purification.  Alternatively, it is 
well known that CAN (ammonium cerium(IV) nitrate) can be used to oxidatively 
cleave PMB ethers.[110]  The reaction was continuously monitored by TLC and 
after 20 minutes it was clear that the reaction was progressing cleanly, with the 
formation of only one new spot.  Disappointingly, over the course of 7 hours, 
additional new spots began to appear and the decision was taken to work-up the 
reaction without the complete consumption of starting material.  It was 
disappointing to see that after purification, the desired deprotected product 
219 was obtained in only 16% yield.  The additional spots formed were isolated 
but found to be unidentifiable by NMR.  Consequently, it was decided to 
continue with the use of DDQ as other PMB removal conditions reported in the 
literature were deemed unsuitable, based on the functionality present in our 
substrate. 
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For our first attempt at saponification of the ester we chose to use 2 N KOH in 
ethanol[111] and found that the reaction proceeded well over the course of 48 
hours under reflux to generate the seco-acid 218 in 57% yield.  Taking guidance 
from reports where other groups have used base-catalysed ester saponification 
on large molecules, the yield gained was comparable and no optimisation 
attempts were performed. 
2.11 Completion of the Synthesis  
With a robust and reliable synthesis to seco-acid 218 established and subjected 
successfully to scale-up, we could now proceed with the key macrolactonisation 
step.  The construction of macrocyclic structures is a recurrent and testing 
problem in synthesis.  Macrocyclic systems can be generated by cyclisation of 
open, long chain precursors, but the ring closure is disfavoured entropically, due 
to loss of entropy associated with the formation of the usually more rigid, cyclic 
structure.  There are two methods which are frequently used for 
macrolactonisation, acid activation and alcohol activation.  Studies carried out 
by Illuminati and colleagues[112] and Stoll and colleagues[113] showed that for 
successful ring formation there are two types of energy to take into account, the 
enthalpy and entropy.  For medium ring formation entropy<enthalpy and for 
large ring formation entropy>enthalpy.  The most difficult ring size to form is n = 
8-11. 
Over time, new synthetic methods have been developed which readily allow the 
formation of macrolides.  The methods that appeal most in respect to our 
synthesis are discussed accordingly. 
2.11.1 Retrosynthetic Analysis for the Final Steps to            
LL-Z1640-2 
As demonstrated in Scheme 77, the final step to the natural product LL-Z1640-2 
is achieved through global deprotection.  The protected compound 225 is a 
direct result of oxidation of the secondary alcohol 226, itself formed from the 
deprotection of the TIPS ether.  Compound 227 is the product of the 
macrolactonisation. 
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Scheme 77:  Retrosynthetic Analysis to LL-Z1640-2 from Seco-Acid 218. 
 
2.11.2 Towards the Total Synthesis of LL-Z1640-2 
The first attempt at forming macrocycle 227 was made using the well known 
Yamaguchi esterification.[114]  The Yamaguchi esterification allows the synthesis 
of highly functionalised esters and lactones via the alcoholysis of the 
corresponding mixed anhydrides.  The conditions are mild, making it compatible 
with compounds which may have sensitive functionalities.  The high catalytic 
activity of DMAP in acyl transfer reactions attracted the attention of the authors 
and they used it in esterifications with mixed anhydrides to investigate the 
synthesis of macrocyclic lactones.  They found that 2,4,6-trichlorobenzoyl 
chloride and DMAP under high dilution was the best combination to give a high 
reaction rate and yield.  
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Scheme 78:  General Formula for the Yamaguchi Esterification. 
 
Yamaguchi took an acid sensitive seco-acid and treated it with 2,4,6-
trichlorobenzoyl chloride in the presence of triethylamine, removing the 
triethylamine hydrochloride by-product.  The mixed anhydride was diluted with 
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toluene and slowly added to a refluxing solution of DMAP in toluene via syringe 
pump in high dilution (0.002 M).  The macrolactone was seen to form with no 
decomposition product.  The mechanism for forming a macrolactone is shown in 
Scheme 79, using simplified models to demonstrate the order of events.  The 
first step (Equation [1]) is the addition of the carboxylate A to the carboxylic 
acid chloride B, forming the tetrahedral intermediate C, which on addition of 
triethylamine eliminates triethylamine hydrochloride to form the mixed 
anhydride D.  In Equation [2], DMAP E attacks at the least hindered carbonyl site 
of D.  As it is a stronger nucleophile than the alcohol, the newly formed 
intermediate is less hindered and DMAP E leaves, generating the product H. 
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Scheme 79:  General Mechanism of the Yamaguchi Macrolactonisation. 
 
With the success experienced by other groups in utilising the Yamaguchi protocol 
for forming macrolactones,[115] we were confident that this procedure would be 
more than suitable for use with our seco-acid.  Treatment of seco-acid 218 
under standard Yamaguchi conditions afforded the desired macrolactone 227 in 
37% yield (Scheme 80).  This was an excellent result for a first attempt and for a 
reaction performed on a test scale. 
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Scheme 80:  Yamaguchi Macrolactonisation of 218.  Reagents and Conditions:  (a) 
Trichlorobenzoyl chloride, Et3N, rt, 2 h then DMAP, toluene, reflux, 6 h, 37%; (b) MNBA, DMAP, 4Å 
MS, toluene, rt, 6 h, 28%. 
 
In an attempt to increase the macrolactonisation yield, we explored the use of 
MNBA.  2-Methyl-6-nitrobenzoic anhydride (MNBA, Figure 22) is an effective 
condensation reagent for the DMAP promoted lactonisation of ω-
hydroxycarboxylic acids, as reported by Shiina and co-workers.[116]  The reagents 
can produce comparable yields to the Yamaguchi conditions[117] but the 
experimental procedure is far simpler.  Unfortunately, cyclisation of seco-acid 
218 to 227 could only be achieved in 28% yield using MNBA (Scheme 80). 
H3C
NO2
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Figure 22:  Structure of MNBA. 
 
There are other potential methods that would allow the macrolactonisation of 
seco-acid 218.  The Keck coupling[118a] uses a combination of a dialkyl 
carbodiimide, an amine hydrochloride and an amine base under high dilution to 
form the activated ester intermediate which then macrolactonises, generating 
N, N'-dialkyurea as a by-product. 
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Scheme 81:  General Formula for the Keck Macrolactonisation. 
 
Another alternative is the Corey-Nicolaou macrolactonisation. [118b]  This is a 
double activation method which forms the lactone from its seco-acid via 2-
pyridinethiol esters.  The reaction occurs under neutral and aprotic conditions 
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and under high dilution to keep the undesired intermolecular ester formation 
low (Scheme 82). 
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Scheme 82:  General Formula for the Corey-Nicolaou Macrolactonisation. 
 
Mukaiyama's lactonisation conditions[37] (Scheme 83) were employed by Tatsuta 
and colleagues[36] in the final stages of their total synthesis of LL-Z1640-2 to 
generate the lactone from the seco-acid (Chapter 1, Scheme 7).  1-Methyl-2-
chloropyridinium iodide (4 eq.) in anhydrous acetonitrile is stirred and a solution 
of seco-acid and triethylamine (8 eq.) in acetonitrile added over 8 hours under 
high dilution. 
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Scheme 83:  General Formula for the Mukaiyama Macrolactonisation. 
 
The Mitsunobu reaction is a versatile and effective reaction used extensively in 
organic synthesis (Scheme 84).  It was reported in 1967[44] that secondary 
alcohols could be acylated with carboxylic acid in the presence of DEAD and 
triphenylphosphine and later that optically active secondary alcohols underwent 
complete inversion of configuration under the conditions.  Currently, the 
Mitsunobu reaction is widely known and described as the substitution of primary 
and secondary alcohols with nucleophiles in the presence of a dialkyl 
azodicarboxylate and a trialkylphosphine. 
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Scheme 84:  General Scheme for the Mitsunobu Reaction. 
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The first step of the assumed mechanism for the lactonisation is the irreversible 
addition of triphenylphosphine to DEAD (Scheme 85, Equation [1], A).  The 
phosphine adds to the weak N=N π bond to give an anion stabilised by one of the 
ester groups.  The zwitterionic adduct B formed is basic enough to then be able 
to abstract a proton from the carboxylic acid of hydroxy acid C, which 
substitutes as the strong nucleophile, to form products D and E.   
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Scheme 85:  General Mechanism of Macrolactonisation via a Mitsunobu Reaction. 
 
Oxygen and phosphorus have a strong affinity and so the alcohol of E 
immediately attacks the positively charged phosphorus atom of D (Scheme 85, 
Equation [2]).  The anion of the nucleophile attacks the phosphorus derivative of 
the alcohol G in a normal SN2 reaction at carbon, with phosphine oxide as the 
leaving group.  This furnishes the lactone product H with inversion of the methyl 
group and phosphine oxide as the side-product. 
Sellès and Lett[41] used a Mitsunobu reaction to carry out the macrolactonisation 
of their hydroxy acid.  At room temperature at 0.007 M the desired macrolide 
was obtained in a good yield of 67%.  Importantly there was complete inversion 
of configuration at C10', with no change of configuration at C6' (MPM protected in 
their case).  The simple experimental procedure associated with the Mitsunobu 
reaction makes it attractive and it was considered useful to attempt the 
reaction with our hydroxy acid to test the procedure in our hands.  Treatment of 
seco-acid 218 under Mitsunobu conditions afforded the desired macrolide 228 in 
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71% yield (Scheme 86).  Despite being run on a small scale there was enough 
material to progress with and test the following transformations. 
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Scheme 86:  Final Steps to LL-Z1640-2.  Reagents and Conditions:  (a) DEAD, PPh3, toluene, 0 
oC → rt, 30 min, 71%; (b) TBAF, THF, 0 oC → rt, 1.25 h, 100%; (c) PCC, CH2Cl2, rt, 3.5 h, 20%; (d) 
1 N HCl, MeOH, rt, 46 h. 
 
Removal of the TIPS ether was undertaken with TBAF, cleanly generating 
secondary alcohol 229 in quantitative yield.  Due to the small scale and from the 
relatively clean 1H NMR spectrum, it was decided not to proceed with any 
purification and the crude product was carried directly to the next step.  
Turning our attention to the oxidation of the secondary alcohol 229, we chose to 
firstly attempt the reaction using pyridinium chlorochromate (PCC).  Chromium 
(IV) reagents are conveniently used to oxidise alcohols to their corresponding 
aldehydes or ketones.  They are convenient to use as they are soluble in dry 
organic solvents, usually dichloromethane for PCC, under anhydrous conditions.  
Alcohol 229 was treated with PCC and careful TLC analysis mapped the reaction, 
showing it to be progressing well over time, with the disappearance of the 
starting material and the gradual appearance of ketone 230.  Following 
purification, ketone 230 was isolated in 20% yield.  Regrettably, the lack of 
material prevented the acquisition of a full data set to absolutely confirm the 
product.   
It was envisaged from the beginning that the MOM ether and acetonide 
protecting groups could be cleaved simultaneously under mild acidic conditions, 
with literature precedent reinforcing this theory.  Keck and co-workers[120] have 
reported using DOWEX-H+ resin in methanol at 70 oC to remove MOM and 
acetonide groups.  Though they had experienced success previously, they found 
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that in the reported case the conditions did not achieve the deprotection, even 
under higher temperatures and longer reaction times.  They went on to find that 
BF3OEt2 in CH2Cl2 was effective at removing both groups (Scheme 87). 
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Scheme 87:  Keck's Removal of Acetonide and MOM Protection Using DOWEX-H+. 
 
Andrus and Shih[121] also reported their use of DOWEX resin in methanol, but at 
room temperature, to achieve the one step removal of both groups (Scheme 88).   
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Scheme 88:  Andrus and Shih's Removal of Acetonide and MOM Protection Using DOWEX-
50. 
 
In 2002, Kiyota, Ley and co-workers[122] reported, as part of their efforts to the 
synthesis, structure revision and absolute configuration of (+)-didemniserinolipid 
B, the simultaneous removal of the acetonide, BDA, Boc and MOM protecting 
groups.  This was accomplished in one step using 1 N HCl in ethanol at 45 oC to 
obtain the fully deprotected target compound (Scheme 89). 
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Scheme 89:  Kiyota and Ley's Simultaneous Removal of Acetonide, BDA, Boc and MOM 
Protection Using 1 N HCl. 
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In his total synthesis of aigialomycin D, Danishefsky successfully performed the 
final global acidic deprotection (two MOM functions and an acetonide) using 0.5 
N HCl in methanol.[76]  Vu also used HCl in methanol for global deprotection of 
the same compound, in his approach to the natural product.[100]  The reaction 
was slow and extended into days for completion, but ultimately was successful 
with Danishefsky reporting a yield in excess of 90% (Scheme 90). 
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Scheme 90:  Generation of Aigialomycin D via Global Acidic Deprotection. 
 
For our first attempt at the global deprotection of 230, we chose the milder 
conditions of 1 N HCl in methanol at room temperature.  Acutely aware of the 
long reaction time that may be required for the completion of the deprotection, 
it was thought responsible to start out with the mildest conditions, which may 
allow us to see clearly the deprotection proceeding by TLC.  It also gave us the 
option of heating the reaction to accelerate a slow rate.  Over the course of 46 
hours, careful TLC analysis showed disappearance of the protected compound 
230 and appearance of two new spots.  It was presumed that cleavage of one 
protecting group was occurring faster than the other. Unfortunately, the small 
scale of the reaction and the lack of material prevented us from performing FCC 
to isolate each spot and hence determine the structure of the compound 
corresponding to each spot.  Likewise, the lack of material prevented the 
acquisition of adequate NMR spectra for analysis. 
It goes without saying that for a total synthesis to a natural product to be as 
successful as possible, as many methods as possible affording the best reliability 
and yields need to incorporated.  With this in mind and taking into account the 
outcome of the Mitsunobu reaction, it naturally prompted us to seriously review 
our strategy as it became clear that a minor change in our already established 
synthesis could enable the very successful Mitsunobu reaction to be integrated 
into the route to LL-Z1640-2.  Although we were able to generate the required 
product with the correct stereochemistry at C10', via the Yamaguchi protocol in 
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acceptable yield and later via a procedure using MNBA in lower yield, we were 
disappointed that our pivotal step was not as fruitful as first hoped.  The 
Mitsunobu protocol has several distinct advantages over other 
macrolactonisation methods: 
1. Fast reaction time 
2. Simple procedure 
3. High dilution 
4. High yield 
5. Clean conversion 
6. No side-products 
7. Complete inversion of stereochemistry 
2.12 Final Synthetic Route to LL-Z1640-2 
The stereochemistry at C10' is introduced as a direct result of the one pot Swern 
oxidation-Grignard acetylide addition of alkyne 223.  The Mitsunobu reaction 
later in the synthesis then serves to completely invert the stereochemistry of the 
methyl group at C10'.  Quite reasonably, if the stereochemistry of 223 was 
changed from S to R, then the already proven higher yielding Mitsunobu 
lactonisation would not only generate the macrolide, but in doing so would 
simultaneously invert the stereochemistry to afford the desired S-configuration.  
TIPS ether cleavage, oxidation and global deprotection would complete the total 
synthesis of LL-Z1640-2. 
The synthesis of the seco-acid epimer 239 began with lithium acetylide 
ethylenediamine, which was treated with (R)-(+)-propylene oxide 232 to afford 
the crude alcohol 233 (Scheme 91). The crude alcohol was then immediately 
protected to generate terminal alkyne 234 in 40% over two steps.  We chose to 
continue with the PMB protecting group due to its proven stability throughout 
the remainder of the synthesis and its relative ease of cleavage.  
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Scheme 91:  Synthesis of 1-Methoxy-4-((R)-1-methyl-but-3-ynyloxymethyl)-benzene.  
Reagents and conditions:  (a) lithium acetylide ethylenediamine complex, DMSO, 0 oC → rt, 48 h; 
(b) NaH (60% in mineral oil), PMBCl, DMF, 0 oC → rt, 17 h, 40% (over 2 steps). 
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Alkyne 234 was deprotonated with ethylmagnesium bromide and the resulting 
anion was added directly to a solution of freshly generated aldehyde (212→224) 
at —78 oC.  Pleasingly, the Grignard acetylide added cleanly to the aldehyde, 
affording propargylic alcohol 235 in 75% yield, an increase of 10% from the 
previous addition.  Similarly, the product was an inseparable mixture of 
diastereoisomers (Scheme 92).  A TIPS ether was again used as the protecting 
group for the newly formed secondary alcohol as it had proven to be stable to 
later conditions and was easily removed using TBAF.  Protection of alcohol 235 
using TIPSCl and imidazole proceeded slowly like before and did not go to 
completion despite multiple attempts and a "recycling" procedure was 
employed.  With the fully protected compound 236 in hand, selective 
hydrogenation was performed to generate the Z-olefin 237 in an excellent 89% 
yield.  Removal of the PMB protecting group with DDQ in CH2Cl2 and pH 7 buffer 
at room temperature afforded alcohol 238 in 87% yield, which was a much more 
acceptable yield than the 77% gained previously.  Saponification of the ester was 
again achieved using 2 N KOH in ethanol and after 48 hours under reflux, seco-
acid 239 was generated in 61% yield.  
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Scheme 92:  Final Synthesis to LL-Z1640-2.  Reagents and Conditions:  (a) (COCl)2, DMSO, 
Et3N, –78 oC → rt; (b) 234, THF, –78 oC → rt, 16 h, 75%; (c) TIPSCl, imidazole, DMF, rt, 19 h, 
80%; (d) H2, Pd/BaSO4, quinoline, MeOH, rt, 2 h, 89%; (e) DDQ, CH2Cl2, pH 7 buffer, rt, 18 h, 87%; 
(f) 2 N KOH, EtOH, 80 oC, 48 h, 61%; (g) DEAD, PPh3, toluene, 0 oC → rt, 10 min, 73%; (h) TBAF, 
THF, 0 oC → rt, 1 h; (i) PCC, CH2Cl2, rt, 18 h, 34%; (j) 1 N HCl, MeOH, rt, 5 d. 
 
Mitsunobu macrolactonisation of seco-acid 239 afforded the macrocyclic lactone 
227 in 73% yield.  Cleavage of the TIPS ether was undertaken using TBAF to 
unmask the secondary alcohol 226, which was used without further purification.  
Oxidation of 226 with PCC generated lactone 225 in 34% yield, but once again 
the small quantities of material obtained prevented the attainment of a 
complete data set.  This extreme lack of material meant that treatment of 
lactone 225 with 1 N HCl was not fruitful.  It could be seen by TLC that a 
reaction was occurring, with two new spots forming like before, but the reaction 
did not go to completion.  1H NMR was not able to clarify if any of the globally 
deprotected product 15 had formed.  Due to time constraints we were unable to 
synthesise more compound 225 and had to relinquish the opportunity to test the 
global deprotection further. 
 
Suzannah J. Harnor, 2010  110 
2.13 Further Investigation and Additional Studies 
2.13.1 Alternative Retrosyntheses to LL-Z1640-2 
As an alternative retrosynthesis to that shown in Scheme 74, we hypothesised 
that following the one-pot oxidation-alkyne coupling, the free hydroxyl of 242 
could be oxidised readily to ketone 243.  This could be followed by 
saponification of the ester to afford acid 241 (Scheme 93).  The reduction of the 
alkyne and removal of the PMB ether would afford the seco-acid 240, which 
after macrolactonisation would yield the desired macrocycle with the lactone 
already in place.  All that would remain would be removal of the MOM ether and 
acetonide protection groups, achievable in one step.  The only concern was 
regarding whether the saponification would proceed in the presence of the 
ketone as deprotonation may occur at the position α to the ketone. 
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Scheme 93:  First Possible Route. 
 
In the second possible route (Scheme 94) it was envisaged that the free hydroxyl 
of 242 could be oxidised readily to the ketone 243, after which the proceeding 
transformations would take place, culminating in the saponification of the ester 
to the carboxylic acid 240.  This seco-acid would then undergo 
macrolactonisation and the enone would already be in place.   
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Scheme 94:  Second Possible Route. 
 
Both methods described above are advantageous.  The benefits of oxidising the 
alcohol at position C6' earlier on in the synthesis, include the loss of a 
stereocentre and simplification of the NMR spectra. 
The final option is the direct saponification of secondary alcohol 242.  There 
were concerns about this method in the guise of whether the secondary alcohol 
could be oxidised in the presence of a carboxylic acid.  There was also some 
apprehension regarding the possibility of spontaneous cyclisation of the alcohol 
moiety onto the acid functionality. 
2.13.2 Practical Studies 
Oxidation of secondary alcohol 198 or 222 to ketone 245 or 246 respectively, 
proceeded smoothly and quantitatively under Swern oxidation conditions, with 
no need for any purification following work-up (Scheme 95).  In the 1H and 13C 
NMR spectra both showed clearly the disappearance of the alcohol and the newly 
formed carbonyl function of the ketone.  Ester hydrolysis was then attempted. 
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Scheme 95:  Oxidation then Saponification Method.  Reagents and Conditions: (a) (COCl)2, 
DMSO, Et3N, CH2Cl2, 2 h, –78 oC → rt, quant.. 
 
Alkali metal trimethylsilanolates (TMSO—M+) have been used widely for the 
efficient conversion of methyl esters to their acid salts under mild, non-aqueous 
conditions.  In comparison with other oxygen anions they are advantageous in 
that they have good solubility in organic solvents, such as dichloromethane and 
diethyl ether.  Encouraged by this and also the work published by Still and co-
workers[123] which shows the hydrolysis of esters using TMSOK.  Unfortunately the 
saponification of ketone 245 was unsuccessful under TMSOK conditions.  A 
characteristic colour change was observed on addition of TMSOK, but after 
prolonged stirring at room temperature no product 247 was witnessed.  This was 
confirmed after work-up when 1H NMR analysis still showed the clear presence of 
the methyl ester signal at 3.87 ppm.  Treatment of ester 246 under basic 
hydrolysis conditions (aq. KOH) also failed to hydrolyse the group to form 248.  
Despite this, it was pleasing to see that the TBS ether was unaffected by both 
sets of conditions and remained in place throughout.   
We tested whether the ester functionality of the newly generated secondary 
alcohol 222 can be directly saponified to allow the acid to be in place 
throughout the future transformations (Scheme 96).  Even after 48 hours under 
reflux there was no reaction observed, likewise there was no appearance of 
spontaneous cyclisation or side reactions and the unreacted starting material 
was recovered. 
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Scheme 96:  Direct Saponification of 222.  Reagents and Conditions:  (a) 2 N KOH, EtOH, 82 
oC, 48 h. 
 
During the studies described thus far we have simultaneously been considering 
and reviewing each step of the synthesis in order to determine whether it could 
be improved upon.  The routes to aromatic fragment 210 and alkene 208 are 
well established and robust and although the cross-metathesis step between the 
two is successful, there are disadvantages associated with it: 
• Long reaction time, 48 hours 
• Difficult and time consuming purification requiring two successive 
flash column chromatography steps 
• High catalyst loading 
• High cost of catalyst  
 
It has been found when repeating the reaction that the yields were not 
consistent and so this step was identified as holding potential for improvement.  
We did not wish to deviate from our original synthesis too much, so bearing this 
in mind we envisaged a Stille coupling between tin derivative 250 and aromatic 
unit 257.  The tin derivative is easily prepared in four steps from alkene 208, 
which has already been efficiently made.  A version of the aromatic fragment 
has already been made and only simple deviation from the original route is 
necessary. 
2.13.3 Stille Coupling 
The Stille reaction is one of the most influential synthetic tools in organic 
chemistry.  First reported in 1978,[124] the Stille coupling is the coupling between 
an organostannane and an organic electrophile to form a new C—C sigma bond 
and has been widely used for the palladium(0)-catalysed coupling of both 
aromatic and vinylic units (Scheme 97).   
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R' Sn(alkyl)3 R'' X R' R'' X Sn(alkyl)3
Pd(0) cat.
ligand  
Scheme 97:  General Formula of the Stille Coupling. 
 
There are numerous advantages associated with the Stille coupling including the 
mild conditions and the fact that the precursor organotin compounds tolerate a 
wide variety of functional groups and are not sensitive to moisture or oxygen.  
On the other hand there is a distinct disadvantage due to their toxicity and the 
difficulty in removing all traces of tin from the reaction mixture and also the 
major side reaction of homocoupling of the organostannane reagent.   
The detailed mechanism is still prone to discussion but the basic catalytic cycle 
(Figure 23) was proposed in 1979.[125]  Oxidative addition of the vinyl/aromatic 
triflate/halide gives a palladium(II) intermediate, which undergoes 
transmetallation with the prepared organostannane.  This gives an 
organopalladium intermediate which then undergoes a reductive elimination 
step, releasing the product and palladium(0) catalyst. 
LnPd(0)
LnPd(II)
LnPd(II) R'
R''
R'' X
R' R''
R' Sn(a lkyl)3
X Sn(alkyl)3
T ransmetall ation
Oxidat ive
Add ition
Reductive
Eli mination
 
Figure 23:  Catalytic Cycle for the Stille Coupling. 
 
Triflates are often used due to their ease of preparation, but typically lithium 
chloride is added to the reaction mixture because the triflate is a counter ion 
and is not bound to the metal as a ligand (Scheme 98).  If transmetallation is to 
occur another ligand must be added to give the necessary square coplanar 
geometry.  The catalyst is a 14 e-, Pd(0) complex and those used commonly are 
Pd(PPh3)4, Pd(dba)2 and Pd(II) catalysts such as Pd(OAc)2, PdCl2(MeCN)2 and 
PdCl2(PPh3)2 can also be used as precursors. 
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Scheme 98:  Stille Couplings with Triflates require the addition of LiCl.[119] 
 
2.13.4 Retrosynthetic Analysis to tert-Butyl-[(4R,5S)-2,2-
dimethyl-5-((E)-3-tributylstannyl-allyl)-[1,3]-dioxolan-4-
ylmethoxy]-dimethylsilane, 250 
As demonstrated in Scheme 99, it was hypothesised that vinylstannane could 
come from hydrostannylation of alkyne 70 which is the product of a Corey-Fuchs 
procedure from aldehyde 252 via dibromoolefin 251.  Aldehyde 252 is the direct 
result of ozonolysis of alkene 208. 
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Scheme 99:  Retrosynthetic Analysis of tributylstannane 250. 
 
2.13.5 Synthesis of tert-Butyl-[(4R,5S)-2,2-dimethyl-5-((E)-3-
tributylstannyl-allyl)-[1,3]-dioxolan-4-ylmethoxy]-dimethylsilane, 
250 
As discussed previously, silyl-protected alkene 208 can be made readily in three 
steps from 2-deoxy-D-ribose 179.  Continuation of the synthesis from alkene 208 
is shown in Scheme 100. 
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Scheme 100:  Synthesis of tributylstannane 250.  Reagents and Conditions: (a) O3, CH2Cl2, –78 
oC, 15 min then DMS, –78 oC → rt, h, 100%; (b) CBr4, PPh3, Zn dust, CH2Cl2, rt, 1.5 h, 100%; (c) 
nBuLi, THF, –78 oC, 2 h then H2O, –78 oC → 0 oC–rt, 61%; (d) PdCl2(PPh3)2), Bu3SnH, THF, 30 
min, rt, 79%. 
 
The first step following formation of the alkene is the formation of the aldehyde 
unit 252.  A classic method of transforming terminal olefins to aldehydes is 
through ozonolysis.  Ozonolysis is a 1,3-diolar cycloaddition, which cleaves π 
bonds oxidatively so two carbonyl groups are formed.  The procedure uses ozone 
which is a symmetrical molecule with a positively charged oxygen and two 
terminal oxygen atoms which share a negative charge (Figure 24). 
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O O O
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Figure 24:  Structure of Ozone. 
 
Mechanistically, the first step involves a 1,3-dipolar cycloaddition to generate 
molozonide.  The unstable molozonide decomposes instantly by a reverse 1,3-
dipolar cycloaddition (Scheme 101, Equation [1]).  The newly formed 1,3-dipole 
adds to the aldehyde in a second cycloaddition step to generate an ozonide.  
Dimethylsulfide is typically used to reduce the ozonide to give DMSO and two 
molecules of aldehyde (Scheme 101, Equation [2]). 
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Scheme 101:  Mechanism of Ozonolysis. 
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Ozonolysis of alkene 208 gave the desired aldehyde 252 with no need for 
purification, based on 1H analysis of the crude material.  The ozonolysis has been 
carried out on both milligram and multigram scales, with the unstable ozonide 
quenched with dimethylsulfide.  This was a lengthy process and required a high 
excess of DMS (approximately 450-500 equivalents), added periodically over a 
prolonged period (typically 3-5 days), in order for complete conversion to the 
aldehyde.  With aldehyde 252 in hand the next step was the transformation into 
terminal alkyne 70, utilising the well-known and reliable Corey–Fuchs 
reaction.[126] 
The Corey-Fuchs conversion of an aldehyde into a terminal alkyne calls for two 
steps, initial generation of the dibromoolefin and the sequential elimination of 
HBr and reduction of the bromoalkyne.  The first step can be achieved in two 
possible ways: (1) the aldehyde is added to a mixture of PPh3 and CBr4 in CH2Cl2 
at 0 oC; (2) zinc dust, PPh3 and CBr4 are mixed together in CH2Cl2 at ambient 
temperature and then the aldehyde is added to this mixture.  This first step is 
comparable to the Wittig reaction and yields are generally high (80-90%).   
The second step of the procedure is the conversion of the dibromoolefin to the 
terminal alkyne which is achieved by treatment with nBuLi in THF at —78 oC to 
promote lithium-halogen exchange.  This firstly rapidly forms the lithio 
derivative of the alkyne (lithium acetylide) which upon protonation produces the 
desired terminal alkyne. 
Scheme 102, Equation [1] shows the first steps of the mechanism in which the 
phosphorus ylide is generated and then Equation [2] shows reaction of this ylide 
with the aldehyde in a manner analogous to the Wittig reaction.  The mechanism 
for the conversion of the dibromoolefin to the alkyne is for the most part 
unknown but is thought to proceed as shown in Equation [3].  The sequential 
attack of two equivalents of nBuLi forms the lithium acetylide which after 
hydrolysis generates the terminal alkyne. 
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Scheme 102:  Mechanism of the Corey-Fuchs Reaction. 
 
To begin with, an aldehyde model system was used to test and establish the 
conditions required for formation of the alkyne.  Gratifyingly, the Corey-Fuchs 
reaction of the model system 253 proceeded cleanly to generate alkyne 255, via 
the dibromoolefin 254 (Scheme 103).[127] 
O HBr
Br
H
a b
253 254 255  
Scheme 103:  Test Corey-Fuchs Reaction.  Reagents and Conditions:  (a) PPh3, CBr4, CH2Cl2, 
20 h, 0 oC → rt, 98%; (b) nBuLi, –78 oC → rt, 2 h then H2O, rt, 1 h, 85%. 
 
Unfortunately, under the same conditions, aldehyde 252 proved slightly more 
troublesome than expected and required a little optimisation.  However, 
treatment of aldehyde 252 under the zinc-mediated olefination conditions[128] 
afforded the dibromoolefin 251 in quantitative yield.  The newly generated 
dibromoolefin was treated with nBuLi to generate alkyne 70 in 61% yield after 
purification.  It is worth mentioning that column purification is not required in 
every instance.  The decision on whether to perform FCC was taken after 
viewing the 1H NMR spectrum of the crude residue. 
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2.13.6 Hydrostannylation 
Organostannanes are of tremendous synthetic utility as building blocks in organic 
chemistry due to the considerable number of C—C bond forming reactions these 
intermediates undergo.  There are three main ways of forming a carbon-tin (C—
Sn) bond: 
1.  Reaction of a tin-metal compound (R3-SnM) with an alkyl halide 
2.  Reaction of an organometallic with a tin halide 
3.  Overall addition of a tin-hydride to an alkyne, alkene or allene. 
 
Method three is widely used due to the mild, neutral conditions and 
consequently there are multiple ways for addition of tin hydride: 
1.  Hydrostannylation under free-radical conditions 
2.  Stannylmetallation-protonation of an alkyne or alkene 
3.  Metal-catalysed hydrostannylation of an alkyne or alkene.   
 
Tributyltinhydride was first synthesised in 1947 by Finholt[129] and has since 
become one of the most popular organometallic and hydrostannation reagents in 
organic synthesis for the formation of vinyl- and allyl- stannanes, mainly due to 
its price and reactivity.[130]  The main problems for the stannylation of alkynes 
are the regio- and stereo-controls of the addition of the stannyl residue to the 
triple bond.  Bu3SnH is commercially available or can be prepared in situ from 
Bu3SnCl and Et3SiH in the presence of Lewis acid catalysts.
[131] 
Beginning from commercially available 2-deoxy-D-ribose, alkyne 70 can be 
readily obtained in six robust steps in 47% overall yield.  With the desired alkyne 
in hand it was thought that it could undergo hydrostannylation to afford the E-
vinylstannane 250 (Scheme 104).   
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Scheme 104:  Formation of E-Vinylstannane 250. 
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Disappointingly and frustratingly, this proved to be more problematic than 
initially anticipated and as a result various reaction conditions were attempted 
(Table 2). 
Entry Reagents Solvent Temperature Time Result 
1 AIBN 
 Bu3SnH 
Toluene 95 oC 24 h 85% 
E:Z + 
alkene 208 
2 Pd(PPh3)4 
Bu3SnH 
CH2Cl2 0 
oC to rt 20 min 68% 
E:Z + 
alkene 208 
3 PdCl2(PPh3)2 
Bu3SnH 
THF Room 
Temperature 
20 min 79% 
E:Z  
  
Table 2:  Attempted Conditions for the Formation of (E)-Vinylstannane 250. 
 
Radical hydrostannylation has been greatly studied and in general gives a 
mixture of stereoisomers with the regiochemistry controlled by the relative 
stability of the two possible intermediate β-stannyl radicals (Scheme 105).[129]  
The method is now less employed for the hydrostannylation of alkynes as the 
regio- and stereo-selectivities cannot be anticipated in advance, but it is still a 
popular radical cyclisation reaction.[130] 
SnR3
R3Sn
SnR3
R3Sn
Favoured β -add ition α -addit ion>  
Scheme 105:  Radical Hydrostannylation. 
 
Addition of azobis(isobutyronitrile) (AIBN) and tributyltinhydride (Bu3SnH) to 
alkyne 70 resulted in the formation of an E:Z-mixture of vinylstannane 250 and 
an unknown compound, later found to be alkene 208.  The isomers and the 
alkene were inseparable, although the yield was a reasonable 85%, suggesting no 
loss of product through side reactions or degradation. 
Stannylmetallation of alkynes can be separated into stoichiometric 
stannylcupration and stannymetallation in the presence of a transition-metal 
catalyst (Scheme 106, Equation [1]).  In the case of alkynes, metal-catalysed 
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hydrostannylation usually occurs with cis-stereoselectivity and good 
regioselectivity.  Palladium is the most widespread catalyst for the 
hydrostannylation and under the reaction conditions, palladium(II) complexes 
are reduced to the catalytically active palladium(0) species (Scheme 106, 
Equation [2]).   
R1 R2
H
R2R1
SnR3 R3Sn
R2
H
R1R3SnH
metal catalyst,
solvent
Pd(II) 2R3SnH Pd(0) (R3Sn)2 H2
[1]
[2]  
Scheme 106:  General Equation for the Hydrostannylation of Alkynes. 
 
In the first instance, stannylmetallation of alkyne 70 was attempted using 
tributyltinhydride (Bu3SnH) and tetrakis(triphenylphosphine)palladium(0) 
(Pd(PPh3)4).  This also resulted in an inseparable E:Z-mixture of product 250 and 
alkene 208, in slightly lower yield of 68%.  Additionally, PdCl2(PPh3)2 was utilised 
as the catalyst and Bu3SnH added.  By this stage, after intense investigation, a 
solvent system had been found to enable the separation of the E:Z-product 250 
from the alkene 208.  As a result, a final yield of 79% was obtained.   
2.13.7 Synthesis of Methyl 4-methoxy-2-(methoxymethoxy)-6-
(trifluoromethylsulfonyloxy)benzoate, 257 
With the kind provision of gram quantities of fully protected aromatic compound 
119 by Dr M. N. Robertson we were able to by-pass the initial stages of the 
synthesis.  Deprotection of silyl ether 119 under standard conditions afforded 
phenol 256 in high yield (Scheme 107).  Reprotection of the alcohol as its MOM 
ether, using MOMBr and Hunig's base, was extremely fruitful and the desired 
fully protected aromatic unit 257 was obtained in 90% yield. 
H3CO
MOMO O
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OTfH3CO OTf
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OCH3
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a b
119 256 257  
Scheme 107:  Synthesis of Aromatic Fragment 257.  Reagents and Conditions: (a) TBAF, THF, 
0 oC → rt, 2 h, 83%; (b) MOMBr, DIPEA, CH2Cl2, 0 oC → rt, 18 h, 90%. 
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Despite the mixture obtained as result of hydrostannylation of alkyne 70, it was 
decided that, rather than disregard the material, it would be used in an attempt 
to couple the triflate 257 (Scheme 108).  In 2004, Baldwin[132] reported that 
combining copper(I) iodide and cesium fluoride can significantly enhance the 
Stille reaction coupling with aryl halides and triflates.  These conditions were 
employed for our coupling partners, but despite promising TLC analysis, 
filtration of the reaction through Celite® was non-trivial and the subsequent 1H 
NMR spectrum of the crude material showed no coupled product.  
Disappointingly, none of the other attempted modified procedures gave any of 
the desired product.  In addition, the attempted coupling of triflate 257 and 
vinylstannane 250 with Pd(PPh3)4 and lithium chloride in 1,4-dioxane at 100 
oC, 
was also unsuccessful. 
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Scheme 108:  Attempted Stille Coupling of Triflate 257 and Vinylstannane 250. 
 
Faced with a rapidly depleting supply of alkyne 70, we chose to use 3-butyn-1-ol 
258 as a model system.  The primary alcohol was protected as its TBS silyl ether 
under standard conditions in 82% yield (Scheme 109).  TBS alkyne 259 was then 
subjected to a number of conditions to introduce the stannyl unit (Table 3). 
H
OH
H
OTBS OTBS
Bu3Sn
a b
258 259 260  
Scheme 109:  Synthesis of E-Vinylstannane 260.  Reagents and Conditions:  (a) TBDMSCl, 
DMAP, Et3N, CH2Cl2, rt, 18 h, 82%; (b) 'conditions', see Table 3. 
 
The most successful conditions were using AIBN and Bu3SnH (Table 3, Entry 5) 
giving vinylstannane 260 as an E:Z-ratio of 79:21 and quantitative yield.  This 
result is comparable to the literature,[133] where the authors achieved an 
inseparable 90:10 mixture of the E- and Z-vinylstannanes. 
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Entry Reagents Solvent Temperature Time Result 
1 CuCN, nBuLi, 
Bu3SnH 
THF –78 oC ~2 h total 
H
H SnBu3
OTBS  
2 Bistributyl tin, 
CuCN, nBuLi, 
MeOH 
THF –78 oC 18 h No 
product 
3 Pd(PPh3)4, 
Bu3SnH 
CH2Cl2 Room 
Temperature 
10 min Mix 3 
products 
4 Pd(PPh3)4, 
Bu3SnH 
THF Room 
Temperature 
10 min Mix 3 
products 
5 AIBN, 
Bu3SnH 
Toluene 80 oC 1.5 h 100% 
79:21 
E:Z 
  
Table 3:  Attempts at the Synthesis of 260. 
 
When palladium-catalysed conditions were employed (Table 3, Entry 3 and 4), a 
quick reaction time was observed. Unfortunately, the crude 1H NMR spectrum 
showed a mixture of three products 261, 262 and 263 (Figure 25). 
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Figure 25:  Products Obtained When Using Palladium-Catalysed Conditions. 
 
The stannylcupration of acetylenes was first discovered in 1981 when Piers and 
colleagues found that a trimethylstannyl copper or cuprate reagent added to 
acetylenic esters.[134]  Reaction of (trialkylstannyl)cuprates with terminal alkynes 
proceeds with high regio- and stereoselectivity via a vinylcopper intermediate.  
Stannylcupration of terminal alkyne 259 with the mixed organocuprate 
Bu3Sn(Bu)CuCNLi2,
[130] using two different reaction conditions gave mixed results.  
Both methods are involved and intricate procedures and while CuCN, nBuLi and 
Bu3SnH in THF gave exclusively 262, CuCN, nBuLi, bistributyltin and methanol in 
THF gave no product whatsoever.  Despite this, ongoing thought and 
investigation led to the attempt of the Stille coupling of vinylstannane 260 with 
aromatic triflate 119.  
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Scheme 110:  Successful Coupling to Generate 263.  Reagents and Conditions:  (a) LiCl, 
Pd(PPh3)4, 1,4-dioxane, 100 oC, 4 d, 21%. 
 
The reaction proceeded with 3 mol% of Pd(PPh3)4 in 1,4-dioxane at 100 
oC over 
four days.  The product was obtained as the pure E-isomer but disappointingly, 
the yield of product 263 was only 21%.  However, we were optimistic about the 
potential of the conditions.  As well as using triflates for palladium(0) catalysed 
couplings, iodides are also widely used.  With this in mind, studies commenced 
into determining whether the corresponding aryl iodide would be a more 
effective coupling partner than the aryl triflate 119.  Aryl triflates can be 
readily converted into iodides through treatment with NaI in DMF at 80 oC.[135]  
Upon applying these conditions to aryl triflate 119, the TBS protecting group 
was also cleaved during the transformation.  Taking advantage of this, phenol 
264 was protected as its MOM ether 18 in 98% yield (Scheme 111).      
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Scheme 111:  Formation of Aryl Iodide 18.  Reagents and Conditions:  (a) NaI, DMF, 80 oC, 4 h; 
(b) MOMBr, DIPEA, CH2Cl2, 0 oC → rt, 24 h, 98%. 
 
Both PdCl2(PPh3)4 and Pd(PPh3)4 were used in our attempts to couple iodide 18 
and vinylstannane 260 (Scheme 112).  Progression of the reactions was followed 
by TLC analysis and to begin with there appeared to be the formation of a new 
product with the slow consumption of starting materials.  Despite the promising 
beginning, after work-up and subsequent FCC to isolate the newly formed spot, 
no desired product was identified. 
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Scheme 112:  Coupling of Aryl Iodide 18 and Vinylstannane 260.  Reagents and Conditions:  
(a) PdCl2(PPh3)2, DMF, 80 oC, 4 d; (b) Pd(PPh3)4, toluene, 100 oC, 3 d. 
 
2.13.8 Sonogashira Couplings 
An alternative to using a Stille coupling involved the use of a Sonogashira 
coupling.[39]  This would directly couple alkyne 70 to aryl triflate 257 (Scheme 
113).   
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Scheme 113:  Sonogashira Coupling of Aryl Triflate 257 and Terminal Alkyne 70. 
 
We were extremely hopeful about the Sonogashira coupling as there is ample 
literature precedence demonstrating its usefulness in coupling terminal alkynes 
and aryl/vinyl halides (Scheme 114). 
H R1 R2 X
Pd, Cu+
Base
R1 R2 H X
 
Scheme 114:  General Scheme for the Sonogashira Coupling. 
 
The Sonogashira coupling is catalysed by two catalysts; a palladium(0) complex 
and a copper(I) co-catalyst.  The palladium complex activates the organic 
halides by oxidative addition into the carbon-halogen bond.  The copper co-
catalyst reacts with the terminal alkyne and produces copper(I) acetylide, which 
acts as an activated species for the coupling reactions.  The reaction conditions 
must be anhydrous, although newer procedures have been developed that 
increase its versatility.  Liang and co-workers,[136] have developed a copper-free 
procedure where the Sonogashira coupling takes place with PdCl2 in water under 
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aerobic conditions.  Mori's procedure,[137] on the other hand, is carried out in 
aqueous ammonia, PdCl2(PPh3)2 and copper iodide in THF.  So as to neutralise 
the hydrogen halide by-product the reaction must be basic.  Triethylamine and 
diethylamine are often used as solvents, though DMF and diethyl ether are also 
suitable. 
The mechanistic cycle of the Sonogashira coupling is shown in Scheme 115.  The 
first step involves the oxidative addition of palladium(0) A with the aryl 
halide/triflate to generate the Pd(II) complex B.  The complex reacts in a 
transmetallation with the copper acetylide (produced in the copper cycle) to 
complex C, ejecting the copper halide F.  Trans-cis isomerisation of the ligands 
form complex D. 
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Scheme 115:  Mechanism of the Sonogashira Coupling.[138] 
 
Regrettably, all coupling attempts using alkyne 70 and aryl triflate 257 failed to 
yield any of the desired product (Scheme 113).  Interestingly, the Sonogashira 
coupling of the silyl-protected alkyne model system 259, with either aryl triflate 
119 or aryl iodide 267, proved futile (Scheme 116).  It served only to afford 
unreacted starting materials. 
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Scheme 116:  Sonogashira Coupling of Aryl Triflate 119 or Aryl Iodide 267 and Terminal 
Alkyne 259.  Reagents and Conditions:  PdCl2(PPh3)2, CuI, Et3N, CH3CN, rt. 
 
The fact that the Stille couplings were more promising than the Sonogashira 
couplings, made us hopeful that a tributylstannane might prove more 
reactive.[139]  Treatment of alkyne 259 with nBuLi and Bu3SnCl gave the desired 
stannane 269, which was found to be unstable and had to be used immediately 
in the next step (Scheme 117). 
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Scheme 117:  Activation of Alkyne 259 and Subsequent Coupling Attempt.  Reagents and 
Conditions:  (a) nBuLi, THF, 0 oC, 1 h then Bu3SnCl, 0 oC → rt, 19 h, 69%; (b) LiCl, Pd(PPh3)4, 1,4-
dioxane, 100 oC, 4.5 h, 33%. 
 
Stannane 269 was successfully coupled with aryl triflate 119 to afford the 
desired coupled product 268 in 33% yield.  Despite the relatively low yield, the 
result was both pleasing and encouraging.  With this product in hand, our 
attention could now turn to reduction of the triple bond to the E-double bond.  
Unfortunately, literature searches did not yield any procedures for doing this.  A 
possibility was to use Na/NH3, but due to the functionality already present and 
the nature of the compound this was not deemed suitable.  As an alternative, 
the triple bond could be reduced to the Z-alkene using Lindlar's catalyst.  Once 
the Z-double bond has been generated, a double bond isomerisation could be 
performed.[36,97,98]  Once again we elected to use a model substrate in order to 
test the reaction conditions (Scheme 118).  3-Iodoanisole 270 was coupled with 
propargyl alcohol 271 in the presence of PdCl2(PPh3)2, copper(I) iodide and 
triethylamine[140] to afford the desired internal alkyne 272 in 82% yield. 
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Scheme 118:  Synthesis of Alkynol 272.  Reagents and Conditions:  (a) 271, PdCl2(PPh3)2, CuI, 
Et3N, CH3CN, rt, 16 h, 82%. 
 
The reduction of alkynol 272 proved to be slightly more complicated than 
originally expected.  Treatment of alkynol 272 with Pd/BaSO4 and quinoline led 
to over-reduction to give the completely saturated product 273 (Scheme 119).  
Reduction of alkynol 272 using Pd(OAc)2, NaOMe and PPh3 also failed to give any 
of the desired product.[141] 
OCH3
OH
OCH3
OHa
272 273  
Scheme 119:  Over-reduction of Alkynol 272 to Alkane 273.  Reagents and Conditions:  (a) H2, 
Pd/BaSO4, quinoline, MeOH, 2 h, 72%. 
 
Seeking to remove the risk of the hydroxyl group coordinating to the palladium 
and aiding in the over-reduction, the hydroxyl group was protected as its silyl 
ether (Scheme 120).  Hydrogenation of the silyl ether 274 was then carried out 
in two simultaneous reactions.  One reaction was stopped after 30 minutes and 
the other after 60 minutes.  After 30 minutes, the 1H NMR spectrum showed an 
inseparable mixture of starting alkyne 274, desired alkene 275 and alkane 276.  
After 60 minutes alkane 276 was the only product. 
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Scheme 120:  Protection of Alkynol 272 and Reduction of Alkyne 274.  Reagents and 
Conditions:  (a) TBDMSCl, DMAP, Et3N, CH2Cl2, rt, 18 h, 78%; (b) H2, Pd/BaSO4, quinoline, 
MeOH, 30 min or 1 h. 
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Despite being a mixture, the reaction material isolated following the 30 minute 
procedure was taken in order to attempt isomerisation reactions (Scheme 121). 
OCH3 OCH3
OTBS
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275 277  
Scheme 121:  Double bond Isomerisation of Alkene 275. 
 
None of the conditions tried (PdCl2(CH3CN)2 and Pd(OAc)2/Bu3SnH/Et3N) were 
successful and didn't provide much scope for using this method as part of our 
synthesis.  The C1'—C2' double bond has been successfully isomerised successfully 
by Tatsuta and co-workers[36] in their synthesis of LL-Z1640-2, though the 
palladium catalyst employed is expensive and time constraints prevented us 
from attempting this procedure. 
As we had our Sonogashira product 268 in hand, we wanted to proceed and 
attempt the hydrogenation (Scheme 122).  Treatment of alkyne 268 with 
Lindlar's catalyst afforded Z-olefin 278 in 52% yield, as confirmed by 1H and 
HRMS.   
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Scheme 122:  Reduction of Alkyne 268.  Reagents and Conditions:  (a) H2, Pd/BaSO4, quinoline, 
MeOH, rt, 2 h, 52%.   
 
At this point in the investigation, this particular route seemed to have hit a 
stumbling block due to the failure of the isomerisation reaction and so it was 
necessary to investigate alternative ways of introducing the E-double bond.  
Although Sonogashira product 268 can be achieved, the yield is low and it was 
postulated whether the aromatic ring may be too substituted.  To test this 
theory, iodobenzoate 280 was synthesised from 2-iodobenzoic acid 279 using 
Fischer esterification[142] and then coupled with alkyne 259 via a Sonogashira 
Suzannah J. Harnor, 2010  130 
coupling.  The desired coupled product 281 was obtained in 71% yield (Scheme 
123). 
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Scheme 123:  Formation of Iodobenzoate 280 and Subsequent Coupling.  Reagents and 
Conditions:  (a) H2SO4, MeOH, reflux, 7 h, 82%; (b) PdCl2(PPh3)2, CuI, Et3N, MeCN, rt, 2 h, 71%. 
 
Takano and co-workers[143] showed that LiAlH4 could selectively transform their 
alkyne 282 into the corresponding E-olefin 283 (Scheme 124).  In our case, this 
would reduce the ester functionality, but if the alkyne could be reduced 
selectively then the formed alcohol could be converted back to the ester.  In our 
hands the procedure wasn't successful, with only trace amounts of alcohol 284 
recovered from the reaction.  The desired E-olefin 285 was not generated. 
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Scheme 124:  Alkyne Reduction Using LiAlH4.  Reagents and Conditions:  (a) LiAlH4, THF, 
reflux, 75 min; (b) LiAlH4, THF, reflux, 24 h. 
 
It was at this stage that time restraints were encountered and with no additional 
progress having been made, the focus turned to areas which could be further 
investigated and the practical work that could be pursued in the future. 
2.14 Future Work 
As noted previously, Carreira and colleagues published their facile synthesis of 
optically active propargylic alcohols 195 from aldehydes, using N-
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methylephedrine 194 as the chiral additive, with 99% e.e. and good yields.[91]  
When we came to employ these conditions for the addition of alkyne 55, we 
encountered problems regarding the stability of aldehyde 197.  This was solved 
and overcome with the development of the one-pot procedure.  The one pot 
oxidation-Grignard addition procedure, allowing the addition of the required 
alkyne unit to the freshly generated aldehyde, was highly successful but the 1H 
NMR spectra for this and subsequent reactions were rather complicated to 
interpret and assign.  An ideal situation would be to enhance and improve the 
total synthesis by exploring further methods that would allow an asymmetric 
synthesis of propargylic alcohol 235.  Following a search of the literature we 
became interested in two methods.[144] 
In 2005, Yamashita[144a] published their findings based on the catalytic 
asymmetric alkynylation of aldehydes with terminal alkynes by chiral alcohol 
(1R,2R)-2-(dimethylamino)-1,2-diphenylethanol 286 (Figure 26), which forms a 
more stable bimetallic complex 287 (than (+/-)-N-methylephidrine) with no 
steric interactions. 
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Figure 26:  Structure of (1R,2R)-2-(dimethylamino)-1,2-diphenylethanol 286 and its Bimetallic 
Complex 287. 
 
The authors concluded that by employing a straightforward procedure and using 
0.22 equivalents of chiral amino alcohol 286, zinc triflate (0.2 eq.) and 
triethylamine (0.5 eq.) in toluene at room temperature, they could bring about 
the asymmetric addition with the enantioselectivity reaching up to 98% (Scheme 
125). 
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Scheme 125:  Example of Chiral Amino Alcohol Mediated Catalytic Asymmetric 
Alkynylation. 
Suzannah J. Harnor, 2010  132 
In 1994, Fujisawa[144b] reported the use of zinc(II) bromide in the highly 
diastereoselective addition of acetylide to a chiral aldehyde.  It is postulated 
that we could potentially apply the method to using our chiral terminal alkyne 
and aldehyde.  The bromozinc acetylide is prepared from the lithium acetylide 
via transmetalation with ZnBr2.  The authors report a reaction time of 15 h, with 
an isolated yield of 81% and >99:1 syn:anti.  Additionally, we would seek to 
investigate Carreira's method further in the hope that optimisation would allow 
the reaction to proceed. 
It was touched upon in 2.13.1 and 2.13.2 that the free hydroxyl of 242 could be 
oxidised readily to the ketone, after which the proceeding transformations 
would take place, culminating in the saponification of the ester to the carboxylic 
acid.  This seco-acid would then undergo macrolactonisation and the enone 
would already be in place.  As time and quantities of material didn't allow the 
trial of this method but it would advantageous to attempt this in order to 
determine whether the enone can be in place throughout the following 
transformations.  This would mean that when the seco-acid is subjected to 
macrolactonisation the product already has the enone in place and all that 
remains is the global deprotection. 
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3 Experimental 
3.1 General Methods 
All reactions were performed under an inert argon atmosphere unless otherwise 
noted.  Reagents and starting materials were obtained from commercial sources 
and used as received, unless otherwise specified.   
Anhydrous dichloromethane (DCM), diethyl ether, toluene and tetrahydrofuran 
(THF) were freshly obtained from in-house solvent purification system, Pure Solv 
400-5MD (Innovative Technology, Inc).  Anhydrous dimethylformamide (DMF) and 
triethylamine (TEA) were purchased from Aldrich Chemical Company.  Petroleum 
ether refers to that with boiling fraction 40—60 oC.  Solutions worked up were 
concentrated under reduced pressure at < 45 oC using a Buchi Rotavapor. 
Melting points were determined using Stuart Scientific Melting Point SMP1 
apparatus. 
Optical rotations were determined as solutions irradiating with the sodium D line 
(λ = 598 nm) using an AA series automatic polarimeter.  [ ]Dα  values are given in 
units 10-1 deg cm2 g-1. 
Infrared (IR) spectra were recorded as thin films on sodium chloride (NaCl) 
plates using a JASCO FTIR 410 spectrometer.  Only significant absorptions (νmax) 
are reported in wavenumbers (cm-1). 
Proton magnetic resonance spectra (1H NMR) were recorded at 400 MHz using a 
Bruker DPX-400 spectrometer for sample solutions in CDCl3, unless otherwise 
indicated.  Chemical shifts (δH) are reported in parts per million (ppm) and are 
referenced to the residual solvent peak.  The order of citation in parentheses is 
(1) number of equivalent nuclei (by integration) (2) multiplicity (s = singlet, d = 
doublet, t = triplet, q = quartet, qn = quintet, sext. = sextet, oct. = octet, m = 
multiplet, br = broad) (3) coupling constant (J) quoted in Hertz to the nearest 
0.1 Hz and (4) proton assignment.  For relevant compounds, the OH signal was 
identified by D2O exchange. 
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Carbon magnetic resonance spectra (13C NMR) were recorded at 100 MHz using a 
Bruker DPX-400 spectrometer for sample solutions in CDCl3, unless otherwise 
indicated.  Chemical shifts (δC) are quoted in parts per million (ppm) and are 
referenced to the residual solvent peak.  For larger, more complex compounds, 
the structure is shown with numbered carbon atoms to assist with the 13C 
assignment. 
Mass spectra were obtained using a JEOL JMS-700 spectrometer.  
TLC was performed on aluminium backed plates pre-coated with silica gel 60 
(Kieselgel 60 F254 aluminium plates, Merck) with A, petroleum ether-ethyl 
acetate (8:2); B, petroleum ether-ethyl acetate (7:3); C, petroleum ether-ethyl 
acetate (6:4); D, petroleum ether-ethyl acetate (9:1); E, petroleum ether-ethyl 
acetate (9.5:0.5); F, petroleum ether-diethyl ether (9.5:0.5); G, toluene-ethyl 
acetate (8:2); H, petroleum ether-ethyl acetate (2:8); I, petroleum ether-ethyl 
acetate (5:5); J, petroleum ether-ethyl acetate (3:7); K, chloroform-ethyl 
acetate (6:4); L, petroleum ether (10:0); M, petroleum ether-ethyl acetate 
(4:6); N, petroleum ether-diethyl ether (7:3); O, petroleum ether-ethyl acetate 
(2:8); P, petroleum ether-diethyl ether (9:1); Q, hexanes (10:0); R, petroleum 
ether-diethyl ether (8:2); S, petroleum ether-diethyl ether (5:5) as developers 
and detection under UV light (λmax 254 nm) and/or by staining with 
anisaldehyde, unless otherwise specified, followed by heating. 
Flash column chromatography (FCC) was performed using Apollo Scientific silica 
gel 60 (0.040-0.063 mm), with the appropriate eluting solvent and elution 
gradient, shown in square brackets as part of the procedure, e.g. purification by 
FCC [petroleum ether-ethyl acetate (85:15)→(75:25)→(60:40)→(50:50)] of the 
crude residue....  
The following chemicals were used at the concentrations given, unless otherwise 
stated: 
• tetra-Butylammonium fluoride (TBAF), 1 M in tetrahydrofuran  
• Oxalyl chloride, 2 M in dichloromethane  
• Ethyl Magnesium Bromide (EtMgBr), 3 M in diethyl ether  
• Potassium bis(trimethylsilyl)amide (KHMDS), 0.5 M in toluene 
• n-Butyllithium (nBuLi), 2.5 M in hexanes. 
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3.2 Synthesis and Characterisation of Compounds 
Methyl 2,4-Dihydroxy-6-methylbenzoate 169[145a] 
OCH3
OOH
HO  
Sodium hydride (5.16 g, 129 mmol, 60% dispersion in mineral oil) was washed 
with petroleum ether (2×10 cm3), suspended in anhydrous THF (50 cm3) and 
then cooled to 0 oC under an argon atmosphere.  Methyl acetoacetonate (9.3 
cm3, 86.1 mmol) was then added dropwise, the solution cooled to —78 oC and 
nBuLi (32.7 cm3, 81.8 mmol) was added.  The reaction mixture was then allowed 
to warm up to room temperature overnight.  The mixture was heated under 
reflux for 24 h, cooled to room temperature and acidified to pH 1-2 with 6 M 
aqueous hydrochloric acid.  The mixture was stirred overnight and the biphasic 
mixture was extracted with ethyl acetate (3×50 cm3).  The organic layers were 
combined, dried over anhydrous sodium sulfate, filtered and concentrated in 
vacuo.  Purification by FCC [petroleum ether–ethyl acetate 
(85:15)→(75:25)→(60:40)→(50:50)] of the crude residue afforded 169 (5.1 g, 
65%) as a pale yellow solid; mp 130-132 oC (rec. from petroleum ether-ethyl 
acetate) (lit.,[145a] 136-138 oC); δH(400 MHz; CDCl3) 2.44 (3 H, s, CH3), 3.90 (3 H, 
s, CO2CH3), 6.05 (1 H, s, HC(COH)2), 6.60 (1 H, s, HCCCH3), 9.40 (1 H, s, OH) and 
11.80 (1 H, s, OH).  The spectral data matches that reported in the 
literature.[145a]   
Also isolated was 2,4-dihyroxy-6-methyl benzoic acid (1.8 g, 25%) as a yellow 
solid; δH(400 MHz; CDCl3) 2.46 (3 H, s, CH3), 6.20 (1 H, s, HC(COH)2), 6.77 (1 H, 
s, HCCCH3), 9.45 (1 H, s, OH), 11.80 (1 H, s, OH) and 12.70 (1 H, s, COOH). 
Methyl 2-hydroxy-4-methoxy-6-methylbenzoate 168[145b] 
OCH3
OOH
H3CO  
To a stirred solution of phenol 169 (1.3 g, 7.32 mmol) in a mixture of 
chloroform/methanol (3:1, 35 cm3) at 0 oC was added 
(trimethylsilyl)diazomethane (4.4 cm3, 8.78 mmol, 2 M in diethyl ether) under an 
argon atmosphere.  The solution was stirred at 0 oC for 3 h and then allowed to 
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warm up to room temperature overnight.  The solution was recooled to 0 oC and 
a second aliquot of (trimethylsilyl)diazomethane (2.2 cm3, 4.39 mmol, 2 M in 
diethyl ether) was added.  After 2 h at 0 oC, the solution was allowed to warm to 
room temperature overnight and the solvent was removed in vacuo.  Purification 
by FCC [petroleum ether-ethyl acetate (95:5)] of the crude residue afforded 
methyl ether 168 (0.97 g, 89%) as a white solid; mp 130-132 oC (rec. from 
petroleum ether-ethyl acetate); νmax(film)/cm
-1 3594 (OH), 1671 (C=O) and 1601 
(C=C); δH(400 MHz; CDCl3) 2.51 (3 H, s, CH3), 3.74 (3 H, s, OCH3), 3.93 (3 H, s, 
CO2CH3), 6.30 (1 H, dd, J 0.4 and 2.4, HCOH), 6.34 (1 H, d, J 2.8, CH) and 11.78 
(1 H, s, OH); δC(100 MHz; CDCl3) 22.1 (CH3), 52.1 (COOCH3), 55.7 (OCH3), 101.0 
(HCCOH), 105.3 (CCOOCH3), 111.2 (HCCCH3), 142.9 (HCCCH3), 164.5 (COH), 
162.6 (COCH3) and 170.3 (C=O); MS (EI) m/z 197 [M+H]
+; HRMS m/z 197.0816 
(197.0814 calcd for C10H13O4, M+H
+).  The spectral data matches that reported in 
the literature.[145b] 
Methyl 2-acetoxy-4-methoxy-6-methylbenzoate 167[146] 
OCH3
OO
H3CO
O
 
To a solution of methyl ether 168 (1.74 g, 8.89 mmol) in dry dichloromethane 
(45 cm3) at 0 oC, was added sequentially pyridine (0.93 cm3, 1.56 mmol), acetic 
anhydride (1.26 cm3, 13.3 mmol) and dimethylaminopyridine (0.54 g, 4.44 
mmol).  The reaction mixture was stirred under argon for 2 h and then allowed 
to warm to room temperature, whereafter the solvent was removed in vacuo.  
Purification by FCC [petroleum ether-ethyl actetate (70:30)] of the crude 
residue afforded acetate 167 (2.05 g, 97%) as a pale yellow oil; Rf 0.31 (solvent 
A); νmax(film)/cm
-1 1777 (C=O), 1609 (C=C), 1280 and 1151; δH(400 MHz; CDCl3) 
2.30 (3 H, s, OCOCH3), 2.44 (3 H, s, CH3), 3.30 (3 H, s, OCH3), 3.88 (3 H, s, 
COOCH3), 6.49 (1 H, d, J 2.4, CH) and 6.67 (1 H, d, J 2.4, CH); δC(100 MHz; 
CDCl3) 20.1 (H3CC=O), 22.1 (CH3), 52.7 (C=OOCH3), 55.9 (OCH3), 108.8 (CH), 
110.4 (CH), 114.7 (CC=OOCH3), 140.1 (CCH3), 151.4 (COC=OCH3), 161.6 (COCH3), 
165.7 (COC=OCH3) and 169.8 (C=O).  All spectral data matches that reported in 
the literature.[146] 
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Methyl 2-acetoxy-6-bromomethyl-4-methoxybenzoate 166[147] 
OCH3
OO
H3CO
O
Br
 
To a stirred solution of acetate 167 (2.05 g, 8.62 mmol) in carbon tetrachloride 
(200 cm3) was added 1,3-dibromo-5,5-dimethylhydantoin (1.43 g, 4.99 mmol) 
and benzoyl peroxide (0.21 g, 0.86 mmol).  The solution was heated under reflux 
under an argon atmosphere for 3.5 h and then cooled to room temperature, 
filtered and the solvent concentrated in vacuo.  Purification by FCC [petroleum 
ether-ethyl acetate (95:5)→(90:10)→(85:15)] of the crude residue afforded 
bromide 166 (2.58 g, 95%) as a yellow oil, which solidifies upon freezing; Rf 0.41 
(solvent A); mp 49-51 oC (rec. from petroleum ether-ethyl acetate); δH(400 
MHz;CDCl3) 2.30 (3 H, s, OCOCH3), 3.86 (3 H, s, OCH3), 3.93 (3 H, s, COOCH3), 
4.71 (2 H, s, CH2Br), 6.61 (1 H, d, J 2.5, CH) and 6.89 (1 H, d, J 2.5, CH); δC(100 
MHz; CDCl3) 20.3 (H3CC=O), 30.9 (CH2Br), 52.4 (C=OOCH3), 55.7 (OCH3), 108.9 
(CH), 110.4 (CH), 114.6 (CC=OOCH3), 140.1 (CCH2Br), 151.1 (COC=OCH3), 161.6 
(COCH3), 165.5 (COC=OCH3) and 169.1 (C=OOCH3).  All spectral data matches 
that reported in the literature.[147] 
Methyl 2-acetoxy-6-(diethoxy-phosphorylmethyl)-4-methoxybenzoate 189 
OCH3
OO
H3CO
O
P(OEt)2
O  
Bromide 166 (350 mg, 1.10 mmol) was dissolved carefully in triethyl phosphite 
(0.23 cm3, 1.35 mmol) and then heated in the microwave at 180 oC for 26 min.  
After cooling down to room temperature, water (10 cm3) was added and then 
the solution was extracted with ethyl acetate (5×15 cm3).  The combined 
organic layers were washed with saturated sodium chloride (2×15 cm3), dried 
over anhydrous sodium sulfate, filtered and concentrated in vacuo.  Short pass 
distillation removed excess triethyl phosphite from the crude residue to afford 
phosphonate 189 (193 mg, 58%) as a yellow oil; Rf 0.41 (solvent B); 
νmax(film)/cm
-1 2982, 1773, 1720, 1612 (C=C), 1192 (P=O) and 1151; δH(400 MHz; 
CDCl3) 1.20 (3 H, t, J 7.0 , CH2CH3), 1.30 (3 H, t, J 7.0, CH2CH3), 2.24 (3 H, s, 
OC=OCH3), 3.50 (2 H, d, 
2JP-H 22.5, CH2), 3.79 (3 H, s, OCH3), 3.83 (3 H, s, 
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COOCH3), 3.98 (2 H, q, J 7.0, CH2CH3), 4.07 (2 H, q, J 7.0, CH2CH3), 6.52 (1 H, d, 
J 1.8, CH) and 6.78 (1 H, d, J 1.8, CH); δC(100 MHz; CDCl3) 14.5 (2×CH2CH3), 
19.3 (CH3C=OO), 30.4 (CH2), 50.3 (COOCH3), 53.8 (OCH3), 60.4 (2×CH2CH3), 
104.4 (CHAr), 106.0(CHAr), 116.4 (CCOOCH3), 138.9 (CCH2), 149.2 (CO), 159.5 
(COCH3), 164.3 (CH3C=O) and 167.2 (C=OOCH3); MS (EI) m/z 374 [M]
+; HRMS m/z 
374.1125 (374.1131 calcd for C16H23O8P, M
+) 
(3-Acetoxy-5-methoxy-2-methoxycarbonylbenzyl)-triphenylphosphonium 
bromide 165[147] 
OCH3
OO
O
H3CO
PPh3Br
 
To a stirred solution of bromide 166 (2.08 g, 6.56 mmol) in toluene (33 cm3) was 
added triphenylphosphine (1.89 g, 7.21 mmol) and the reaction mixture heated 
to 110 oC for 24 h under argon.  After allowing the reaction to cool down to room 
temperature, the solid was filtered under vacuum, washed with petroleum ether 
and allowed to air dry to afford phosphonium salt 165 (2.48 g, 65%) as a cream 
solid; mp 183-186 oC (rec. from petroleum ether); δH(400 MHz; CDCl3) 2.20 (3 H, 
s, OCOCH3), 3.37 (3 H, s, OCH3), 3.70 (3 H, s, COOCH3), 5.90 (2 H, d, 
2JP-H 15.1, 
CH2), 6.55 (1 H, t, J 2.4, CHCCH2), 7.38 (1 H, t, J 2.7, CH) and 7.60-7.80 (15 H, 
m, 3×Ph); δC(100 MHz; CDCl3) 20.1 (OCOCH3), 54.5 (CO2CH3), 55.7 (OCH3), 60.0 
(CH2), 102.9 (CH), 110.0 (CH), 112.4 (CCO2CH3), 128.6 (9×CH), 136.1 (6×CH), 
137.8 (3×P-C), 139.9 (CCH2), 151.0 (COCOCH3), 165.6 (COCH3), 169.0 (OCOCH3) 
and 171.2 (CO2CH3); δP 24.1.  All spectral data matches that reported in the 
literature.[147] 
2-Deoxy-3,4-O-isopropylidene-D-pentopyranose 144[51] 
O
OH
O
O
 
Under an argon atmosphere, a —10 oC stirred solution of 2-deoxy-D-ribose (3.0 g, 
22.4 mmol) in ethyl acetate (150 cm3) was treated with 2-methoxypropene (2.8 
cm3, 29.1 mmol) and pyridinium p-toluenesulfonate (224 mg, 0.694 mmol).  The 
solution was allowed to stir at —10 oC for 2.5 h before allowing it to warm up to 
room temperature overnight.  The reaction was quenched with triethylamine 
(1.5 cm3) and then concentrated in vacuo.  Purification by FCC [petroleum 
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ether-ethyl acetate (90:10)→(80:20)→(70:30)→(50:50)] of the crude residue 
afforded ketal 144 (2.39 g, 62%) as a white solid; Rf 0.30 (Solvent M); [ ]20Dα  –29.3 
(c 1.1, CHCl3) (lit.,
[51] [ ]21Dα  –46.0 (c 0.1, water); νmax(film)/cm-1 2984 (OH), 2938, 
1663, 1369; δH(400 MHz; CDCl3) (major α anomer) 1.31 (3 H, s, CH3), 1.48 (3 H, 
s, CH3), 1.75 (1 H, ddd, J 4.2, 7.0 and 14.8, CH2CHOH), 2.22 (1 H, dt, J 4.2 and 
14.8, CH2CHOH), 3.67 (1 H, dd, J 3.6 and 12.7, CH2), 3.94 (1 H, dd, J 3.6 and 
12.7, CH2), 4.12-4.16 (1 H, m, CHOC), 4.41-4.47 (1 H, m, CHOC) and 5.23 (1 H, 
dd, J 4.2 and 7.2, CHOH); δC(100 MHz;CDCl3) 25.4 (CH3), 27.3 (CH3), 32.1 (CH2), 
62.1 (CH2COH), 70.8 (CH), 71.6 (CH), 90.9 (COH) and 108.8 (C(CH3)2); MS (EI) 
m/z 197 [M]+; HRMS m/z 197.0772 (197.0784 calcd for C8H14NaO4, M
+); δH(400 
MHz; CDCl3) (minor β anomer) 1.32 (3 H, s, CH3), 1.57 (3 H, s CH3), 2.10 (2 H, t, 
J 3.8, CH2CHOH), 3.65-3.71 (1 H, m, CH2), 3.95-4.02 (1 H, m, CH2), 4.13-4.23 (1 
H, m, CHOC), 4.43-4.45 (1 H, m, CHOC) and 5.09 (1 H, m, CHOH).  All spectral 
data matches that reported in the literature.[51] 
Methyl 2-hydroxy-6-{(E/Z)-3-[(4S,5R)-5-hydroxymethyl-2,2-dimethyl-
[1,3]dioxolan-4-yl]-propenyl}-4-methoxybenzoate 185 
OH
H3CO
O
OCH3
OH
O
O
 
Procedure A 
Sodium hydride (60% in mineral oil, 0.27 g, 6.65 mmol) was washed with 
petroleum ether (2×5 cm3), suspended in dry tetrahydrofuran (13 cm3) and 
added via cannula to a solution of phosphonium bromide 165 (3.70 g, 6.43 
mmol) in dry tetrahydrofuran/dimethylformamide (5:1, 18:3.5 cm3), all under an 
argon atmosphere.  Stirring was continued for 45 min and then a solution of 
lactol 144 (0.75 g, 4.29 mmol) in dry tetrahydrofuran (13 cm3) was added and 
the mixture heated at 80 oC for 30 min.  The solution was allowed to cool down 
to room temperature and then sodium methoxide (25% solution in methanol, 
1.02 cm3, 4.72 mmol) was added and the stirring continued for a further 15 min.  
The reaction mixture was diluted with water (50 cm3) and extracted with ethyl 
acetate (3×50 cm3). The combined organic layers were dried over anhydrous 
sodium sulfate, filtered and concentrated in vacuo.  Purification by FCC 
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[petroleum ether-ethyl acetate (80:20)→(70:30)→(60:40)] of the crude residue 
afforded diol 185 (0.61 g, 40%) as a yellow oil and as a 3:2 (E:Z) inseparable 
mixture of isomers; [ ]24Dα  –1.2 (c 1.0, CHCl3); δH(400 MHz; CDCl3) (E-isomer) 1.38 
(3 H, s, CCH3), 1.50 (3 H, s, CCH3), 2.41-2.50 (2 H, m, CH2), 3.71 (2 H, d, J 6.2, 
CH2OH), 3.80 (3 H, s, OCH3), 3.93 (3 H, s, COOCH3), 4.12-4.19 (1 H, m, 
CH=CHCH2CH), 4.33 (1 H, q, J 6.2, CHCH2OH), 5.89-5.98 (1 H, m, CH=CHCH2), 
6.39 (1 H, d, J 2.6, CHAr), 6.46 (1 H, d, J 2.6, CHAr), 7.02 (1 H, d, J 15.5, 
CH=CHCH2) and 11.58 (1 H, s, OH); Z-isomer (inter alia) 5.61-5.67 (1 H, m, 
CH=CHCH2) and 6.76 (1 H, d, J 11.4, CH=CHCH2); δC(100 MHz; CDCl3) (E-isomer) 
25.5 (2×CH3), 32.9 (CH2), 52.2 (O=COCH3), 55.5 (OCH3), 61.6 (CH2OH), 77.8 
(CH=CHCH2CHO and OCHCH2OH), 99.8 (CAr), 99.9 (CAr), 108.3 (CC=O), 108.6 
(OCO), 127.8 (CCH=CH), 132.9 (CCH=CH), 140.4 (CCH=CH), 162.9 (COH), 164.3 
(COCH3) and 171.5 (C=O); MS (FAB) m/z 353.5 [M+H]
+; HRMS m/z 353.1591 
(353.1600 calcd for C18H25O7, M+H
+). 
Procedure B 
To a stirred solution of diol 185 (106 mg, 299 µmol) in dry dichloromethane (10 
cm3) was added palladium(II)acetate (Pd(OAc)2) (3.4 mg, 14.9 µmol) and 
triethylamine (0.01 cm3, 47.9 µmol) at room temperature under argon.  To this 
mixture was added tributyltinhydride (70 µL, 0.258 mmol) dropwise and the 
reaction solution was heated under reflux for 45 h.  The reaction was cooled 
down to room temperature, filtered through Celite® and the solvent 
concentrated carefully in vacuo.  Purification by FCC [chloroform-ethyl acetate, 
(80:20)(70:30)] of the crude residue afforded phenol 185 (35 mg, 33%); Rf 0.41 
(solvent K); 1H NMR spectroscopy showed a slight Z to E isomerisation of the 
double bond from 3:2 to 4.8:2; δH(400 MHz; CDCl3) (E-isomer) 1.38 (3 H, s, 
CCH3), 1.50 (3 H, s, CCH3), 2.34-2.40 (2 H, m, CH2), 3.71 (2 H, d, J 6.2, CH2OH), 
3.79 (3 H, s, OCH3), 3.93 (3 H, s, COOCH3), 4.11-4.16 (1 H, m, CH=CHCH2CH), 
4.33 (1 H, q, J 6.2, CHCH2OH), 5.87-5.93 (1 H, m, CH=CHCH2), 6.38 (1 H, d, J 
2.6, CHAr), 6.47 (1 H, d, J 2.6, CHAr), 7.02 (1 H, d, J 15.5, CH=CHCH2) and 11.58 
(1 H, s, OH); Z-isomer (inter alia) 5.60-5.65 (1 H, m, CH=CHCH2) and 6.74 (1 H, 
d, J 11.4, CH=CHCH2). 
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2-{(E/Z)-3-[(4S,5S)-5-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-dimethyl-
methyl [1,3]dioxolan-4-yl]-propenyl}-6-hydroxy-4-methoxybenzoate 186 
OCH3
OOH
H3CO OTBS
O
O
 
To a stirred solution of alcohol 185 (536 mg, 1.52 mmol) in dry 
dimethylformamide (30 cm3) under argon was added tert-butyldimethylsilyl 
chloride (252 mg, 1.67 mmol) and imidazole (207 mg, 3.04 mmol).  The solution 
was stirred for 3 h at room temperature and then diluted with distilled water (50 
cm3) and extracted with 50% diethyl ether in petroleum ether (3×150 cm3).  The 
combined organic layers were washed with water (50 cm3), dried over anhydrous 
sodium sulfate, filtered and concentrated in vacuo.  Purification by FCC 
[petroleum ether-ethyl acetate (90:10)] of the crude residue afforded silyl ether 
186 (377 mg, 55%; 65% based on starting material consumed) as a thick, 
colourless oil (recovered starting material 102 mg) and as a 7:5 (E:Z) mixture of 
isomers; Rf 0.56 (Solvent D); [ ]20Dα  –1.2 (c 1.0, CHCl3); νmax(film)/cm-1 2953 (OH), 
2930, 1655 (C=O), 1610 (C=C), 1329, 1254, 1157 (O-Si) and 1074; δH(400 MHz; 
CDCl3) (E-isomer) 0.02 (6 H, s, Si(CH3)2), 0.80 (9 H, s, SiC(CH3)3), 1.25 (3 H, s, 
CCH3), 1.46 (3 H, s, CCH3), 2.35-2.50 (2 H, m, CH2), 3.65 (2 H, d, 6.2, CH2OTBS), 
3.73 (3 H, s, OCH3), 3.81 (3 H, s, COOCH3), 3.96-4.05 (1 H, m, CH=CHCH2CH), 
4.18-4.22 (1 H, m, CHCH2OTBS), 5.89-5.96 (1 H, m, CH=CHCH2), 6.39 (1 H, d, J 
2.6, CHAr), 6.42 (1 H, d, J 2.6, CHAr), 6.94 (1 H, d, J 15.5, CH=CHCH2) and 11.57 
(1 H, s, OH); Z-isomer (inter alia) 5.61 (1 H, m, CH=CHCH2) and 6.68 (1 H, d, J 
11.6, CH=CHCH2); δC(100 MHz; CDC3) (E-isomer) -5.7 (Si(CH3)2), 18.2 (SiC(CH3)3), 
25.5 (2×CH3), 25.9 (SiC(CH3)3), 32.9 (CH2), 52.2 (O=COCH3), 55.5 (OCH3), 61.6 
(CH2OH), 77.8 (2×CO), 99.8 (CAr), 99.9 (CAr), 108.3 (CC=O), 108.6 (OCO), 127.8 
(CCH=CH), 132.9 (CCH=CH), 140.4 (CCH=CH), 162.9 (COH), 164.3 (COCH3) and 
171.5 (C=O); MS (FAB) m/z 489.6 [M+Na]+; HRMS m/z 489.2279 (489.2284 calcd 
for C24H38NaO7Si, M+Na
+). 
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Methyl 2-{(E/Z)-3-[(4S,5S)-5-(tert-butyl-dimethyl-silanyloxymethyl)-2,2-
dimethyl-[1,3]dioxolan-4-yl]-propenyl}-4-methoxy-6-(4-methoxybenzyloxy)-
benzoate 187 
OCH3
OPMBO
H3CO OTBS
O
O
 
Alcohol 186 (377 mg, 0.808 mmol) was dissolved in anhydrous 
dimethylformamide (60 cm3) and potassium carbonate (168 mg, 1.21 mmol), p-
methoxybenzyl chloride (0.12 cm3, 0.889 mmol) and tetra-butylammonium 
iodide (30 mg, 0.0808 mmol) were added sequentially at room temperature.  
The resulting yellow solution was heated at 80 oC overnight after which time TLC 
analysis showed the reaction to be complete.  After cooling down to room 
temperature, the reaction mixture was diluted with diethyl ether (50 cm3) and 
quenched with water (50 cm3).  The organic layer was separated, washed with 
water (3×80 cm3), dried over anhydrous sodium sulfate, filtered and 
concentrated in vacuo.  Purification by FCC [petroleum ether-ethyl acetate 
(80:20)] of the crude residue afforded PMB ether 187 (426 mg, 90%) as a thick, 
pale yellow oil and as a 6:4 (E:Z) mixture of isomers; Rf 0.34 (solvent A); [ ]22Dα  –
1.5 (c 0.9, CHCl3); νmax(film)/cm
-1 2932, 1728 (C=O), 1599 (C=C), 1514, 1250, 
1159 (O-Si) and 1099; δH(400 MHz; CDCl3) (E-isomer) 0.02 (6 H, s, Si(CH3)2), 0.81 
(9 H, s, SiC(CH3)3), 1.23 (3 H, s, CH3), 1.37 (3 H, s, CH3), 2.34-2.50 (2 H, m, CH2), 
3.55-3.61 (2 H, m, CH2OTBS), 3.71 (3 H, s, OCH3), 3.79 (3 H, s, COOCH3), 3.82 (3 
H, s, OCH2ArOCH3), 3.96-4.19 (2 H, m, 2×CHO), 4.92 (2 H, d, J 3.3, OCH2), 5.73-
5.79 (1 H, m, CH=CH), 6.30-6.39 (2 H, m, 2×CHAr), 6.84 (1 H, d, J 15.4, CH=CH) 
and 7.20-7.26 (4 H, m, 4×CHAr); (Z-isomer) (inter alia) 5.72-5.81 (1 H, m, 
CH=CHCH2) and 6.80 (1 H, d, J 11.5, CH=CHCH2); δC(100 MHz; CDCl3) (E-isomer) -
5.4 (Si(CH3)2), 18.3 (SiC(CH3)3), 25.9 (SiC(CH3)3), 28.1 (C(CH3)2), 33.3 (CH2), 52.1 
(CO2CH3), 55.3 (2×OCH3), 61.9 (CH2OTBS), 70.4 (OCH2), 77.1 (HCCH2OTBS), 77.7 
(C=CCH2CH), 99.4 (CH), 101.9 (CH), 106.5 (CCO2CH3), 108.0 (C(CH3)2), 113.9 
(2×CH(Ph)), 128.3 (C=C), 128.6 (OCH2C and 2×CH(Ph)), 130.3 (C=C), 137.5 
(CC=C), 157.1 (C(Ph)OCH3), 159.3 (COPMB), 161.2 (COCH3) and 168.5 (C=O); MS 
(FAB) m/z 609.7 [M+Na]+; HRMS m/z 609.2859 (609.2860 calcd for C32H46O8SiNa, 
M+Na+). 
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Methyl 2-{(E/Z)-3-[(4S,5R)-5-hydroxymethyl-2,2-dimethyl-[1,3]dioxolan-4-
yl]-propenyl}-4-methoxy-6-(4-methoxybenzyloxy)-benzoate 196 
OCH3
OPMBO
H3CO OH
O
O
 
Procedure A 
A solution of silyl ether 187 (426 mg, 0.725 mmol) in tetrahydrofuran (5 cm3) 
was cooled to 0 oC and tert-butylammonium fluoride (1.45 cm3, 1.5 mmol) was 
added.  After 10 min, the ice-water bath was removed and stirring was 
continued for 2 h.  Diethyl ether (50 cm3) and water (50 cm3) were then added 
and the layers separated.  The organic layer was dried over anhydrous sodium 
sulfate, filtered and concentrated in vacuo.  Purification by FCC [petroleum 
ether-ethyl acetate, (30:70)] of the crude residue removed the slight, 
unidentifiable impurity and afforded alcohol 196 (324 mg, 94%) as a thick yellow 
oil and as a 7:5 (E:Z) mixture of isomers; Rf 0.5 (solvent H); [ ]20Dα  +12.0 (c 1.0, 
CHCl3); νmax(film)/cm
-1 2933 (OH), 1652 (C=O), 1607, 1254, 1156 and 1040 (C-O); 
δH(400 MHz; CDCl3) (E-isomer) 1.26 (3 H, s, CH3), 1.38  (3 H, s, CH3), 2.29-2.39 (2 
H, m, CH=CHCH2), 3.60 (2 H, d, J 5.6, CH2OH), 3.70 (3 H, s, OCH3), 3.73 (3 H, s, 
COOCH3), 3.85 (3 H, s, OCH2ArOCH3), 4.02-4.21 (2 H, m, 2×CHO), 4.90 (2 H, s, 
OCH2), 6.05-6.12 (1 H, m, CH=CH), 6.31 (1 H, d, J 2.2, CHAr), 6.33 (1 H, d, J 2.2, 
CHAr), 6.79 (1 H, d, J 15.7, CH=CH) and 7.18-7.22 (4 H, 2×d, J 6.0, 4×CHAr); (Z-
isomer) (inter alia) 5.66-5.71 (1 H, m, HC=CHCH2), 6.89 (1 H, d, J 11.4, 
HC=CHCH2); δC(100 MHz; CDCl3) (E-isomer) 25.4 (OCCH3), 28.1 (OCCH3), 33.2 
(CH=CHCH2), 52.3 (COOCH3), 55.3 (2×OCH3), 61.6 (CH2OH), 70.4 (OCH2), 77.8 
(CHO), 77.8 (CHO), 99.4 (CHAr), 102.2 (CHAr), 106.4 (CCOOCH3), 108.4 
(OC(CH3)2), 113.9 (2×CHAr), 128.6 (CH=CH, CCH2O, 2×CHAr), 129.2 (CH=CH), 
137.5 (CCH=CH), 157.3 (COCH3), 159.3 (COCH2), 161.3 (COCH3) and 168.1 (C=O); 
MS (FAB) m/z 473.4 [M+H]+; HRMS m/z 473.2171 (473.2175 calcd for C26H33O8, 
M+Na+). 
Procedure B 
To a stirred solution of PMB ether 196 (55.6 mg, 117 µmol) in chloroform (7 cm3) 
was added palladium(II) acetate (Pd(OAc)2) (1.3 mg, 58.8 µmol) and 
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triethylamine (10 µL, 47.9 µmol) at room temperature under argon.  To this 
mixture was added tributyltinhydride (0.07 cm3, 0.258 mmol) dropwise and the 
reaction solution was heated under reflux for 50 h.  The reaction was cooled 
down to room temperature and stirred for a further 74 h.  The solvent was 
concentrated slowly in vacuo, then potassium fluoride (4 eq., 27 mg, 0.470 
mmol), water (4 eq. 0.01 cm3) and ethyl acetate (3 cm3) were added and the 
reaction mixture stirred overnight.  The potassium fluoride/tributyltinfluoride 
solid was filtered through Celite® with a little MgSO4 added to absorb the water.  
The solvent was concentrated carefully in vacuo and the work-up procedure 
repeated on the now orange solution for 2 h.  FCC [petroleum ether-ethyl 
acetate, (100:0)(70:30)] of the residue afforded 196 (30 mg, 54%); 1H NMR 
spectroscopy showed a slight Z to E isomerisation of the double bond from 7:5 to 
2:1.  
Methyl 2-{(E/Z)-3-[(4S,5S)-5-formyl-2,2-dimethyl-[1,3]dioxolan-4-yl]-
propenyl}-4-methoxy-6-(4-methoxybenzyloxy)-benzoate 197 
OCH3
OPMBO
H3CO O
O
O H
 
To a —78 oC solution of oxalyl chloride (0.10 cm3, 0.203 mmol) in anhydrous 
dichloromethane (0.1 cm3) was added dimethylsulfoxide (0.03 cm3, 0.406 mmol).  
After stirring for 1 h, a solution of alcohol 196 in dichloromethane (0.7 cm3) was 
added and stirring continued for a further 1 h.  Triethylamine (0.08 cm3, 0.609 
mmol) was added and the reaction allowed to warm up to room temperature.  
The reaction was diluted with dichloromethane (7 cm3), quenched with 1 M 
hydrochloric acid (7 cm3) and then extracted with dichloromethane (2×10 cm3).  
The combined organic layers were washed with saturated aqueous sodium 
chloride (10 cm3), dried over anhydrous sodium sulfate, filtered and 
concentrated in vacuo to afford aldehyde 197 as an unstable yellow oil; δH(400 
MHz; CDCl3) 9.72 (CHO). 
 
 
 
Suzannah J. Harnor, 2010  145 
(S)-(+)-Pent-4-yn-2-ol 190[89] 
H
OH
 
A stirred suspension of lithium acetylide ethylenediamine complex (4.74 g, 51.6 
mmol) in anhydrous dimethylsulfoxide (100 cm3) at 0 oC was treated with a 
solution of S-(+)-propylene oxide (3.0 cm3, 43.0 mmol) dropwise.  The reaction 
was then allowed to warm up to room temperature where it was stirred for 48 h.  
The suspension was poured onto ice (100 cm3) and extracted with diethyl ether 
(4×70 cm3).  The combined ether extracts were washed with brine (6×30 cm3), 
water (2×30 cm3) and dried over anhydrous magnesium sulfate.  Careful 
evaporation of the solvent under atmospheric pressure yielded the crude alcohol 
190 (3.6 g, 100%) as a colourless liquid, which was taken on without any further 
purification; [ ]22Dα  +16.5 (c 1.0, CHCl3) (lit.,[89] [ ]26Dα  +17.8 (c 0.2, CHCl3)); 
νmax(film)/cm
-1 3379 (OH), 3280 (C≡C) and 2340; δH(400 MHz; CDCl3) 1.26 (3 H, 
d, J 6.0, CH3), 2.08 (1 H, t, J 2.7, HC≡C), 2.33 (1 H, ddd, J 2.7, 5.3 and 16.0, 
CH2), 2.42 (1 H, ddd, J 2.7, 6.2 and 16.0, CH2) and 3.99-4.04 (1 H, m, HCOH).  
All spectral data matches that reported in the literature.[89] 
(S)-(-)-tert-Butyldimethyl(pent-4-yn-2-yloxy)silane 55[148] 
H
OTBS
 
A solution of alcohol 190 (3.6 g, 42.8 mmol) and imidazole (5.83 g, 85.6mmol) in 
dimethylformamide (215 cm3) under argon was treated with tert-
butyldimethylsilyl chloride (7.09 g, 47.1 mmol) and the resulting mixture was 
stirred at room temperature overnight.  The reaction mixture was diluted with 
water (70 cm3) and the product extracted with diethyl ether (3×50 cm3).  The 
combined ether extracts were washed with brine (3×50 cm3) then water (3×50 
cm3) and dried over anhydrous sodium sulfate, filtered and concentrated in 
vacuo.  Purification by FCC [petroleum ether-diethyl ether (90:10)] of the crude 
residue afforded silyl ether 55 (6.6 g, 78%) as a colourless liquid; [ ]23Dα  –0.9 (c 
1.0, CHCl3) (lit.,
[148] [ ]25Dα  –1.2 (c 10.0, CHCl3); vmax(film)/cm-1 3309 (C≡C) and 
1040 (C-O); δH(400 MHz; CDCl3) 0.06 (6 H, s Si(CH3)2), 0.90 (9 H, s, SiC(CH3)3), 
1.22 (3 H, d, J  6.1, CH3), 2.00 (1 H, t, J 2.7, HC≡C), 2.23 (1 H, ddd, J 2.7, 7.0 
and 16.5, CH2), 2.33 (1 H, ddd, J 2.7, 5.5 and 16.5, CH2) and 3.98-4.03 (1 H, m, 
HCOTBS); δC(100 MHz; CDCl3) -5.0 (Si(CH3)2), 18.2 (SiC(CH3)3), 25.0 (CH3), 25.8 
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(SiC(CH3)3), 31.1 (CH2), 66.9 (HCOTBS), 69.7 (HC≡C) and 82.2 (HC≡C).  All 
spectral data matches that reported in the literature.[148] 
Methyl 2-(3-{(4S,5R)-5-[(R)-5-(tert-butyldimethylsilanyloxy)-1-hydroxy-hex-2-
ynyl]-2,2-dimethyl-[1,3]dioxolan-4-yl}-propenyl)-4-methoxy-6-(4-methoxy-
benzyloxy)-benzoate 198 
OPMBO
H3CO
O
O
OH
OTBS
OCH3
 
A solution of alkyne 55 (29 mg, 0.155 mmol) in THF (1 cm3) at room temperature 
was treated with ethylmagnesium bromide (0.04 cm3, 0.124 mmol) and the 
resulting light brown mixture was stirred for 3 h. 
Whilst the above deprotonation was being carried out, a —78 oC solution of 
oxalyl chloride (0.10 cm3, 0.207 mmol) in tetrahydrofuran (1 cm3) at —78 oC was 
treated with dimethylsulfoxide (0.03 cm3, 0.414 mmol). After stirring at —78 oC 
for 30 min, a solution of alcohol 196 (49 mg, 0.103 mmol) in tetrahydrofuran 
(0.5 cm3) was added and stirring continued for 1 h.  Triethylamine (0.12 cm3, 
0.829 mmol) was added and the reaction was allowed to warm up to room 
temperature.  After 30 min at room temperature the reaction mixture was 
cooled back down to —78 oC and the deprotonated alkyne solution was added.  
The resulting mixture was allowed to warm up to room temperature and was 
stirred overnight.  The reaction was then quenched with saturated aqueous 
ammonium chloride (10 cm3) and extracted with ethyl acetate (3×15 cm3). The 
organic layers were dried over anhydrous sodium sulfate, filtered and 
concentrated in vacuo.  Purification by FCC [petroleum ether-ethyl actetate 
(60:40)] of the crude residue afforded alcohol 198 (20 mg, 30%) as a thick, 
yellow oil and as an inseparable mixture of diastereoisomers; Rf 0.57 (solvent I); 
νmax(film)/cm
-1 2925 (OH), 2841, 1732 (C=O), 1596 (C=C), 1258 and 1112 (O-Si); 
δH(400 MHz; CDCl3) 0.00 (6 H, s, Si(CH3)2), 0.79 (9 H, s, SiC(CH3)3), 1.18 (3 H, s, 
CH3), 1.38 (3 H, s, CCH3), 1.54 (3 H, s, CCH3), 2.17-2.22 (2 H, m, CH2), 2.42-2.48 
(2 H, m, CH2), 3.83-3.87 (1 H, m, CHOTBS), 3.79 (3 H, s, OCH2PhOCH3), 3.82 (3 
H, s, OCH3), 3.87 (3 H, s, CO2CH3), 4.24-4.35 (2 H, m, 2×OCH), 4.44-4.50 (3 H, 
m, CHOH and OCH2PhOCH3), 6.21-6.29 (1 H, m, CH=CH), 6.42-6.49 (1 H, m, 
CH=CH), 6.63 (1 H, s, CH), 6.71 (1 H, s, CH), 6.90 (2 H, d, J 8.5, 2×CH) and 7.30 
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(2 H, d, J 8.5, 2×CH); δC(100 MHz; CDCl3) -4.8 (Si(CH3)2), 17.9 (SiC(CH3)3), 19.7 
(C28), 25.3 (C20), 25.9 (SiC(CH3)3), 26.9 (C26), 27.7 (C21), 31.3 (C31), 33.5 
(C17), 52.0 (C29), 55.3 (C1), 55.6 (C12), 62.4 (C22), 70.5 (C23), 73.0 (C8), 73.3 
(C27), 79.9 (C18), 80.1 (C25), 84.5 (C24), 100.9 (C10), 103.8 (C13), 108.8 (C19), 
113.7 (C3 and C4), 128.7 (C16), 129.3 (C15), 129.3 (C18), 130.2 (C5 and C6), 
137.6 (C14), 155.6 (C2), 161.3 (C9), 168.2 (C11) and 171.3(C30); MS (CI) m/z 668 
[M]+; HRMS m/z 668.3375 (668.3381 calcd for C37H52O9Si, M
+). 
OCH3
OO
H3CO
O
O
8
9
10
1112
13
14
15
16
17
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293031 OH
OCH3
1
2
3 4
56
7
O
28
Si
 
13C assignment 
Methyl 2-((E/Z)-3-{(4S,5S)-5-[(R)-5-(tert-butyldimethylsilyloxy)hex-2-ynoyl]-
2,2-dimethyl-[1,3]dioxolan-4-yl}-propenyl)-4-methoxy-6-(4-
methoxybenzyloxy)benzoate 245 
OPMBO
H3CO
O
O
O
OTBS
OCH3
 
A solution of oxalyl chloride (30 µL, 59.8 µmol) in anhydrous dichloromethane 
(0.6 cm3) was treated with dimethylsulfoxide (10 µL, 0.119 mmol) at —78 oC.  
After stirring at —78 oC for 30 min, a solution of alcohol 198 (20 mg, 29.9 µmol) 
in anhydrous dichloromethane (0.3 cm3) was added and stirring continued for 1 
h.  Triethylamine (0.03 cm3, 0.239 mmol) was added and the reaction was 
allowed to warm up to room temperature.  After 30 min at room temperature 
the reaction mixture was diluted with dichloromethane (10 cm3) and separated 
with 1 N hydrochloric acid (10 cm3).  The organic layers were washed with 
saturated aqueous sodium hydrogencarbonate (20 cm3), dried over anhydrous 
sodium sulfate, filtered and concentrated in vacuo to afford 245 (20 mg, 100%) 
as an off-white oil requiring no further purification; Rf 0.77 (Solvent I); δH(400 
MHz; CDCl3) 0.05 (6 H, s, Si(CH3)2), 0.86 (9 H, s, SiC(CH3)3), 1.22 (3 H, s, CH3), 
1.39 (3 H, s, CCH3), 1.54 (3 H, s, CCH3), 2.30-2.55 (4 H, m, 2×CH2), 3.79 (6 H, 
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2×s, OCH2PhOCH3 and OCH3), 3.84 (3 H, s, CO2CH3), 3.98-4.04 (1 H, m, CHOTBS), 
4.24-4.35 (2 H, m, 2×OCH), 5.00 (2 H, s, OCH2PhOCH3), 5.78-5.82 (1 H, m, 
CH=CH), 6.18-6.22 (1 H, m, CH=CH), 6.40 (1 H, s, CH), 6.62 (1 H, s, CH), 6.90 (2 
H, d, J 8.5, 2×CH) and 7.30 (2 H, d, J 8.5, 2×CH); δC(100 MHz; CDCl3) -4.8 
(Si(CH3)2), 17.9 (SiC(CH3)3), 19.7 (C28), 25.3 (C20), 25.9 (SiC(CH3)3), 26.8 (C26), 
27.7 (C21), 31.2 (C31), 33.6 (C17), 52.0 (C29), 55.3 (C1), 55.8 (C12), 62.4 (C22), 
73.1 (C8), 73.3 (C27), 79.9 (C18), 80.0 (C25), 84.5 (C24), 101.0 (C10), 103.7 
(C13), 108.8 (C19), 113.9 (C3 and C4), 128.8 (C16), 129.3 (C15), 129.4 (C18), 
130.0 (C5 and C6), 137.8 (C14), 155.7 (C2), 161.3 (C9), 168.1 (C11),170.9.3(C30) 
and 185.7 (C23). 
OCH3
OO
H3CO
O
O
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9
10
1112
13
14
15
16
17
18
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OCH3
1
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3 4
56
7
28
O
Si
 
13C Assignment 
Methyl 2-(tert-butyldimethylsilanyloxy)-4-methoxy-6-vinyl-benzoate 120 
TBSO
OMe
OCH3
O
 
Lithium chloride (430 mg, 10.1 mmol) was dissolved in anhydrous 
dimethylformamide (24 cm3) and then tri-2-furylphosphine (125 mg, 0.534 mmol) 
and tris[dibenzylideneacetone]dipalladium(0) (Pd2(dba)3) (62 mg, 0.0675 mmol) 
were added sequentially at room temperature followed by a solution of triflate 
119 (1.5 g, 3.37 mmol) in anhydrous dimethylformamide (10 cm3).  The resulting 
reaction mixture was stirred for 30 min before tributylvinyl tin (1.2 cm3, 4.05 
mmol) was added.  The reaction solution was heated to 60 oC for 3 h after which 
it was cooled down to room temperature, diluted with dichloromethane (40 cm3) 
and water (40 cm3).  The aqueous layer was removed and the organic phase 
washed with 1 M potassium fluoride aqueous solution (3×50 cm3).  The reaction 
mixture was shaken in a separatory funnel for 1 minute each wash.  After the 
first wash solid tributyltinfluoride precipitate formed at the interface and was 
filtered out through Celite®.  The combined organic layers were washed with 
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brine (50 cm3), dried over anhydrous Na2SO4, filtered and concentrated in vacuo.  
Purification by FCC [petroleum ether-ethyl acetate (100:0)→(95:5) then 
petroleum ether-diethyl ether (100:0)→(95:5)] of the crude residue afforded an 
inseparable mixture of alkenes 120; Rf 0.60 (Solvent A) and 210; Rf 0.59 (Solvent 
A) (736 mg) as a white solid. 
Silylated compound  120:  δH(400 MHz; CDCl3) 0.01 (6 H, s, Si(CH3)2), 0.76 (9 H, 
s, SiC(CH3)3), 3.82 (3 H, s, CH3), 3.91 (3 H, s, COOCH3), 5.21 (1 H, dd, J 1.6 and 
10.8, CH=CH2), 5.45 (1 H, dd, J 1.6 and 17.1, CH=CH2), 6.30 (1 H, d, J 2.4, 
CH(OTBS)), 6.42 (1 H , d, J 2.4, CH(COCH3)) and 6.68-6.75 (1 H, m, CH=CH2); 
δC(100 MHz; CDCl3) -4.3 (Si(CH3)2), 17.8 (SiC(CH3)3), 25.8 (SiC(CH3)3), 52.0 
(CO2CH3), 55.9 (OCH3), 100.3 (CH), 103.5 (CH), 108.7 (CCO2CH3), 115.9 
(HC=CH2), 138.4 (HC=CH2), 143.9 (CHC=CH2), 164.3 (COH), 165.0 (COCH3) and 
171.8 (C=O). 
Desilylated compound  210:  δH(400 MHz; CDCl3) 3.78 (3 H, s, CH3), 3.87 (3 H, s, 
COOCH3), 5.18 (1 H, dd, J 1.5 and 10.8, CH=CH2), 5.42 (1 H, dd, J 1.5 and 17.1, 
CH=CH2), 6.36 (1 H, d, J 2.6, CH(OH)), 6.46 (1 H , d, J 2.6, CH(COCH3)), 7.23-
7.30 (1 H, m, CH=CH2) and 11.61 (1 H, s, OH). 
Methyl 2-hydroxy-4-methoxy-6-vinylbenzoate 210[149] 
OH
MeO
OCH3
O
 
A solution of alkenes 120 and 210 (736 mg, 2.28 mmol) in anhydrous 
tetrahydrofuran (10 cm3) was cooled down to 0 oC.  tetra-Butylammonium 
fluoride (4.5 cm3, 4.56 mmol) was added and the ice-water bath was removed 
after 10 min, whereafter the reaction was allowed to warm up to room 
temperature.  After 2 h, the reaction mixture was diluted with diethyl ether (30 
cm3) and diluted with water (30 cm3).  The organic layer was dried over 
anhydrous Na2SO4, filtered and concentrated in vacuo.  The crude residue was 
passed through a pad of silica gel which was eluted with 20% diethyl ether-
petroleum ether to remove excess TBS.  The fractions were concentrated under 
reduced pressure to afford phenol 210 (517 mg, 74% over two steps) as a white 
solid; Rf 0.56 (Solvent A); mp 78-80 
oC (from diethyl ether-petroleum ether) 
(lit.,[149] 75-76 oC); νmax (film)/cm
-1 2925, 2854, 1733 (C=O), 1648 (C=C), 1437, 
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1328, 1257, 1159; δH(400 MHz; CDCl3) 3.78 (3 H, s, OCH3), 3.87 (3 H, s, COOCH3), 
5.18 (1 H, dd, J 1.6 and 10.8, CH=CH2), 5.42 (1 H, dd, J 1.6 and 17.1, CH=CH2), 
6.36 (1 H, d, J 2.6, CH), 6.46 (1 H , d, J 2.6, CH), 7.23-7.33 (1 H, m, CH=CH2) 
and 11.61 (1 H, s, OH); δC(100 MHz; CDCl3) 52.1 (CO2CH3), 55.5 (OCH3), 100.3 
(CH), 103.9 (CH), 108.3 (CCO2CH3), 115.8 (HC=CH2), 138.4 (HC=CH2), 143.6 
(CHC=CH2), 164.3 (COH), 165.1 (COCH3) and 171.7 (C=O); MS (EI) m/z 208.0 [M]
+; 
HRMS m/z 208.0734 (208.0736 calcd for C11H12O4, M
+).  All spectral data matches 
that reported in the literature.[149] 
((4S,5R)-5-Allyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-methanol 213[76] 
OH
O
O
 
Potassium bis(trimethylsilyl)amide (32 cm3, 16.1 mmol) was added to a —78 oC 
stirred suspension of methyl triphenylphosphonium iodide (8.74 g, 21.5 mmol) in 
anhydrous tetrahydrofuran (40 cm3).  The reaction was warmed up to 0 oC and 
stirred for 30 min before cooling back down to —78 oC.  A solution of acetonide 
144 (937 g, 5.38 mmol) in anhydrous tetrahydrofuran (10 cm3) was added and 
the yellow solution was warmed up to room temperature overnight.  The 
reaction was quenched with saturated aqueous ammonium chloride (50 cm3) and 
extracted with ethyl acetate (3×50 cm3).  The organic layers were combined, 
dried over anhydrous sodium sulfate, filtered and concentrated in vacuo.  
Purification by FCC [petroleum ether-ethyl acetate (100:0)→(70:30)→(60:40)] of 
the crude residue afforded alcohol 213 (557 g, 60%) as a yellow oil; Rf 0.54 
(Solvent M); [ ]19Dα  –15.7 (c 1.0, CHCl3) (lit.,[76] [ ]25Dα  +54.8 (c 0.26, CHCl3); νmax 
(film)/cm-1 3450 (OH), 2987, 2853, 1643, 1457, 1379, 1235, 1217, 1045 (C-O); 
δH(400 MHz;CDCl3) 1.37 (3 H, s, CH3), 1.48 (3 H, s, CH3), 2.23-2.32 (1 H, m, CH2), 
2.36-2.46 (1 H, m, CH2), 3.64 (2 H, t, J 5.8, CH2), 4.17 (1 H, q, J 5.9, CHCH2), 
4.25 (1 H, q, J 5.9, CHCH2OH), 5.09-5.18 (2 H, m, CH2=CH) and 5.78-5.90 (1 H, 
m, CH2=CH); δC(100 MHz; CDCl3) 25.4 (CH3), 28.0 (CH3), 33.5 (CH2), 61.3 
(CH2OH), 76.2 (CH), 77.8 (CH), 108.1 (C(CH3)2), 117.2 (HC=CHCH2) and 134.2 
(HC=CHCH2); MS (CI) m/z 173 [M+H]
+; HRMS m/z 173.1174 (173.1178 calcd for 
C9H17O3, M+H
+).  All spectral data matches that reported in the literature.[76] 
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((4S,5S)-5-Allyl-2,2-dimethyl-[1,3]dioxolan-4-ylmethoxy)-tert-
butyldimethylsilane 208 
OTBS
O
O
 
Alcohol 213 (446 mg, 2.59 mmol) was dissolved in anhydrous dichloromethane 
(13 cm3) and triethylamine (0.65 cm3, 4.66 mmol) and dimethylaminopyridine 
(32 mg, 0.259 mmol) were added sequentially at room temperature.  The 
reaction mixture was stirred for 5 min and then tert-butyldimethylsilyl chloride 
(507 mg, 3.37 mmol) was added.  After 18 h, the reaction was quenched with 
saturated aqueous ammonium chloride (10 cm3) and extracted with 
dichloromethane (3×10 cm3).  The combined organic layers were dried over 
anhydrous Na2SO4, filtered and concentrated in vacuo.  Purification by FCC 
[petroleum ether-ethyl acetate (95:5)] of the crude residue afforded silyl ether 
208 (643 mg, 87%) as an orange oil; Rf 0.83 (Solvent A); [ ]23Dα  –0.4 (c 1.0, CHCl3); 
νmax (film)/cm
-1
 2954, 1643 (C=C), 1472, 1257 (Si-CH3); δH(400 MHz; CDCl3) 0.06 
(6 H, s, Si(CH3)2), 0.89 (9 H, s, SiC(CH3)3), 1.34 (3 H, s, CH3), 1.43 (3 H, s, CH3), 
2.29-2.46 (2 H, m, CH2), 3.59-3.71 (2 H, m, CH2OTBS), 4.03-4.07 (1 H, m, 
CHCH2), 4.18-4.22 (1 H, m, CHCH2OTBS), 5.00-5.16 (2 H, m, CH2=CH) and 5.83-
5.95 (1 H, m, CH2=CH); δC(100 MHz; CDCl3) -5.5 (SiCH3), -5.4 (SiCH3), 18.3 
(C(CH3)3), 25.5 (CH3), 25.9 (3×CH3), 28.1 (CH3), 33.8 (CH2), 61.9 (CH2OTBS), 76.7 
(CH), 77.8 (CH), 107.9 (C(CH3)2), 116.8 (CH=CHCH2) and 135.2 (CH=CHCH2); MS 
(CI) m/z 287.1 [M+H]+; HRMS m/z 287.2047 (287.2042 calcd for C15H31O3Si, 
M+H+). 
2-{(E)-3-[(4S,5S)-5-(tert-butyldimethylsilanyloxymethyl)-2,2-dimethyl-methyl 
[1,3]dioxolan-4-yl]-propenyl}-6-hydroxy-4-methoxybenzoate 186 
OCH3
OOH
H3CO OTBS
O
O
 
A stirred solution of styrene 210 (966 mg, 4.64 mmol) and alkene 208 (2.66 g, 
9.28 mmol) in anhydrous dichloromethane (75 cm3) was treated with Hoveyda-
Grubbs second generation catalyst (872 mg, 1.39 mmol) and the resulting 
mixture was heated to reflux in the dark for 48 h.  The reaction mixture was 
allowed to cool down to room temperature and was filtered through silica gel 
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and concentrated in vacuo.  Purification by FCC [petroleum ether-ethyl acetate 
(95:5)→(90:10)] of the crude residue afforded alkene 186 (1.4 g, 65%) as a 
colourless oil; Rf 0.53 (Solvent N); [ ]23Dα  –1.3 (c 1.0, CHCl3); νmax(film)/cm-1 2930 
(OH), 2856, 1655 (C=C), 1437, 1327, 1213, 1159 and 1097 (O-Si); δH(400 MHz; 
CDCl3) 0.00 (6 H, s, Si(CH3)2), 0.82 (9 H, s, SiC(CH3)3), 1.27 (3 H, s, CH3), 1.37 (3 
H, s, CH3), 2.35-2.50 (2 H, m, CH2), 3.55-3.69 (2 H, m, CH2), 3.80 (3 H, s, OCH3), 
3.89 (3 H, s, COOCH3), 4.12-4.30 (2 H, m, 2×OCH), 5.98 (1 H, dt, J 6.9 and 15.5, 
CH=CH), 6.36 (1 H, d, J 2.5, CH(Ar)), 6.48 (1 H, d, J 2.5, CH(Ar)), 7.01 (1 H, d, J 
15.5, CH=CH) and 11.61 (1 H, s, OH); δC(100 MHz; CDCl3) -5.3 (SiCH3), -5.2 
(SiCH3), 18.4 (SiC(CH3)3), 25.7 (CH), 26.0 (SiC(CH3)3), 28.3 (CH), 33.2 (CH2), 52.1 
(CO2CH3), 55.5 (OCH3), 62.0 (CH2OTBS), 77.3 (CH(O)), 77.8 (CH(O)), 99.9 
(CH(Ar)), 103.8 (CH(Ar)), 108.1 (CCO2CH3), 116.6 (C(CH3)2), 129.2 (HC=CHCH2), 
133.0 (HC=CHCH2), 143.2 (CHC=CHCH2), 164.1 (COH), 165.1 (COCH3) and 171.9 
(C=O); MS (CI) m/z 467 [M+H]+; HRMS m/z 467.2466 (467.2465 calcd for 
C24H39O7Si, M+H
+). 
Methyl 2-{(E)-3-[(4S,5S)-5-(tert-butyldimethylsilanyloxymethyl)-2,2-
dimethyl-[1,3]dioxolan-4-yl]-propenyl}-4-methoxy-6-methoxymethyl-
benzoate 211 
OCH3
OMOMO
H3CO OTBS
O
O
 
Phenol 186 (263 mg, 0.565 mmol) was dissolved in anhydrous dichloromethane 
(6 cm3) and N,N'-diisopropylethylamine (DIPEA) (0.30 cm3, 1.60 mmol) was added 
at room temperature.  The reaction mixture was cooled down to 0 oC and 
bromomethyl methyl (MOMBr) ether (0.10 cm3, 1.13 mmol) was slowly added.  
The ice-water bath was removed after 10 min and the reaction allowed to warm 
up to room temperature and stirred for 18 h.  After this time, starting material 
was still present, so the above procedure was repeated and the reaction left for 
another 18 h.  The reaction was quenched with saturated aqueous sodium 
hydrogen carbonate (40 cm3) and extracted with ethyl acetate (3×40 cm3).  The 
combined organic layers were washed with water (50 cm3), then brine (50 cm3), 
dried over anhydrous sodium sulfate, filtered and concentrated in vacuo.  
Purification by FCC [petroleum ether-diethyl ether (80:20)→(70:30)] of the 
crude residue afforded MOM ether 211 (170 mg, 60%) as a colourless oil; Rf 0.26 
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(Solvent N); [ ]20Dα  –29.3 (c 1.1, CHCl3); νmax(film)/cm-1 2984, 2938, 1663 (C=C), 
1369; δH(400 MHz; CDCl3) 0.00 (6 H, s, Si(CH3)2), 0.82 (9 H, s, SiC(CH3)3), 1.26 (3 
H, s, OCCH3), 1.36 (3 H, s, OCCH3), 2.40-2.58 (2 H, m, CH=CHCH2), 3.45 (3 H, s, 
OCH2OCH3), 3.63-3.71 (2 H, m, 2×CHOC), 3.80 (3 H, s, OCH3), 3.89 (3 H, s, 
COOCH3), 4.09-4.15 (1 H, m, CH2), 4.18-4.23 (1 H, m, CH2), 5.13 (2 H, s, 
OCH2OCH3), 6.21-6.31 (1 H, m, CH=CHCH2), 6.42 (1 H, d, J 15.7, CH=CHCH2), 
6.59 (1 H, d, J 2.2, CH(Ar)) and 6.69 (1 H, d, J 2.2, CH(Ar)); δC(100 MHz; CDCl3) -
5.3 (SiCH3), -5.2 (SiCH3), 18.4 (SiC(CH3)3), 25.7 (CH), 26.0 (SiC(CH3)3), 28.3 (CH), 
33.4 (CH2), 52.2 (CO2CH3), 55.5 (OCH3), 56.3 (OCH2OCH3), 62.0 (CH2OTBS), 77.3 
(CH(O)), 77.8 (CH(O)), 95.9 (OCH2OCH3), 100.0 (CHAr), 103.8 (CHAr), 108.1 
(CCO2CH3), 116.6 (C(CH3)2), 129.2 (HC=CHCH2), 130.6 (HC=CHCH2), 137.7 
(CHC=CHCH2), 155.7 (COCH2OCH3), 161.4 (COCH3) and 168.5 (C=O); MS (EI) m/z 
197 [M]+; HRMS m/z 197.0772 (197.0784 calcd for C8H14NaO4, M
+). 
Methyl 2-[(E)-3-((4S,5R)-5-hydroxymethyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-
propenyl]-4-methoxy-6-methoxymethylbenzoate 212 
OCH3
OMOMO
H3CO OH
O
O
 
MOM ether 211 (373 mg, 0.730 mmol) was dissolved in anhydrous 
tetrahydrofuran (5 cm3) and cooled down to 0 oC before the addition of tetra-
butylammonium fluoride (1.5 cm3, 1.46 mmol).  After 10 min, the ice-water bath 
was removed and the reaction allowed to warm up to room temperature.  After 
1.5 h, the reaction was diluted with ethyl acetate (10 cm3) and water (10 cm3) 
was added.  The organic layer was separated, dried over anhydrous sodium 
sulfate, filtered and concentrated in vacuo.  Purification by FCC [petroleum 
ether-ethyl acetate (30:70)] of the crude residue afforded alcohol 212 (268 mg, 
93%) as an off white oil; Rf 0.40 (Solvent O); [ ]20Dα  –6.0 (c 1.1, CHCl3); 
νmax(film)/cm
-1 2988, 2937, 1601 (C=C), 1433; δH(400 MHz; CDCl3) 1.35 (3 H, s, 
OCCH3), 1.48 (3 H, s, OCCH3), 2.37-2.47 (1 H, m, CH=CHCH2), 2.49-2.58 (1 H, m, 
CH=CHCH2), 3.45 (3 H, s, OCH2OCH3), 3.67 (2 H, t, J 5.8, CH2OH), 3.79 (3 H, s, 
OCH3), 3.88 (3 H, s, COOCH3), 4.20 (1 H, q, J 5.8, CH2CH), 4.28 (1 H, dt, J 5.8 
and 8.0, CHCH2OH), 5.13 (2 H, s, OCH2OCH3), 6.18 (1 H, ddd, J 6.1, 7.8 and 15.6, 
CH=CHCH2), 6.43 (1 H, d, J 15.6, CH=CHCH2), 6.59 (1 H, d, J 2.1, CH(Ar)) and 
Suzannah J. Harnor, 2010  154 
6.69 (1 H, d, J 2.1, CH(Ar)); δC(100 MHz; CDCl3) 25.4 (C(CH3)), 28.0 (C(CH3)), 
33.2 (CH2), 52.2 (CO2CH3), 55.4 (OCH3), 56.1 (OCH2OCH3), 61.3 (CH2OH), 76.3 
(CH(O)), 77.8 (CH(O)), 94.7 OCH2OCH3), 100.6 (CHAr), 103.6 (CHAr), 108.2 
(CCO2CH3), 116.2 (C(CH3)2), 128.8 (HC=CHCH2), 129.6 HC=CHCH2), 137.3 
(CHC=CHCH2), 155.5 COCH2OCH3), 161.2 (COCH3) and 168.3 (C=O); MS (EI) m/z 
396 [M]+; HRMS m/z 396.1787 (396.1784 calcd for C20H28O8, M
+). 
1-Methoxy-4-((S)-1-methyl-but-3-ynyloxymethyl)-benzene 223[150] 
H
OPMB
 
To a suspension of 60% NaH in mineral oil (2.51 g, 62.9 mmol) in anhydrous 
dimethylformamide (70 cm3) at 0 oC was added a solution of the freshly 
generated crude alcohol 190 (4.81 g, 57.2 mmol) in anhydrous 
dimethylformamide (70 cm3).  The reaction mixture was stirred for 15 min, then 
p-methoxybenzyl chloride (11.6 cm3, 85.8 mmol) was added and the reaction 
mixture allowed to warm up to room temperature and stirred for 17 h.  The 
reaction mixture was poured onto brine (400 cm3) and extracted with diethyl 
ether (3×100 cm3).  The combined organic layers were concentrated under 
reduced pressure, then washed with brine (300 cm3), dried over anhydrous 
magnesium sulfate, filtered through cotton wool and the solvent removed under 
vacuum.  Purification by FCC [petroleum ether-ethyl acetate (95:5)] of the crude 
residue afforded PMB ether 223 (5.26 g, 45%) as a colourless oil; [ ]20Dα  –8.8 (c 
1.0, CHCl3) (lit.,
[150] [ ]26Dα  +6.5 (c 1.04, CHCl3); νmax(film)/cm-1 3294 (C≡C), 1511 
(C=C), 1243 and 1033 (C-O); δH(400 MHz; CDCl3) 1.34 (3 H, d, J 6.0, CH3), 2.08 (1 
H, s, HC), 2.35-2.42 (1 H, m, HCCH2), 2.51-2.58 (1 H, m, HCCH2), 3.71 (1 H, app. 
sext, J 6.0 and 12.3, CHCH3), 3.82 (3H, s, OCH3), 4.53 (2 H, s, OCH2), 6.91 (2 H, 
d, J 8.6, 2×CHAr) and 7.32 (2 H, d, J 8.6, 2×CHAr); δC(100 MHz; CDCl3) 19.5 
(CH3), 26.0 (CH2), 55.2 (OCH3), 70.1 (CHCH3), 70.3 (HCCCH2), 72.8 (OCH2), 81.3 
(HCCCH2), 113.8 (2×CHAr), 129.3 (2×CHAr), 130.6 (OCH2C) and 159.2 (COCH3).  
All 1H and 13C data matches that reported in the literature.[150]   
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Methyl 2-((E)-3-{(4S,5R)-5-[(R)-1-hydroxy-5-(4-methoxybenzyloxy)-hex-2-
ynyl]-2,2-dimethyl-[1,3]dioxolan-4-yl}-propenyl)-4-methoxy-6-
methoxymethylbenzoate 222 
OCH3
OMOMO
H3CO
O
O OH
OPMB
 
A solution of alkyne 223 (466 mg, 2.43 mmol) in anhydrous tetrahydrofuran (9.5 
cm3) was treated with ethylmagnesium bromide (0.76 cm3, 2.27 mmol) at room 
temperature and the resulting solution was stirred for 5 h. 
Whilst the above deprotonation was being carried out, a —78 oC solution of 
oxalyl chloride (1.52 cm3, 3.03 mmol) in anhydrous tetrahydrofuran (15 cm3) was 
treated with dimethylsulfoxide (0.47 cm3, 6.06 mmol).  After 30 min, a solution 
of alcohol 212 (560 mg, 1.52 mmol) in anhydrous tetrahydrofuran (7 cm3) was 
added and the reaction was stirred at —78 oC for 1 h.  After this time, 
triethylamine (1.69 cm3, 12.1 mmol) was added and the reaction was allowed to 
warm up to room temperature.  After 30 min, the reaction was cooled back 
down to —78 oC and a solution of the deprotonated alkyne was added.  The 
reaction mixture was allowed to warm to room temperature and stirring 
continued for 14 h.  The reaction mixture was quenched with saturated aqueous 
ammonium chloride (30 cm3) and extracted with ethyl acetate (2×40 cm3).  The 
combined organic layers were dried over anhydrous sodium sulfate, filtered and 
concentrated in vacuo.  Purification by FCC [petroleum ether-ethyl acetate 
(50:50)] of the crude residue afforded propargylic alcohol 222 (585 mg, 65%) as 
a thick, yellow oil and as an inseparable mixture of diastereoisomers; Rf 0.33 
(Solvent I); [ ]19Dα  –0.9 (c 1.0, CHCl3); νmax(film)/cm-1 2928, 1728 (C=O), 1601 
(C=C), 1250, 1153 and 1034 (C-O); δH(400 MHz; CDCl3) 1.30 (3 H, s, CH3), 1.38 (3 
H, s, CCH3), 1.54 (3 H, s, CCH3), 2.39-2.78 (4 H, m, 2×CH2), 3.50 (3 H, s, 
OCH2OCH3), 3.69-3.71 (1 H, m, CHOPMB), 3.81 (3 H, s, OCH2ArOCH3), 3.83 (3 H, 
s, OCH3), 3.91 (3 H, s, CO2CH3), 4.10-4.18 (1 H, m, OCH), 4.24-4.35 (1 H, m, 
OCH), 4.45-4.55 (3 H, m, CHOH and OCH2ArOCH3), 5.18 (2 H, s, OCH2OCH3), 
6.19-6.29 (1 H, m, CH=CH), 6.49 (1 H, d, J 15.7, CH=CH), 6.62 (1 H, s, CH), 6.71 
(1 H, s, CH), 6.89 (2 H, d, J 8.5, 2×CH) and 7.27 (2 H, d, J 8.5, 2×CH); δC(100 
MHz; CDCl3) 19.8 (C22), 25.5 (C14), 26.5 (C20), 27.6 (C15), 31.0 (C33), 33.3 
(C11), 52.3 (C31), 55.3 (C30), 55.5 (C6), 56.2 (C1), 62.1 (C16), 70.4 (C17), 72.9 
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(C23), 73.1 (C21), 79.7 (C12), 80.4 (C19), 84.5 (C18), 94.8 (C2), 100.7 (C4), 
103.8 (C7), 108.6 (C13), 113.8 (C27 and C28), 128.7 (C10), 129.2 (C9), 129.3 
(C24), 130.2 (C25 and C26), 137.6 (C8), 155.6 (C29), 161.3 (C3), 168.0 (C5) and 
171.1 (C32); MS (FAB) m/z 599.3 [M+H]+; HRMS m/z 599.2862 (599.2856 calcd for 
C33H43O10, M+H
+). 
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13C Assignment 
Methyl 4-methoxy-2-((E)-3-{(4S,5S)-5-[(R)-5-(4-methoxybenzyloxy)-hex-2-
ynoyl]-2,2-dimethyl-[1,3]dioxolan-4-yl}-propenyl)-6-methoxymethylbenzoate 
246 
OCH3
OMOMO
H3CO
O
O O
OPMB
 
A solution of oxalyl chloride (0.19 cm3, 0.376 mmol) in anhydrous 
dichloromethane (2 cm3) was treated with dimethylsulfoxide (0.06 cm3, 0.752 
mmol) at —78 oC.  After 30 min, a solution of alcohol 222 (112 mg, 0.188 mmol) 
in anhydrous dichloromethane (1 cm3) was added and the reaction mixture 
stirred at —78 o for 1 h.  After this time, triethylamine (0.21 cm3, 1.50 mmol) 
was added and the reaction was allowed to warm to room temperature, where it 
was stirred for a further 30 min.  The reaction mixture was diluted with 
dichloromethane (10 cm3) and quenched with 1 N hydrochloric acid (10 cm3).  
The phases were separated and the organic layer was washed with saturated 
aqueous sodium hydrogencarbonate (20 cm3), dried over anhydrous sodium 
sulfate, filtered and concentrated in vacuo.  Purification by FCC [petroleum 
ether-ethyl acetate (50:50)] of the crude residue afforded ketone 246 (95 mg, 
85%) as a thick, yellow oil; Rf 0.53 (Solvent I); [ ]23Dα  –3.1 (c 1.1, CHCl3); 
νmax(film)/cm
-1 2203, 1714 (C=O), 1575 (C=C) and 1100; δH(400 MHz; CDCl3) 1.23 
(3 H, d, J 6.1, CH3), 1.32 (3 H, s, CCH3), 1.56 (3 H, s, CCH3), 2.27-2.66 (4 H, m, 
2×CH2), 3.39 (3 H, s, OCH2OCH3), 3.71 (3 H, s, OCH2ArOCH3), 3.65-3.73 (1 H, m, 
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CHOPMB), 3.74 (3 H, s, OCH3), 3.81 (3 H, s, CO2CH3), 4.36-4.43 (3 H, m, OCH and 
OCH2ArOCH3), 4.50 (1 H, d, J 7.3, OCH), 5.08 (2 H, s, OCH2OCH3), 6.08-6.18 (1 H, 
m, CH=CH), 6.38 (1 H, d, J 15.8, CH=CH), 6.54 (1 H, s, CH), 6.61 (1 H, s, CH), 
6.79 (2 H, d, J 8.5, 2×CH) and 7.19 (2 H, d, J 8.5, 2×CH); δC(100 MHz; CDCl3) 
18.89 (C22), 24.3 (C15), 25.9 (C20), 26.0 (C14), 33.0 (C11), 51.2 (C31), 54.23 
(C30), 54.4 (C6), 55.1 (C1), 69. 6 (C23), 71.3 (C21), 76.9 (C12), 80.5 (C19), 82.1 
(C16), 93.8 (C18), 95.2 (C2), 99.7 (C4), 102.8 (C7), 109.8 (C33), 112.8 (C27 and 
C28), 115.5 (C13), 128.0 (C10), 128.2 (C25 and 26), 128.3 (C9), 129.1 (C24), 
136.2 (C8), 154.5 (C29), 158.2 (C3), 160.2 (C5), 167.3 (C32) and 185.5 (C17); MS 
(FAB) m/z 597.3 [M+H]+; HRMS m/z 597.2712 (597.2699 calcd for C33H41O10, 
M+H+). 
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13C Assignment 
Methyl 4-methoxy-2-((E)-3-{(4S,5S)-5-[(R)-5-(4-methoxybenzyloxy)-1-
triisopropylsilanyloxy-hex-2-ynyl]-2,2-dimethyl-[1,3]dioxolan-4-yl}-
propenyl)-6-methoxymethylbenzoate 221 
OCH3
OMOMO
H3CO
O
O OTIPS
OPMB
 
To a solution of alcohol 222 (585 mg, 0.977 mmol) in anhydrous 
dimethylformamide (10 cm3) was added imidazole (199 mg, 2.93 mmol) and 
stirred until homogenous.  Triisopropylsilyl chloride (0.25 cm3, 1.17 mmol) was 
then added at room temperature and the reaction was stirred for 16 h.  The 
reaction mixture was then diluted with ethyl acetate (30 cm3) and quenched 
with water (40 cm3).  The organic phase was washed with water (4×100 cm3), 
dried over anhydrous sodium sulfate, filtered and concentrated in vacuo.  
Purification by FCC [petroleum ether-ethyl acetate (60:40)] of the crude residue 
afforded silyl ether 221 (386 mg, 52%, 83% based on starting material consumed) 
as a yellow oil (recovered starting material 216 mg); Rf 0.66 (Solvent I); [ ]24Dα  –
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27.0 (c 1.0, CHCl3); νmax(film)/cm
-1 2942, 2865, 1731 (C=O), 1600 (C=C), 1247, 
1152 and 1048 (C-O); δH(400 MHz; CDCl3) 1.01-1.12 (21 H, m, 3×SiCH(CH3)2), 1.29 
(3 H, d, J 6.1, CH3), 1.37 (3 H, s, CCH3), 1.50 (3 H, s, CCH3), 2.34 (1 H, dd, J 7.6 
and 16.5, C≡CCH2), 2.51-2.74 (3 H, m, CH=CHCH2 and C≡CCH2), 3.46 (3 H, s, 
OCH2OCH3), 3.60-3.67 (1 H, m, CHOPMB), 3.76 (3 H, s, OCH2ArOCH3), 3.81 (3 H, 
s, OCH3), 3.88 (3 H, s, COOCH3), 4.09-4.29 (2 H, m, 2×CHO), 4.48 (2 H, d, J 6.7, 
OCH2ArOCH3), 4.53 (1 H, d, J 6.8, HCOTIPS), 5.14 (2 H, s, OCH2OCH3), 6.18-6.25 
(1 H, m, CH=CH), 6.40 (1 H, dd, J 4.4 and 15.6, CH=CH), 6.60 (1 H, s, CH(Ar)), 
6.69 (1 H, d, J 3.3, CH(Ar)), 6.87 (2 H, t, J 6.8, 2xCH(Ar)) and 7.24-7.28 (2 H, m, 
2xCH(Ar)); δC(100 MHz; CDCl3) 12.3 (C34), 17.7 (C35), 19.8 (C22), 25.7 (C15), 
26.5 (C20), 27.8 (C14), 34.0 (C11), 52.2 (C31), 55.3 (C30), 55.5 (C6), 56.2 (C1), 
62.7 (C17), 70.3 (C23), 73.2 (C21), 77.3 (C12), 80.4 (C16), 80.7 (C19), 83.9 
(C18), 94.8 (C2), 100.7 (C4), 103.5 (C7), 108.6 (C33), 109.0 (C13), 113.8 (C27 
and C28), 128.2 (C9), 129.2 (C25 and C26), 130.9 (C24), 131.0 (C10), 137.1 (C8), 
156.1 (C29), 159.0 (C3), 161.2 (C5) and 168.0 (C32); MS (FAB) m/z 777.3 
[M+Na]+; HRMS m/z 777.4014 (777.4010 calcd for C42H62NaO10Si, M+Na
+). 
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13C Assignment 
Methyl 4-methoxy-2-((E)-3-{(4S,5S)-5-[(Z)-(S)-5-(4-methoxybenzyloxy)-1-
triisopropylsilanyloxy-hex-2-enyl]-2,2-dimethyl-[1,3]dioxolan-4-yl}-
propenyl)-6-methoxymethylbenzoate 220 
CO2Me
MOMO
H3CO
O
O
OTIPS
PMBO
 
A solution of alkyne 221 (270 mg, 0.357 mmol) in methanol (7 cm3) was treated 
with a catalytic amount of Pd/BaSO4 catalyst and poisoned with quinoline (0.05 
cm3, 0.45 mmol).  The flask was evacuated and after purging three times with 
hydrogen gas via a balloon, the mixture was stirred under an atmosphere of 
hydrogen for 4 h at room temperature.  TLC analysis deemed the reaction 
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complete and the solution was filtered through a pad of Celite® to remove the 
catalyst and the solvent concentrated in vacuo.  Purification by FCC [petroleum 
ether-ethyl acetate (60:40)] of the crude residue afforded alkene 220 (225 mg, 
83%) as a pale yellow oil; Rf 0.72 (Solvent I); [ ]24Dα  +26.7 (c 1.0, CHCl3); 
νmax(film)/cm
-1 2963, 2918, 2851, 2363, 1969, 1734 (C=O), 1259,1014 and 793; 
δH(400 MHz; CDCl3) 1.04 (3 H, s, 3×SiCH(CH3)2), 1.09 (18 H, s, 3×SiCH(CH3)2), 
1.23 (3 H, d, J 6.1, CH3), 1.32 (3 H, s, CCH3), 1.42 (3 H, s, CCH3), 2.22-2.69 (4 H, 
m, 2×CH2), 3.45 (3 H, s, OCH2OCH3), 3.58-3.63 (1 H, m, CHOPMB), 3.77 (3 H, s, 
OCH2ArOCH3), 3.81 (3 H, s, OCH3), 3.87 (3 H, s, COOCH3), 3.92-4.16 (2 H, m, 
2×CHO), 4.36-4.52 and 4.61-4.70 (3 H, m, OCH2ArOCH3 and HCOTIPS), 5.14 (2 H, 
s, OCH2OCH3), 5.48-5.68 (2 H, m, CH=CH), 6.20-6.30 (1 H, m, CH=CH), 6.44-6.47 
(1 H, m, CH=CH) 6.59 (1 H, s, CH(Ar)), 6.74 (1 H, s, CH(Ar)), 6.85 (2 H, t, J 6.7, 
2xCH(Ar)) and 7.24-7.27 (2 H, m, 2xCH(Ar)); δC(100 MHz; CDCl3) 12.3 (C34), 17.7 
(C35), 19.8 (C22), 25.6 (C15), 26.9 (C20), 27.4 (C14), 33.7 (C11), 52.0 (C31), 
55.3 (C30), 55.4 (C6), 56.2 (C1), 60.4 (C17), 70.2 (C23), 74.3 (C21), 77.8 (C12), 
80.5 (C16),  94.8 (C2), 99.2 (C4), 107.6 (C33), 107.8 (C7), 113.8 (C27 and C28), 
117.3 (C13), 127.9 (C9), 129.2 (C25 and C26), 130.9 (C24), 131.0 (C19), 131.5 
(C10), 132.3 (C18), 142.4 (C8), 155.5 (C29), 159.1 (C3), 161.2 (C5) and 168.7 
(C32); MS (FAB) m/z 781.2 [M+Na]+; HRMS m/z 779.4157 (779.4169 calcd for 
C42H64NaO10Si, M+Na
+). 
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13C Assignment 
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Methyl 2-{(E)-3-[(4S,5S)-5-((Z)-(S)-5-hydroxy-1-triisopropylsilanyloxy-hex-2-
enyl)-2,2-dimethyl-[1,3]dioxolan-4-yl]-propenyl}-4-methoxy-6-
methoxymethylbenzoate 219 
OCH3
OMOMO
H3CO
O
O
OTIPS
HO
 
To a solution of PMB ether 220 (246 mg, 0.325 mmol) in dichloromethane (7 
cm3) and pH 7 buffer (7 cm3) at 0 oC was added dichlorodicyanobenzoquinone (96 
mg, 0.422 mmol).  The reaction was allowed to warm to room temperature over 
16 h.  The reaction was then diluted with dichloromethane (30 cm3) and 
quenched with saturated aqueous sodium hydrogencarbonate (30 cm3).  The 
aqueous layer was extracted with dichloromethane (3×30 cm3) and the 
combined organic layers were dried over anhydrous sodium sulfate, filtered and 
concentrated in vacuo.  Purification by FCC [petroleum ether-ethyl acetate 
(70:30)] of the crude residue afforded free alcohol 219 (160 mg, 77%) as a thick, 
yellow oil; Rf 0.24 (Solvent B); [ ]24Dα  –19.0 (c 0.9, CHCl3); νmax(film)/cm-1 2928, 
2867, 1732 (C=O), 1601 (C=C), 1464, 1264, 1154 and 1048 (O-Si); δH(400 MHz; 
CDCl3) 0.93 (3 H, s, 3×SiCH(CH3)2), 1.07 (18 H, s, 3×SiCH(CH3)2), 1.19 (3 H, dd, J 
3.9 and 6.1, CH3), 1.32 (3 H, s, CCH3), 1.40 (3 H, s, CCH3), 2.14-2.70 (4 H, m, 
2CH2), 3.46 (3 H, s, OCH2OCH3), 3.75 (3 H, s, OCH3), 3.86 (3 H, s, COOCH3), 3.91-
4.19 (3 H, m, 2×CHO and CHOH), 4.66-4.78 (1 H, m, CHOTIPS), 5.12 (2 H, s, 
OCH2OCH3), 5.48-5.71 (2 H, m, CH=CH), 6.25-6.28 (1 H, m, CH=CH), 6.38-6.42 (1 
H, m, CH=CH), 6.41 (1 H, d, J 2.2, CH(Ar)), and 6.54 (1 H, d, J 2.2, CH(Ar)); 
δC(100 MHz; CDCl3) 12.4 (C26), 18.2 (C27), 23.4 (C22), 25.5 (C15), 27.1 (C20), 
27.5 (C14), 33.5 (C11), 52.0 (C23), 55.4 (C6), 56.2 (C1), 66.4 (C17), 68.1 (C21), 
77.9 (C12), 80.4 (C16), 94.9 (C2), 99.2 (C4), 107.6 (C25), 108.1 (C7), 116.6 
(C13), 127.0 (C9), 128.7 (C19), 132.2 (C10), 134.7 (C18), 142.4 (C8), 155.5 (C3), 
161.2 (C5), and 168.1 (C24); MS (FAB) m/z 637.2 [M+H]+; HRMS m/z 637.3768 
(637.3772 calcd for C34H57O9Si, M+H
+). 
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13C Assignment 
2-{(E)-3-[(4S,5S)-5-((Z)-(S)-5-Hydroxy-1-triisopropylsilanyloxy-hex-2-enyl)-
2,2-dimethyl-[1,3]dioxolan-4-yl]-propenyl}-4-methoxy-6-
methoxymethylbenzoic acid 218 
OH
OMOMO
H3CO
O
O
OTIPS
HO
 
A solution of ester 219 (80 mg, 0.125 mmol) in ethanol (1 cm3) was treated with 
the dropwise addition of 2 N potassium hydroxide (1 cm3).  The reaction mixture 
was heated under reflux for 48 h then cooled down to room temperature, 
diluted with water (5 cm3) and acidified to pH 1 with 6 N hydrochloric acid.  The 
organics were extracted with ethyl acetate (2×10 cm3) and the combined 
organic phases were washed with water (7 cm3) then brine (7 cm3) and dried 
over anhydrous sodium sulfate.  The solution was filtered and concentrated in 
vacuo.  Purification by FCC [ethyl acetate (100)] of the crude residue afforded 
acid 218 (33 mg, 57%) as a thick, yellow oil; Rf 0.1 (Solvent I); [ ]22Dα  –18.2 (c 1.0, 
CHCl3); νmax(film)/cm
-1 2940, 1591, 1447, 1253 and 1148; δH(400 MHz: CDCl3) 
0.95 (3 H, s, 3×SiCH(CH3)2), 1.04 (18 H, s, 3×SiCH(CH3)2), 1.18 (3 H, dd, J 3.9 
and 6.1, CH3), 1.33 (3 H, s, CCH3), 1.43 (3 H, s, CCH3), 2.16-2.81 (4 H, m, 
2xCH2), 3.48 (3 H, s, OCH2OCH3), 3.82 (3 H, s, OCH3), 3.97-4.36 (3 H, m, 2xCHO 
and CHOH), 4.70-4.76 (1 H, m, CHOTIPS), 5.20 (2 H, s, OCH2OCH3), 5.59-5.71 (2 
H, m, CH=CH), 6.12-6.23 (1 H, m, CH=CH), 6.44-6.47 (1 H, m, CH=CH), 6.51 (1 H, 
s, CH(Ar)), and 6.72 (1 H, s, CH(Ar)); δC(100 MHz; CDCl3) 12.9 (C25), 18.2 (C26), 
23.1 (C22), 25.8 (C15), 27.8 (C17), 29.7 (C14), 34.0 (C11), 37.9 (C20), 55.6 (C6), 
56.5 (C1), 67.9 (C21), 77.4 (C12), 80.3 (C16), 95.4 (C2), 100.9 (C4), 105.6 (C24), 
108.7 (C7), 113.4 (C13), 127.1 (C9), 129.9 (C19), 130.3 (C10), 132.4 (C18), 139.9 
(C8), 156.0 (C3), 161.7 (C5), and 168.2 (C23); MS (EI) m/z 271.1 
[H3CCH(OH)CH2CH=CHCH(OTIPS)]
+. 
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13C Assignment 
(2E,11Z)-(5S,9S,14S)-20-Methoxy-18-methoxymethyl-7,7,14-trimethyl-10-
triisopropylsilanyloxy-6,8,15-trioxa-tricyclo[15.4.0.05,9]henicosa-
1(21),2,11,17,19-pentaen-16-one 227 
H3CO
MOMO O
O O
O
OTIPS
 
Procedure A 
Trichlorobenzoyl chloride (4.5 µL, 28.7 µmol) was added to a mixture of seco-
acid 218 (17.9 mg, 28.7 µmol) and triethylamine (4.4 µL, 31.5 µmol) and the 
reaction mixture stirred at room temperature under argon for 2 h.  The resulting 
mixture was filtered through a short pad of Celite®, diluted with toluene (15 
cm3) and added to a refluxing solution of dimethylaminopyridine (21 mg, 0.172 
mmol) in toluene (15 cm3) over a period of 6 h.  The reaction was then cooled 
down to room temperature, then diluted with diethyl ether (15 cm3) and washed 
sequentially with 1 N hydrochloric acid (15 cm3), saturated aqueous sodium 
hydrogencarbonate (2×15 cm3) and brine (15 cm3).  The solution was dried over 
anhydrous sodium sulfate, filtered and concentrated in vacuo.  Purification by 
FCC [petroleum ether-ethyl acetate (70:30)] of the crude residue afforded 
lactone 227 (6.5 mg, 37%) as a thick, yellow oil; Rf 0.61 (Solvent I); [ ]22Dα  –1.8 (c 
1.0, CHCl3); νmax(film)/cm
-1 2935, 1269 and 1089 (O-Si); δH(400 MHz; CDCl3) 0.09 
(3 H, s, 3×SiCH(CH3)2), 1.05 (18 H, s, 3×SiCH(CH3)2), 1.22-1.24 (3 H, m, CH3), 
1.32 (3 H, s, CCH3), 1.48 (3 H, s, CCH3), 2.18-2.21 (2 H, m, CH2), 2.47-2.54 (2 H, 
m, CH2), 3.42 (3 H, s, OCH2OCH3), 3.83 (3 H, s, OCH3), 3.94-4.05 (3 H, m, 2×CHO 
and CHCH3), 4.74-4.78 (1 H, m, CHOTIPS), 5.20 (2 H, s, OCH2OCH3), 5.61-5.76 (2 
H, m, CH=CH), 6.44-6.47 (1 H, m, CH=CH), 6.65-6.69 (1 H, m, CH=CH), 6.61 (1 H, 
d, J 2.1, CH), and 6.78 (1 H, s, CH); δC(100 MHz; CDCl3) 12.8 (C25), 18.3 (C26), 
23.8 (C22), 26.4 (C15), 28.9 (C17), 29.7 (C14), 30.4 (C11), 38.7 (C20), 55.4 (C6), 
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56.2 (C1), 68.2 (C21), 77.4 (C12), 81.4 (C16), 94.7 (C2), 100.6 (C4), 104.9 (C24), 
107.8 (C7), 113.7 (C13), 128.8 (C9), 130.1 (C19), 131.0 (C10), 132.5 (C18), 137.8 
(C8), 156.1 (C3), 161.4 (C5), and 167.8 (C23).  The compound failed to ionise 
under all mass spectrometry conditions attempted. 
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13C Assignment 
Procedure B 
A mixture of 2-methyl-6-nitrobenzoic anhydride (15.2 mg, 44 µmol), 
dimethylaminopyridine (16.2 mg, 132 µmol) and powdered activated 4Å 
molecular sieves in dry toluene (10 cm3) was stirred at room temperature for 30 
min.  A solution of seco-acid 218 (18.4 mg, 29 µmol) in dry toluene (6 cm3) was 
then added slowly over 4 h.  After the addition was complete, the reaction 
mixture was stirred for 2 h at room temperature.  The mixture was then diluted 
with ethyl acetate (5 cm3), passed through a pad of Celite® and then washed 
with saturated aqueous sodium hydrogen carbonate (10 cm3), water (10 cm3) and 
brine (10 cm3).  The solution was dried over anhydrous sodium sulfate, filtered 
and concentrated in vacuo.  Purification by FCC [petroleum ether-ethyl acetate 
(80:20)] of the crude residue afforded lactone 227 (5 mg, 28%) as a thick, yellow 
oil; Rf 0.57 (Solvent C).  
1H and 13C match that reported for Procedure A. 
(2E,11Z)-(5S,9S,14R)-20-Methoxy-18-methoxymethyl-7,7,14-trimethyl-10-
triisopropylsilanyloxy-6,8,15-trioxa-tricyclo[15.4.0.05,9]henicosa-
1(21),2,11,17,19-pentaen-16-one 228 
H3CO
MOMO O
O O
O
OTIPS
 
To a solution of seco-acid 218 (27.5 mg, 44.1 µmol) in anhydrous toluene (6.3 
cm3) was added triphenylphosphine (23 mg, 88.3 µmol) and the solution stirred 
until dissolved.  The mixture was cooled to 0 oC and diethyl azodicarboxylate 
Suzannah J. Harnor, 2010  164 
(DEAD) (14 µL, 88.3 µmol) was added slowly.  After 5 min, the ice-water bath 
was removed and the reaction allowed to warm up to room temperature.  After 
30 min, the reaction was diluted with toluene (10 cm3) and the solvent then 
evaporated slowly under vacuum to leave an orange viscous mass.  Purification 
by FCC [petroleum ether–ethyl acetate (50:50)] of the residue afforded lactone 
228 (19 mg, 71%) as a yellow oil; Rf 0.67 (Solvent M); [ ]22Dα  +2.0 (c 1.1, CHCl3); 
νmax(film)/cm
-1 2929, 1262, 1089 (O-Si) and 1028; δH(400 MHz; CDCl3) 0.94 (3 H, 
s, 3×SiCH(CH3)2), 1.02 (18 H, s, 3×SiCH(CH3)2), 1.26 (3 H, d, J 7.0, CH3), 1.38 (3 
H, s, CCH3), 1.45 (3 H, s, CCH3), 1.80-2.05 (2 H, 2×m, CH2), 2.40-2.60 (2 H, m, 
CH2), 3.44 (3 H, s, OCH2OCH3), 3.78 (3 H, s, OCH3), 3.90-4.00 (2 H, m, 2×CHO), 
4.22 (1 H, dd, J 1.7 and 7.0, CHCH3), 4.52 (1 H, dd, J 8.2 and 9.3, CHOTIPS), 
5.12 (2 H, s, OCH2OCH3), 5.42-5.90 (4 H, m, 2×CH=CH), 6.34 (1 H, d, J 2.2, CH), 
and 6.54 (1 H, d, J 2.2, CH); δC(100 MHz; CDCl3) 12.6 (C25), 18.1 (C26), 24.6 
(C22), 26.9 (C15), 28.1 (C17), 29.6 (C14), 29.9 (C11), 36.7 (C20), 55.4 (C6), 56.2 
(C1), 68.9 (C21), 77.3 (C12), 81.3 (C16), 94.6 (C2), 99.4 (C4), 107.4 (C24), 107.5 
(C7), 116.9 (C13), 128.5 (C9), 130.5 (C19), 131.3 (C10), 132.5 (C18), 141.2 (C8), 
155.3 (C3), 161.0 (C5), and 167.6 (C23).  The compound failed to ionise under all 
mass spectrometry conditions attempted. 
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13C Assignment 
(2E,11Z)-(5S,9R,14R)-10-Hydroxy-20-methoxy-18-methoxymethyl-7,7,14-
trimethyl-6,8,15-trioxa-tricyclo[15.4.0.05,9]henicosa-1(21),2,11,17,19-
pentaen-16-one 229 
H3CO
MOMO O
O O
O
OH
 
Tetra-butylammonium fluoride (60 µL, 62.4 µmol) was added to a solution of 
TIPS ether 228 (19 mg, 31.2 µmol) in anhydrous tetrahydrofuran (1 cm3).  The 
reaction mixture was stirred at 0 oC for 10 min and was then allowed to warm up 
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to room temperature.  After 1.25 h the reaction was diluted with diethyl ether 
(5 cm3) and quenched with water (5 cm3).  The organic layer was separated, 
dried over anhydrous sodium sulfate, filtered and concentrated in vacuo to yield 
alcohol 229 as a yellow, thick oil; Rf 0.32 (Solvent M); [ ]22Dα  +2.5 (c 1.0, CHCl3); 
νmax(film)/cm
-1 1670 (C=O), 1159 and 1012; δH(400 MHz; CDCl3) 1.24 (3 H, d, 
CH3), 1.35 (3 H, s, CCH3), 1.44 (3 H, s, CCH3), 1.80-2.05 (2 H, m, CH2), 2.50-2.80 
(2 H, m, CH2), 3.45 (3 H, s, OCH2OCH3), 3.77 (3 H, s, OCH3), 3.90-4.04 (2 H, m, 
2×CHO), 4.27-4.29 (2 H, m, CHCH3 and CHOH), 5.12 (2 H, s, OCH2OCH3), 5.20-
5.50 (2 H, m, CH=CH), 5.70-5.99 (2 H, m, CH=CH), 6.34 (1 H, d, J 2.0, CH) and 
6.53 (1 H, d, J 2.0, CH); δC(100 MHz; CDCl3) 24.3 (C22), 26.3 (C15), 28.2 (C17), 
29.3 (C14), 29.7 (C11), 35.2 (C20), 55.4 (C6), 56.2 (C1), 68.9 (C21), 77.6 (C12), 
80.4 (C16), 94.5 (C2), 99.2 (C4), 107.4 (C24), 107.9 (C7), 116.9 (C13), 128.5 
(C9), 130.1 (C19), 131.7 (C10), 132.1 (C18), 141.3 (C8), 154.9 (C3), 161.0 (C5), 
and 167.6 (C23). 
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13C Assignment 
(2E,11Z)-(5S,9S,14R)-20-Methoxy-18-methoxymethyl-7,7,14-trimethyl-
6,8,15-trioxa-tricyclo[15.4.0.05,9]henicosa-1(21),2,11,17,19-pentaene-
10,16-dione 230 
H3CO
MOMO O
O O
O
O
 
A solution of pyridinium chlorochromate (16 mg, 77.4 µmol) in anhydrous 
dichloromethane (1 cm3) was treated with a solution of alcohol 229 (16.7 mg, 
37.2 µmol) in anhydrous dichloromethane (1 cm3) at room temperature.  After 
3.5 h, the reaction mixture was diluted with dichloromethane (2 cm3) and passed 
through a short column of SiO2, eluting with dichloromethane.  The solvent was 
concentrated in vacuo to leave enone 230 (3.3 mg, 20%) as a thick, orange 
viscous mass; Rf 0.71 (Solvent M); δH(400 MHz; CDCl3) 1.24 (3 H, d, J 6.4, CH3), 
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1.38 (3 H, s, CCH3), 1.45 (3 H, s, CCH3), 2.08-2.12 (2 H, m, CH2), 2.46-2.50 (2 H, 
m, CH2), 3.40 (3 H, s, OCH2OCH3), 3.73 (3 H, s, OCH3), 4.30-4.55 (2 H, m, CCH3 
and CH2CHO), 4.72 (2 H, s, OCH2OCH3), 5.00-5.03 (1 H, m, CHO), 5.37-5.43 (2 H, 
m, CH=CH), 6.05-6.12 (2 H, m, CH=CH), 6.17 (1 H, d, J 2.8, CH), and 6.23 (1 H, 
d, J 2.8, CH).  The lack of material prevented the acquisition of a full data set. 
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13C Assignment 
(R)-(-)-Pent-4-yn-2-ol 233 
H
OH
 
A stirred suspension of lithium acetylide ethylenediamine complex (5.7 g, 62.0 
mmol) in anhydrous dimethylsulfoxide (110 cm3) at 0 oC was treated dropwise 
with R-(+)-propylene oxide (3.6 cm3, 51.6 mmol).  The reaction was then 
allowed to warm up to room temperature, where it was stirred for 48 h.  The 
suspension was poured onto ice (100 cm3) and extracted with diethyl ether 
(4×80 cm3).  The combined ether extracts were washed with brine (6×30 cm3), 
water (2×30 cm3) and dried over anhydrous magnesium sulfate.  Careful 
evaporation of the solvent at atmospheric pressure yielded the crude alcohol 
233 which was taken on without any purification; [ ]22Dα  –18.0 (c 1.0, CHCl3); 
νmax(film)/cm
-1 3340 (OH), 3301 (C≡C) and 2360; δH(400 MHz; CDCl3) 1.20 (3 H, 
d, J 6.0, CH3), 2.10 (1 H, t, J 2.7, HC≡C), 2.33 (1 H, ddd, J 2.7, 5.3 and 16.0, 
CH2), 2.42 (1 H, ddd, J 2.7, 6.2 and 16.0, CH2) and 4.02-4.04 (1 H, m, HCOH); 
δC(100 MHz; CDCl3) 24.7 (CH3), 32.8 (CH2), 67.2 (HCOH), 71.1 (HC≡C) and 85.1 
(HC≡C); MS (CI) m/z 67 [M-OH]+; HRMS m/z 67.0550 (67.0548 calcd for C5H7, M-
OH+). 
1-Methoxy-4-((R)-1-methyl-but-3-ynyloxymethyl)-benzene 234 
H
OPMB
 
A suspension of 60% in mineral oil NaH (2.27 g, 56.7 mmol) at 0 oC, was diluted 
with anhydrous dimethylformamide (65 cm3) and a solution of the freshly 
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generated crude alcohol 233 (4.34 g, 51.6 mmol) in anhydrous 
dimethylformamide (65 cm3) was added.  The reaction mixture was stirred for 15 
min, then p-methoxybenzyl chloride (10.5 cm3, 77.4 mmol) was added and the 
reaction mixture was allowed to warm up to room temperature and stirred for 
17 h.  The solution was then poured onto brine (400 cm3) and extracted with 
diethyl ether (3×100 cm3).  The combined organic layers were concentrated 
under reduced pressure, then washed with brine (300 cm3), dried over anhydrous 
magnesium sulfate, filtered and the solvent concentrated.  Purification by FCC 
[petroleum ether-ethyl acetate (95:5)] of the crude residue afforded PMB ether 
234 (4.13 g, 40%) as a colourless oil; Rf 0.69 (Solvent A); [ ]19Dα  +11.2 (c 1.1, 
CHCl3); νmax (film)/cm
-1
 2253, 911 and 739; δH(400 MHz; CDCl3) 1.32 (3 H, d, J 
6.0, CH3), 2.04 (1 H, t, J 2.6, HC≡C), 2.38 (1 H, ddd, J 2.6, 7.0 and 16.6, CH2), 
2.52 (1 H, ddd, J 2.6, 4.9 and 16.6, CH2), 3.70 (1 H, sext., J 6.0, CH), 3.86 (3 H, 
s, OCH3), 4.53 (2 H, s, OCH2), 6.91 (2 H, d, J 8.6, Ar) and 7.31 (2 H, d, J 8.6, Ar); 
δC(100 MHz; CDCl3) 19.5 (CH3), 26.0 (CH2), 55.3 (OCH3), 69.9 (CH), 70.3 (HC≡C), 
72.8 (OCH2), 81.3 (HC≡C), 113.8 (2×CH), 129.2 (2×CH), 130.6 (C) and 159.1 
(COCH3); MS (EI) m/z 204.04 [M]
+; HRMS m/z 204.1146 (204.1150 calcd for 
C13H16O2, M
+). 
Methyl 2-((E)-3-{(4S,5R)-5-[(S)-1-hydroxy-5-(4-methoxybenzyloxy)-hex-2-
ynyl]-2,2-dimethyl-[1,3]dioxolan-4-yl}-propenyl)-4-methoxy-6-
methoxymethylbenzoate 235 
OCH3
OMOMO
H3CO
O
O OH
OPMB
 
A solution of alkyne 234 (82.4 mg, 0.403 mmol) in anhydrous tetrahydrofuran (2 
cm3) was treated with ethyl magnesium bromide (0.13 cm3, 0.378 mmol) at room 
temperature and the resulting solution was stirred for 5.5 h. 
Whilst the above deprotonation was being carried out, a —78 oC solution of 
oxalyl chloride (0.25 cm3, 0.504 mmol) in anhydrous tetrahydrofuran (3 cm3) was 
added dimethylsulfoxide (70 µL, 1.00 mmol).  After stirring for 30 min a solution 
of alcohol 212 (100 mg, 0.252 mmol) in anhydrous tetrahydrofuran (1.5 cm3) was 
added and stirring continued for 1 h at —78 oC.  After this time, triethylamine 
(0.28 cm3, 2.02 mmol) was added and the reaction allowed to warm up to room 
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temperature.  After 30 min the reaction was cooled back down to —78 oC and a 
solution of the deprotonated alkyne was added.  The mixture was then allowed 
to warm up to room temperature overnight.  The reaction was then quenched 
with saturated aqueous ammonium chloride (10 cm3) and extracted with ethyl 
acetate (3×20 cm3).  The combined organic layers were dried over anhydrous 
sodium sulfate, filtered and concentrated in vacuo.  Purification by FCC 
[petroleum ether-ethyl acetate (50:50)] of the crude residue afforded 
propargylic alcohol 235 (113 mg, 75%) as a pale yellow oil and as an inseparable 
mixture of diastereoisomers; Rf 0.27 (Solvent I); [ ]25Dα  +0.04 (c 0.9, CHCl3); 
νmax(film)/cm
-1 3434, 3019, 1720 (C=O), 1602 (C=C), 1215, 765, 669; δH(400 MHz; 
CDCl3) 1.30 (3 H, s, CH3), 1.38 (3 H, s, CCH3), 1.54 (3 H, s, CCH3), 2.39-2.78 (4 H, 
m, 2×CH2), 3.50 (3 H, s, OCH2OCH3), 3.60-3.70 (1 H, m, CHOPMB), 3.81 (3 H, s, 
OCH2ArOCH3), 3.83 (3 H, s, OCH3), 3.91 (3 H, s, CO2CH3), 4.20-4.30 (1 H, m, 
OCH), 4.43-4.47 (1 H, m, OCH), 4.45-4.55 (3 H, m, CHOH and OCH2ArOCH3), 5.18 
(2 H, s, OCH2OCH3), 6.23-6.29 (1 H, m, CH=CH), 6.49 (1 H, d, J 15.7, CH=CH), 
6.62 (1 H, s, CH), 6.71 (1 H, s, CH), 6.89 (2 H, d, J 8.5, 2×CH) and 7.27 (2 H, d, 
J 8.5, 2×CH); δC(100 MHz; CDCl3) 19.8 (C22), 25.5 (C14), 26.5 (C20), 27.6 (C15), 
31.0 (C33), 33.3 (C11), 52.3 (C31), 55.3 (C30), 55.5 (C6), 56.2 (C1), 62.1 (C16), 
70.4 (C17), 72.9 (C23), 73.1 (C21), 79.7 (C12), 80.4 (C19), 84.5 (C18), 94.8 (C2), 
100.7 (C4), 103.8 (C7), 108.6 (C13), 113.8 (C27 and C28), 128.7 (C10), 129.2 
(C9), 129.3 (C24), 130.2 (C25 and C26), 137.6 (C8), 155.6 (C29), 161.3 (C3), 
168.0 (C5) and 171.1 (C32); MS (FAB) m/z 599.3 [M+H]+; HRMS m/z 599.2843 
(599.2857 calcd for C33H43O10, M+H
+). 
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13C Assignment 
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Methyl 4-methoxy-2-((E)-3-{(4S,5S)-5-[(S)-5-(4-methoxybenzyloxy)-1-
triisopropylsilanyloxy-hex-2-ynyl]-2,2-dimethyl-[1,3]dioxolan-4-yl}-
propenyl)-6-methoxymethylbenzoate 236 
MOMO
MeO
O
O
OTIPS
OPMB
O
OCH3
 
Propargylic alcohol 235 (113 mg, 0.188 mmol) was dissolved in anhydrous 
dimethylformamide (2 cm3), imidazole (38 mg, 0.566 mmol) added and the 
solution was stirred until homogenous.  Triisopropylsilyl chloride (0.05 cm3, 
0.226 mmol) was then added at room temperature and the reaction left to stir 
overnight.  The reaction mixture was diluted with ethyl acetate (10 cm3) and 
quenched with water (10 cm3).  The organic layer was separated, extracted with 
water (3×30 cm3), dried over anhydrous sodium sulfate, filtered and 
concentrated in vacuo.  Purification by FCC [petroleum ether-ethyl acetate 
(50:50)] of the crude residue afforded TIPS ether 236 (114 mg, 80%) as a yellow 
oil; Rf 0.60 (Solvent I); [ ]19Dα  –2.2 (c 1.13, CHCl3); vmax(film)/cm-1 2943, 2866, 
1725 (C=O), 1601 (C=C), 1513, 1266, 1215, 1154, 757; δH(400 MHz; CDCl3) 1.01-
1.12 (21 H, m, TIPS), 1.29 (3 H, s, CH3), 1.37 (3 H, s, CCH3), 1.50 (3 H, s, CCH3), 
2.34 (1 H, dd, J 7.6 and 16.5, C≡CCH2), 2.51-2.74 (3 H, m, CH=CHCH2 and 
C≡CCH2), 3.46 (3 H, s, OCH2OCH3), 3.61-3.67 (1 H, m, CHOPMB), 3.76 (3 H, s, 
OCH2ArOCH3), 3.81 (3 H, s, OCH3), 3.88 (3 H, s, COOCH3), 4.09-4.29 (2 H, m, 
2×CHO), 4.48 (2 H, d, J 6.7, OCH2PhOCH3), 4.53 (1 H, d, J 6.4, HCOTIPS), 5.14 
(2 H, s, OCH2OCH3), 6.22-6.31 (1 H, m, CH=CH), 6.40 (1 H, dd, J 4.4 and 15.6, 
CH=CH), 6.60 (1 H, s, CH(Ar)), 6.69 (1 H, d, J 3.3, CH(Ar)), 6.87 (2 H, t, J 6.8, 
2×CH(Ph)) and 7.22-7.27 (2 H, m, 2×CH(Ph)); δC(100 MHz; CDCl3) 12.3 (C34), 
17.7 (C35), 19.8 (C22), 25.7 (C15), 26.5 (C20), 27.8 (C14), 34.0 (C11), 52.2 
(C31), 55.3 (C30), 55.5 (C6), 56.2 (C1), 62.8 (C17), 70.3 (C23), 73.2 (C21), 77.3 
(C12), 80.5 (C16), 80.7 (C19), 83.7 (C18), 94.8 (C2), 100.7 (C4), 103.6 (C7), 
108.5 (C33), 109.0 (C13), 113.8 (C27 and C28), 128.3 (C9), 129.2 (C25 and C26), 
130.9 (C24), 131.0 (C10), 137.1 (C8), 156.1 (C29), 159.0 (C3), 161.2 (C5) and 
168.0 (C32); MS (FAB) m/z 777.7 [M+Na]+; HRMS m/z 777.4019 (777.4012 calcd 
for C42H62NaO10Si, M+Na
+). 
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13C Assignment 
Methyl 4-methoxy-2-((E)-3-{(4S,5S)-5-[(Z)-(R)-5-(4-methoxy-benzyloxy)-1-
triisopropylsilanyloxy-hex-2-enyl]-2,2-dimethyl-[1,3]dioxolan-4-yl}-
propenyl)-6-methoxymethylbenzoate 237 
CO2Me
MOMO
H3CO
O
O
OTIPS
PMBO
 
A solution of TIPS ether 236 (59 mg, 0.0779 mmol) in methanol (1.5 cm3) was 
treated with a catalytic amount of Pd/BaSO4 catalyst and poisoned with 
quinoline (0.01 cm3, 97.3 µmol).  The flask was evacuated and after purging 
three times with hydrogen gas via a balloon, the mixture was stirred under an 
atmosphere of hydrogen for 2 h at room temperature.  TLC analysis deemed the 
reaction complete and the solution was filtered through a pad of Celite® to 
remove the catalyst and the solvent concentrated in vacuo.  Purification by FCC 
[petroleum ether-ethyl acetate (60:40)] of the crude residue afforded alkene 
237 (53 mg, 89%) as a pale yellow oil; Rf 0.68 (Solvent I); [ ]26Dα  –2.4 (c 0.9, 
CHCl3); νmax(film)/cm
-1 2943, 2865, 1729 (C=O), 1602 (C=C), 1513; δH(400 MHz; 
CDCl3) 1.04 (3 H, s, 3×CH(CH3)2), 1.09 (18 H, s, 3  CH(CH3)2), 1.23 (3 H, d, J 6.1, 
CH3), 1.32 (3 H, s, CCH3), 1.42 (3 H, s, CCH3), 2.22-2.69 (4 H, m, 2×CH2), 3.45 (3 
H, s, OCH2OCH3), 3.56-3.60 (1 H, m, CHOPMB), 3.77 (3 H, s, OCH2ArOCH3), 3.81 
(3 H, s, OCH3), 3.87 (3 H, s, COOCH3), 3.92-4.16 (2 H, m, 2×CHO), 4.36-4.52 (2 
H, m, OCH2ArOCH3), 4.61-4.70 (1 H, m, HCOTIPS), 5.14 (2 H, s, OCH2OCH3), 5.48-
5.68 (2 H, m, CH=CH), 6.25-6.31 (1 H, m, CH=CH), 6.43-6.47 (1 H, m, CH=CH) 
6.59 (1 H, s, CH(Ar)), 6.74 (1 H, s, CH(Ar)), 6.85 (2 H, d, J 6.7, 2×CH(Ar)) and 
7.24-7.27 (2 H, m, 2×CH(Ar)); δC(100 MHz; CDCl3) 12.8 (C34), 17.7 (C35), 19.8 
(C22), 25.6 (C15), 27.0 (C20), 27.5 (C14), 34.0 (C11), 52.1 (C31), 55.3 (C30), 
55.5 (C6), 56.2 (C1), 68.1 (C17), 70.1 (C23), 74.3 (C21), 77.6 (C12), 80.3 (C16),  
94.8 (C2), 100.7 (C4), 108.2 (C33), 108.3 (C7), 113.8 (C27 and C28), 117.0 (C13), 
128.2 (C9), 129.2 (C25 and C26), 130.9 (C24), 131.0 (C19), 131.2 (C10), 132.3 
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(C18), 142.4 (C8), 155.5 (C29), 159.1 (C3), 161.2 (C5) and 168.7 (C32); MS (FAB) 
m/z 779.7 [M+Na]+; HRMS m/z 779.4168 (779.4169 calcd for  C42H64NaO10Si, 
M+Na+).  
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13C Assignment 
Methyl 2-{(E)-3-[(4S,5S)-5-((Z)-(R)-5-hydroxy-1-triisopropylsilanyloxy-hex-2-
enyl)-2,2-dimethyl-[1,3]dioxolan-4-yl]-propenyl}-4-methoxy-6-
methoxymethylbenzoate 238 
H3CO
MOMO
O
O
OTIPS
O
OCH3
HO
 
PMB ether 237 (148 mg, 0.195 mmol) was dissolved in a mixture of 
dichloromethane (2 cm3) and pH 7 buffer (2 cm3) and cooled to 0 oC.  2,3-
Dichloro-5,6-dicyano-1,4-benzoquinone (58 mg, 25.4 µmol) was then added with 
vigorous stirring and the reaction allowed to warm up to room temperature 
overnight.  After this time, the reaction was re-cooled to 0 oC and further 2,3-
dichloro-5,6-dicyano-1,4-benzoquinone (58 mg, 25.4 µmol) was added.  After 
allowing the reaction to warm up to room temperature overnight, the reaction 
mixture was diluted with dichloromethane (15 cm3) and quenched with saturated 
aqueous sodium hydrogen carbonate (15 cm3).  The aqueous layer was separated 
and extracted with dichloromethane (3×40 cm3).  The combined organic layers 
were washed with brine (40 cm3), dried over anhydrous Na2SO4, filtered and 
concentrated in vacuo.  Purification by FCC [petroleum ether-ethyl acetate 
(60:40)] of the crude residue afforded alcohol 238 (108 mg, 87%) as a yellow oil; 
Rf 0.52 (Solvent I); [ ]26Dα  –0.03 (c 1.4, CHCl3); νmax(film)/cm-1 3450, 2942, 2865, 
1721 (C=O), 1598, 1150; δH(400 MHz; CDCl3) 0.93 (3 H, s, 3×CH(CH3)2), 1.06 (18 
H, s, 3×CH(CH3)2), 1.18 (3 H, d, J 6.1, CH3), 1.31 (3 H, s, CCH3), 1.46 (3 H, s, 
CCH3), 2.12-2.18 (1 H, m, CH2), 2.23-2.32 (1 H, m, CH2), 2.45-2.63 (2 H, m, CH2), 
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3.45 (3 H, s, OCH2OCH3), 3.80 (3 H, s, OCH3), 3.86 (3 H, s, COOCH3), 3.96-4.02 (1 
H, dd, J 5.6 and 8.9, CHO), 4.22-4.29 (1 H, m, CHOH), 4.73 (1 H, t, J 8.5, 
CHOTIPS), 5.12 (2 H, s, OCH2OCH3), 5.56-5.67 (2 H, m, CH=CH), 6.23-6.30 (1 H, 
m, CH=CH), 6.40 (1 H, d, J 15.7, CH=CH), 6.57 (1 H, d, J 2.2, CH(Ar)) and 6.71 (1 
H, d, J 2.2, CH(Ar)); δC(100 MHz; CDCl3) 12.9 (C26), 18.2 (C27), 23.8 (C22), 26.1 
(C15), 28.1 (C17), 29.7 (C14), 34.4 (C11), 38.7 (C20), 52.1 (C23), 55.4 (C6), 56.2 
(C1), 66.7 (C21), 77.7 (C12), 80.3 (C16), 94.8 (C2), 100.7 (C4), 103.7 (C25), 
108.8 (C7), 116.5 (C13), 128.7 (C9), 129.9 (C19), 130.4 (C10), 133.8 (C18), 137.5 
(C8), 155.5 (C3), 161.2 (C5), and 168.4 (C24); MS (EI) m/z 636.6 [M]+; HRMS m/z 
636.3699 (636.3694 calcd for C34H56O9Si, M
+).   
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O O
OCH3 O
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13C Assignment 
2-{(E)-3-[(4S,5S)-5-((Z)-(R)-5-Hydroxy-1-triisopropylsilanyloxy-hex-2-enyl)-
2,2-dimethyl-[1,3]dioxolan-4-yl]-propenyl}-4-methoxy-6-
methoxymethylbenzoic acid 239 
H3CO
MOMO
O
O
OTIPS
O
OH
HO
 
Methyl ester 238 (79 mg, 0.124 mmol) was dissolved in ethanol (1.5 cm3) and 2 N 
potassium hydroxide (1.5 cm3) was added dropwise.  A colour change from 
yellow to orange was observed after the addition of base.  The reaction was 
heated under reflux for 48 h whereafter it was cooled down to room 
temperature and diluted with water (10 cm3).  The solution was acidified to pH 
1-2 using 6 N hydrochloric acid and was then extracted with ethyl acetate (3×15 
cm3).  The combined organic layers were washed with water (20 cm3), then brine 
(20 cm3), dried over anhydrous sodium sulfate, filtered and concentrated in 
vacuo.  Purification by FCC [petroleum ether-ethyl acetate (80:20)] of the crude 
residue afforded seco-acid 239 (47 mg, 61%) as a thick, pale orange oil; Rf 0.17 
(Solvent I); [ ]21Dα  –0.1 (c 1.0, CHCl3); νmax(film)/cm-1 3447, 2941, 2866, 2359, 
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1724 (C=O), 1604 (C=C), 1248, 1155 and 1041 (C-O); δH(400 MHz; CDCl3) 0.94 (3 
H, s, 3×CH(CH3)2), 1.02 (18 H, s, 3×CH(CH3)2), 1.21 (3 H, d, J 6.1, CH3), 1.30 (3 
H, s, CCH3), 1.47 (3 H, s, CCH3), 2.08-2.45 (2 H, m, CH2), 2.80-3.00 (2 H, m, 
CH2), 3.52 (3 H, s, OCH2OCH3), 3.82 (3 H, s, OCH3), 3.94-4.20 (3 H, m, 2×CHO 
and CHOH), 4.63-4.67 (1 H, m, CHOTIPS), 5.23 (2 H, s, OCH2OCH3), 5.59-5.71 (2 
H, m, CH=CH), 6.20-6.27 (1 H, m, CH=CH), 6.42-6.48 (1 H, m, CH=CH), 6.51 (1 H, 
s, CH(Ar)), and 6.72 (1 H, s, CH(Ar)); δC(100 MHz; CDCl3) 12.5 (C25), 18.2 (C26), 
23.5 (C22), 26.0 (C15), 28.0 (C17), 29.7 (C14), 34.4 (C11), 38.7 (C20), 55.4 (C6), 
56.5 (C1), 67.0 (C21), 77.5 (C12), 80.3 (C16), 95.3 (C2), 100.7 (C4), 105.5 (C24), 
108.9 (C7), 114.0 (C13), 128.7 (C9), 130.2 (C19), 131.0 (C10), 133.0 (C18), 139.7 
(C8), 156.2 (C3), 161.7 (C5), and 169.0 (C23); MS (FAB) m/z 645.6 [M+Na]+; HRMS 
m/z 645.3436 (645.3437 calcd for C33H54NaO9Si, M+Na
+). 
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13C Assignment 
(2E,11Z)-(5S,9S,14S)-20-Methoxy-18-methoxymethyl-7,7,14-trimethyl-10-
triisopropylsilanyloxy-6,8,15-trioxa-tricyclo[15.4.0.05,9]henicosa-
1(21),2,11,17,19-pentaen-16-one 227 
H3CO
MOMO
O
O
OTIPS
O
O
 
Seco-acid 239 (45 mg, 72.4 µmol) was dissolved in anhydrous toluene (10 cm3) 
and triphenylphosphine (38 mg, 145 µmol) was added at room temperature.  The 
mixture was stirred until homogenous and then the reaction mixture was cooled 
down to 0 oC at which stage, diethyl azodicarboxylate (20 µL, 145 µmol) was 
added dropwise.  The ice-water bath was removed after 5 min and after a 
further 5 min, TLC analysis (solvent M) showed the total consumption of starting 
material.  The solvent was then carefully evaporated in vacuo.  Purification by 
FCC [petroleum ether – ethyl acetate (70:30)] of the crude residue afforded 
lactone 227 (31 mg, 73%) as a yellow oil; Rf 0.87 (Solvent M); [ ]21Dα  –1.6 (c 1.0, 
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CHCl3); νmax(film)/cm
-1 3439, 2941, 2866, 1725 (C=O), 1606 (C=C), 1249; δH(400 
MHz; CDCl3) 0.80 (3 H, s, 3×CH(CH3)2), 0.99 (18 H, s, 3×CH(CH3)2), 1.18 (3 H, s, 
CH3), 1.26 (3 H, s, CCH3), 1.42 (3 H, s, CCH3), 2.02-2.70 (4 H, m, 3×CH2), 3.38 (3 
H, s, OCH2OCH3), 3.70 (3 H, s, OCH3), 3.75-4.05 (3 H, m, 2×CHO and CHCH3), 
4.73-4.76 (1 H, m, CHOTIPS), 5.08 (2 H, s, OCH2OCH3), 5.47-5.76 (2 H, m, 
CH=CH), 6.07-6.13 (1 H, m, CH=CH), 6.25-6.29 (1 H, m, CH=CH), 6.45 (1 H, s, 
CH), and 6.51 (1 H, s, CH); δC(100 MHz; CDCl3) 12.8 (C25), 18.3 (C26), 23.8 
(C22), 26.4 (C15), 28.9 (C17), 29.7 (C14), 30.4 (C11), 38.7 (C20), 55.5 (C6), 56.2 
(C1), 68.2 (C21), 77.2 (C12), 81.4 (C16), 94.7 (C2), 100.6 (C4), 104.9 (C24), 
107.8 (C7), 113.7 (C13), 128.8 (C9), 130.1 (C19), 131.0 (C10), 132.5 (C18), 137.8 
(C8), 156.1 (C3), 161.4 (C5), and 167.8 (C23); MS (FAB) m/z 627 [M+Na]+; HRMS 
m/z 627.3324 (627.3329 calcd for C33H52NaO8Si, M+Na
+). 
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13C Assignment 
(2E,11Z)-(5S,9R,14S)-10-Hydroxy-20-methoxy-18-methoxymethyl-7,7,14-
trimethyl-6,8,15-trioxa-tricyclo[15.4.0.05,9]henicosa-1(21),2,11,17,19-
pentaen-16-one 226 
H3CO
MOMO
O
O
OH
O
O
 
Lactone 227 (31 mg, 51.9 µmol) was dissolved in anhydrous tetrahydrofuran (2 
cm3) and the solution was cooled down to 0 oC.  tetra-Butylammonium fluoride 
(0.1 cm3, 0.104 mmol) was added and the ice-water bath  removed after 10 min.  
After 1 h, the reaction mixture was diluted with ethyl acetate (10 cm3) and 
water (10 cm3).  The organic layer was separated and dried over anhydrous 
sodium sulfate, filtered and concentrated in vacuo, to afford alcohol 226 which 
was used without any further purification; Rf 0.18 (Solvent C); [ ]24Dα  –2.8 (c 1.0, 
CHCl3); νmax(film)/cm
-1 3360 (OH), 2922, 2851, 1720 (C=O), 1661 (C=C), 1468, 
1155 and 1043 (C-O); δH(400 MHz; CDCl3) 1.16 (3 H, s, CH3), 1.22 (3 H, s, CCH3), 
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1.40 (3 H, s, CCH3), 2.00-2.63 (4 H, m, 2×CH2), 3.38 (3 H, s, OCH2OCH3), 3.68 (3 
H, s, OCH3), 3.75-4.00 (3 H, m, 2×CHO and CHCH3), 4.33-4.37 (1 H, m, CHOH), 
5.10 (2 H, s, OCH2OCH3), 5.47-5.76 (2 H, m, 2×CH=CH), 5.90-6.10 (2 H, m, 
2×CH=CH), 6.45 (1 H, s, CH), and 6.51 (1 H, s, CH); δC(100 MHz; CDCl3) 23.8 
(C22), 26.5 (C15), 28.9 (C17), 29.7 (C14), 30.4 (C11), 38.8 (C20), 55.4 (C6), 56.2 
(C1), 68.2 (C21), 77.2 (C12), 81.4 (C16), 94.7 (C2), 100.6 (C4), 104.9 (C24), 
107.9 (C7), 113.7 (C13), 128.8 (C9), 130.1 (C19), 131.0 (C10), 132.5 (C18), 137.8 
(C8), 156.1 (C3), 161.4 (C5), and 168.0 (C23). 
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13C Assignment 
(2E,11Z)-(5S,9S,14S)-20-Methoxy-18-methoxymethyl-7,7,14-trimethyl-
6,8,15-trioxa-tricyclo[15.4.0.05,9]henicosa-1(21),2,11,17,19-pentaene-
10,16-dione 225 
H3CO
MOMO
O
O
O
O
O
 
Pyridinium chlorochromate (29 mg, 132 µmol) was dissolved in anhydrous 
dichloromethane (1.6 cm3) and a solution of alcohol 226 (30 mg, 66 µmol) in 
anhydrous dichloromethane (1.6 cm3) was added at room temperature.  The 
reaction was stirred for 18 h and then decanted into a clean flask and the 
residue washed with dichloromethane (2×10 cm3).  The solvent was 
concentrated in vacuo and the residual material diluted with diethyl ether (20 
cm3).  The suspension was filtered through cotton wool to remove the chromium 
salts.  The ethereal component was washed with 1 M sodium hydroxide (15 cm3), 
then brine (15 cm3) and dried over anhydrous Na2SO4, filtered and concentrated 
in vacuo to leave an orange/brown residue.  Purification by FCC [petroleum 
ether – ethyl acetate (50:50)] of the crude residue afforded protected LL-Z1640-
2 225 (10 mg, 34%); Rf 0.38 (Solvent C); [ ]22Dα  –0.16 (c 1.0, CHCl3); νmax(film)/cm-
1 2952 (C-H), 1760 (C=O), 1599 (C=C), 1019 and 979; δH(400 MHz; CDCl3) 1.24 (6 
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H, s, 2×CCH3), 1.32 (3 H, d, J 12.6, CH3), 2.45-2.70 (4 H, m, 2×CH2), 3.43 (3 H, 
s, OCH2OCH3), 3.75 (3 H, s, OCH3), 4.41-4.43 (1 H, m, CH2CHO), 4.53-4.56 (1 H, 
m, HCCH3), 4.63 (1 H, d, J 7.8, CHO), 5.08-5.15 (1 H, m, CH=CH), 5.29 (2 H, s, 
OCH2OCH3), 5.43-5.48 (1 H, m, CH=CH(C=O)), 6.01-6.05 (1 H, m, CH=CH(C=O)), 
6.30-6.54 (2 H, m, CH=CH and CH) and 6.54 (1 H, m, CH).  The lack of material 
prevented the acquisition of a full data set.  
2-[(4S,5S)-5-((tert-Butyldimethylsilyloxy)methyl)-2,2-dimethyl-1,3-dioxolan-
4-yl]acetaldehyde 252 
OTBS
O
O
O
 
Alkene 208 (620 mg, 2.16 mmol) was dissolved in dichloromethane (15 cm3) and 
ozone was bubbled through the solution at —78 oC until the blue colour persisted 
(15 min).  The reaction was quenched with dimethylsulfide (500 eq., 80 cm3, 
1.08 mol; added periodically in 20 cm3 aliquots) and the resulting solution 
warmed up to room temperature and stirred until the disappearance of the 
ozonide (approx. 4 d).  The reaction mixture was washed with water (25 cm3) 
and the organic layers separated.  The organic phase was dried over anhydrous 
sodium sulfate, filtered and concentrated in vacuo to afford aldehyde 252 (650 
mg, 100%) as a colourless oil; Rf 0.44 (Solvent E); [ ]22Dα  +1.9 (c 1.0, CHCl3) 
(lit.,[151] [ ]23Dα  +2.2 (c 5.0, CHCl3); δH(400 MHz; CDCl3) 0.00 (6 H, s, Si(CH3)2), 0.82 
(9 H, s, SiC(CH3)3), 1.30 (3 H, s, CH3), 1.36 (3 H, s, CH3), 2.68 (1 H, dd, J 7.8 and 
16.8, CH2), 2.80 (1 H, dd, J 5.6 and 16.8, CH2), 3.52-3.56 (2 H, m, CH2OTBS), 
4.11 (1 H, dd, J 5.6 and 12.1, CHCH2), 4.65 (1 H, dd, J 6.2 and 12.6, CHCH2OTBS) 
and 9.74 (1 H, s, CHO); δC(100 MHz; CDCl3) -5.5 (Si(CH3)2), 18.2 (Si-C), 25.3 
(CH3), 25.8 (SiC(CH3)3), 27.9 (CH3), 43.7 (CH2), 61.5 (CH2OTBS), 71.9 (CH), 108.3 
(C(CH3)2) and 200.1 (C=O).  All spectral data matches that reported in the 
literature.[151]  
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tert-Butyl{[(4S,5S)-5-(3,3-dibromoallyl)-2,2-dimethyl-1,3-dioxolan-4-
yl]methoxy}dimethylsilane 251 
OTBS
O
O
Br
Br
 
A solution of aldehyde 252 (656 mg, 2.18 mmol) in anhydrous dichloromethane 
(27 cm3) at room temperature was treated sequentially with carbon 
tetrabromide (2.9 g, 8.73 mmol), zinc dust (571 mg, 8.73 mmol) and 
triphenylphosphine (2.3 g, 8.73 mmol).  The addition of triphenylphosphine was 
done in portions so as to keep the reaction temperature at 25 oC.  Over the 
reaction time, the colour changed from a green solution to a pinkish brown 
colour.  After 1.5 h, the reaction was diluted with hexanes (100 cm3), passed 
through a pad of silica gel and washed with diethyl ether.  The solvent was 
concentrated in vacuo to afford dibromide 251 (995 mg, 100%) as a colourless 
oil, which was used without any further purification; Rf 0.79 (Solvent A); [ ]20Dα  –
0.14 (c 1.4, CHCl3); νmax (film)/cm
-1 2486, 2071, 1193 and 1121 (C-O); δH(400 
MHz; CDCl3) 0.05 (6 H, s, Si(CH3)2), 0.85 (9 H, s, SiC(CH3)3), 1.31 (3 H, s, CH3), 
1.41 (3 H, s, CH3), 2.22-2.30 (1 H, m, CH2), 2.36-2.43 (1 H, m, CH2), 3.64 (2 H, d, 
J 6.0, CH2OTBS), 4.10 (1 H, q, J 6.0, CHCH2), 4.18-4.23 (1 H, m, CHCH2OTBS) and 
6.54 (1 H, t, J 6.8, CH=Br2); δC(100 MHz; CDCl3) -2.5 (Si(CH3)2), 19.1 (SiC(CH3)3), 
26.3 (2×CH3), 26.5 (SiC(CH3)3), 36.3 (CH2), 64.7 (CH2OTBS), 71.8 (CH), 75.9 (CH), 
90.1 (C=CBr2), 108.0 ((C(CH3)2) and 137.6 (C=CBr2); MS (CI) m/z 310.2 [M-OTBS]
+; 
HRMS m/z 310.9284 (310.9282 calcd for C9H13Br2O2, M-OTBS
+). 
tert-Butyl[(4S,5S)-2,2-dimethyl-5-prop-2-ynyl-[1,3]-dioxolan-4-ylmethoxy]-
dimethylsilane 70 
OTBS
O
O
 
Dibromoolefin 251 (1.0 g, 2.19 mmol) was dissolved in anhydrous 
tetrahydrofuran (27 cm3), cooled down to —78 oC and treated with nBuLi (1.6 M 
in hexanes, 2.7 cm3, 4.38 mmol).  The reaction was kept at —78 oC for 2 h and 
then quenched with water (40 cm3).  The mixture was stirred for 15 min at —78 
oC and then allowed to warm up slowly to 0 oC and then room temperature.  The 
reaction mixture was extracted with ethyl acetate (3×40 cm3) and the combined 
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organics were dried over anhydrous sodium sulfate, filtered and concentrated in 
vacuo.  Purification by FCC [petroleum ether – ethyl acetate (97:3)] of the crude 
residue afforded alkyne 70 (395 mg, 61%) as a yellow oil; Rf  0.57 (Solvent D); 
[ ]20Dα  –0.2 (c 1.0, CHCl3); νmax (film)/cm-1 2477 (C≡C), 2051, 1201 and 1120 (C-O); 
δH(400 MHz; CDCl3) 0.15 (6 H, s, Si(CH3)2), 0.88 (9 H, s, SiC(CH3)3), 1.34 (3 H, s, 
CH3), 1.45 (3 H, s, CH3), 2.02 (1 H, t, J 2.6, C≡CH), 2.44-2.62 (2 H, m, CH2), 3.71 
(2 H, dd, J 5.0 and 6.8, CH2OTBS), 4.15 (1 H, q, J 6.0, CHCH2OTBS) and 4.30-4.34 
(1 H, m, CHCH2); δC(100 MHz; CDCl3) -5.4 (Si(CH3)2), 20.1 (SiC(CH3)3), 25.4 (CH2), 
25.9 (SiC(CH3)3), 27.8 (CH3), 29.7 (CH3), 61.5 (CH2OTBS), 69.7 (HC≡C), 75.7 
(HC≡CCH2C), 77.4 (CCH2OTBS), 81.2 (HC≡C) and 108.6 (C(CH3)2); MS (CI) m/z 
153.1 [M-OTBS]+; HRMS m/z 153.0912 (153.0916 calcd for C9H13O2, M-OTBS
+). 
tert-Butyl-[(4S,5S)-2,2-dimethyl-5-((E/Z)-3-tributylstannyl-allyl)-[1,3]-
dioxolan-4-ylmethoxy]-dimethylsilane 250 
OTBS
O
O
Bu3Sn
 
Procedure A 
A solution of alkyne 70 (40 mg, 0.135 mmol) and 
bis(triphenylphosphine)palladium dichloride ((Ph3P)2PdCl2) (catalytic amount) in 
anhydrous tetrahydrofuran (2 cm3) at room temperature, was treated by the 
slow addition of a solution of tributyltinhydride (40 µL, 142 µmol) in 
tetrahydrofuran (0.2 cm3).  Upon addition, the colour of the solution changed 
from pale yellow to orange-brown.  After 20 min, the now brown coloured 
reaction was complete and the mixture was concentrated in vacuo.  Purification 
by FCC [petroleum ether-diethyl ether (95:5)] of the crude residue afforded 
stannane 250 (62 mg, 79%) as a colourless oil and as an inseparable trans:cis 
mixture; Rf  0.83 (Solvent E); [ ]20Dα  –1.8 (c 0.7, CHCl3); νmax (film)/cm-1 2928, 2362 
and 1255; δH(400 MHz; CDCl3) (trans) 0.04 (6 H, s, Si(CH3)2), 0.80-0.92 (24 H, m, 
SiC(CH3)3, (CH3)3, (CH2)3), 1.20-1.36 (9 H, m, CH3, (CH2)3), 1.38 (3 H, s, CH3), 
1.40-1.60 (6 H, m, (CH2)3), 2.22-2.45 (2 H, m, (CH2)3), 3.53-3.70 (2 H, m, 
CH2OTBS), 4.03-4.09 (1 H, m, CHCH2OTBS), 4.14-4.20 (1 H, m, CHCH2), 5.05 (1 H, 
d, J  19.0, CH=CH) and 5.81-5.83 (1 H, m, CH=CH); (cis) (inter alia) 5.08 (1 H, d, 
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J 11.5, CH=CH).  MS (CI) m/z 291.3 [Bu3Sn]
+, 361.5 [Bu3SnCH=CHCH2CH2OH], 
461.4 [M-TBS]+ and 577.6 [M+H]+. 
Procedure B 
Alkyne 70 (41.6 mg, 0.1403 mmol) in toluene (5 cm3) was treated with 2,2'-
azobis(2-methyl)propionitrile (AIBN) (1.2 mg, 7 µmol) and Bu3SnH (0.04 cm
3, 
0.154 mmol) under argon.  The mixture was heated to 95 oC for 24 h.  The 
reaction mixture was then cooled down to room temperature and the solvent 
evaporated in vacuo.  Purification by FCC [petroleum ether-ethyl acetate 
(100:0)→(98.5:1.5)] of the crude residue afforded an inseparable mixture of E:Z-
stannane 250 and alkene 208 (70 mg, 85%) as a colourless oil; Rf 0.54 (Solvent 
E).  The spectral data matches that for Procedure A.  
Methyl 2-hydroxy-4-methoxy-6-(trifluoromethylsulfonyloxy)benzoate 256  
OH
OTf
OCH3
O
H3CO  
A solution of triflate 119 (1.23 g, 2.77 mmol) in anhydrous tetrahydrofuran (15 
cm3) at 0 oC, was treated with tetra-butylammonium fluoride (5.5 cm3, 5.53 
mmol) and the ice-water bath was removed after 10 min.  After 2 h, the 
reaction mixture was diluted with ethyl acetate (20 cm3) and quenched with 
water (20 cm3).  The phases were separated and the aqueous layer was 
extracted with ethyl acetate (20 cm3).  The combined organic layers were dried 
over anhydrous sodium sulfate, filtered and concentrated in vacuo.  Purification 
by FCC [petroleum ether–ethyl acetate (80:20)] of the crude residue afforded 
phenol 256 (754 mg, 83%) as a white solid; Rf 0.62 (Solvent A); mp 35-38 
oC 
(from petroleum ether-ethyl acetate); νmax (film)/cm
-1 3367, 1671 (C=O), 1635 
(C=C), 1570, 1427, 1341, 1219; δH(400 MHz; CDCl3) 3.74 (3 H, s, OCH3), 3.88 (3 
H, s, CO2CH3), 6.25 (1 H, s, CH), 6.39 (1 H, s, CH) and 11.59 (1 H, s, OH); δC(100 
MHz; CDCl3) 52.5 (CO2CH3), 56.0 (OCH3), 100.3 (CCOH), 100.9 (CCO2CH3), 103.2 
(HCCOTf), 149.5 (COTf), 164.5 (COH), 165.3 (COCH3) and 168.8 (CO2CH3); MS (CI) 
m/z 331.2 [M+H]+; HRMS m/z 331.0100 (331.0100 calcd for C10H10F307S, M+H
+). 
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Methyl 4-methoxy-2-(methoxymethyl)-6-(trifluoromethylsulfonyloxy)- 
benzoate 257 
MOMO
OTf
OCH3
O
H3CO  
Phenol 256 (412 mg, 1.25 mmol) was dissolved in anhydrous dichloromethane (7 
cm3) and N,N-diisopropylethylamine (0.65 cm3, 3.74 mmol) was added at room 
temperature.  The reaction mixture was cooled to 0 oC and bromomethyl methyl 
ether (0.2 cm3, 2.50 mmol) was added.  After 10 min, the the ice-water bath 
was removed and the reaction mixture allowed to warm up to room temperature 
overnight.  The now yellow solution was poured into saturated aqueous sodium 
hydrogen carbonate (30 cm3) and extracted with ethyl acetate (3×40 cm3).  The 
combined organic layers were washed sequentially with brine (30 cm3) then 
water (30 cm3), dried over anhydrous sodium sulfate, filtered and concentrated 
in vacuo.  Purification by FCC [petroleum ether–ethyl acetate (80:20)] of the 
crude residue afforded MOM ether 257 (421 mg, 90%) as a pale yellow solid; Rf 
0.24 (Solvent A); mp 26-28 oC (from petroleum ether-ethyl acetate); 
νmax(film)/cm
-1 3434, 1630, 1425; δH(400 MHz; CDCl3) 3.53 (3 H, s, OCH2OCH3), 
3.86 (3 H, s, OCH3), 3.94 (3 H, s, CO2CH3), 5.24 (2 H, s, CH2), 6.52 (1 H, s, CH) 
and 6.79 (1 H, s, CH); δC(100 MHz; CDCl3) 52.5 (CO2CH3), 55.9 (OCH2OCH3), 56.5 
(OCH3), 95.2 (OCH2OCH3), 101.0 (CCO2CH3), 101.5 (2×CH(Ar)), 149.3 (COTf), 
157.5 (COCH2OCH3), 157.4 (COCH3) and 162.3 (C=O); MS (CI) m/z 375.3 [M+H]
+; 
HRMS m/z 375.0359 (375.0362 calcd for C12H14F308S, M+H
+). 
tert-Butyl-but-3-ynyloxy-dimethylsilane 259 
H
OTBS
 
A solution of 3-butyn-1-ol (2.0 g, 28.5 mmol) in dichloromethane (140 cm3) at 
room temperature, was treated with dimethylaminopyridine (348 mg, 2.85 
mmol) and triethylamine (7 cm3, 51.3 mmol).  After 5 min, tert-
butyldimethylsilyl chloride (5.6 g, 37.1 mmol) was added and the colourless 
solution was stirred for 18 h.  The reaction was quenched with saturated 
aqueous ammonium chloride (100 cm3) and extracted with dichloromethane 
(3×20 cm3).  The combined organic layers were dried over anhydrous sodium 
sulfate, filtered and concentrated in vacuo.  Purification by FCC [petroleum 
ether–diethyl ether (90:10)] of the crude residue afforded 259 (4.3 g, 82%) as a 
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colourless oil; Rf  0.87 (Solvent A); δH(400 MHz; CDCl3) 0.06 (6 H, s, Si(CH3)2), 
0.88 (9 H, s, SiC(CH3)3), 1.94 (1 H, t, J 2.6, H), 2.39 (2 H, dt, J 2.4 and 7.2, CH2) 
and 3.71 (2 H, t, J 7.2, CH2OTBS).  All spectral data matches that reported in the 
literature.[152] 
tert-Butyl-[(E/Z)-4-(dibutylethylstannanyl)-but-3-enyloxy]-dimethylsilane 
260[133]  
Bu3Sn
OTBS
 
A neat mixture of alkyne 259 (103 mg, 0.559 mmol) and 2,2'-azobis(2-
methyl)propionitrile (AIBN) (5 mg, 27.9 µmol) under argon was heated to 80 oC 
for 1.5 h.  The reaction mixture was then cooled down to room temperature and 
the excess alkyne 259 was removed under high vacuum to yield (265 mg) as an 
E:Z-mixture (79:21) of stannane 260 in quantitative yield and as a colourless oil.  
No separation was necessary and the mixture was used in the next step without 
any further purification; Rf 0.89 (Solvent D); νmax(film)/cm
-1 2924, 2855, 1464 
and 1100 (O-Si); δH(400 MHz; CDCl3) (E-isomer) 0.05 (6 H, s, Si(CH3)2), 0.89 (9 H, 
s, SiC(CH3)3), 1.21-1.34 (9 H, m, 3×CH3), 1.42-1.55 (18H, m, 9×CH2), 2.34-2.36 
(2 H, m, CH2), 3.64 (1 H, t, J 6.8, CH2OTBS) and 5.93 (2 H, s, HC=CH); (Z-isomer) 
0.06 (6 H, s, Si(CH3)2), 0.91 (9 H, s, SiC(CH3)3), 1.21-1.34 (9 H, m, 3×CH3), 2.24-
2.27 (2 H, m, CH2), 3.66 (1 H, t, J 7.0, CH2OTBS), 5.89 (1 H, dt, J 1.2 and 12.4, 
HC=CH) and 6.53 (1 H, dt, J 6.8 and 12.8, HC=CH); MS (CI) m/z 419 [M-C(CH3)3]
+; 
HRMS m/z 419.1800 (419.1792 calcd for C18H39OSiSn, M-C(CH3)3
+).  All spectral 
data matches that reported in the literature.[133] 
Methyl 2-(tert-butyldimethylsilanyloxy)-6-[(E)-4-(tert-
butyldimethylsilanyloxy)-but-1-enyl]-4-methoxybenzoate 263 
TBSO
H3CO
OCH3
O
OTBS  
A solution of triflate 119 (127 mg, 286 µmol) in dioxane (6 cm3) was treated with 
stannane 260 (163 mg, 343 µmol), lithium chloride (36 mg, 857 µmol) and 
tetrakis(triphenylphosphine)palladium(0) (Pd(PPh3)4) (10 mg, 8.57 µmol).  The 
mixture was heated to 100 oC for 24 h and then treated with a further portion of 
lithium chloride (36 mg, 857 µmol) and Pd(PPh3)4 (10 mg, 8.57 µmol).  The 
reaction mixture was then heated under reflux for 3 d and then cooled down to 
room temperature and concentrated in vacuo.  Purification by FCC [petroleum 
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ether – diethyl ether (100:0)→(97:3)→(95:5)] of the crude residue afforded 
alkene 263 (29 mg, 21%) as colourless oil; Rf 0.5 (Solvent R); νmax(film)/cm
-1 
2931, 1730 (C=O) and 1257; δH(400 MHz; CDCl3) 0.04 (6 H, s, Si(CH3)2), 0.20 (6 H, 
s, Si(CH3)2), 0.89 (9 H, s, SiC(CH3)3), 0.94 (9 H, s, SiC(CH3)3), 2.40 (2 H, q, J 6.7, 
CH2), 3.69 (2 H, t, J 6.7, CH2OTBS), 3.77 (3 H, s, OCH3), 3.83 (3 H, s, CO2CH3), 
6.15-6.18 (1 H, m, HC=CH), 6.25 (1 H, d, J 2.0, CH), 6.39 (1 H, d, J 15.7, 
HC=CH), 6.60 (1 H, d, J  7.0, CH); δC(100 MHz; CDCl3) -5.3 (Si(CH3)2 (CH2OTBS), -
4.4 (Si(CH3)2 (OTBS), 18.0 (SiC(CH3)3), 18.3 (SiC(CH3)3), 25.5 (SiC(CH3)3 
(CH2OTBS), 25.9 (SiC(CH3)3 (OTBS)), 36.7 (CH2), 52.0 (CO2CH3), 55.3 (OCH3), 62.8 
(CH2OTBS), 102.8 (CH), 104.5 (CH), 118.3 (CCOOCH3), 128.4 (HC=CH), 130.4 
(HC=CH), 137.9 (CHC=CH), 154.0 (COTBS), 160.8 (COCH3) and 168.6 (C=O); MS 
(EI) m/z 480.16 [M]+; HRMS m/z 480.2725 (480.2727 calcd for C25H44O5Si2, M
+), 
481.2775 (481.2806 calcd for C25H45O5Si2, M+H
+). 
tert-Butyldimethyl-(3-(tributylstannyl)but-3-enyloxy)silane 262[153] 
SnBu3
H
H
OTBS  
To a suspension of copper cyanide (194 mg, 2.17 mmol) in anhydrous 
tetrahydrofuran (8.5 cm3) was added nBuLi (1.6 M in hexanes, 2.8 cm3, 4.54 
mmol) at —78 oC.  The solution was warmed up to —40 oC and stirred for 10 min 
(pale yellow colour).  The mixture was cooled back down to —78 oC and 
tributyltinhydride (1.2 cm3, 4.54 mmol) was added.  The solution was warmed up 
to —40 oC and stirred for 10 min (yellow/gold colour).  The solution was cooled 
back down to —78 oC and a solution of alkyne 259 (200 mg, 1.08 mmol) in 
anhydrous tetrahydrofuran (1 cm3) was added.  The reaction mixture was 
allowed to warm up to —30 oC for 1 h and was then poured into a saturated 
aqueous ammonium chloride solution (10 cm3) at —10 oC.  After 30 min, the 
reaction mixture was extracted with diethyl ether.  The combined organic layers 
were washed with brine (20 cm3), dried over magnesium sulfate, filtered and the 
solvent concentrated in vacuo to afford stannane 262 quantitatively as a 
colourless oil; Rf 0.66 (Solvent E); δH(400 MHz; CDCl3) 0.00 (6 H, s, Si(CH3)2), 
0.72-0.92 (24 H, m, SiC(CH3)3, (CH3)3, (CH2)3), 1.20-1.30 (6 H, m, (CH2)3), 1.39-
1.49 (6 H, m, (CH2)3), 2.28-2.30 (2 H, m, CH2), 3.60 (2 H, t, J  7.2, CH2OTBS) and 
5.90 (2 H, s, C=CH2).  All spectral data matches that reported in the 
literature.[153]  
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tert-Butyl-dimethyl-(4-tributylstannanyl-but-3-ynyloxy)-silane 269[139] 
Bu3Sn
OTBS
 
Alkyne 259 (225 mg, 1.22 mmol) was dissolved in anhydrous tetrahydrofuran (10 
cm3) and cooled to 0 oC.  nBuLi (0.9 cm3, 1.46 mmol) was then added and the 
reaction mixture stirred for 10 min before it was allowed to warm up to room 
temperature, where it was stirred for 1 h.  After this time, the reaction was 
cooled back down to 0 oC and tributyltinchloride (0.4 cm3, 1.46 mmol) added.  
The pale yellow solution was stirred overnight at room temperature and then 
diluted with dichloromethane (20 cm3).  The mixture was washed with water (20 
cm3) and the phases separated and dried over anhydrous sodium sulfate, filtered 
and concentrated in vacuo.  Purification by FCC [hexanes (100) then ethyl 
acetate (100)] of the crude residue afforded alkyne 269 (397 mg, 69%) as a 
yellow oil; Rf 0.07 (Solvent Q); δH(400 MHz; CDCl3) 0.08 (6 H, s, Si(CH3)2), 0.85-
0.91 (24 H, m, SiC(CH3)3 and (CH3)3 and (CH2)3), 1.22-1.27 (6 H, m, (CH2)3), 1.46-
1.49 (6 H, m, (CH2)3), 2.39 (2 H, t, J 7.3, CH2) and 3.66 (2 H, t, J 7.3, CH2OTBS).  
All spectral data matches that reported in the literature.[139] 
Methyl 2-(tert-butyl-dimethyl-silanyloxy)-6-[4-(tert-butyl-dimethyl-
silanyloxy)-but-1-ynyl]-4-methoxybenzoate 268 
TBSO
H3CO
O
OCH3
OTBS  
A mixture of triflate 119 (310 mg, 0.699 mmol), lithium chloride (89 mg, 2.10 
mmol), stannane 269 (397 mg, 0.838 mmol) and 
tetrakis(triphenylphosphine)palladium(0) (Pd(PPh3)4) (24 mg, 20.9 µmol) in 1,4-
dioxane (15 cm3) was heated at 100 oC for 4.5 h.  The reaction was then cooled 
down to room temperature and the solvent was removed under reduced 
pressure.  Initial purification by FCC [petroleum ether – diethyl ether (90:10)] 
followed by a second purification by FCC [petroleum ether – diethyl ether (95:5)] 
afforded alkyne 268 (111 mg, 33%) as a yellow oil; Rf 0.6 (Solvent P); 
vmax(film)/cm
-1 2931, 1732 (C=O) and 1265; δH(400 MHz;CDCl3) 0.00 (6 H, s, 
Si(CH3)2), 0.12 (6 H, s, Si(CH3)2), 0.82 (9 H, s, SiC(CH3)3), 0.88 (9 H, s, SiC(CH3)3), 
2.52 (2 H, t, J 7.4, CH2), 3.68 (3 H, s, OCH3), 3.70 (2 H, t, J  7.8, CH2OTBS), 3.76 
(3 H, s, CO2CH3), 6.24 (1 H, d, J 2.1, CH) and 6.50 (1 H, d, J 2.1, CH); δC(100 
MHz;CDCl3) –5.3 (Si(CH3)2 from CH2OTBS), -4.4 (Si(CH3)2 from OTBS), 18.1 (SiC 
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from OTBS), 18.4 (SiC from CH2OTBS), 23.9 (CH2), 25.5 (SiC(CH3)3 from OTBS), 
25.9 (SiC(CH3)3 from CH2OTBS), 52.1 (CO2CH3), 55.4 (OCH3), 61.9 (CH2OTBS), 
79.8 (C≡C(CH2)2), 90.1 (C≡C(CH2)2), 106.5 (CH), 109.8 (CH), 121.9 (C(CO2CH3)), 
123.6 (C(C≡C)), 153.2 (C(OTBS)), 160.7 (C(OCH3)) and 167.3 (CO2CH3); MS (CI) 
m/z 479.4 [M+H]+; HRMS m/z 479.2644 (479.2650 calcd for C25H43O5Si2, M+H
+). 
Methyl 2-(tert-butyl-dimethyl-silanyloxy)-6-[(Z)-4-(tert-
butyldimethylsilanyloxy)-but-1-enyl]-4-methoxybenzoate 278 
TBSO O
OCH3
H3CO
OTBS
 
A solution of alkyne 268 (111 mg, 0.232 mmol) in methanol (2 cm3) was treated 
with a catalytic amount of Pd/BaSO4 catalyst and poisoned with quinoline (30 
µL, 289 µmol).  The flask was evacuated and after purging three times with 
hydrogen gas via a balloon, the mixture was stirred under an atmosphere of 
hydrogen for 2 h at room temperature.  TLC analysis deemed the reaction 
complete and the solution was filtered through silica gel to remove the catalyst 
and the solvent concentrated in vacuo.  Purification by FCC [petroleum ether-
diethyl ether (95:5)→(90:10)] of the crude residue afforded (Z)-alkene 278 (58 
mg, 52%) as a yellow oil; Rf 0.63 (Solvent R); vmax(film)/cm
-1 3055, 1734 (C=O) 
and 1255; δH(400 MHz;CDCl3) 0.02 (6 H, s, Si(CH3)2), 0.20 (6 H, s, Si(CH3)2), 0.87 
(9 H, s, SiC(CH3)3), 0.95 (9 H, s, SiC(CH3)3), 2.38 (2 H, q, J 6.5, CH2), 3.62 (2 H, t, 
J 6.5, CH2OTBS), 3.75 (3 H, s, OCH3), 3.79 (3 H, s, CO2CH3), 5.67-5.73 (1 H, m, 
HC=CH), 6.24 (1 H, d, J 2.0, CH), 6.43-6.49 (2 H, d, J 11.0, HC=CH); δC(100 
MHz;CDCl3) -5.3 (Si(CH3)2 (CH2OTBS), -4.4 (Si(CH3)2 (OTBS), 18.1 (SiC(CH3)3), 18.4 
(SiC(CH3)3), 25.5 (SiC(CH3)3 (CH2OTBS), 26.0 (SiC(CH3)3 (OTBS), 32.2 (CH2), 51.9 
(CO2CH3), 55.3 (OCH3), 62.8 (CH2OTBS), 104.0 (CH), 108.5 (CH), 118.9 
(CCOOCH3), 128.1 (HC=CH), 130.7 (HC=CH), 137.9 (CHC=CH), 154.0 (COTBS), 
160.6 (COCH3) and 168.4 (C=O); MS (FAB)
 m/z 481.3 [M+H]+; HRMS m/z 481.2810 
(481.2806 calcd for C25H45O5Si2, M+H
+). 
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3-(Methoxy-phenyl)-prop-2-yn-1-ol 272[140] 
OCH3
OH
 
3-Iodoanisole (1.0 g, 4.27 mmol) in anhydrous acetonitrile (40 cm3) was treated 
with PdCl2(PPh3)2 (375 mg, 0.534 mmol), copper iodide (203 mg, 1.07 mmol) and 
triethylamine (3 cm3, 21.3 mmol).  To this was added propargyl alcohol (287 mg, 
5.12 mmol) and the reaction stirred in the dark for 16 hours at room 
temperature.  The solids were removed by filtration, washed with diethyl ether 
(2×60 cm3) and the solvent concentrated in vacuo.  Purification by FCC 
[petroleum ether-ethyl acetate (70:30)] of the crude residue afforded alkynol 
272 (567 mg, 82%); Rf 0.31 (Solvent S); δH(400 MHz;CDCl3) 1.71 (1 H, s, OH), 3.80 
(3 H, s, OCH3), 4.49 (2 H, s, CH2OH), 6.88 (1 H, ddd, J 0.6, 2.8 and 8.4, CH), 
6.98 (1 H, dd, J 1.2 and 2.4, CH), 7.03 (1 H, dt, J 0.8 and 7.6, CH) and 7.21 (1 H, 
dd, J 0.8 and 8.0, CH).  The spectral data matches that reported in the 
literature.[140] 
3-(3-Methoxy-phenyl)-propan-1-ol 273[154] 
OCH3
OH
 
Alkynol 272 (114 mg, 0.703 mmol) was dissolved in methanol (10 cm3)  and was 
treated with a catalytic amount of Pd/BaSO4 catalyst and poisoned with 
quinoline (0.10 cm3, 0.879 mmol).  The flask was evacuated and after purging 
three times with hydrogen gas via a balloon, the mixture was stirred under an 
atmosphere of hydrogen for 2 h at room temperature.  TLC analysis deemed the 
reaction complete and the solution was filtered through a pad of silica gel and 
the solvent concentrated in vacuo.  Purification by FCC [diethyl ether (100)] of 
the crude residue afforded alkane 273 (83 mg, 72%) as a pale yellow oil; Rf 0.23 
(Solvent A); δH(400 MHz;CDCl3) 1.80 (1 H, br s, OH), 2.39 (2 H, dd, J 6.4 and 
14.2, CH2CH2CH2), 3.19 (2 H, t, J 6.4, CH2CH2CH2), 4.17 (2 H, t, J 6.4, 
CH2CH2CH2), 4.29 (3 H, s, OCH3), 7.20-7.32 (2 H, m, CH1 and CH3), 7.68 (1H, t, J 
7.6, CH2) and 7.74 (1 H, s, CH4); MS (EI) m/z 166 [M]+; HRMS m/z 166.0996 
(166.0994 calcd for C10H14O2, M
+).  All spectral data matches that reported in the 
literature.[154] 
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OCH3
1
2
3
4
OH
 
1H Assignment 
tert-Butyl-[3-(3-methoxyphenyl)-prop-2-ynyloxy]-dimethylsilane 274 
OCH3
OTBS
 
Alkynol 272 (200 mg, 1.23 mmol) was dissolved in dichloromethane (10 cm3) at 
room temperature and dimethylaminopyridine (15 mg, 0.123 mmol) and 
triethylamine (0.31 cm3, 2.22 mmol) were added successively.  tert-
Butyldimethylsilyl chloride (242 mg, 1.60 mmol) was added and the reaction 
stirred at room temperature for 18 h.  The cloudy, yellow solution was quenched 
with saturated aqueous ammonium chloride (20 cm3) and extracted with 
dichloromethane (3×20 cm3).  The combined organic layers were dried over 
anhydrous Na2SO4, filtered and concentrated in vacuo.  Purification by FCC 
[petroleum ether – diethyl ether (80:20)] of the crude residue afforded alkyne 
274 (264 mg, 78%) as a pale orange oil; Rf 0.67 (Solvent A); vmax(film)/cm
-1 2928 
and 1257; δH(400 MHz; CDCl3) 0.17 (6 H, s, Si(CH3)2), 0.93 (9 H, s, SiC(CH3)3), 
3.80 (3 H, s, CH3), 4.52 (2 H, s, CH2), 6.85 (1 H, d, J 8.3, CH1), 6.93 (1 H, s, 
CH4), 7.00 (1 H, d, J 7.5, CH3) and 7.19 (1 H, t, J 8.0, CH2); δC(100 MHz; CDCl3) 
-5.0 (Si(CH3)2), 18.3 (SiC(CH3)3), 25.9 (SiC(CH3)3), 52.3 (CH2OTBS), 55.3 (OCH3), 
84.8 (C≡C), 87.8 (C≡C), 114.8 (C1 and C3), 116.5 (C4), 124.2 (CC≡CCH2OTBS), 
129.3 (C2) and 159.3 (COCH3); MS (EI) m/z 276.1 [M]
+, 261.0 [M-CH3]
+, 145.0 [M-
OTBS]+; HRMS m/z 276.1543 (276.1546 calcd for C16H24O2Si, M
+), 277.1483 
(277.1625 calcd for C16H25O2Si, M+H
+). 
OCH3
OTBS
1
2
3
4
 
1H and 13C Assignment 
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Methyl 2-(tert-Butyldimethylsilanyloxy)-6-iodo-4-methoxybenzoate 267 
OCH3
O
I
TBSO
H3CO  
A dry flask was charged with triflate 119 (242 mg, 0.544 mmol) and sodium 
iodide (163 mg, 1.09 mmol).  The reaction flask was flushed with argon and dry 
dimethylformamide (5 cm3) was injected.  The heterogeneous solution was 
heated to 80 oC for 17.5 h.  After cooling down to room temperature, the 
reaction was poured into a mixture of saturated sodium thiosulphate (20 cm3) 
and ethyl acetate (20 cm3).  The organic layer was separated and then washed 
with water (2×40 cm3) and brine (30 cm3), dried over anhydrous Na2SO4, filtered 
and concentrated in vacuo.  Purification by FCC [petroleum ether – diethyl ether 
(80:20)] of the crude residue afforded 267 (99 mg, 43%) as a colourless oil; Rf 
0.43 (Solvent R); vmax(film)/cm
-1 1265; δH(400 MHz; CDCl3) 0.00 (6 H, s, Si(CH3)2), 
0.82 (9 H, s, SiC(CH3)3), 3.75 (3 H, s, OCH3), 3.88 (3 H, s, CO2CH3), 6.32 (1 H, d, J 
2.4, CH) and 6.47 (1 H, d, J 2.4, CH); δC(100 MHz; CDCl3) –3.6 (Si(CH3)2), 18.1 
(SiC(CH3)3), 25.7 (SiC(CH3)3), 52.5 (CO2CH3), 56.0 (OCH3), 100.0 (CI), 100.9 
(HCCOTBS), 103.3 (HICI), 133.7 (CCOOCH3), 164.7 (COTBS), 165.4 (C=O) and 
168.9 (COCH3).  The compound failed to ionise under all mass spectrometry 
conditions attempted. 
tert-Butyl-[3-(3-methoxyphenyl)-allyloxy]-dimethylsilane 276 
OCH3
OTBS
 
Alkyne 274 (130 mg, 0.470 mmol) was dissolved in methanol (6 cm3) and was 
treated with a catalytic amount of Pd/BaSO4 catalyst and poisoned with 
quinoline (0.07 cm3, 0.588 mmol).  The flask was evacuated and after purging 
three times with hydrogen gas via a balloon, the mixture was stirred under an 
atmosphere of hydrogen for 1 h at room temperature.  TLC analysis deemed the 
reaction complete and the solution was filtered through a pad of Celite® and the 
solvent concentrated in vacuo.  Purification by FCC [diethyl ether (100)] of the 
crude residue afforded alkane 276 (92 mg, 70%) as a pale yellow oil; Rf 0.23 
(Solvent A); νmax(film)/cm
-1 2951, 2857, 1258 and 1100 (O-Si); δH(400 MHz; 
CDCl3) 0.09 (6 H, s, Si(CH3)2), 0.91 (9 H, s, SiC(CH3)3), 1.78-1.82 (2 H, m, 
CH2CH2CH2), 2.62 (2 H, t, J 7.6, CH2CH2CH2), 3.61 (2 H, t, J 6.3, CH2CH2CH2), 
Suzannah J. Harnor, 2010  188 
3.76 (3 H, s OCH3), 6.70 (1 H, d, J 7.7, CH1), 6.73 (1 H, s, CH4), 6.78 (1 H, dd, J 
7.7, CH3) and 7.20 (1 H, t, J 7.7, CH2); δC(100 MHz; CDCl3) -5.3 (Si(CH3)2), 18.3 
(SiC(CH3)3), 25.9 (SiC(CH3)3), 32.2 (CH2CH2CH2OTBS), 34.4 (CH2CH2CH2OTBS), 55.1 
(OCH3), 62.4 (CH2CH2CH2OTBS), 111.0 (C1), 114.2 (C4), 121.1 (C3), 128.7 (C2), 
142.0 (C) and 162.2 (COCH3); MS (CI) m/z 281 [M+H]
+; HRMS m/z 281.1934 
(281.1937 calcd for C16H29O2Si, M+H
+). 
OCH3
OTBS
1
2
3
4
 
1H and 13C Assignment 
tert-Butyl-[(Z)-3-(3-methoxyphenyl)-allyloxy]-dimethylsilane 275  
OTBS
OCH3  
Alkyne 274 (130 mg, 0.470 mmol) was dissolved in methanol (6 cm3) and was 
treated with a catalytic amount of Pd/BaSO4 catalyst and poisoned with 
quinoline (0.07 cm3, 0.588 mmol).  The flask was evacuated and after purging 
three times with hydrogen gas via a balloon, the mixture was stirred under an 
atmosphere of hydrogen for 30 min at room temperature.  TLC analysis deemed 
the reaction complete and the solution was filtered through a pad of Celite® and 
the solvent concentrated in vacuo.  Purification by FCC [petroleum ether - 
diethyl ether (90:10)] of the crude residue afforded 274 and 275 and 276 (114 
mg, 87%, 4:89:7) as an inseparable mixture and as a yellow oil; Rf 0.61 (Solvent 
P); δH(400 MHz; CDCl3) (Z-Alkene) 0.05 (6 H, s, Si(CH3)2), 0.87 (9 H, s, SiC(CH3)3), 
3.78 (3 H, s, OCH3), 4.43 (2 H, d, J 5.9, CH2), 5.80 (1 H, dt, J 5.9 and 11.8, 
CH=CHCH2), 6.41 (1 H, d, J 11.8, CH=CH), 6.69-6.80 (3 H, m, 3×CH) and 7.15-
7.21 (1 H, m, CH); (Alkane) 0.09 (6 H, s, Si(CH3)2), 0.91 (9 H, s, SiC(CH3)3), 1.77-
1.81 (2 H, m, CH2CH2CH2), 2.62 (2 H, t, J 7.6, CH2CH2CH2), 3.61 (2 H, t, J 6.3, 
CH2CH2CH2), 3.76 (3 H, s OCH3), 6.69-6.80 (3 H, m, 3×CH) and 7.15-7.21 (1 H, m, 
CH). 
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Methyl 2-iodo-benzoate 280[155] 
OCH3
O
I  
To a solution of 2-iodobenzoic acid (1.0 g, 4.03 mmol) in methanol (4 cm3) was 
added concentrated sulphuric acid (0.24 cm3).  The reaction mixture was heated 
under reflux for 7 h, then cooled down to room temperature, diluted with water 
(10 cm3) and extracted several times with chloroform (5×30 cm3).  The 
combined organic layers were washed with water (40 cm3), 5% saturated 
aqueous sodium hydrogen carbonate (2×40 cm3), water (40 cm3) and brine (2×40 
cm3), dried over anhydrous sodium sulfate, filtered and concentrated in vacuo.  
Purification by FCC [petroleum ether–diethyl ether (70:30)] of the crude residue 
afforded iodide 280 (868 mg, 82%) as a colourless oil; Rf 0.43 (Solvent R); 
νmax(film)/cm
-1 1725 (C=O), 1582 (C=C), 1430, 1249, 1100 and 1013; δH(400 MHz; 
CDCl3) 3.96 (3 H, s, CH3), 7.18 (1 H, dt, J 1.8 and 7.8, H1), 7.44 (1 H, dt, J 1.2 
and 7.6, H3), 7.82 (1 H, dd, J 1.7 and 7.8, H4) and 8.04 (1 H, dd, J 1.1 and 8.0, 
H1); δC(100 MHz; CDCl3) 52.5 (CH3), 94.1 (C-I), 127.9 (C2), 130.9 (C1), 132.6 
(C3), 135.1 (C(CO2CH3), 141.3 (C4) and 166.9 (C=O); MS (CI) m/z 262 [M+H]
+; 
HRMS m/z 262.9566 (262.9569 calcd for C8H8IO2, M+H
+).  All spectral data 
matches that reported in the literature.[155] 
OCH3
O
I
1
2
3
4  
1H and 13C Assignment 
Methyl 2-[4-(tert-Butyldimethylsilanyloxy)-but-1-ynyl]-benzoate 281 
OCH3
O
OTBS  
To a mixture of iodobenzoate 280 (300 mg, 1.14 mmol), alkyne 259 (253 mg, 
1.37 mmol), bis(triphenylphosphine)palladium dichloride (PdCl2(PPh3)2) (80 mg, 
0.114 mmol) and copper iodide (22 mg, 0.114 mmol) in anhydrous acetonitrile 
(11 cm3) under argon was added triethylamine (0.80 cm3, 5.72 mmol) at room 
temperature.  The reaction mixture was stirred in the dark for 2 h, then filtered 
through Celite® to remove the solids and washed with diethyl ether.  The solvent 
was concentrated in vacuo.  Purification by FCC [petroleum ether – diethyl ether 
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(90:10) of the crude residue afforded 281 (260 mg, 71%) as a yellow oil; Rf 0.39 
(Solvent R); vmax(film)/cm
-1 2929, 1728 (C=O) and 1255; δH(400 MHz; CDCl3) 0.09 
(6 H, s, Si(CH3)2), 0.90 (9 H, s, SiC(CH3)3), 2.68 (2 H, t, J 7.3, CH2), 3.84 (2 H, t, 
J 7.3, CH2OTBS), 3.89 (3 H, s, CH3), 7.31 (1 H, dt, J 1.4 and 7.8, H2), 7.41 (1 H, 
dt, J 1.4 and 7.8, H3), 7.50 (1 H, dd, J 1.1 and 7.7, H4) and 7.88 (1 H, dd, J 1.1 
and 7.7, H1); δC(100 MHz; CDCl3) -5.3 (Si(CH3)2), 18.3 (SiC(CH3)3), 24.2 (C≡CCH2), 
25.9 (SiC(CH3)3), 52.0 (COOCH3), 61.9 (CH2OTBS), 80.2 (C≡C), 92.5 (C≡C), 124.2 
(CCOOCH3), 127.3 (C2), 130.2 (C1), 131.5 (C3), 132.2 (CC≡C), 134.3 (C4) and 
167.21 (C=O); MS (FAB) m/z 319.2 [M+H]+; HRMS m/z 319.1727 (319.4906 calcd 
for C18H27O3Si, M+H
+). 
OCH3
O
OTBS
1
2
3
4  
1H and 13C Assignment 
[2-(4-(tert-Butyldimethylsilyloxy)but-1-ynyl)phenyl]-methanol 284 
OH
OTBS  
To a solution of alkyne 281 (91 mg, 0.286 mmol) in anhydrous tetrahydrofuran (3 
cm3) was added lithium aluminium hydride (17 mg, 0.457 mmol) under argon.  
The resulting grey solution was heated under reflux for 23 h.  The reaction 
mixture was cooled down to room temperature and then 0 oC, before the careful 
addition of diethyl ether (3 cm3) and then water dropwise with stirring.  As a 
white precipitate was formed, the water was added more quickly until 
approximately 10 cm3 had been added.  The resulting mixture was left to stir for 
20 min at 0 oC, until no grey lithium aluminium hydride was visible.  The entire 
solution was poured into a separating funnel and washed with 1 M sodium 
hydroxide (20 cm3).  The aqueous layer was separated and extracted with 
diethyl ether (2×15 cm3).  The combined organic layers were combined, dried 
over anhydrous sodium sulfate, filtered and the solvent concentrated in vacuo.  
Purification by FCC [petroleum ether – diethyl ether (90:10)] of the crude 
residue afforded alcohol 284 (4.3 mg) as an oil and an unknown compound (8.1 
mg). 
Suzannah J. Harnor, 2010  191 
Alcohol  284:  Rf 0.2 (Solvent R); νmax(film)/cm
-1 3365 (OH), 2929, 1265 and 1105 
(O-Si); δH(400 MHz; CDCl3) 0.10 (6 H, s, Si(CH3)2), 0.89 (9 H, s, SiC(CH3)3), 2.65 (2 
H, t, J 6.7, CH2), 3.62 (2 H, t, J 6.7, CH2OTBS), 4.77 (2 H, d, J 5.4, CH2OH) and 
7.19-7.46 (4 H, m, 4×CH); δC(100 MHz; CDCl3) -5.2 (Si(CH3)2), 18.4 (SiC(CH3)3), 
24.0 (CH2), 25.9 (SiC(CH3)3), 62.0 (CH2OTBS), 64.3 (CH2OH), 79.8 (C≡C), 92.5 
(C≡C), 122.1 (C2), 127.5 (C4), 128.1 (C6), 132.1 (C5), 139.2 (C3) and 142.8 (C1); 
MS (CI) m/z 291.1 [M+H]+; HRMS m/z  291.1779 (291.1781 calcd for C17H27O2Si, 
M+H+). 
Unknown:  Rf 0.8 (Solvent R); δH(400 MHz; CDCl3) 0.09 (6 H, s, Si(CH3)2), 0.88 (9 
H, s, SiC(CH3)3), 2.55 (1 H, t, J 7.2), 2.64 (1H, t, J 7.2), 3.75 (2 H, dt, J 7.2 and 
12.5), 7.23-7.32 (2 H, m), 7.43 (1 H, d, J 7.0) and 7.50 (1 H, t, J 7.0). 
Methyl 2-hydroxy-6-iodo-4-methoxybenzoate 264 
OCH3
O
I
OH
H3CO  
A dry flask was charged with triflate 119 (447 mg, 1.00 mmol) and sodium iodide 
(301 mg, 2.01 mmol).  The reaction flask was flushed with argon and anhydrous 
dimethylformamide (10 cm3) was injected.  The heterogeneous solution was 
heated to 80 oC for 4 h.  After cooling down to room temperature, the reaction 
was poured into a mixture of saturated sodium thiosulphate (20 cm3) and ethyl 
acetate (20 cm3).  The organic layers were washed with water (2×40 cm3) and 
brine (30 cm3), dried over anhydrous sodium sulfate, filtered and concentrated 
in vacuo.  Purification by FCC [petroleum ether – diethyl ether (80:20)] of the 
crude residue afforded iodide 264 (99 mg, 43%) as a colourless oil; 
νmax(film)/cm
-1 1739 (C=O) and 520; δH(400 MHz; CDCl3) 3.88 (3 H, s, OCH3), 4.02 
(3 H, s, CO2CH3), 6.38 (1 H, s, CH) and 6.53 (1 H, d, J 2.2, CH) and 7.29 (1 H, s, 
OH); δC(100 MHz; CDCl3) 52.5 (CO2CH3), 56.0 (OCH3), 100.0 (CI), 101.9 (HCCOH), 
103.9 (HCCI), 133.6 (CCOOCH3), 164.9 (COH), 165.4 (C=O) and 168.9 (COCH3).  
The compound failed to ionise under all mass spectrometry conditions 
attempted. 
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Methyl 2-iodo-4-methoxy-6-methoxymethylbenzoate 18[36] 
MOMO
OCH3
O
H3CO I  
Phenol 264 (160 mg, 0.519 mmol) was dissolved in dichloromethane (5 cm3) and 
N,N-diisopropylethylamine (0.27 cm3,1.56 mmol) was added at room 
temperature.  The reaction mixture was cooled down to 0 oC and bromomethyl 
methyl ether (0.10 cm3, 1.04 mmol) was added.  After 10 min, the ice-water 
bath was removed and the reaction allowed to warm to room temperature 
overnight.  After this time, further N,N'-diisopropylethylamine (0.27 cm3,1.56 
mmol) and bromomethyl methyl ether (0.10 cm3, 1.04 mmol at 0 oC) were 
added.  After 2 h, the reaction mixture was poured into saturated aqueous 
sodium hydrogen carbonate (20 cm3) and extracted with ethyl acetate (3×20 
cm3).  The combined organic layers were washed with water (20 cm3), then brine 
(20 cm3), dried over anhydrous sodium sulfate, filtered and concentrated in 
vacuo.  Purification by FCC [petroleum ether – diethyl ether (80:20)] of the 
crude residue afforded MOM ether 18 (179 mg, 98%) as a colourless oil; Rf 0.11 
(Solvent R); νmax(film)/cm
-1 1737 (C=O), 1620 (C=C), 1213, 1149, 1024 and 513; 
δH(400 MHz; CDCl3) 3.49 (3 H, s, OCH2OCH3), 3.81 (3 H, s, OCH3), 3.90 (3 H, s, 
CO2CH3), 5.19 (2 H, s, OCH2OCH3), 6.47 (1 H, d, J 2.2, CH) and 6.73 (1 H, d, J 
2.2, CH); δC(100 MHz; CDCl3) 52.3 (CO2CH3), 56.0 (OCH2OCH3), 56.6 (OCH3), 95.2 
(OCH2OCH3), 101.0 (C-I), 101.5 (CH), 110.8 (CH), 147.5 (COCH3), 157.5 
(COCH2OCH3), 162.4 (CCO2CH3) and 163.1 (C=O); MS (CI) m/z 375.2 [M+Na]
+; 
HRMS m/z 374.9700 (374.9705 calcd for C11H13INaO5, M+Na
+).  All spectral data 
matches that reported in the literature.[36] 
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4 Introduction 
4.1 Natural Products 
A natural product can be described as a chemical compound or substance that is 
created by a living organism.  In the pharmaceutical industry, these compounds 
are often isolated and characterised, with specific focus on whether they possess 
any biological activity, which would render them of interest as a potential drug 
lead. 
For many years numerous compounds have been isolated through tissue 
extraction of plants, animals and microorganisms.  Through the use of highly 
specialised techniques, their novel chemical structures have been elucidated 
and solved. 
Most biologically active natural products are secondary metabolites with highly 
complex structures hence; the construction of natural products synthetically 
provides challenges, both intellectually and practically.  Since the synthesis of 
urea and acetic acid in the early 1800's, chemistry has evolved so that highly 
complex targets are now achievable.   
4.2 Alkaloids 
The alkaloids are a family of naturally occurring heterocyclic organic compounds 
which contain nitrogen and an alkaline pH.  Alkaloids can be produced by plants, 
bacteria, fungi or animals and many have been found to exert pharmacological 
effects and are now used as medicines, for example morphine, or in some cases 
as recreational drugs such as cocaine.  The alkaloids have been further classified 
by way of their structure, chemical features, biological origin and the biogenetic 
origin if known,[156] culminating in a quite exhaustive classification: 
• Pyridine group 
• Pyrrolidine group 
• Tropane group 
• Indolizidine 
• Quinoline 
• Isoquinoline 
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• Phenanthrene 
• Phenethylamine 
• Indole 
• Purine 
• Terpenoid 
• Quaternary 
• Miscellaneous 
 
Some well known examples are caffeine, which is a purine alkaloid and further 
classified as a xanthine and ephedrine, a phenethylamine alkaloid (Figure 27). 
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Figure 27:  Structure of Caffeine 288 and Ephedrine 289. 
The total synthesis of alkaloids is prevalent in the literature and some of these 
often fascinating and hugely important, complex molecules have been 
synthesised and re-synthesised to take advantage of new synthetic 
developments.  In addition, molecules that were previously resistant, have at 
long last succumbed to total synthesis. 
4.3 Spirocyclic Pyrans and Piperidines 
A number of natural products and biologically important compounds contain 
spirocyclic pyran and piperidine ring systems as part of their overall 
structures.[157]  In the past it was common that the difficulty in achieving the 
total synthesis of such natural products was the formation of the spirocyclic core 
structures.  As a result, numerous synthetic approaches have been developed 
towards their generation, however most of these tend to be substrate specific 
and afford a limited number of functional handles from which synthetic 
diversification can take place.   
4.4 Pinnaic Acid 
In 1996, Uemura reported the isolation of pinnaic acid and tauropinnaic acid 
from the Okinawan bivalve Pinna muricata (Figure 28).[158] 
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Figure 28:  Structures of Pinnaic Acid 290 and Tauropinnaic Acid 291. 
These compounds were the first members of a novel class of alkaloids, 
characterised by an azaspiro[4.5]decane ring system (highlighted in red).  
Subsequent research showed that pinnaic acid and tauropinnaic acid were found 
to exhibit inhibitory activity towards cytosolic phospholipase A2 (cPLA2).  The 
phospholipase A2 (PLA2) family consists of lipolytic enzymes whose constituents 
catalyse the hydrolysis of intra- and extra-cellular membrane phospholipids.[159]  
Cytosolic phospholipase A2 (cPLA2) is an 85 kDa phospholipase which is important 
in the family as it has a significant role in the generation of free arachiodonic 
acid from cellular phospholipids in mammalian cells.[160]  This acid can then go 
on to mediate the biosynthesis of, for example, prostaglandins and 
thromboxanes.  These biological messengers influence cell proliferation and 
inflammatory responses and it is for this reason that selective cPLA2 inhibitors 
are potential targets for the development of novel anti-inflammatory drugs.  
Pinnaic acid inhibits cPLA2 in vitro, with an IC50 of 0.2 mM and as a result of this 
anti-inflammatory activity, suspicion arose that pinnaic acid may be a potential 
drug for the treatment of inflammation.[158,161]  
Shortly after its isolation in 1996, the configuration at C14 of pinnaic acid was 
assigned to be R, via magnetic resonance methods, though this was never 
conclusive.  The stereochemistry at C17 was not assigned at all.
[158]
  The isolation 
process yielded only several milligrams of the natural material, preventing 
further pharmacological and structural studies meaning only total synthesis of 
the natural product would provide a resolution to the initial speculation over the 
assignment, as well as determining the configuration at C17.  
There have been numerous research groups who have become intensely 
motivated to study the synthetic chemistry of pinnaic acid, with the work 
summarised in a review published in 2005 by Clive and colleagues.[162]  By this 
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stage there were three total syntheses of pinnaic acid,[159,163-165] and two further 
formal syntheses of this alkaloid.[166,167,168]   
4.4.1 Danishefsky's Total Synthesis of Pinnaic Acid 
In 2001, Danishefsky and co-workers published the first total synthesis of pinnaic 
acid.[159,164]  The synthesis is neat and concise and begins from Meyers' lactam 
(Scheme 126).  Meyers' lactam 292 was asymmetrically allylated to give bicyclic 
lactam 293.  After N-protection (Boc), stereoselective alkylation of the lithium 
enolate of 295 with methyl iodide gave 296.  Base-induced hydrolysis of 296 
and reduction of the anhydride intermediate gave alcohol 298 as the major 
product.  Subsequent protection gave the protected amino alcohol 299.   
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Scheme 126:  Danishefsky's Synthesis of Pinnaic Acid.  Reagents and Conditions:  (a) 
Me3SiCH2CH=CH2, TiCl4, CH2Cl2, –78 oC → rt, 18 h, 98%; (b) Na, EtOH, NH3/THF, –33 oC, 1 h, 
88%; (c) Boc2O, DMAP, THF, rt, 18 h, 93%; (d) LiHMDS, hexanes/THF, –78 oC → –40 oC, 1.5 h, 
then MeI, –40 oC, 1 h; (e) LiOH, THF/H2O, rt, 18 h; (f) ClCO2Et, Et3N, THF, –10 oC, 1 h, then 
NaBH4, MeOH, 0 oC → rt, 1 h, 39% over three steps; (g) TBDPSCl, Et3N, DMAP, 0 oC → rt, 96%. 
The next series of transformations culminated in the generation of the azaspiro 
core.  The alkylborane of 299 was coupled with vinyl iodide 306, itself 
generated from the corresponding vinyl stannane, to give 300 in 75% yield 
(Scheme 127).  The removal of the Boc protecting group enabled the free amine 
301 to undergo a base-induced cyclisation to afford desired piperidine 302 with 
good diastereoselectivity and as the exclusive E-isomer at C2—C3. 
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Scheme 127:  Danishefsky's Synthesis of Pinnaic Acid.  Reagents and Conditions:  (a) 9-BBN, 
THF, rt, 1.5 h; (b) 306, Pd(dppf)Cl2·CH2Cl2, AsPh3, Cs2CO3, DMF/H2O, rt, 3 h, 75%; (c) CF3CO2H, 
CH2Cl2, rt, 1 h; (d) DBU, rt, 18 h, 81% over two steps; (e) TFAA, DIPEA, 1,2-CH2ClCH2Cl, 0 oC, 5 
min, 88%; (f) HF-pyridine, THF/pyridine, 0 oC → rt, 18 h, 91%; (g) TPAP, NMO, 3Å MS, MeCN, 30 
min, 84%. 
Following removal of the TBDPS protecting group, the free alcohol 304 was 
subjected to oxidation conditions, but as the authors report, this was 
troublesome and the desired aldehyde could not be generated.  It was 
eventually found that continued nitrogen protection was necessary, protection 
that would not be affected by proceeding transformations, but likewise would be 
readily removed at a later stage.  In the end, the authors settled on the 
trifluoroacetyl derivative and created 303, following which the TBDPS 
protection was removed using HF-pyridine.  The free alcohol 304 was then 
readily oxidised to aldehyde 305 in 84% yield using TPAP and NMO. 
Base-mediated reaction of 305 with phosphonate 307 produced an inseparable 
mixture of product 308 and starting aldehyde 305.  Despite this, the authors 
advanced with the mixture and following reduction with either R- or S-alpine 
borane, the alcohol was gained in 30% isolated yield over two steps (Scheme 
128).  Silyl deprotection gave diol 309 and cleavage of the TFA (→310) and 
ethyl ester functions gave what the authors believed to be pinnaic acid (PAI).  
The signals in the high field of the NMR spectrum were comparable with 
Uemura's, but the lack of authentic natural product was a disadvantage as the 
synthetic and natural compounds could not be directly compared by NMR.   
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Scheme 128:  Danishefsky's Synthesis of Pinnaic Acid.  Reagents and Conditions:  (a) 
LiHMDS, THF, –78 oC, 30 min; (b) 305, THF/HMPA, –78 oC → rt, 2 d; (c) (R)- or (S)-alpine hydride, 
30% over two steps; (d) HF-pyridine, THF/pyridine, 0 oC, 1 h, 95%; (e) NaBH4, EtOH, rt, 18 h, 93%; 
(f) LiOH, THF/MeOH/H2O, 4 h, 40 oC, 90%. 
Shrewdly, the authors took 308 and reduced the carbonyl to the alcohol 311 
using NaBH4 (Scheme 129).  This was then used to generate a different form of 
pinnaic acid which differed only in the configuration at C17.  Alcohol 311 was 
desilylated (→309) and the TFA (→310) and ester groups removed.  This new 
pinnaic acid, PAII, exhibited an NMR spectrum which was vastly different in the 
high field area to the spectrum of natural pinnaic acid (from Uemura's work). 
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Scheme 129:  Danishefsky's Synthesis of Pinnaic Acid.  Reagents and Conditions: (a) NaBH4, 
CeCl3·H2O, MeOH, rt, 30 min, 23%; (b) HF-pyridine, THF/pyridine, 0 oC, 1 h, 71%; (c) NaBH4, 
EtOH, rt, 18 h, 90%; (d) LiOH, THF/MeOH/H2O, 40 oC, 4 h, 97%. 
After additional synthetic studies (not discussed here), the authors had strong 
evidence that compound PAI matched the natural pinnaic acid, making the 
configuration at C14 S.  To determine the configuration at C17, diol 310 was 
exposed to acetic anhydride/pyridine and catalytic DMAP for two hours at room 
temperature (Scheme 130).  This capped the free hydroxyls (→312) and 
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subsequent ozonolysis of the C15=C16 bond gave chloroaldehyde 313.  Reduction 
(→314) followed by acetylation afforded 315.  The degradation product 315 
was consistent with the R configuration at C17. 
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Scheme 130:  Danishefsky's Synthesis of Pinnaic Acid.  Reagents and Conditions:  (a) Ac2O, 
pyridine, DMAP, rt, 2 h, 80%; (b) O3, MeOH, –40 oC, then Me2S; (c) NaBH4, CeCl3·H2O, MeOH; (d) 
Ac2O, Et3N, rt, 35% over three steps. 
4.4.2 Uemura's Asymmetric Synthesis of Pinnaic Acid 
In 2007, Uemura and co-workers reported their asymmetric total synthesis of 
pinnaic acid.[169]  The synthesis began from a chiral cyclopentanone, developed 
especially for the investigation, with the overall route being neat and concise, 
incorporating impressive and intricate transformations. 
In Uemura's synthesis, (R)-(+)-pulegone 316 was transformed into chiral 
compound 317 in five steps, with an overall yield of 41%.[169]  Enone 317 then 
underwent a key Pd-TMM (trimethylenemethane) [3+2]-cyclisation in high yield 
and high stereoselectivity to afford the anti-adduct 319 (Scheme 131). 
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Scheme 131:  Uemura's Asymmetric Synthesis of Pinnaic Acid.  Reagents and Conditions:  (a) 
Pd(OAc)2, (iPrO)3P, THF, reflux, 80%; (b) 4Å MS, alumina, CH2Cl2, rt, 43% (100% based on 
recovered starting material); (c) O3, MeOH, –78 oC; then Me2S, –78 oC, 82%; (d) TsNHNH2, MeOH, 
50 oC; (e) NaBH3CN, TsOH, THF, reflux, 60% over two steps; (f) NaH, CbzCl, THF, reflux, 87%; (g) 
NaBH4, LiBr, THF, 50 oC, quant.; (h) TBDPSCl, DMAP, Et3N, CH2Cl2, rt; i) CAN, MeCN/H2O (1:1), 0 
oC, 76% over two steps; (j) SO3·pyridine, Et3N, DMSO, rt; (k) 326, Et3N, LiCl, THF, 30 oC, quant. in 
two steps.  
Lactam 321 was obtained from lactone 319 through a Beckman rearrangement 
using O-mesitylsulfonylhydroxylamine (MSH, 320).  Ozonolysis of the exo-olefin, 
hydrazone formation and deoxygenation gave 322.  Alcohol 324 was obtained 
following amide protection (→323) and reductive opening of lactam 322.  
Interestingly, Uemura reported that no racemisation had occurred from 
cyclopentanone 317. Silyl protection of the primary alcohol, followed by PMP 
ether removal gave alcohol 325.  Oxidation of alcohol 325 into the 
corresponding aldehyde, followed by a HWE reaction with phosphonate 326 
furnished enone 327 as the E-isomer.     
To construct the piperidine ring with the correct configuration at C5 the authors 
use an innovative tandem hydrogenation-cyclisation procedure.  This consists of 
four, one-pot transformations: (1) alkene saturation; (2) Cbz removal; (3) 
intramolecular cyclic imine and/or enamine formation and (4) stereoselective 
reduction of imine/enamine intermediate (Scheme 132). 
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Scheme 132:  Uemura's Asymmetric Synthesis of Pinnaic Acid.  Reagents and Conditions:  (a) 
H2, Pd(OH)2/C (20 mol%), HOAc (7 equiv), EtOH, 25 oC; (b) TFAA, iPr2NEt/ClCH2CH2Cl (1:5), 0 oC, 
81% over two steps; (c) PPTS, EtOH, 25 oC; (d) o-NO2PhSeCN, nBu3P, THF, rt; then mCPBA, rt, 
88% over two steps. 
Piperidine 328 was formed by reaction of enone 327 with 20 mol% palladium 
catalyst.  Protection of the amino group (→329) and selective deprotection of 
the TBS group followed by a Grieco elimination[170] led to olefin 330.   
Installation of the side chain was completed successfully via cross-metathesis of 
olefin 330 using Hoveyda-Grubbs second generation catalyst, with ethyl 
methacrylate as the solvent (Scheme 133).  Hence, trisubstituted alkene 331 
was obtained exclusively as the E-isomer. 
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Scheme 133:  Completion of Uemura's Asymmetric Synthesis of Pinnaic Acid.  Reagents and 
Conditions: (a) ethyl methacrylate, Hoveyda-Grubbs second generation catalyst (10 mol%), neat, 
reflux, 74%; (b) HF·pyridine, 45 oC; (c) o-NO2PhSeCN, nBu3P, THF, rt; then mCPBA, rt, 90% over 
two steps; (d) 333 (5.5 equiv), Grubbs second generation catalyst (80 mol%), toluene, 90 oC, 40%; 
(e) HF·pyridine/pyridine (1:3), 25 oC; (f) NaBH4, EtOH, 25 oC; then NaOH (1.6 M in 1:2 EtOH/H2O), 
40 oC, 86% over two steps. 
Treatment of 331 with HFpyridine afforded the terminal alcohol, which upon a 
second Grieco elimination gave terminal alkene 332.  In this strategy the 
authors installed the C17 centre as part of 333 and then introduced it to the 
spirocyclic core, via cross-metathesis.  As expected, the terminal olefins were 
more reactive than the internal double bonds and the cross-metathesis 
proceeded in 69% yield to furnish 334 as the single trans-isomer (C15—C16 bond).  
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After removal of the two silyl groups, TFA amide and the ethyl ester, the chiral 
pinnaic acid was obtained as its sodium salt 335.  1H NMR comparison of this and 
the racemic form proved to be identical. 
The method developed by Uemura and colleagues is advanced and relies heavily 
on the success of some intricate and complex reactions.  Despite this, all the 
stereochemistry (apart from C17) can be efficiently controlled from the methyl 
group in cyclopentone 317. 
4.5 Halichlorine 
In 1996, as well as reporting the isolation of pinnaic acid, Uemura also isolated 
the novel marine alkaloid, halichlorine, from the Japanese black marine sponge 
Halichondria okadai (Figure 29).[158]  It is an interesting compound in that it 
shares the same azaspiro[4.5]decane core with pinnaic acid. 
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Figure 29:  Structure of Halichlorine 336. 
Halichlorine is a crystalline compound and its structure was assigned only after 
extensive NMR studies; structurally it possesses 23 carbon atoms and five 
stereocentres.  Halichlorine selectively inhibits induced expression of vascular 
cell adhesion molecule-1 (VCAM-1) with an IC50 of 7 µg/mL.  VCAM-1 is a member 
of the immunoglobulin superfamily and is expressed on the surface of 
endothelium cells.  VCAM-1 monitors and regulates leukocyte recruitment into 
inflamed tissue.[163,171]  Since leukocyte recruitment is involved in allergic 
inflammatory disorders, VCAM-1 has been identified as a target for drug 
discovery.  
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4.5.1 First Total Synthesis of (+)-Halichlorine 
With its interesting biological profile, halichlorine was the subject of study in 
numerous groups but it wasn't until three years after its isolation that it finally 
succumbed to total synthesis.  In 1999, Danishefsky and colleagues discussed 
their studies towards and most importantly, the first total synthesis of 
halichlorine.[171-173]  In their initial publication[171] they discussed the 
stereoselective, asymmetric synthesis of the spiroquinolizidine subunit 344, 
which contains 17 out of the 23 carbon's and four of the five stereocentres.  
Danishefsky's synthesis began with Meyers lactam 292 which was made by 
heating racemic carboxylic acid 337 with D-(—)-phenylglycinol 338 (Scheme 
134).  Treatment of the Meyers lactam 292 with allyl TMS in the presence of 
Lewis acid gave bicyclolactam 293.  After debenzylation (→294) and nitrogen 
protection, the bicyclic N-Boc-lactam 295 was stereoselectively methylated 
from the convex face to afford 296.    This compound was hydrolysed (→297) 
and then reduced.  The resulting primary alcohol 298 was protected to afford 
silyl ether 299.   
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Scheme 134:  Danishefsky's Synthesis of the Spiroquinolizidine Core of Halichlorine.  
Reagents and Conditions:  (a) PhMe, reflux, 95%; (b) allyl TMS, TiCl4, CH2Cl2, –78 oC → rt, 99%; 
(c) Na, NH3, THF, EtOH, –78 oC, 92%; (d) Boc2O, DMAP, THF, 96%; (e) (i) LiHMDS, THF, –40 oC; 
(ii) MeI, –78 oC → 0 oC, 90%; (f) LiOH, THF, H2O, 89%; (g) (i) ClCOOEt, Et3N, THF; (ii) NaBH4, 
MeOH, 82%; (h) TBDPSCl, Et3N, DMAP, CH2Cl2, 95%; (i) (i) 9-BBN, THF; (ii) Z-I-CH=CH=COOMe, 
Pd(dppf)Cl2, AsPh3, Cs2CO3, DMF, H2O; (j) (i) TFA, CH2Cl2; (ii) H2O, K2CO3, 77%. 
At this juncture, three of the stereogenic centres had been introduced and the 
next stage was the formation of the C5 stereocentre.  Hydroboration of alkene 
299 and subsequent palladium mediated Suzuki coupling of the resulting borane 
with Z-3-iodoacrylate allowed elongation of the allylic side chain to generate 
Suzannah J. Harnor, 2010  204 
unsaturated ester 339.  Deprotection of the amino function and basification 
allowed an intramolecular Michael addition to take place and generate 
piperidine 340.  The authors discuss the stereochemical control of this 
transformation as originating from the chair-conformation transition state, 
whereby the larger substituent adopts a pseudoequatorial position. 
As shown in Scheme 135, crossed Claisen condensation of 340 with tert-butyl 
acetate produced the β-keto ester 341.  Quinolizidine ring closure was then 
effected by a Mannich reaction with formaldehyde.  Tricycle 342 was then 
converted into the α,β-unsaturated ester 343, which after deprotection gave 
spiroquinolizidine 344. 
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Scheme 135:  Danishefsky's Synthesis of the Spiroquinolizidine Core of Halichlorine.  
Reagents and Conditions:  (a) tBuOAc, LiHMDS, THF, –50 oC → rt, 86%; (b) H2CO, EtOH, 73%; (c) 
(i) LiHMDS, THF, 0 oC; (ii) Cp2Zr(H)Cl, rt, 91%; (d) HF-pyridine, THF, 94%. 
Alcohol 344 was oxidised to aldehyde 345 using TPAP/NMO and then treated 
with Gilbert's reagent[174] to produce alkyne 346 in reasonable yield. 
Hydrozirconation, followed by transmetallation gave zincate 347, which was 
then coupled to aldehyde 349 (aldehyde 349 was prepared from the known 
Weinreb amide 348[175]).  The reaction was carried out in the presence of amino 
alcohol 350, which led to a 4:1 mixture of the desired 17R epimer 351.  
Treatment of the mixture with TBSOTf generated both the silyl ester of the 
carboxylic acid and the protection of the secondary alcohol (→352).    
Simultaneous cleavage of the carboxyl and primary silyl groups (→353) was 
brought about by the addition of ammonium fluoride in aqueous methanol.  
Crucially, the secondary TBS group remained intact.  Macrolactonisation under 
Keck conditions enabled the formation of 17-TBS-halichlorine 354 and 
importantly allowed the separation of the 17R and 17S epimers.  The final step 
entailed deprotection at C17 with HF-pyridine to afford halichlorine 336.  The 
spectral data of the 17R synthetic material matched that of an authentic 
specimen. 
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Scheme 136:  Completion of Danishefsky's Synthesis of Halichlorine.  Reagents and 
Conditions:  (a) TPAP, NMO, MeCN, rt; (b) N2CHP(O)(OMe)2, KOtBu, THF, –78 oC, 57% over two 
steps; (c) (i) [Cp2Zr(H)Cl], CH2Cl2; (ii) Zn2Me, heptane, –65 oC; (iii) 350 (10 mol%), –65 oC → –30 
oC; (iv) 349, –30 oC → rt, 67% overall; (d) DIBAH, PhMe, CH2Cl2, –78 oC, 82%; (e) TBSOTf, 2,6-
lutidine, CH2Cl2, –78 oC → rt; (f) NH4F, MeOH, H2O, 66% overall from 351; (g) EDCI, DMAP, 
DMAP·HCl, CHCl3, THF, reflux, 54%; (h) HF-pyridine, pyridine, THF, 95%. 
4.6 Christie and Heathcock's Total Synthesis of (±)-
Pinnaic Acid and (±)-Halichlorine 
In 2004, PNAS published a fascinating report by Christie and Heathcock in which 
they reported the synthesis of both pinnaic acid and halichlorine, from a 
common late-stage intermediate. 
As shown in Scheme 137, acylimmonium precursor 353 was prepared from keto-
alcohol 352.  Condensation of ketone 352 with benzyl carbamate gave the cis-
fused bicyclic carbamate 353 as a 6:1 ratio of diastereoisomers.  The structure 
was epimeric at C14, with the major compound being the isomer with the methyl 
group on the convex face. 
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Scheme 137:  Christie and Heathcock's Synthesis.  Reagents and Conditions:  (a) Benzyl 
carbamate, Amberlyst-15, benzene, reflux, 2 h, 91%; (b) TiCl4, H2C=CHCH2SiMe3, CH2Cl2, –50 oC 
→ –20 oC, 7 h, 53%; (c) (i) recrystallise as the hydroacetate salt; (ii) CbzCl, NaOH, H2O, 15 h; (iii) 
MeOH, K2CO3, overnight; (d) Ac2O, DMAP, Et3N, CH2Cl2, rt, 1 h; (e) Grubbs second generation 
catalyst, CH2Cl2, 40 oC, 3.5 h; (f) 55 psi H2, Pd/C, EtOAc, rt, 50 h. 
Carbamate 353 was treated with allyl TMS and TiCl4 to afford alcohol 354 in 53% 
yield, together with free amine 355.  Amine 355 could be reprotected hence, 
increasing the allylation yield to 65%.  Acetylation of the primary hydroxyl of 
354 afforded 357, which underwent cross-metathesis with Nazarov ester 358[176] 
in the presence of Grubbs second generation catalyst, to produce enone 359.  
Reduction of enone 359 generated piperidine 360 as a single isomer at C5. 
With the core in place, the focus turned to functionalisation of the side chains.  
Protection of the nitrogen atom and C5 side chain function was achieved through 
treatment of amino acid (obtained from amino ester 360) with the modified 
Mukaiyama reagent 369 (Scheme 138).   
Cleavage of the acetate group of β-lactam 361, gave alcohol 362, which was 
then oxidised to aldehyde 363.  Aldehyde 363 was then treated with 
phosphorane 370 to yield dienone 364 in 77% yield. 
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Scheme 138:  Christie and Heathcock's Synthesis.  Reagents and Conditions:  (a) TFAA, rt, 35 
min; (b) i-Pr2Net, 369, MeCN, 70 oC, 80%; (c) K2CO3, MeOH, rt, 2 h, 97%; (d) 
tetrapropylammonium perruthenate, N-methylmorpholine N-oxide, CH2Cl2, rt, 10 min, 92%; (e) 370, 
MeOH, 65 oC, 3 d, 77%; (f) NaBH4, CeCl3·7H2O, MeOH, rt, 90% (5:2); (g) TESCl, DMAP, i-Pr2Net, 
CH2Cl2, –78 oC → 0 oC, 92%; (h) Red-Alp/tBuOK, methyl tert-butyl ether, rt, 3 h, 78%.  
Reduction of ketone 364 gave alkenol 365 as a 5:2 mixture of diastereoisomers, 
which upon TES protection gave the fully protected compound 366.  Cleavage of 
the β-lactam proceeded best when using "Red-Alp", a pyrrolidine-modified Red-
Al reagent,[177] to enable the formation of aldehyde 368 via the decomposition 
of enamine 367 on silica gel.  This amino aldehyde became the precursor for 
both pinnaic acid and halichlorine. 
4.6.1 Completion of Pinnaic Acid 
HWE reaction of aldehyde 368 afforded the entire carbon skeleton of pinnaic 
acid, in 54% yield.  The authors make no mention of the obtained E:Z-selectivity 
in their publication.  The silicon protecting groups were readily removed under 
standard conditions to afford diol 372 in 85% yield.  Ester hydrolysis afforded the 
carboxylate salt 335, which upon treatment with pH 7 buffer allowed its 
purification as its zwitterion 290 by reverse-phase HPLC. 
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Scheme 139:  Completion of the Synthesis of Pinnaic Acid.  Reagents and Conditions:  (a) 
(EtO)2P(O)CH(CH3)CO2Et, LiCl, DBU, MeCN, rt, 12 h, 54%; (b) TBAF, THF, 0 oC, 2 h, 85%; (c) 
NaOH, MeOH, H2O, rt → 45 oC, 4 h, 90%; (d) pH 7 buffer/nBuOH extract. 
4.6.2 Completion of Halichlorine 
To enable the conversion of aldehyde 368 into halichlorine 336, a new 6-
membered ring fused to the spirocyclic core had to be created as well as the 
generation of the 15-membered macrocycle.  Aldehyde 368 was treated with 
trimethyl phosphonoacrylate and lithium thiophenoxide to afford a mixture of 
the desired E:Z-thioether 373.  Interestingly, when the E-isomer was treated 
with excess thiophenoxide a mixture was obtained that contained predominantly 
the Z-isomer.  Heating of either the E:Z-mixture or the pure Z-isomer in a basic 
thiophenoxide solution resulted in the formation of dehydroquinolizidine 375.  
By allowing the nitrogen atom to add to the unsaturated ester of intermediate 
374, addition/elimination of thiophenoxide could occur to form the 
dehydroquinolizidine.  The silyl protecting groups were cleaved using TBAF 
(→376) and the resulting ester was saponified to give the sodium salt.  
Application of Keck's macrolactonisation conditions allowed the formation of (±)-
halichlorine 336.  The NMR spectra of the synthetic material were identical to 
that of the authentic material. 
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Scheme 140:  Completion of the Synthesis of Halichlorine.  Reagents and Conditions:  (a) 
Trimethyl phosphonoacrylate, PhSLi, THF, 0 oC → rt, 12 h, 71%; (b) K2CO3, PhSH, DMF, 55 oC, 35 
h, 48-61%; (c) TBAF, THF, 0 oC, 3 h, 77%; (d) NaOH, MeOH, H2O, 55 oC, 2 h, then rt, overnight; 
(e) N-(3-methylaminopropyl)-N'-ethylcarbodiimide hydrochloride, N-dimethylaminopyridine·HCl, 
CHCl3, THF, reflux, 10 h, 32%. 
4.7 Kibayashi's Synthesis of (±)-Pinnaic Acid and (±)-
Halichlorine 
Kibayashi's laboratory reported the efficient synthesis of ketone 381 
incorporating the azaspirobicyclic core, via the 6-azaspiro[4.5]decane skeleton 
380 (Scheme 141).[178]  In a subsequent publication by the same authors,[166] 
ketone 381 was able to be used as a precursor in the synthesis of Danishefsky 
intermediate 303 and 401 (the ethyl ester of Danishefsky intermediate 344), to 
further enable a formal total synthesis of (±)-halichlorine and (±)-pinnaic acid. 
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Scheme 141:  Summary of the Synthesis to Kibayashi's Common Precursor 381. 
Addition of allylmagnesium bromide to ketone 381 gave the tertiary alcohol 
382.  The allylation is directed to the less hindered face by the N-benzyloxy 
group.  Oxidative cleavage of alkene 382 gave carboxylic acid 383, which upon 
cleavage of the benzyloxy group (→384), followed by lactam cyclisation gave 
the hydroxy tricyclic lactam 385.  Dehydration of lactam 385 yielded a 2:1 
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mixture of the α,β- and β,γ-lactams 386 and 387 respectively.  Catalytic 
hydrogenation of the mixture gave the tricyclic lactam 388 as a single product.  
Removal of the silyl group afforded alcohol 389 which upon C7 methylation from 
the β-face gave 390 and 391 with 15:1 selectivity.   
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Scheme 142:  Kibayashi's Synthesis towards Pinnaic Acid.  Reagents and Conditions:  (a) 
H2C=CHCH2MgBr, THF, 0 oC, 99%; (b) OsO4, NaIO4, H2O, THF, rt, 82%; (c) NaClO2, NaH2PO4, 2-
methyl-2-butene, H2O, t-BuOH, rt, 95%; (d) H2, Pd-C, EtOH, 97%; (e) ClCO2CH2CHMe2, Et3N, 
toluene, rt, 90%; (f) SOCl2, Et3N, CH2Cl2, 0 oC, 92%; (g) H2, Pd-C, MeOH, 99%; (h) 1 M HCl, THF, 
rt, 99%; (i) MeI, LDA, THF, –78 oC, 78%. 
Protection of the primary alcohol 390 as the benzyl ether 392, was followed by 
lactam cleavage to produce amino ester 394 using methyl triflate (Scheme 143), 
via iminium intermediate 393.  The 1,7-disubstituted spirobicyclic compound 
underwent ester reduction to yield alcohol 395, which was converted to 396 by 
TBDPS protection, N-trifluoroacetylation and O-debenzylation.  Dess–Martin 
oxidation of alcohol 396 gave the corresponding aldehyde 397, which after HWE 
homologation provided the TBDPS-protected Danishefsky intermediate 303.  This 
intermediate had previously been converted to pinnaic acid (see Section 4.4.1) 
and thus constituted a formal synthesis of (±)-pinnaic acid by Kibayashi and co-
workers. 
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Scheme 143:  Kibayashi's Synthesis towards Pinnaic Acid.  Reagents and Conditions:  (a) 
BnBr, NaH, THF, rt, 90%; (b) TfOMe, ClCH2CH2Cl, 60 oC; (c) H2O, THF, rt; (d) LiAlH4, THF, 0 oC, 
74% over 2 steps; (e) TBDPSCl, Et3N, DMAP, CH2Cl2, rt, 95%; (f) TFAA, i-PrNEt, ClCH2CH2Cl, 0 
oC, 99%; (g) H2, Pd(OH)2-C, MeOH, 99%; (h) Dess–Martin periodinane, CH2Cl2, rt, 95%; (i) 
EtO2CCH(Me)P(O)(OEt)2, NaH, THF, –78 oC, 76%. 
Wittig methylenation, N-protection and introduction of the alkenyl chain into 
the secondary amine allowed the azaspirobicyclic aldehyde 397 to be converted 
into diene 399 (Scheme 144).  Ring-closing metathesis with Grubbs second 
generation catalyst enabled the formation of 400 in high yield.  Finally, removal 
of the silyl protection furnished intermediate 401 (the ethyl ester of Danishefsky 
intermediate 344).    Similarly this intermediate had been transformed into 
halichlorine (see Section 4.5.1) and so a formal synthesis of racemic halichlorine 
had also been achieved by Kibayashi and co-workers. 
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Scheme 144:  Kibayashi's Synthesis towards Halichlorine.  Reagents and Conditions:  (a) 
Ph3P+MeBr-, BuLi, THF, 0 oC, 80%; (b) NaBH4, EtOH, rt, 83%; (c) H2C=C(CH2Br)CO2Et, K2CO3, 
MeCN, 60 oC, 88%; (d) Grubbs second generation catalyst, CH2Cl2, reflux, 99%; (e) TREAT·HF, 
Et3N, MeCN, rt, 94%. 
4.8  Investigation of Alternative Routes to the Spirocyclic 
Core of Pinnaic Acid and Halichlorine 
The unique azaspiro[4.5]decane core structure present in both pinnaic acid and 
halichlorine has imparted challenges to synthetic chemists, who have strived for 
an easily accessible and reliable route to the core structure.  As a consequence 
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many authors have described their synthetic approaches.[178-183]  In addition to 
those methods already described herein, it is not feasible and in the scope of 
this thesis to discuss every approach in depth.  However, the work of many 
groups is portrayed in the informative review by Clive, Yu, Wang, Yeh and Kang 
in 2005.[162]   
4.9 The Achmatowicz and aza-Achmatowicz Oxidative 
Rearrangement 
Hexoses have been successfully synthesised by routes which incorporate 
oxidative rearrangement of furylcarbinols 402 to pyranones 403, with chirality 
at the furylic position being conserved during the rearrangement (Scheme 145).  
This transformation has been termed the Achmatowicz rearrangement as a result 
of the pioneering work of O. Achmatowicz.[184] 
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Scheme 145:  The Achmatowicz Rearrangement. 
mCPBA is most commonly used as the peracid needed for the rearrangement to 
take place, though other reagents such as vanadyl acetylacetonate (VO(acac)2) 
and N-bromosuccinimide (NBS) have also been reported as suitable.  In a quest 
for 2-(1-hydroxyalkyl)-3(2H)-furanones Ho and Sapp[185] investigated the 
epoxidation of 2-furancarbinols 404 with tert-butyl hydroperoxide in the 
presence of VO(acac)2.  It was expected that the double bond linked directly to 
the hydroxyalkyl chain would undergo the reaction regioselectively, with the 
resultant dioxabicyclo(3.1.0)hexane derivative rearranging to furanone 408 
(Scheme 146).  Oxidation was reasonably rapid and the 3(2H)-pyranones were 
obtained in acceptable yield. 
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Scheme 146:  Formation of Furanones 408 from 2-Furancarbinols. 
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These compounds underwent epoxide ring opening in a direction governed by the 
relative stability of the cyclic vanadate intermediate 409.  Vanadates derived 
from the vic-glycol systems are the most favourable (Figure 30). 
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Figure 30:  Cyclic Vanadate Intermediate 409. 
Efforts to develop new routes to nitrogen bearing substances have been of 
considerable interest to synthetic chemists for some time.  The aza-
Achmatowicz rearrangement emerged in the 1980s in response to the synthetic 
problems the indolizidine and quinolizidine structures posed.  Ciufolini and 
Wood[186] reasoned that ketone 412 may be accessible from the enone 411.  
Enone 411 is in turn accessible through an aza-Achmatowicz rearrangement, 
starting from a substrate such as 410 (Scheme 147).  
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Scheme 147:  The aza-Achmatowicz Rearrangement. 
A hypothesis emerged that if similarly protected furfurylamines could be 
oxidised to nitrogen heterocycles, then they could be used as building blocks to 
readily incorporate nitrogen-containing heterocycles into natural product 
synthesis.  Ciufolini reported that carbamate protected furfurylamines were 
unstable and readily hydrolysed to 3-hydroxypyridines under oxidation 
conditions.  Further investigation by Zhou[187] and Altenbach[188] established that 
sulphonamide protection was well-suited under aza-Achmatowicz oxidation 
conditions and consequently the N-tosyl group is regularly used as a protecting 
group.   
Since its conception, the aza-Achmatowicz reaction has been further developed 
and applied to the synthesis of a number of classes of compounds including 
piperidine alkaloids, azasaccharides and izidines.  For the scope of this thesis it 
is not appropriate to discuss all of the synthetic situations in which the aza-
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Achmatowicz has been used, but nevertheless some important and interesting 
examples are highlighted below. 
4.9.1  Formation of Substituted Piperidines via the aza-
Achmatowicz Rearrangement 
In 2002, Harris and Padwa published their short and concise route to 2,5,6-
trisubstituted piperidines, which incorporated an aza-Achmatowicz oxidation.[189]  
They postulated that this specific reaction could be used to prepare indolizidine 
systems such as 413 from furylamides 416 and subsequently a variety of 
piperidines-based alkaloids (Scheme 148).  
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Scheme 148:  Padwa's Synthesis of 2,5,6-Trisubstituted Piperidines 413. 
To enable the formation of systems such as 413, a 1,4-conjugate addition to 415 
is necessary to introduce the R3 substituent.  To investigate the stereochemical 
aspects of this addition, 418 was prepared from furyl sulphonamide 417 and 
from NOE evaluation was assigned as the cis-isomer (Scheme 149).  The authors 
reason that the "exclusive formation of 418 can be rationalised by assuming that 
A1,3-strain between the two substituents and the tosyl group forces the methoxy 
and methyl groups to adopt a pseudoaxial orientation."[189]   
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Scheme 149:  Padwa's Synthesis of 2,5,6-Trisubstituted Piperidines.  Reagents and 
Conditions:  (a) mCPBA, CH2Cl2, 2 h, rt, 85%; (b) (MeO)3CH, BF3·OEt2, CH2Cl2, 0 oC, 3 h, 85%; (c) 
cuprate reagent, 85-90%; (d) allyl TMS, BF3·OEt2, CH2Cl2, 0 oC. 
When enone 418 was treated with various cuprate reagents the reaction proved 
to be stereospecific, providing the corresponding Michael adducts in pure 
diastereomeric form.  The stereochemistry is a result of axial attack from the 
face that is opposite to the diaxial substituents at C2 and C6.  This may occur due 
to steric hindrance between the pseudoaxial 2,6-substituents and the equatorial 
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approach of the nucleophile, thus forming the kinetically favoured 1,4-adduct.  
Following this, the pyridinone ring can be functionalised at C6 by treatment of 
419 with allyl trimethylsilane and BF3OEt2 at 0 
oC.  The product 420 is a single 
diastereoisomer with 2,6-cis-disubstituted stereochemistry as dictated by the 
tosyl group which shields the opposite face of the molecule as a result of the 
A1,3-strain between the tosyl and methyl groups.  The size of the tosyl group 
directs nucleophile attack on the iminium ion to the side of the C2 methyl, 
generating the cis-product. 
In 2003, Padwa applied his methodology towards trisubstituted piperidines, 
which culminated in the synthesis of 6-epi-indolizidine 223A.[190]  A number of 
indolizidine alkaloids have been isolated from neotropical frogs, with a new 
subclass called 223A identified in 1997, after its extraction from a skin extract of 
the frog Dendrobatidae.[191]  The actual structure of 223A was finally elucidated 
in 2002 and was shown to contain an atypical 5,6,8-trisubstituted indolizidine 
ring (Figure 31).[192] 
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Figure 31:  Indolizidine Alkaloid 223A.  The originally proposed structure[191] is shown (421), 
along with the revised structure[192] (422). 
A taxing problem in the synthesis of indolizidine alkaloids is the creation of the 
correct stereocentres in the piperidine ring, but Padwa envisioned that the aza-
Achmatowicz reaction could be utilised to solve this issue and enable a synthesis 
of 6-epi-indolizidine 223A.  At the outset of their work the revised structure had 
not been published, so the synthesis is directed towards the originally proposed 
structure 421. 
The more complex dihydro-2H-pyridone 426 was synthesised from 
benzophenone-derived imine 423, which was alkylated, hydrolysed and the 
amine treated with tosyl chloride to generate 424 (Scheme 150).  Oxidative 
rearrangement of 424 using mCPBA gave the desired 6-hydroxy-2,6-
dihydropyridinone 425 as a single diastereoisomer, which was then transformed 
into alkene 426 through reaction with allylsilane.   
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Scheme 150:  Synthesis of 6-epi-Indolizidine 223A.  Reagents and Conditions:  (a) n-BuLi, THF, 
BrCH2CH2CH2OTBDPS, 86%; (b) 1 N HCl, acetone, 95%; (c) TsCl, Et3N, CH2Cl2, 90%; (d) 
mCPBA, CH2Cl2, rt, 4 h; (e) CH2=CHCH2SiMe3, BF3·OEt2, CH2Cl2, 0 oC, 64% over two steps; (f) 
(Et)2CuMgBr, THF, 0 oC, 90%; (g) PhNTf2, NaHMDS, –78 oC, 95%; (h) CH2=CHSnBu3, Pd(PPh3)4, 
LiCl, THF, 85%; (i) PtO2, H2, EtOH, 95%; (j) TBAF, THF, 90%; (k) Na, C10H8, –78 oC; (l) CBr4, PPh3, 
Et3N, 50% over three steps; (m) PtO2, H2, EtOH, 90%. 
The synthesis afforded 6-epi-indolizidine 223A 421 in eight further steps, making 
the total synthesis thirteen steps long; with an overall yield of 13.1%.  The 
incorporation of the aza-Achmatowicz oxidative rearrangement allows the 5,6,8-
trisubstituted core structure to be easily obtainable, from which further 
functionalisation can take place. 
4.9.2 Towards Hydroxylated Piperidine Alkaloids 
In 2004, Cassidy and Padwa[193] utilised the aza-Achmatowicz oxidative 
rearrangement as the crucial step in their synthesis of cis-2,3,6-trisubstituted 
piperidines.  Padwa then proceeded to demonstrate its use in the synthesis of 
the biologically active alkaloids (±)-azimic acid and (±)-deoxocassine.  Both 
compounds are 2,6-disubstituted piperidin-3-ol alkaloids, with azimic acid 434 
being a product of the hydrolysis of azimine 433.  Azimic acid, azimine and 
deoxocassine 435 (Figure 32) have attracted a great deal of attention since their 
isolation. 
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Figure 32:  Structures of Azimic Acid 434 and Deoxocassine 435. 
In Padwa's synthesis of (±)-azimic acid and (±)-deoxocassine,[189] furyl 
sulphonamide 417 was oxidatively ring expanded with mCPBA, followed by 
treatment with trimethyl orthoformate and BF3OEt2 to generate aminal 418 
(Scheme 151).  Reduction under Luche conditions gave the cis-alcohol 436 as a 
single diastereoisomer.  Following TBS protection (→437), addition of methyl 3-
(trimethylsilyl)-4-pentenoate, led to the formation of piperidine intermediate 
438.  The cis-substitution can be explained by assuming that the steric bulk of 
the tosyl group directs the allylsilane attack on the iminium ion to the side of 
the C2-methyl group, leading to cis-stereochemistry. 
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Scheme 151:  Formation of Functionalised Piperidino Ester 439.  Reagents and Conditions:  
(a) (i) mCPBA, CH2Cl2, 2 h, rt, 85%; (ii) (MeO)3CH, BF3·OEt2, CH2Cl2, 0 oC, 3 h, 85%; (b) NaBH4, 
CeCl3, MeOH, –40 oC, 60%; (c) TBDMSCl, imidazole, DMAP, CH2Cl2, rt, 82%; (d) methyl 3-
(trimethylsilyl)-4-pentenoate, BF3·OEt2, CH2Cl2, –78 oC; (e) H2, PtO2, MeOH, rt, 57%.  
To complete the synthesis of deoxocassine, ester 439 was converted to the 
Weinreb amide 440 in high yield (Scheme 152).  Treatment of amide 440 with 6-
heptenyllithium gave ketone 441.  Ketone reduction via the corresponding 
tosylhydrazone afforded 442.  Hydrogenation, followed by global deprotection, 
resulted in the formation of deoxocassine 435 in an excellent 92% over the final 
three steps. 
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Scheme 152:  Completion of (±)-Deoxocassine.  Reagents and Conditions:  (a) 
MeNH(OMe)·HCl, iPrMgCl, THF, –20 oC, 85%; (b) CH2=CH(CH2)5I, t-BuLi, heptane, –78 oC, 56%; 
(c) TsNHNH2, EtOH, rt; (d) DIBAH, NaOH, CH2Cl2, 0 oC; (e) H2, PtO2, MeOH; (f) TBAF, THF, 0 oC; 
(g) Li, NH3, THF, –78 oC, 92%. 
The synthesis of azimic acid began from the same precursor 439 (Scheme 153).  
Ester 439 was reduced with LAH and the resulting alcohol 443 was converted to 
the mesylate before cyanide displacement resulted in the formation of nitrile 
444.  Hydrolysis of the nitrile, with consequential TBS cleavage, generated 
carboxylic acid 445.  Finally, removal of the tosyl group afforded azimic acid 
434. 
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Scheme 153:  Completion of (±)-Azimic Acid.  Reagents and Conditions:  (a) LiAlH4, THF, 0 oC, 
97%; (b) MsCl, Et3N, CH2Cl2, 0 oC; (c) NaCN, DMF, 50 oC; (d) NaOH, MeOH, 70 oC, 89%; (e) Li, 
NH3, THF, –78 oC, 70%. 
The routes reported provide an efficient synthesis of two hydroxlated piperidine 
alkaloids.  They both rely on the aza-Achmatowicz rearrangement as the pivotal 
step to provide the key N-tosyl-O-methylaminal from which the necessary 
functionalisation can take place. 
4.10 Polymaxenolide 
A coelenterate is an invertebrate of the phylum Coelenterata, which has a 
saclike body with a single mouth, which occurs in polyp and medusa forms.  The 
group includes jellyfish, sea anemones and corals.  A cnidarian is any 
coelenterate of the subphylum Cnidaria and the soft corals are a group of 
cnidarians that make up a large part of the biomass in tropical reefs.  A good 
number of soft corals are of the genus Sinularia, which are inclined to form large 
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monospecific 'carpets' of up to 10 m2.[194]  It is known that the soft corals 
produce multiple classes of unique secondary metabolites such as sesquiterpenes 
and diterpenes, with a broad range of carbon skeletons and biological activities.   
The effects of natural hybridisation on secondary metabolite production and 
diversification has been largely ignored in marine organisms, despite the fact 
that it appears to be a widespread occurrence, having a bearing on the evolution 
of marine organisms.  In 2004, Kamel and co-workers discovered hybridisation 
between Sinularia maxima and Sinularia polydactyla and reported the isolation 
(from Piti bomb holes in Guam) of a novel metabolite they termed 
polymaxenolide. Later, in 2009, Kamel and colleagues[195] further examined the 
CH2Cl2/MeOH extracts and isolated additional related metabolites, 7E-
polymaxenolide, 7E-5-epipolymaxenolide and polymaxenolides A—C.  
The structure of polymaxenolide was resolved via mass spectrometry, IR 
spectrometry and extensive and intricate 1D and 2D NMR experiments.  
Fortunately for the authors, the isolated compound was in solid form, so x-ray 
crystallography was used to further determine the structure.  The outcome of 
this investigation revealed that polymaxenolide 446 was composed of a fusion of 
a cembrane diterpene with an africanane-type sesquiterpene with the skeleton 
joined via a C—C bond (Figure 33). 
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Figure 33:  Structure of Polymaxenolide 446.  The spirocyclic core structure is highlighted in red. 
Other than the accounts documenting its isolation and structural determination, 
there have been no biological or synthetic studies of polymaxenolide reported.  
Therefore, as a result of our interest in the synthesis of the spirocyclic 
piperidine and spirocyclic pyran core of natural products, we believed that we 
could use our prior synthetic experience and knowledge to establish a route to 
the spirocyclic core of polymaxenolide. 
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In our proposed approach, Lewis acid mediated ring-closing of 448 enables the 
formation of spirocyclic structure 447 (Scheme 154).  Spirocycle 448 is the 
result of Achmatowicz rearrangement of TMS alkene 449, which itself is a 
product of Grubbs-mediated cross-metathesis of allyl TMS with terminal alkene 
450.  The known alkene 450 can be easily accessible from furan 453 in three 
steps.  
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Scheme 154:  Retrosynthetic Analysis to Polymaxenolide 446. 
In conclusion, the Achmatowicz and aza-Achmatowicz rearrangement reactions 
have become integral steps in the synthesis of natural products.  With this in 
mind, we hope to build upon prior knowledge from our own laboratories and the 
chemistry community, to allow the use of this powerful rearrangement in our 
efforts towards the synthesis of the azaspiro cores of pinnaic acid and 
halichlorine, with the potential to develop a total synthesis of these alkaloids.  
We also believe that the rearrangement can be used to reach the spirocyclic 
core of polymaxenolide, with the view to then focus on a first total synthesis of 
this natural product. 
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5 Results and Discussion 
At the outset of this project we envisioned that the work would ultimately lead 
towards a total synthesis of the marine natural product, pinnaic acid. 
5.1 Retrosynthetic Analysis to Pinnaic Acid  
As shown in Scheme 155, we envisaged pinnaic acid as having originated from 
spirocyclic piperidine 454, which could be obtained from the Nozaki coupling of 
vinyl iodide 455 and aldehyde 456.  Vinyl iodide 455 is derived from conjugated 
ester 457.  The fundamental spiropiperidine core 457 is thought to originate 
from aza-Achmatowicz rearrangement-intramolecular cyclisation sequence of 
allylsilane 458.  This allylsilane could be generated from amino furan 459. 
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Scheme 155:  Retrosynthetic Analysis to Pinnaic Acid 290. 
5.2 Previous Work 
The aza-Achmatowicz rearrangement has been explored in recent times by 
groups such as Ciufolini, Nelson and Padwa[193,196,197] as a method of generating 
aza-saccharides and polysubstituted piperidine units.  The generation of the 
enantiomerically pure furanyl alcohol limits the use of the rearrangement and 
though various approaches have been broached, we chose to take advantage of 
readily available oxynitrilases to introduce the desired hydroxyl functionality.  It 
has formerly been demonstrated within the Marquez group that trimethylsilyl 
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cyanohydrins can be treated with ammonia and transformed into their amine 
derivatives with complete inversion of configuration.  We tentatively 
hypothesised that amino unit 462 could be obtained in a single step from 
aldehyde 480 by introduction of the appropriate ammonium salt into the 
enzymatic step (Scheme 156). 
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Scheme 156:  Conversion of TMS Cyanohydrins into their Corresponding Amino Units.  
Reagents and Conditions:  (a) (S)-Oxynitrilase, HCN; (b) TMSCl, Et3N, DMAP, CH2Cl2; (c) NH3. 
In addition, it has previously been demonstrated in our laboratory that highly 
functionalised spirocyclic pyrans can be obtained via the Achmatowicz 
rearrangement of furyl carbinols (Scheme 157).[157]  This methodology, which 
takes advantage of the different rates of reaction for epoxidation and 
nucleophilic addition, has allowed spirocyclic units of different sizes to be 
selectively generated with complete stereocontrol. 
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Scheme 157:  Synthesis of Highly Functionalised Spirocyclic Pyrans via Achmatowicz 
Rearrangement. 
It is thought that the methodology established can be applied to the synthesis of 
both natural and unnatural spirocyclic piperidines beginning from the 
corresponding furfuryl amines (Scheme 158).  Although it had been formerly 
shown that the rearrangement of α-hydroxyfurans could take place in the 
presence of olefins, there were concerns about the rearrangement of α-amino 
furans in the presence of double bonds. 
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Scheme 158:  Proposed Synthesis of Spirocyclic Piperidines from Furfuryl Amines. 
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5.3 Synthesis of the Spirocyclic Core 
5.3.1 Retrosynthetic Analysis 
Before progressing to the commencement of reactions that involved compounds 
that necessitated the incorporation of stereochemistry, the decision was made 
to work with racemic material first, to test procedures and conditions and to 
allow evaluation of the results.  A suitable retrosynthetic analysis was devised 
and is revealed in Scheme 159. 
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Scheme 159:  Retrosynthetic Analysis to Spirocyclic Piperidine Core 470 via a Racemic 
Route. 
Retrosynthetically, spirocyclic compound 470 could be achieved via a Grubbs-
mediated ring-closing metathesis of 471, itself generated from 
diastereoselective allylation of 472 with allyl TMS.  Hemi-aminal 472 is the 
product of the aza-Achmatowicz rearrangement of 473, which is flexible in 
having an alkyl side-chain which can vary in length and nature.  Tosylate 474 
could be generated through nitrogen protection of amine 475, the result of 
conversion from TMS-cyanohydrin 476.  Cyanohydrin 476 can be formed directly 
from 2-furaldehdye or via cyanohydrin 477, itself made from 2-furaldehdye 460.  
The presence of CN as a leaving group allows the introduction of a yet to be 
determined side-chain.  The proposed route is novel, flexible and versatile and 
we aimed to demonstrate improvement over existing methodologies.  Following 
the ring-closing metathesis step there is the opportunity to form spirocyclic 
cores with different ring sizes.  
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5.3.2 Studies Towards the Synthesis of the Spirocyclic Core 
The synthesis began with the commercially available and inexpensive starting 
material, 2-furaldehyde which was treated with 10% aqueous sodium hydrogen 
sulphite solution and 20% sodium cyanide solution.  NaHSO3 is a nucleophile 
which adds to aldehydes to give the bisulfite addition compound 479 via the 
mechanism detailed in Scheme 160.  Nucleophilic attack of the sulphur lone pair 
on the carbonyl group of 460, leaves a positively charged sulphur atom which 
upon proton transfer leads to the bisulfite addition compound 479.  When 
sodium cyanide is added, the formation of the bisulfite compound is reversed.  
Bisulfite then provides the single proton required to re-install the hydroxyl group 
of 484 at the end of the reaction. 
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Scheme 160:  Mechanism for the Formation of Cyanohydrin 484.  Adapted from Reference 
119. 
After 2 hours, the reaction had reached completion, but flash column 
purification proved to be troublesome due to crude product insolubility.  Pre-
adsorption onto silica gel also failed to yield any product.  Modification of the 
work-up isolation allowed normal flash column chromatography to be carried 
out, affording the desired cyanohydrin 484 as a viscous, brown oil in 94% yield 
(Scheme 161).  Protection of the alcohol as its TMS ether (476) using TMSCl 
failed to achieve completion, hence an alternative method was found. 
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Scheme 161:  Synthesis of the Protected Amine.  Reagents and Conditions:  (a) 10% aq. 
NaHSO3, 10% aq. NaCN, 0 oC → rt, 3.5 h, 94%; (b) TMSCl, pyridine, Et2O, 0 oC, 22 h; (c) TMSCN, 
Et3N, 1.5 h, 99%; (d) 2 M NH3, EtOH, 40 oC, 2 h, 61%; (e) TsCl, DMAP, Et3N, CH2Cl2, 0 oC → rt, 18 
h, 12% or BnBr, DMAP, Et3N, CH2Cl2, 0 oC → rt, 16 h, 27%. 
2-Furaldehyde was treated carefully with TMSCN, which showed complete 
conversion after 2 hours.  However, column chromatography proved troublesome 
and no desired product could be retrieved from the column.  The reaction was 
repeated and the crude 1H NMR spectra showed that other than excess 
triethylamine being present, the required product was clean, requiring no 
purification.  The triethylamine was simply evaporated off the residue, yielding 
the TMS cyanohydrin 476 in 99%.  This procedure was advantageous due to the 
fact that the starting aldehyde could be directly transformed into the TMS-
cyanohydrin in one step,[198] avoiding the intermediate cyanohydrin altogether. 
In terms of the mechanism (Scheme 162) the reaction is a nucleophilic addition 
reaction to the carbonyl group.  As the reaction is run with TMSCN, the TMS is 
present in the reaction mixture, which is then able to be attacked by the 
alkoxide 487, to generate the final TMS-cyanohydrin 476. 
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Scheme 162:  Mechanism for the Formation of TMS-Cyanohydrin 476. 
With TMS-cyanohydrin 476 in hand, conversion to the amino cyanohydrin was 
attempted.  Treatment of TMS-cyanohydrin 476 with ammonia in ethanol 
generated amino cyanohydrin 475, with 1H NMR spectroscopy of the crude 
residue showing that no further purification was necessary.  A tosylate 
protecting group was chosen to mono-protect the nitrogen.  It was found by 
Ciufolini[186,197,199] that carbamate protected furfurylamines were unstable and 
readily hydrolysed to 3-hydroxypyridines under typical oxidation conditions.  
Sulphonamide protecting groups don't display this instability and are compatible 
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with the aza-Achmatowicz oxidation reaction.  Amine 475 was treated with tosyl 
chloride and the desired protected compound 485 was isolated in 14% yield.  
Following a published procedure,[200] the crude material was treated to 
precipitate any remaining impurities, affording tosyl amine 485 with only slight 
improvement in purity.  This result was disappointing due to the relative 
simplicity of the reaction and on further attempts at protection with other 
groups similar results were also obtained.  Some improvement was noted when 
using a benzyl ether protection, with mono-benzyl protected 486 isolated in 27% 
yield, a two-fold improvement in yield compared to the tosyl protection.  Boc 
protection and benzoyl mono-protection of amine 475 was unsuccessful in both 
cases.  At this stage it was clear that the protection step was hindering the 
synthesis, certainly insufficient product was always obtained which meant that 
the synthesis could not go forward as first planned.   
Having had no success with the cyanohydrin approach, a new strategy was 
devised to generate the desired furfuryl amine.  It has been reported that 
aldehydes can be aminoallylated using ammonia and allylating agents to give 
homoallylic primary amines with high chemoselectivity (amine vs. alcohol) 
(Scheme 163).[201-203]  This method affords α-amino furan units such as 488, 
while simultaneously incorporating a useful synthetic handle onto which further 
functionality could be added.  This method is also advantageous as it avoids the 
use and handling of cyanide and cyano-containing compounds.   
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Scheme 163:  α-Aminoallylation Using Ammonia. 
Ammonia is a versatile and inexpensive nitrogen source and has been used as a 
nucleophile to incorporate nitrogen into organic molecules.  The α-
aminoalkylation of carbonyl compounds using ammonia has been reported, 
however, low yields have been the norm.  Kobayashi and colleagues utilised the 
potential of ammonia and investigated α-aminoallylation of carbonyl compounds, 
using allylating agents as the carbon nucleophiles.  It was Kobayashi who first 
described the novel three-component reactions of aldehydes, ammonia and 
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allylboronates to yield homoallylic primary amines with high chemo- and stereo-
selectivities (Scheme 164).[201] 
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Scheme 164:  α-Aminoallylation of Aldehydes.   
Kobayashi reported that since solvent has no effect in the reaction outcome, 
ethanol was chosen for its high solubility of ammonia and limited environmental 
impact.  Variations of the allylboronated species also had little effect and 
pinacol allylboronate 489 was selected due to its high stability.  Experimentally, 
Kobayashi found that a large excess of liquid ammonia was necessary to obtain 
high chemoselectivity of amine versus alcohol. 
In subsequent communications Kobayashi reported the use of aqueous ammonia 
for the α-aminoallylation, making it an easy and convenient procedure.[202]  
Although initial results had shown that the use of aqueous ammonia led to a 
decrease in chemoselectivity (84:3 to 80:8, amine vs. alcohol).  The inclusion of 
dodecylbenzenesulfonic acid (DBSA, Figure 34) as an additive was effective in 
improving the chemoselectivity.  Since toluenesulfonic acid demonstrated much 
lower activity, it was thought that the hydrophobic element of DBSA played an 
important role.[202]  Further optimisation by the authors determined that α-
aminoallylations carried out with 10 mol% of DBSA in aqueous ammonia at room 
temperature for 6-12 hours, provided the best yields and selectivity.   
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Figure 34:  Structure of Dodecylbenzenesulfonic acid.  The hydrophobic and acidic elements 
are highlighted. 
In our hands, the α-aminoallylation of 2-furaldehyde turned out to be an 
exceptionally reliable reaction, with identical yields obtained every time the 
reaction was carried out.  The homoallylic amine 490 was reliably obtained in 
55% yield and the matching alcohol side-product 491 in 3% yield (Scheme 165).   
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Scheme 165:  Synthesis of Rearrangement Product 493.  Reagents and Condition:  (a) allyl 
boronic acid pinacol ester, DBSA, 25wt% aq. NH3, rt, 2 h, 55%; (b) TsCl, Et3N, DMAP, CH2Cl2, 0 oC 
→ rt, 18 h, 100%; (c) mCPBA, CH2Cl2, 0 oC → rt, 18 h, 48%. 
Despite the disappointing result with mono-tosylation of amine 475, we were 
optimistic about the chances of success with protection of homoallylic amine 
490.  Treatment of amine 490 with tosyl chloride gave a spot to spot conversion 
to yield tosyl amine 492 in quantitative yield.  NMR spectroscopy confirmed the 
product as being extremely clean and impurity free.   
We were delighted with the successful α-aminoallylation reaction as it meant we 
were now in a strong position to proceed with the pivotal aza-Achmatowicz 
rearrangement.[184]  We were extremely pleased when treatment of tosyl amine 
492 with mCPBA afforded the desired enone 493 in 59% yield.  To our 
knowledge, this is the first example of a successful aza-Achmatowicz 
rearrangement in the presence of an olefin, the mechanism for which is 
demonstrated in Scheme 166.   
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Scheme 166:  Mechanism of Formation of 493 via the aza-Achmatowicz Rearrangement. 
Attempts to optimise the rearrangement yields by using purified mCPBA[204] 
failed to increase the yield of the reaction.  Also, it has been found through 
multiple reactions on similar scales that the yield is not consistent and 
fluctuates between 26% and 48%. 
It was hypothesised that replacing the tosyl group on the amine with an electron 
donating group might improve the overall efficiency of the rearrangement.  
Treatment of amine 490 with benzyl bromide afforded the mono-protected 
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amine 494 in 43% yield, together with 10% of di-benzylated product 495 
(Scheme 167).  Interestingly, aza-Achmatowicz rearrangement of 494 gave dione 
496, rather than the expected enone.  The yield for the transformation was 26%, 
with the product being confirmed by NMR and mass spectrometry. 
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Scheme 167:  Synthesis of Rearrangement Product 496.  Reagents and Conditions:  (a) BnBr, 
Et3N, DMAP, CH2Cl2, 0 oC → rt, 18 h, 43%; (b) mCPBA, CH2Cl2, 0 oC → rt, 19 h, 26%. 
Knowing that the rearrangement was viable without affecting the terminal 
double bond, our attention focused on introducing the functionality at position 
C5 of the furyl ring.  It was envisaged that deprotonation of 492 and addition of 
the appropriate bromoalkene would lead to addition product 497.  The length of 
the chain introduced would dictate the final obtained ring size of product 498, 
following ring-closing metathesis (Scheme 168).  
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Scheme 168:  Formation of 498 via Addition Product 497. 
Hence, tosyl amine 492 was treated with nBuLi for 24 hours before being 
quenched with 6-bromo-1-hexene.  After 24 hours the reaction afforded the 
desired disubstituted furan in 19% yield (48% based on starting material 
consumed).  Unfortunately, despite extensive experimentation, which took into 
account equivalents, reaction times and bases, the reaction yield failed to 
improve. 
Due to these difficulties an alternative route to 497 was explored, whereby the 
C5 side chain would be installed first (→501), followed by the introduction of 
the aldehyde at the C2 position (→500) by deprotonation and trapping with DMF.  
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As shown in Scheme 169, this then sets the molecule up for the reactions that 
have already been performed and shown to work. 
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Scheme 169:  Alternative Route to 497. 
Treatment of furan 453 with nBuLi and quenching with 4-bromo-1-butene 
afforded the desired alkenyl furan 501, n=2 in a disappointing 12% yield after 
purification.  The low yield observed is presumably due to the relative volatility 
of the compound and the fact that two purification procedures were required.  
Similarly, freshly distilled furan was treated with nBuLi and 5-bromo-1-pentene 
to generate alkenyl furan 501, n=3.  A decision was taken not to purify the 
crude residue as the 1H NMR spectrum showed it to be sufficiently clean to be 
taken on to the next step.   
The Bouveault synthesis of aldehydes[205] is well known (Scheme 170) and 
following a procedure reported by Marshall and colleagues,[206] formylation of 
the furfuryl alkene was attempted.  Unfortunately, treatment of alkenes 501 
(n=1 and n=3) with sBuLi and quenching with DMF failed to generate the desired 
aldehydes.  Alternative procedures were explored in the alkenes were treated 
with nBuLi and quenched with ethyl formate.  However, despite repeated 
attempts no product could be detected, with the starting material remaining 
unaffected.   
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Scheme 170:  Bouveault Synthesis of Aldehydes. 
To check that deprotonation was taking place and the effect of the C5 
substituent in the reaction, freshly distilled furan was treated with nBuLi then 
quenched with DMF.  NMR analysis of the crude reaction mixture showed that 2-
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furaldehyde had been formed by the appearance of the characteristic aldehyde 
signal at 9 ppm (together with an unknown side-product).  Likewise, when 
freshly distilled furan was treated with nBuLi and quenched with freshly distilled 
ethyl formate, NMR analysis of the crude product once again showed the 
presence of 2-furaldehyde.  From these particular results it seemed that the 
procedure employed was suitable for the installation of the aldehyde at the C2 
position and perhaps it was the presence of the side chain at C5 that was causing 
the reaction not to proceed.  Additionally, the fact that the material was used 
crude in some cases, may have an impact on the success of the reaction. 
As the main problem seemed to be the addition of the C5 alkenyl chain, a new 
strategy had to be devised which would allow for the effective introduction of 
both side chains (Scheme 171).  In a new approach, the disubstituted furan 497 
originates from the tosyl protection of amine 499, itself a result of α-
aminoallylation of aldehyde 500.  The aldehyde 500 is a product of oxidation of 
primary alcohol 502 which is the result of TBS cleavage of 503.  Silyl ether 503 
is the product of alkenyl chain addition onto 504 which comes from the TBS 
protection of the readily available furfuryl alcohol 505.   
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Scheme 171:  New Retrosynthesis to Furfuryl Compound 497. 
The first step of the synthesis (shown in Scheme 172) is the straightforward TBS 
protection of furfuryl alcohol 505 which was achieved in quantitative yield after 
only 10 minutes, to afford the silyl ether 504.  There was no need for further 
purification. 
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Scheme 172:  Alternative Synthesis of 514.  Reagents and Conditions:  (a) TBDMSCl, imidazole, 
DMF, rt, 10 min, 100%; (b) alkenyl bromide, nBuLi, THF, 0 oC → rt, 18–24 h, 63-91%; (c) HF:Pyr, 
pyridine, THF, rt, 2 h or TBAF, THF, 0 oC → rt, 1.5 h, 30–63%; (d) (COCl)2, DMSO, Et3N, CH2Cl2, –
78 oC → rt, 2 h, 87%; (e) allylboronic acid pinacol ester, DBSA, 25 wt% aq. NH3, rt, 2 h, 76%; (f) 
TsCl, DMAP, Et3N, CH2Cl2, 0 oC → rt, 20 h, 35%. 
The introduction of the C5 alkenyl substituent was attempted using conditions 
which had been successfully employed for the synthesis of 2-(5-(allyl)-
furylmethanol 509.[207]  Hence, TBS ether 504 was treated with nBuLi and 
quenched with freshly distilled allyl bromide.  1H NMR analysis of the crude 
residue showed the formation of a clean product but a short column was 
undertaken to remove the excess silyl product remaining from the protection 
step.  This meant that the desired compound 506 was isolated in an excellent 
91% yield.  Switching the solvent from tetrahydrofuran to diethyl ether resulted 
in an incomplete conversion of starting material to product.  TBAF deprotection 
of the TBS ether proved not as reliable as expected and the desired primary 
alcohol 509 was isolated in 54%.  The addition of 1% triethylamine to the column 
eluent failed to improve the yield.  Switching the fluoride source from TBAF to 
hydrogen fluoride in pyridine was more successful, affording alcohol 509 in 61% 
yield after purification.  Swern oxidation of alcohol 509 afforded the crude 
aldehyde 512 in 87%.  The potential instability of this compound and the clean 
nature of the 1H NMR spectrum, showing the characteristic aldehyde signal at 
9.49 ppm, meant that the product was not purified and taken on crude to the 
next step.  With great satisfaction we now had the alkenyl chain in place at 
position C5 and the aldehyde at the C2 furan position, which left us in prime 
position to perform the α-aminoallylation.  Due to the reliable success of this 
transformation previously, we were confident that the reaction would provide us 
with the correct adduct.  This indeed turned out to be the case, with the 
reaction proceeding smoothly to afford the required amine 513 in 76% yield, 
with no purification required.  Surprisingly, the tosylation of amine 513 only 
gave the required nitrogen protected compound 514 in a mere 35%.  With this 
we could now proceed with the aza-Achmatowicz rearrangement of 514 (Scheme 
173).  In anticipation of the planned synthesis being successful, we synthesised 
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the additional compounds 507 and 508 with varying chain length at the C5 
position.  The TBS ether was removed in each case using TBAF to afford the 
corresponding alcohols 510 and 511 (Scheme 172). 
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Scheme 173:  aza-Achmatowicz Rearrangement of 515. 
A number of different oxidative conditions and methods were attempted, 
including vanadyl acetoacetonate (VO(acac)2),
[208] however, none of them 
yielded the desired product 515.  It was postulated that a possible reason why 
the rearrangement was not working could be due to the multiple double bonds 
present in the molecule.  In order to test this hypothesis, the decision was made 
to remove the double bond on the C2 substituent of 492.  Synthetically, this 
meant reverting back to a modified version of a previously attempted synthesis, 
whereby the C5 substituent is installed and then rearrangement performed.  
Hydrogenation of furan 492 using palladium on carbon was extremely successful, 
giving the required alkane 516 in 99% yield (Scheme 174).  Deprotonation using 
nBuLi and trapping of the resulting lithiate with allyl bromide gave the di-
substituted furan 517 in good yield, together with 44% of unreacted starting 
material.  
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Scheme 174:  Hydrogenation of Furan 492.  Reagents and Conditions:  (a) H2, Pd/C, MeOH, 40 
min, rt, 99%; (b) allyl bromide, nBuLi, THF, 16 h, 0 oC → rt, 66% based on starting material 
consumed; (c) 'oxidative conditions'. 
Unfortunately, the same problems with the rearrangement were encountered, 
with mCPBA, VO(acac)2/
tBuOOH and NBS all failing to promote the desired 
rearrangement to generate spirocyclic piperidine 518.  We were particularly 
disappointed as NBS has been reported to give good yields via a very simple 
procedure.  Although NBS has been successfully used, as the oxidative reagent 
for the Achmatowicz rearrangement, in synthesis by Couladouros[209] and 
O'Doherty,[210,211] their reported conditions were unsuccessful in our hands. 
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Faced with this lack of success, we sought to remove the remaining terminal 
olefin of 517 to discover whether the dialkyl derivative 519 would then be able 
to oxidise successfully.  Hydrogenation of alkene 517 proceeded in 98% yield to 
yield dialkane 519, which was subjected to the oxidative conditions.  Once again 
there was no positive outcome, with no formation of 520.   
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Scheme 175:  Hydrogenation of 517 and attempted aza-Achmatowicz Rearrangement.  
Reagents and Conditions:  (a) H2, Pd/C, MeOH, 45 min, rt, 98%; (b) mCPBA, CH2Cl2, 0 oC → rt. 
Although until this point the assumption had been made that the oxidative 
conditions used were not rearranging our substrates, there was also the 
possibility that the desired aminal might be formed under our conditions, but 
not able to withstand work-up and purification.  For this reason it was decided 
to cap the aminal's hydroxyl group with a methyl unit.  Reactions of this type 
have been demonstrated successfully by Padwa[189], so furyl sulphonamide 517 
was oxidatively rearranged with mCPBA and the crude residue treated with 
trimethyl orthoformate and BF3OEt (Scheme 176).  Unfortunately, TLC analysis 
showed no clear appearance of product 521 and resulted in the eventual 
degradation of all starting material. 
Intriguingly, there are reports of the aza-Achmatowicz oxidative rearrangement 
being performed at elevated temperatures (up to 60 oC).  Following helpful 
discussions with Dr D. P. Furkert[212] a solution of furyl sulphonamide 521 in 
chloroform was treated with mCPBA at 55 oC.  After 6 hours, the starting 
material seemed to have been consumed by TLC, together with the faint 
appearance of a possible product.  Taking precedent from work by Padwa,[190] 
the crude product was treated with allyl trimethylsilane and BF3OEt2.  NMR 
spectroscopy of the crude residue was not conclusive and at this stage time did 
not permit repeated attempts at this transformation as we wished to progress to 
trial supplementary ideas.  This area of investigation is worth revisiting in the 
future with respect to applying efforts towards optimising reaction conditions.    
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Scheme 176:  Additional Rearrangement Studies.  Reagents and Conditions:  (a) mCPBA (2.3 
eq.), CH2Cl2, 0 oC → rt, 2.5 h then mCPBA (1.9 eq.), 2.5 h, rt; (b) (MeO)3CH, BF3·OEt2, CH2Cl2, 0 
oC, 24 h; (c) mCPBA (2.3 eq.), CH2Cl2, 55 oC, 6 h; (d) Allyl TMS, BF3·OEt2, 4Å MS, CH2Cl2, –78 oC 
→ 0 oC → rt, 2.5 h. 
The findings thus far, suggested that the rearrangement proceeded well in the 
presence of the alkenyl chain at the C2 position as long as there were no 
substituents at C5.  Substitution at both C2 and C5 caused the oxidative aza-
Achmatowicz rearrangement to not proceed.  Furthermore, hydrogenation of 
one or both of the terminal olefins did not aid the rearrangement in either case.  
As a result, we contemplated whether the oxidation would come about if the C5 
substitution was in place but the C2 substitution was simplified.  This would 
require the synthesis of the simplified analogue 524 (Scheme 177). 
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Scheme 177:  Retrosynthesis to Rearrangement Product 523 via Simplified Furyl 
Sulfonamide 524. 
Synthetically, furfurylamine 526 was monoprotected in quantitative yield and 
the resulting tosylate 525 was treated sequentially with nBuLi and allyl bromide 
(Scheme 178).  Gratifyingly, allyl furan 524 was obtained in 88% yield, with no 
need for purification.  Treatment of tosyl amine 524 with excess mCPBA 
consumed the starting material, however the 1H NMR showed that no desired 
product 523 was present. 
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Scheme 178:  Synthesis Towards 523.  Reagents and Conditions:  (a) TsCl, DMAP, Et3N, 
CH2Cl2, 0 oC → rt, 1 h, 100%; (b) nBuLi, allyl bromide, THF, 0 oC → rt, 20 h, 88%; (c) mCPBA, 
CH2Cl2, 0 oC → rt; (d) H2, Pd/C, MeOH, 45 min, rt, 92%. 
Out of interest, the terminal olefin was removed using palladium on carbon to 
generate 528 in 92% yield with no column purification needed.  Once again the 
aza-Achmatowicz reaction let us down and the rearrangement product 529 was 
not formed.  Rearrangement of protected amine 525 also failed, with no 
reaction occurring the simple starting material was recovered after work-up.  
Additionally, protected amine 525 was taken and deprotonated at C5 to enable 
the addition of 4-bromo-1-butene to form 530 in 43% yield, which was then 
treated with mCPBA, but again the reaction failed (Scheme 179). 
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Scheme 179:  Attempts with Longer Chain Substituent at C5 Position.  Reagents and 
Conditions:  (a) nBuLi, 4-bromo-1-butene, THF, 0 oC → rt, 20 h, 43%; (b) mCPBA, CH2Cl2, 0 oC → 
rt. 
An attempt was also made with the Boc protected amine (Scheme 180).  
Oxidative rearrangement of Boc protected furfuryl amine 532 with mCPBA also 
caused the starting material to disappear by TLC, although 1H NMR spectra 
showed a mixture of unknown signals. 
O
NH2
O
NHBoc
NBoc
O
OH
a b
526 532 533  
Scheme 180:  Investigation with Boc Protected Amine.  Reagents and Conditions:  (a) (Boc)2O, 
H2O, rt, 40 min, 97%; (b) mCPBA, CH2Cl2, 0 oC → rt. 
Suzannah J. Harnor, 2010  237 
The most interesting set of results were obtained when methyl furfurylamine 
was used as our starting substrate (Scheme 181).  Methyl furfurylamine 534 was 
protected to afford the desired mono-tosylated product 535 in quantitative yield 
after purification.  Tosyl amine 535 was treated with mCPBA under similar 
conditions to those used for all the previous rearrangement attempts.  On this 
occasion we were delighted to see the successful aza-Achmatowicz reaction 
product 536, which was isolated in quantitative yield after work-up.  1H NMR 
analysis showed that no purification was required.  Simultaneously, methyl 
furfurylamine was protected as the Boc amine 537 in quantitative yield.  The 
rearrangement proceeded well by TLC but surprisingly; the product 538 was not 
easily isolated and after work-up NMR spectroscopy showed a significant number 
of additional signals that could not be attributed to any other realistic 
compound.  Due to the great success of the tosylated compound the Boc 
analogue was abandoned. 
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Scheme 181:  Successful aza-Achmatowicz Reactions.  Reagents and Conditions:  (a) TsCl, 
DMAP, Et3N, CH2Cl2, 0 oC → rt, 1 h, 100%; (b) mCPBA, CH2Cl2, 0 oC → rt, 4 h, 100%; (c) (Boc)2O, 
H2O, rt, 40 min, 82%. 
Though we were thrilled with this success, we were intrigued as to why the 
rearrangement would now proceed with presence of a methyl group at C5, when 
it would not proceed with a longer chain or no substituent at all.  To supplement 
our existing knowledge, the same process was executed with 5-
methylfuraldehyde (Scheme 182).   
5-Methylfuraldehyde 539 was subjected to the same α-aminoallylation reaction 
in aqueous ammonia described previously, which provided homoallylic amine 
540 in 77% yield.  Amine 540 was then monoprotected as either the tosyl amine 
541 or Boc amine 543 in 93% yield and 81% yield respectively.   
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Scheme 182:  Reaction with 5-methylfuraldehyde.  Reagents and Conditions:  (a) allyl boronic 
acid pinacol ester, DBSA, 25wt% aq. NH3, rt, 2 h, 77%; (b) TsCl, DMAP, Et3N, CH2Cl2, 0 oC → rt, 1 
h, 93%; (c) mCPBA, CH2Cl2, rt, 40 min, 99%; (d) (Boc)2O, H2O, rt, 30 min, 81%; (e) mCPBA, 
CH2Cl2, rt, 1 h, 88%. 
Treatment of amines 541 and 543 under the same oxidative rearrangement 
conditions led to the clean formation of enones 542 and 544 in 99% yield and 
88% yield respectively, with no need for further purification.  No additional 
products were seen by 1H NMR spectroscopy proved the result, with no need for 
any purification. 
5.4 Efforts Towards the Synthesis of the Tricyclic Core 
of Halichlorine 
5.4.1 Retrosynthetic Analysis 
We envisaged that the results and information gained, as part of the previous 
studies described above, could be utilised to develop a short, concise route to 
the tricyclic core of halichlorine (Figure 35). 
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Figure 35:  Structure of Halichlorine 336.  The tricyclic core is highlighted in red. 
A retrosynthetic route was devised as shown in Scheme 183.  It was hypothesised 
that the basic, initial tricyclic core 545, from which further functionalisation 
could be introduced, is the product of ring-closing metathesis of diene 546.  
Diene 546 was thought of as being a product of treatment of 547 with 
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allylstannane.  Bicyclic structure 547 is generated from the reduction of 
dicarbonyl 548. This dicarbonyl is afforded after removal of the hydroxyl 
function of 549 using triethylsilane and a Lewis acid.  549 is a result of the aza-
Achmatowicz oxidative rearrangement of 550, which in turn is gained from ring-
closing metathesis of diene 551.  Diene 551 could in turn be obtained through 
the protection of previously generated homoallylic amine 490, itself obtained 
via α-aminoallylation of 2-furaldehyde. 
O
NH2
OO
HN
O
HN
O
N
O
O
OH
N
O
O
N
O
NN
545 546 547 548
549 550 551 490  
Scheme 183:  Retrosynthetic Analysis to Tricyclic Core 545. 
5.4.2 Initial Synthetic Investigations 
Our synthesis began with homoallylic amine 490, which was prepared using the 
procedure described previously.  Homoallylic amine 490 was treated with 
acryloyl chloride to generate amide 551 in a non-reproducible 63% yield after 
purification (Scheme 184).  We were surprised that the yield was not higher for 
such a simple transformation, but a minor modification of the reaction 
conditions[213] allowed us to obtain vastly improved and reliable quantitative 
yields. 
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Scheme 184:  Synthesis of Bicyclic Structure 549.  Reagents and Conditions:  (a) allylboronic 
acid pinacol ester, DBSA, 25wt% aq. NH3, rt, 2 h, 55%; (b) CH2=CHCOCl, DIPEA, CH2Cl2, rt, 2 h, 
100%; (c) Grubbs first generation catalyst (10 mol%), CH2Cl2, reflux, 18 h, 84%; (d) mCPBA, 
CHCl3, 60 oC, 3.5 h then rt, 18 h, 70%. 
Ring-closing metathesis of diene 551 using Grubbs first generation catalyst 
afforded lactam 550 in reproducible 76-84% yields.  Disappointingly, aza-
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Achmatowicz rearrangement of 550 failed to generate the desired product 
under a variety of conditions.  We were delighted when the reaction was run 
with mCPBA at 60 oC in chloroform.  In this case, the desired bicyclic lactam 549 
was isolated in 70% yield, together with traces of unreacted starting material 
550.  Unfortunately, this reaction could not be repeated to reproduce the 
successful result and for the most part, no reaction was seen to occur at all.  
Out of interest, to determine the effect of the double bond on the success of the 
reaction, the double bond of 550 was hydrogenated using palladium on activated 
carbon to generate 552 in 70% yield (Scheme 185).  Regrettably, time 
constraints meant that only one attempt was made at the rearrangement to 
form 553 and it was disappointing to see no observed reaction and the starting 
material was recovered. 
O
HN
O
N
O
OOH
ba
O
HN
O
550 552 553  
Scheme 185:  Attempted Rearrangement of 662.  Reagents and Conditions:  (a) H2, Pd/C, 
MeOH, 35 min, rt, 70%; (b) mCPBA, CHCl3. 
5.5 Efforts Towards the Synthesis of the Spirocyclic 
Core of Polymaxenolide 
5.5.1 Retrosynthetic Analysis 
As a result of our continued interest in the synthesis of the spirocyclic cores of 
natural products, we believed that we could utilise our learned knowledge and 
apply it further.  Drawing from our synthetic experience thus far, we wanted to 
establish a route to the spirocyclic unit of polymaxenolide 446 (Figure 36), a 
route that would incorporate the Achmatowicz rearrangement. 
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Figure 36:  Structure of Polymaxenolide 446.  The spirocyclic unit is highlighted in red. 
It was visualised that the spirocyclic unit 447 could be the product of Lewis 
acid-mediated ring-closing of 448, itself a product of the Achmatowicz 
rearrangement of 449 (Scheme 186). Grubbs-mediated cross-metathesis of 
alcohol 450 with allyltrimethylsilane could afford 449, with the alcohol a result 
of the silyl group removal in 451.  The C5 addition of an alkenyl chain of varying 
length to 452 gives 451, while 452 is prepared from the addition of 
isobutyraldehyde to furan 453, followed by silyl protection. 
O
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Scheme 186:  Retrosynthetic Analysis to 447. 
5.5.2 Initial Synthetic Investigations 
The synthesis began with 2-lithiofuran which was trapped with isobutyraldehyde 
to generate the furfuryl alcohol 554 in 96% yield.  Alcohol 554 was then 
protected as its corresponding TBS ether to give the desired protected 
compound 452 in 84% yield. 
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Scheme 187:  Synthesis of Spirocyclic Compound 448.  Reagents and Conditions:  (a) nBuLi, 
TMEDA, isobutyraldehyde, 0 oC → –78 oC, 3 h, 96%; (b) TBDMSCl, DMAP, Et3N, CH2Cl2, rt, 16 h, 
84%; (c) nBuLi, 4-bromo-1-butene, 0 oC → rt, 16 h, 91%; (d) TBAF, THF, 0 oC → rt, 19 h, 81%; (e) 
allyltrimethylsilane, Grubbs second generation catalyst, reflux, 48 h, 52%; (f) VO(acac)2, TBHP, 
CH2Cl2, 0 oC, 2 h, 9 %. 
Deprotonation of 452 at C5 with nBuLi, followed by the addition of 4-bromo-1-
butene enabled the formation of 451 in excellent yield.  Removal of the silyl 
protection group with TBAF then afforded the corresponding secondary alcohol 
450 in 81% yield.  Cross-metathesis of alkene 450 with allyltrimethylsilane in the 
presence of Grubbs second generation catalyst[214] converted the terminal double 
bond into the allylsilane 449 in 52% yield (Entry 2, Table 4).  1H NMR analysis 
showed that 449 was formed as an inseparable mixture of E:Z-isomers (6.15:1).  
The remainder of the yield can be attributed to the formation of the 
homodimer.  Efforts to improve the yield of the cross-metathesis reaction using 
alternative catalysts concluded in mixed results (Table 4). 
Entry Catalyst Conditions Result 
1 Grubbs 1st Gen. (5 mol%) Allyl TMS (3 eq.) 
CH2Cl2, reflux, 48 h 
43% 
2 Grubbs 2nd Gen. (5 mol%) Allyl TMS (3 eq.) 
CH2Cl2, reflux, 48 h 
52% 
3 Hoveyda-Grubbs 2nd Gen. (5 mol%) Allyl TMS (3 eq.) 
CH2Cl2, reflux, 48 h 
27% 
  
Table 4:  Cross-Metathesis of 450 with Allyltrimethylsilane. 
The Achmatowicz rearrangement of alkene 449 was initially attempted with the 
addition of mCPBA in two portions.  Initially, the TLC of the reaction mixture 
gave cause to be optimistic about the success of the reaction, with the 
appearance of a major new spot thought to be the desired rearranged product.  
However, after work-up a second precautionary TLC showed the appearance of 
additional spots, bringing the total number to seven spots, with one being a 
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trace amount of remaining starting material.  The spot thought to be the 
product was still the major spot and FCC was performed to isolate as many as 
possible.  Unfortunately, even though the isolation was successful, 1H NMR 
spectroscopy showed a compound that had clearly degraded.  As an alternative 
oxidising agent, VO(acac)2
[208] was used and this proved to be a significant 
improvement.  TLC anlaysis showed a clean, spot to spot conversion with the 
only other spot being a faint showing at the baseline.  FCC of the residue 
afforded the desired product 448 in 9% yield.  It was postulated that 
degradation may be occurring on the silica column, therefore the feasibility of a 
one-pot, two-step procedure was investigated. 
It was known from TLC analysis that the rearrangement product 448 was being 
formed cleanly as the major product.  It was tentatively thought that filtering 
the reaction through Celite® would not greatly affect the compound.  Therefore, 
a second method was tried in which 448 was not purified but used immediately 
in the second cyclisation procedure (Scheme 188).  With the knowledge that 
VO(acac)2 was the superior oxidising agent for the Achmatowicz rearrangement, 
the same procedure was carried out as described above.  The reaction was 
filtered through Celite® and the solvent was concentrated to approximately 1 
cm3 and then fresh, anhydrous CH2Cl2 added and the solution cooled to —78 
oC.  
The BF3 complex, BF3OEt2, was slowly added and then the stirring continued for 
30 minutes at —78 oC.  Disappointingly, the yield was very low (~1%) and only 1H 
NMR spectroscopy was able to be performed on such a small amount.  Despite 
this, we believe that the desired product was indeed formed and isolated.   
O
O
OH
TMS
O
O
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449 448 447
 
Scheme 188:  One-pot, two-step Procedure.  Reagents and Conditions:  (a) VO(acac)2, TBHP, 
CH2Cl2, 0 oC, 2 h, 9 %; (b) BF3·OEt2, CH2Cl2, –78 oC, 30 min, ~1%. 
Due to time restraints this method was only carried out once, but we believe 
that we have identified a novel route to the spirocyclic structure of 
polymaxenolide 447, incorporating the Achmatowicz rearrangement as the key 
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step.  In addition we consider the one-pot method to be the correct reaction for 
the transformations and reason that further investigation will optimise the yield. 
In addition to carrying out the above investigation into the synthesis of the 
spirocyclic core of polymaxenolide, we simultaneously began the synthesis of the 
additional units that would be needed.  In readiness for the synthesis of 
spirocyclic core units with different ring sizes the appropriate compounds were 
prepared as shown below in Scheme 189, with no difficulties encountered.  Once 
again, an inseparable E:Z-mixture of isomers of allylsilanes 561 and 562 was 
obtained. 
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Scheme 189:  Synthesis of Compounds with Different C5 Substitution.  Reagents and 
Conditions:  (a) nBuLi, allyl bromide, THF, 0 oC → rt, 16 h, 92%; (b) nBuLi, 5-bromo-1-pentene, 
THF, 0 oC → rt, 16 h, 86%; (c) nBuLi, 6-bromo-1-hexene, THF, 0 oC → rt, 16 h, 100%; (d) TBAF, 
THF, 0 oC → rt, 19 h, 87%; (e) TBAF, THF, 0 oC → rt, 19 h, 81%; (f) TBAF, THF, 0 oC → rt, 19 h, 
80%; (g) Grubbs second generation catalyst, allyl TMS, CH2Cl2, reflux, 48 h, 36%; (h) Grubbs 
second generation catalyst, allyl TMS, CH2Cl2, reflux, 48 h, 45%.     
We are encouraged by all of the progress that has been made in the three areas 
of our interest in spirocyclic piperidines and pyrans, but realise that further 
investigation is necessary in each area in order to progress further.  This will 
mostly involve the testing of new reagents and optimisation of reaction 
conditions. 
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5.6 Future Work 
5.6.1 Enantioselective α-Aminoallylation 
The enantioselective synthesis of homoallylic primary amines has been 
reported.[202]  The synthesis is based on asymmetric 2-azonia-Cope 
rearrangement (Scheme 190).  The authors term this transfer aminoallylation as 
"both the amino and the allyl groups are incorporated into the product". 
NH2
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R H
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Scheme 190:  Transfer Aminoallylation. 
α-Aminoketone 564 was readily synthesised from (1R)-camphorquinone 563 in 
80%, with >99% d.e. and then used for the transfer aminoallylation of 2-
furaldehyde (Scheme 191).[202]  The desired optically active amine was obtained 
in 60% yield and 97% e.e..  It would be interesting to carry out this transfer 
aminoallylation on 2-furaldehyde to obtain the primary amine 565, which after 
mono-tosylation (→566) could be subjected to the aza-Achmatowicz 
rearrangement.  This would generate lactone 567. 
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NH3, MeOH
rt, 24 h
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CSA (10 mol%)
DCE, 24 h, 50 oC
then H2NOH.AcOH  
Scheme 191:  Synthesis of α-Aminoketone 564 and Transfer Aminoallylation of 2-
Furaldehyde. 
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5.6.2 Pinnaic Acid 
It has been determined in the studies described that the aza-Achmatowicz 
rearrangement is highly successful for compounds that have either no 
substitution or methyl substitution at position C5.  This holds true for tosyl (or 
Boc) protected compounds with a terminal olefin, produced as a result of an α-
aminoallylation reaction, or for the simpler tosyl protected amine (Figure 37). 
O
NHTs
O
NHTs
O
NHTs
492 541 535  
Figure 37:  C5 Substitution Enabling a Successful aza-Achmatowicz Rearrangement. 
For clarification it is vital that the rearrangement of 514 is further investigated.  
From experience in trying various conditions for a variety of rearrangements, 
there is the belief that from the analysis of TLC's of various reactions, the 
rearrangement may be occurring and it is the work-up that is causing the 
product to be destroyed.  Another possibility is that the product is extremely 
unstable and begins to decompose before it can be properly identified.  In the 
future the solvent should not be evaporated to dryness unless the compound is 
stable.  It was thought that 515 would be stable due to the hemiaminal being 
substituted.  It is also possible that the residue may be undergoing rapid 
decomposition due to the peroxide reacting further with the hemiaminal.   
Therefore, a sensible course of action would be to fully and rigorously 
investigate this particular reaction.  This would involve complete examination 
of: 
Reagents - with care taken to distill/purify any commercial reagents before use 
Equivalents – trialling a range of equivalents from small to large, adding 
equivalents in one portion and/or portionwise 
Temperature – adding reagents at a temperature lower/higher than room 
temperature, changing temperature throughout the course of the reaction, 
heating for prolonged period 
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Time – allowing a reaction to run its course to allow full consumption of starting 
material, seemingly dormant reactions should be left for prolonged periods to 
ensure that they are not just slow running.  Particular care and attention must 
be made to TLC analysis must be made in these cases. 
Following oxidative rearrangement it would be necessary to either: 
Perform work-up - followed by reduction of the reaction solvent to ~1 cm3 and 
then carry out the Lewis acid mediated addition of allyltrimethylsilane to 
generate 522.  The first wash after this reaction would be a sat. aq. 
NaHCO3/NaSO3 to remove any residual peroxide. 
Not perform work-up - followed by reduction of the reaction solvent to ~1 cm3 
and then carry out the Lewis acid mediated addition of allyltrimethylsilane.  The 
first wash after this reaction would be a sat. aq. NaHCO3/NaSO3 to remove any 
residual peroxide. 
If may also be necessary to perform the ring-closing metathesis immediately 
after the Lewis acid mediated addition, with careful work-up and no column 
purification (Scheme 192).  If successful, the procedure could be applied to 
compounds with longer substitution at C5, in order to generate larger ring sizes.  
Appropriate functionalisation could then take place utilising the terminal olefin. 
O
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Scheme 192:  Proposed Three-Step Procedure to 568. 
5.6.3 Halichlorine 
It is difficult to know how to progress with this area in as much as the conditions 
which worked once do not enable a repeat result.  A possibility is to investigate 
an alternative oxidising agent such as dimethyldioxirane (DMDO), which should 
be more reactive than mCPBA.  DMDO is easily generated[215] and used as a 
solution in acetone, with the products being only the oxidised compound and 
acetone.  In 1991, Adger and colleagues reported their use of DMDO for the 
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oxidation of furans.[216]  With 1 equivalent of DMDO in acetone at room 
temperature they were able to successfully oxidise furfuryl alcohol 505 to 2H-
pyran-3(6H)-one 569 and the substituted furfuryl alcohols 570 and 572 to their 
corresponding pyranones 571 and 573 respectively.  No mention of yields is 
made in the publication.  
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Scheme 193:  Oxidation of Furfuryl Alcohol with DMDO.  Reagents and Conditions:  DMDO (1 
eq.) in acetone (0.05 mol dm-3), acetone, rt. 
5.6.4 Polymaxenolide 
There is a desire to further develop the one-pot, two-step reaction sequence in 
order to generate the bicyclic core 447 in higher yield (Scheme 194).  Although 
it has been shown that the Lewis acid, BF3OEt2 is effective to promote the 
cyclisation, there is a wish to perform a Lewis acid screen to test the 
effectiveness of other Lewis acids beginning with:  EtAlCl2, Et2AlCl, SnCl4, 
TiCl3(O
iPr), TiCl2(O
iPr)2 and TiCl(O
iPr)3.  In addition there would be an 
investigation into the effect of temperature on the reaction. 
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Scheme 194:  Generation of 447. 
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6 Experimental 
6.1 General Methods 
All reactions were performed under an inert argon atmosphere unless otherwise 
noted.  Reagents and starting materials were obtained from commercial sources 
and used as received, unless otherwise specified.   
Anhydrous dichloromethane (DCM), diethyl ether, toluene and tetrahydrofuran 
(THF) were freshly obtained from in-house solvent purification system, Pure Solv 
400-5MD (Innovative Technology, Inc).  Anhydrous dimethylformamide (DMF) and 
triethylamine (TEA) were purchased from Aldrich Chemical Company.  Petroleum 
ether refers to that with boiling fraction 40–60 oC.  Solutions worked up were 
concentrated under reduced pressure at < 45 oC using a Buchi Rotavapor. 
Melting points were determined using Stuart Scientific Melting Point SMP1 
apparatus. 
Optical rotations were determined as solutions irradiating with the sodium D line 
(λ = 598 nm) using an AA series automatic polarimeter.  [ ]Dα  values are given in 
units 10-1 deg cm2 g-1. 
Infrared (IR) spectra were recorded as thin films on sodium chloride (NaCl) 
plates using a JASCO FTIR 410 spectrometer.  Only significant absorptions (νmax) 
are reported in wavenumbers (cm-1). 
Proton magnetic resonance spectra (1H NMR) were recorded at 400 MHz using a 
Bruker DPX-400 spectrometer for sample solutions in CDCl3, unless otherwise 
indicated.  Chemical shifts (δH) are reported in parts per million (ppm) and are 
referenced to the residual solvent peak.  The order of citation in parentheses is 
(1) number of equivalent nuclei (by integration) (2) multiplicity (s = singlet, d = 
doublet, t = triplet, q = quartet, qn = quintet, sext. = sextet, oct. = octet, m = 
multiplet, br = broad) (3) coupling constant (J) quoted in Hertz to the nearest 
0.1 Hz and (4) proton assignment.  For relevant compounds, the OH signal was 
identified by D2O exchange. 
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Carbon magnetic resonance spectra (13C NMR) were recorded at 100 MHz using a 
Bruker DPX-400 spectrometer for sample solutions in CDCl3, unless otherwise 
indicated.  Chemical shifts (δC) are quoted in parts per million (ppm) and are 
referenced to the residual solvent peak. 
For convenient 1H and 13C NMR spectroscopy characterisation, furanyl compounds 
have been labelled as shown below: 
O
1
2 3
1 = CHO
2 = CH=CO
3 = CHCO
 
Mass spectra were obtained using a JEOL JMS-700 spectrometer.  
TLC was performed on aluminium backed plates pre-coated with silica gel 60 
(Kieselgel 60 F254 aluminium plates, Merck) with A, petroleum ether-ethyl 
acetate (8:2); B, petroleum ether-ethyl acetate (7:3); C, petroleum ether-ethyl 
acetate (6:4); D, petroleum ether-ethyl acetate (9:1); E, petroleum ether-ethyl 
acetate (9.5:0.5); F, petroleum ether-diethyl ether (9.5:0.5); G, toluene-ethyl 
acetate (8:2); H, petroleum ether-ethyl acetate (2:8); I, petroleum ether-ethyl 
acetate (5:5); J, petroleum ether-ethyl acetate (3:7); K, chloroform-ethyl 
acetate (6:4); L, petroleum ether (10:0); M, petroleum ether-ethyl acetate 
(4:6); N, petroleum ether-diethyl ether (7:3); O, petroleum ether-ethyl acetate 
(2:8); P, petroleum ether-diethyl ether (9:1); Q, hexanes (10:0); R, petroleum 
ether-diethyl ether (8:2); S, petroleum ether-diethyl ether (5:5) as developers 
and detection under UV light (λmax 254 nm) and/or by staining with 
anisaldehyde, unless otherwise specified, followed by heating. 
Flash column chromatography (FCC) was performed using Apollo Scientific silica 
gel 60 (0.040-0.063 mm), with the appropriate eluting solvent and elution 
gradient, shown in square brackets as part of the procedure, e.g. purification by 
FCC [petroleum ether-ethyl acetate (85:15)→(75:25)→(60:40)→(50:50)] of the 
crude residue.... 
The following chemicals were used at the concentrations given, unless otherwise 
stated: 
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• tetra-Butylammonium fluoride (TBAF), 1 M in tetrahydrofuran  
• Oxalyl chloride, 2 M in dichloromethane  
• Ethyl Magnesium Bromide (EtMgBr), 3 M in diethyl ether  
• Potassium bis(trimethylsilyl)amide (KHMDS), 0.5 M in toluene 
• n-Butyllithium (nBuLi), 2.5 M in hexanes. 
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6.2 Synthesis and Characterisation of Compounds 
Furan-2-yl-hydroxy-acetonitrile 477[217] 
O
OH
CN
 
A mixture of 2-furaldehyde (1.00 g, 10.4 mmol) and 10% aqueous NaHSO3 (15.6 
cm3) was stirred in diethyl ether at 0 oC for 1 h.  20% aqueous sodium cyanide 
(4.16 cm3) was added and stirring continued, allowing the reaction to warm to 
room temperature over 2.5 h.  The reaction was diluted with ethyl acetate (30 
cm3) and water (30 cm3) was added.  The phases were separated and the 
aqueous layer extracted with ethyl acetate (3×20 cm3).  The combined organic 
extracts were washed with brine (30 cm3), dried over anhydrous sodium sulfate, 
filtered and concentrated in vacuo.  Purification by FCC [petroleum ether-ethyl 
acetate, (80:20)→(70:30)→(60:40)] of the crude residue gave cyanohydrin 477 
(1.20 g, 94%) as a thick brown oil; Rf 0.71 (solvent C); νmax(film)/cm
-1 3360 (OH) 
and 2252 (C≡N); δH(400 MHz; CDCl3) 5.21 (1 H, s, CHCN), 6.30 (1 H, dd, J 1.9 and 
3.3, CH=CO), 6.48 (1 H, d, J 3.3, CHCO) and 7.40 (1 H, d, J 1.9, CHO).  The 
spectral data matches that reported in the literature.[217] 
Furan-2-yl-trimethylsilanyloxy-acetonitrile 476[198]  
O
OTMS
CN
 
A stirred solution of 2-furaldehyde (2.00 g, 20.8 mmol) in triethylamine (1.45 
cm3, 10.4 mmol) at room temperature was treated by the careful dropwise 
addition of trimethylsilylcyanide (2.86 cm3, 22.8 mmol).  The reaction mixture 
was kept at room temperature for 1.5 h and the triethylamine was then 
evaporated under vacuum to afford TMS ether 476 (4.00 g, 99%) as a thick brown 
oil, with no need for further purification; Rf 0.82 (solvent A, PMBA); 
νmax(film)/cm
-1 2960, 1669 (C=C) and 1394; δH(400 MHz; CDCl3) 0.00 (9 H, s, 
3×CH3), 5.35 (1 H, s, CHCN), 6.20 (1 H, dd, J 1.9 and 3.3, CH=CO), 6.35 (1 H, d, 
J 3.3, CHCO) and 7.25 (1 H, d, J 1.9, CHO); δC(125 MHz; CDCl3) 57.0 (CHCN), 
108.8 (CHCO), 109.7 (CH=CO), 116.9 (CN), 142.7 (CHO) and 147.4 (CO); MS (EI) 
m/z 68.0 [M-C5H9ONSi]
+, 106.0 [M-C3H9OSi]
+, 180.0 [M-N]+; HRMS m/z 195.0715 
(195.0716 calcd for C9H13O2NSi, M
+).  The spectral data matches that reported in 
the literature.[198] 
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Amino-furan-2-yl-acetonitrile 475 
O
NH2
CN
 
Silyl ether 476 (1.50 g, 7.68 mmol) was dissolved in 2 M ammonia in ethanol (4.6 
cm3, 9.22 mmol) at room temperature and the reaction mixture was stirred at 40 
oC for 2 h.  The reaction was quenched with CHCl3 (75 cm
3) and water (75 cm3).  
The phases were separated and the organic layer was acidified with 1 M 
hydrochloric acid (50 cm3).  To the acid layer 2 M sodium hydroxide (200 cm3) 
was added, followed by extraction with chloroform (3×75 cm3).  The organic 
layer was dried over anhydrous sodium sulfate, filtered and concentrated in 
vacuo to give amine 475 (0.58 g, 61%) as a thick brown oil, with no need for 
further purification; Rf 0.12 (solvent B); δH(400 MHz; CDCl3)  1.95 (2 H, br s, 
NH2), 4.90 (1 H, s, CHCN), 6.30 (1 H, dd, J 1.9 and 3.3, CH=CO), 6.40 (1 H, d, J 
3.3, CHCO) and 7.40 (1 H, d, J 1.9, CHO). 
N-(Cyano-furan-2-yl-methyl)-4-methyl-benzenesulfonamide 485[218] 
O
NHTs
CN
 
A solution of amine 475 (50 mg, 0.387 mmol) in anhydrous CH2Cl2 (7 cm
3) at 0 
oC, was treated with triethylamine (0.08 cm3, 0.580 mmol), 
dimethylaminopyridine (14 mg, 0.116 mmol) and p-toluenesulfonyl chloride (111 
mg, 0.580 mmol) successively.  The reaction mixture was warmed to room 
temperature and stirred for 18 h, after which further portions of 
dimethylaminopyridine were added (0.116 mmol then 0.058 mmol) due to the 
slow progress of the reaction.  The reaction was diluted with diethyl ether (10 
cm3) and the organic layer was washed sequentially with water (10 cm3), 
saturated aqueous sodium hydrogen carbonate (10 cm3) and dried over 
anhydrous sodium sulfate.  The solution was filtered and concentrated in vacuo 
to give a crude residue which was purified by FCC [petroleum ether-ethyl 
acetate, (80:20)] to give tosylamine compound 485 (14 mg, 12%) together with a 
non-separable impurity. NMR spectrum shows required product plus impurity); Rf 
0.44 (solvent C); δH(400 MHz; CDCl3) 1.60 (1 H, br s, NH), 2.44 (3 H, s, CH3), 5.23 
(1 H, s, CHCN), 6.52 (1 H, dd, J 1.8 and 3.4, CH=CO),  6.82 (1 H, dd, J 0.7 and 
3.4, CHCO), 7.32 (2 H, d, J 8.4, 2×CH), 7.53 (1 H, dd, J 0.7 and 1.8, CHO) and 
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7.81 (2 H, d, J 8.4, 2×CH).  The spectral data matches that reported in the 
literature.[218] 
Benzylamino-furan-2-yl-acetonitrile 486 
O
NHBn
CN
 
A solution of amine 475 (165 mg, 1.35 mmol) in anhydrous dichloromethane (7 
cm3) was cooled to 0 oC and treated with triethylamine (0.41 cm3, 2.97 mmol) 
and dimethylaminopyridine (99 mg, 0.811 mmol).  The reaction was stirred at 0 
oC for 10 min before the addition of benzyl bromide (0.18 cm3, 1.49 mmol).  The 
solution was kept at 0 oC for 20 min and then was allowed to warm up to room 
temperature.  The reaction was stirred for 16 h and then was diluted with 
dichloromethane (20 cm3).  The layers were separated and the organic layer was 
washed sequentially with water (2×20 cm3), saturated aqueous sodium hydrogen 
carbonate (2×20 cm3), dried over anhydrous sodium sulfate and concentrated in 
vacuo.  Purification of the crude residue by FCC [petroleum ether-ethyl acetate, 
(90:10)→(85:15)] gave the benzyl protected amine 486 (76 mg, 27%); 
νmax(film)/cm
-1 2245 (C≡N), 1608 (C=C) and 1595; δH(400 MHz; CDCl3) 3.50 (2 H, 
s, CH2), 5.02 (1 H, s, CH), 6.18 (1 H, dd, J 1.6 and 3.2, CH=CO), 6.30 (1 H, dd, J 
0.7 and 3.2, CHCO), 7.17-7.35 (5 H, m, ArCH) and 7.60 (1 H, dd, J 0.7 and 1.6, 
CHO); δC(100 MHz; CDCl3) 45.0 (CH2), 49.8 (CH), 106.4 (ArCH), 111.1 (ArCH), 
118.2 (C≡N), 127.1 (PhpCH), 127.5 (2×PhCH), 128.2 (2×PhCH), 141.9 (CH2C), 
139.0 (ArCH) and 152.2 (OC); MS (EI) m/z 213 [M+H]+; HRMS m/z 213.1031 
(213.1028 calcd for C13H13N2O, M+H
+). 
1-Furan-2-yl-but-3-enylamine 490[202]  
O
NH2
 
A mixture of allylboronate pinacol ester (1.17 cm3, 6.24 mmol) and 
dodecylbenzenesulfonic acid (0.17 cm3, 0.520 mmol) in 25 wt% aqueous 
ammonia (10.4 cm3) was stirred at room temperature for 30 min.  To this 
suspension was added 2-furaldehyde (0.43 cm3, 5.20 mmol) and the reaction 
mixture was stirred vigorously at room temperature for 2 h.  The reaction 
mixture was acidified to pH 1-2 with 3 N hydrochloric acid and extracted with 
dichloromethane (3×50 cm3).  The combined organic phases were dried over 
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anhydrous sodium sulfate, filtered and concentrated in vacuo to afford the crude 
alcohol 491 (14.4 mg, 2%); Rf 0.59 (solvent B).  The aqueous layer was basified 
to pH 12-13 with 6 N sodium hydroxide and extracted with dichloromethane 
(3×50 cm3).  The combined organic phases were dried over anhydrous sodium 
sulfate, filtered and concentrated in vacuo to yield amine 490 (392 mg, 55%) as 
an orange oil, with no need for further purification; Rf 0.21 (solvent B); 
νmax(film)/cm
-1 2917, 1640 (C=C), 1438 and 1148; δH(400 MHz; CDCl3) 1.80 (2 H, 
br s, NH2), 2.20-2.30 (1 H, m, CH2), 2.40-2.50 (1 H, m, CH2), 3.85 (1 H, dd, J 5.9 
and 7.2, CHN), 4.90-5.05 (2 H, m, CH=CH2), 5.55-5.70 (1 H, m, CH=CH2), 6.0 (1 
H, dd, J 0.9 and 3.2, CH=CO), 6.15 (1 H, d, J 3.2, CHCO) and 7.20 (1 H, d, J 0.9, 
CHO); δC(100 MHz; CDCl3) 40.9 (CH2), 49.2 (CHNH2), 104.4 (CH=CO), 110.0 
(CHCO), 118.0 (HC=CH2), 134.7 (HC=CH2), 141.3 (CCHN) and 158.5 (CHO); MS (CI) 
m/z 96.97 [M-CH2CH=CH2]
+, 138.11 [M+H]+; HRMS m/z 138.0917 (138.0920 calcd 
for C8H12NO, M+H
+).   
N-(1-Furan-2-yl-but-3-enyl)-4-methyl-benzenesulfonamide 492[219]  
O
NHTs
 
To a solution of allylic amine 490 (100 mg, 0.729 mmol) in anhydrous 
dichloromethane (7 cm3) at 0 oC was added triethylamine (0.22 cm3, 1.60 mmol), 
dimethylaminopyridine (53 mg, 0.437 mmol) and tosyl chloride (210 mg, 1.09 
mmol).  The reaction mixture was stirred at 0 oC for 30 min, then allowed to 
warm to room temperature and was then stirred for a further 18 h.  The reaction 
was diluted with diethyl ether (20 cm3) and the layers were separated.  The 
organic phase was washed with water (2×20 cm3) followed by saturated aqueous 
sodium hydrogen carbonate (2×20 cm3).  The solution was dried over anhydrous 
sodium sulfate, filtered and concentrated in vacuo to afford tosylamine 492 (212 
mg, 100%) as a brown crystalline solid with no need for further purification; Rf 
0.64 (solvent C); mp 83-85 oC (from diethyl ether) (lit.,[219] 86.6-88.6 oC); 
νmax(film)/cm
-1 3272, 1642 (C=C), 1430, 1328, 1158 and 1092; δH(400 MHz; CDCl3) 
2.22 (3 H, s, CH3), 2.28-2.43 (2 H, m, CH2), 4.50 (1 H, q, J 6.8, CHN), 5.02-5.07 
(2 H, m, CH=CH2), 5.53-5.58 (1 H, m, CH=CH2), 5.97 (1 H, d, J 3.2, CHCO), 6.15 
(1 H, dd, J 2.0 and 3.2, CH=CO), 7.17 (1 H, dd, J 0.4 and 2.0, CHO), 7.21 (2 H, d, 
J 8.4, 2×CH) and 7.63 (2 H, d, J 8.4, 2×CH); δC(100 MHz; CDCl3) 21.5 (CH3), 39.0 
(CH2), 50.9 (CHN), 107.1 (CH=CO), 110.0 (CHCO), 119.3 (CH=CH2), 127.0 (CH), 
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129.4 (CH), 132.6 (CH=CH2), 137.5 (CCHN), 141.9 (CHO), 143.1 (C) and 152.8 (C); 
MS (FAB) m/z 292.2 [M+H]+; HRMS m/z 292.1004 (292.1007 calcd for C15H18NO3S, 
M+H+).  Spectral data matches that reported in the literature.[219]   
2-Allyl-6-hydroxy-1-(toluene-4-sulfonyl)-1,6-dihydro-2H-pyridin-3-one 493  
NTs
O
OH  
Homoallylic amine 492 (100 mg, 0.343 mmol) was dissolved in dry 
dichloromethane (1.7 cm3) and cooled to 0 oC before being treated with meta-
chloroperoxybenzoic acid (mCPBA) (84.4 mg, 0.489 mmol).  The reaction was 
stirred at 0 oC for 30 min and then allowed to warm to room temperature where 
it was stirred for 18 h.  The reaction was quenched by stirring with saturated 
aqueous sodium hydrogen carbonate (10 cm3) for 1 h and was then diluted with 
dichloromethane (10 cm3).  The layers were separated and the organic phase 
was washed with saturated aqueous sodium hydrogen carbonate (2×10 cm3), 
water (2×10 cm3) and dried over anhydrous sodium sulfate.  The solvent was 
evaporated in vacuo and FCC of the crude residue [petroleum ether-ethyl 
acetate, (80:20)→(70:30)→(65:35)] afforded hemi-aminal 493 (50.2 mg, 48%; 
59% based on starting material consumed) as a yellow oil; Rf 0.39 (solvent C); 
νmax(film)/cm
-1 3460 (OH), 2926, 1687, 1332, 1161, 1033 and 729; δH(400 MHz; 
CDCl3) 2.30 (3 H, s, CH3), 2.51-2.60 (1 H, m, CH2), 2.66-2.75 (1 H, m, CH2), 3.40 
(1 H, d, J 4.5, OH), 4.35 (1 H, t, J 7.4, CH(N)), 5.00-5.10 (2 H, m, CH=CH2), 5.71-
5.82 (1 H, m, CH=CH2), 5.77 (1 H, s, CH(OH)), 5.88 (1 H, dd, J 1.2 and 10.4, 
CH=CH), 6.70 (1 H, dd, J 4.4 and 10.4, CH=CH), 7.20 (2 H, d, J 6.6, 2×CH) and 
7.50 (2 H, d, J 6.6, 2×CH); δC(100 MHz; CDCl3) 21.5 (CH3), 40.0 (CH2), 61.0 
(CH(N)), 73.4 (CH(OH)), 118.9 (CH=CH2), 126.7 (2×CH), 126.8 (CH=CH), 130.1 
(2×CH), 133.2 (CH=CH2), 136.6 (C), 143.0 (CH=CH), 144.3 (C) and 193.6 (C=O); 
MS (CI) m/z 290.3 [M-OH]+, 308.3 [M+H]+; HRMS m/z 308.0959 (308.0956 calcd 
for C15H18NO4S, M+H
+). 
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Benzyl-(1-furan-2-yl-but-3-enyl)-amine 494[220] 
O
NHBn
 
A mixture of homoallylic amine 490 (100 mg, 0.728 mmol), 
dimethylaminopyridine (53.4 mg, 0.437 mmol) and triethylamine (0.32 cm3, 2.33 
mmol) in anhydrous dichloromethane (7 cm3) was stirred at 0 oC for 30 min 
before being treated with benzyl bromide (0.13 cm3, 1.12 mmol).  The reaction 
mixture was then allowed to warm to room temperature and was stirred for a 
further 18 h.  The reaction was quenched with water (10 cm3).  The organic 
layer was separated, dried over anhydrous sodium sulfate, filtered and 
concentrated in vacuo.  Purification by FCC [petroleum ether-ethyl acetate 
(90:10)→(85:15)] of the crude residue afforded benzyl amine 494 (71 mg, 43%); 
Rf 0.57 (solvent B); νmax(film)/cm
-1 908 and 734; δH(400 MHz; CDCl3) 1.65 (1 H, br 
s, NH), 2.42-2.50 (2 H, m, CH2), 3.52 (2 H, d, J 13.2, CH2Ph), 3.66-3.69 (1 H, m, 
CHN), 4.92-5.04 (2 H, m, CH=CH2), 5.57-5.70 (1 H, m, CH=CH2), 6.09 (1 H, d, J 
3.1, CH=CO), 6.24 (1 H, dd, J 1.8 and 3.1, CHCO), 7.11-7.25 (5 H, m, Ph) and 
7.31 (1 H, dd, J 0.5 and 1.8, CHO); MS (CI) m/z 228.20 [M+H]+; HRMS m/z 
228.1394 (228.1389 calcd for C15H18NO, M+H
+).  Spectral data matches that 
reported in the literature.[220] 
O
BnN
Bn
 
The di-protected compound 495 was also isolated (16 mg, 10%); Rf 0.83 (solvent 
B); δH(400 MHz; CDCl3) 2.47-2.52 (1 H, m, CH2), 2.50-2.55 (1 H, m, CH2), 3.01 (2 
H, d, J 13.9, CH2Ph), 3.55-3.59 (3 H, m, CHN and CH2Ph), 4.88-4.97 (2 H, m, 
CH=CH2), 5.60-5.73 (1 H, m, CH=CH2), 6.07 (1 H, d, J 3.1, CH=CO), 6.30 (1 H, dd, 
J 1.9 and 3.1, CHCO), 7.40 (1 H, d, J 1.9, CHO) and 7.01-7.35 (10 H, m, 2×Ph). 
6-Allyl-1-benzyl-1,6-dihydropyridine-2,5-dione 496 
NBn
O
O  
meta-Chloroperoxybenzoic acid (mCPBA) (76 mg, 0.338 mmol) was added to a 0 
oC solution of amine 494 (70 mg, 0.307 mmol) in anhydrous dichloromethane 
(1.5 cm3).  The reaction was stirred at 0 oC for 30 min before allowing it to warm 
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up to room temperature and stirring overnight.  The reaction was then diluted 
with dichloromethane (5 cm3) and quenched with saturated aqueous sodium 
hydrogen carbonate (5 cm3).  The organic layer was separated and was washed 
sequentially with saturated aqueous sodium hydrogen carbonate (2×10 cm
3) and 
water (10 cm3).  The solution was dried over anhydrous sodium sulfate, filtered 
and concentrated in vacuo.  Purification by  FCC [petroleum ether-ethyl acetate 
(90:10)→(85:15)→(80:20)→(70:30)] of the crude residue afforded benzyl 
protected dione 496 (19.4 mg, 26%); Rf 0.34 (solvent B); νmax(film)/cm
-1 2924, 
1643, 1456, 1296, 1139, 1010 and 733; δH(400 MHz; CDCl3) 2.82-2.89 (1 H, m, 
CH2), 3.20-3.29 (1 H, m, CH2), 5.04 (1 H, t, J 7.5, CH(N)), 5.11 (1 H, br d, J 10.3, 
CH=CH2), 5.25 (1 H, dd, J 1.4 and 17.1, CH=CH2), 5.79 (1 H, ddt, J 7.5, 10.3 and 
17.1, CH=CH2), 6.40 (1 H, dd, J 1.8 and 3.2, CH=CHCO), 6.56 (1 H, d, J 3.2, 
CH=CH(CO)), 7.38-7.45 (5 H, m, Ph) and 8.21-8.23 (2 H, m, CH2Ph); δC(100 MHz; 
CDCl3) 29.7 (CH2CH=CH2), 35.1 (CH2Ph), 73.3 (HCN), 119.0 (CH=CH2), 128.5 
(2× CH(Ph)), 128.8 (2× CH(Ph)), 130.3 (C(Ph), 130.5 (CH(Ph), 132.7 (CH=CH), 
133.7 (CH=CH2), 143.1 (CH=CH), 149.8 (O=C-N) and 191.0 (C=O); MS (CI) m/z 242 
[M+H]+; HRMS m/z 242.1179 (242.1181 calcd for C15H16NO2, M+H
+). 
N-[1-(5-But-3-enyl-furan-2-yl)-but-3-enyl]-4-methyl-benzensulfonamide 497, 
(n=2)  
O
NHTs
n
 
Procedure A 
A solution of tosyl amine 492 (126 mg, 0.432 mmol) in anhydrous 
tetrahydrofuran (2.2 cm3) was cooled to —20 oC and nBuLi (0.18 cm3, 0.454 
mmol) was slowly added.  The solution was stirred for 30 min at —20 oC before 
being cooled to —78 oC.  The reaction was stirred for 45 min before being 
treated with tBuLi (1.7 M in pentane, 0.28 cm3, 0.475 mmol) and the resulting 
reaction was stirred at —78 oC for 1 h.  The reaction was warmed up to —20 oC 
and was then treated with 4-bromo-1-butene (0.06 cm3, 0.562 mmol).  After 1 h 
at —20 oC, the reaction mixture was warmed to 0 oC and then room temperature 
where it was left to stir for 48 h.  The reaction was quenched by being pouring 
onto ice (20 cm3) and diluting with diethyl ether (10 cm3).  The phases were 
separated and the organic layer was washed with water (2×10 cm3), saturated 
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aqueous sodium chloride (2×10 cm3) and dried over anhydrous sodium sulfate.  
The solvent was evaporated in vacuo and the crude residue was purified by FCC 
[petroleum ether-ethyl acetate (90:10→85:15→80:20)] to yield diene 497, n=2 
(20.6 mg, 17%) as a yellow oil; Rf 0.60 (solvent A); νmax(film)/cm
-1 2935, 1350, 
1171 and 1020; δH(400 MHz; CDCl3) 1.82-1.95 (1 H, m, CH2CH2), 2.10-2.20 (1 H, 
m, CH2CH2), 2.35 (3 H, s, CH3), 2.48-2.52 (1 H, m, CH2CH=CH2), 2.64-2.70 (1 H, 
m, CH2CH=CH2), 2.96-3.04 (2 H, m, CH2CH2), 4.72-5.07  (5 H, m, 2×CH=CH2 and 
CHN), 5.47-5.70 (2 H, m, 2×CH=CH2), 6.01 (1 H, d, J 3.2, CH=CO), 6.20 (1 H, d, J 
3.2, CHCO) and 7.20 (2 H, d, J 8.2, 2×CH) and 7.65 (2 H, d, J 8.2, 2×CH); δC(100 
MHz; CDCl3) 22.7 (CH3), 27.7 (H2C=CHCH2CH2), 29.1 (H2C=CHCH2), 41.4 
(CH2CH=CH2), 55.1 (HCNH), 108.9 (2×CH), 117.8 (2×H2C=CH), 127.4 (2×PhCH), 
129.4 (2×PhCH), 134.2 (CH=CH2), 136.7 (CCH3), 138.5 (H2C=CH), 140.5 (SO2C), 
147.8 (CCHNH) and 151.0 (H2C=CH(CH2)2C); MS (CI) m/z 346.2 [M+H]
+; HRMS m/z 
346.1480 (346.1477 calcd for C19H24NO3S, M+H
+). 
Procedure B 
 A solution of homoallylic amine 492 (112 mg, 0.384 mmol) in anhydrous 
tetrahydrofuran (2.0 cm3) was cooled to —20 oC and nBuLi (0.16 cm3, 403 µmol) 
was slowly added.  The solution was stirred for 30 min at —20 oC and then tBuLi 
(1.7 M in pentane, 0.25 cm3, 0.422 mmol) was added. The reaction was stirred 
at —20 oC for 1 h and then warmed to 0 oC before 4-bromo-1-butene (50 µL, 
0.499 mmol) was added.  After 1 h at 0 oC the reaction mixture was warmed to 
room temperature and stirred for 48 h.  The reaction was quenched by pouring 
onto ice (20 cm3) and diluting with diethyl ether (10 cm3).  The phases were 
separated and the organic layer was washed with water (2×10 cm3) and 
saturated aqueous sodium chloride (2×10 cm3).  The organic solution was dried 
over anhydrous sodium sulfate, filtered and concentrated in vacuo.  Purification 
by FCC [petroleum ether-ethyl acetate (90:10→85:15→80:20)] of the crude 
residue yielded 497, n=2 (11.3 mg, 9%) as a yellow oil; Rf 0.68 (solvent A).  The 
spectroscopic data obtained matches that for Procedure A. 
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N-[1-(5-Hex-5-enyl-furan-2-yl)-but-3-enyl]-4-methyl-benzenesulfonamide 
497, n=4  
O
NHTs
n
 
A solution of homoallylic amine 492 (106 mg, 0.363 mmol) in anhydrous THF (1.8 
cm3) was treated with nBuLi (0.15 cm3, 0.363 mmol) at room temperature and 
the resulting solution was stirred for 24 h.  6-Bromo-1-hexene (0.049 cm3, 0.363 
mmol) was then added and the reaction mixture was stirred for a further 24 h.  
The reaction was quenched by pouring onto ice (20 cm3) and diluting with 
diethyl ether (20 cm3).  The phases were separated and the organic layer was 
washed with water (2×10 cm3) and saturated aqueous sodium chloride (2×10 
cm3).  The solution was dried over anhydrous sodium chloride, filtered and 
concentrated in vacuo.  Purification by FCC [petroleum ether-ethyl acetate, 
(90:10)→(80:20)] of the crude residue gave diene 497, n=4 (25.5 mg, 19%; 48% 
based on starting material consumed); Rf 0.65 (solvent B); νmax(film)/cm
-1 2937, 
1346, 1173 and 1020; δH(400 MHz; CDCl3) 1.00-1.50 (8 H, m, 4×CH2), 1.70-2.01 
(2 H, m, CHNCH2), 2.34 (3 H, s, CH3), 4.05 (1 H, q, J 7.1, CHN), 4.58-5.0 (4 H, m, 
2×CH=CH2), 5.56-5.58 (2 H, m, 2×CH=CH2), 6.00 (1 H, d, J 3.2, CH=CO), 6.17 (1 
H, dd, J 1.6 and 3.2, CHCO), 7.20 (2 H, d, J 8.2, 2×CH) and 7.66 (2 H, d, J 8.2, 
2×CH); δC(100 MHz; CDCl3) 22.6 (CH3), 27.7 (H2C=CHCH2CH2CH2CH2), 27.9 
(H2C=CHCH2CH2CH2CH2), 28.5 (H2C=CHCH2CH2CH2CH2), 29.1 
(H2C=CHCH2CH2CH2CH2), 41.3 (CH2CH=CH2), 55.1 (HCNH), 108.9 (2×CH), 117.6 
(2×H2C=CH), 127.4 (2×PhCH), 129.4 (2×PhCH), 134.3 (CH=CH2), 136.9 (CCH3), 
138.4 (H2C=CH), 140.5 (SO2C), 147.8 (CCHNH) and 151.1 (H2C=CH(CH2)2C); MS 
(CI) m/z 374.1 [M+H]+; HRMS 374.1786 (374.1790 calcd for C21H28NO3S, M+H
+). 
tert-Butyl-(furan-2-ylmethoxy)-dimethyl-silane 504[207] 
O
OTBS
 
To anhydrous dimethylformamide (10 cm3) was added furfuryl alcohol 505 (1.00 
g, 10.1 mmol) at room temperature and the resulting solution was stirred for 10 
min.  Imidazole (2.08 g, 30.5 mmol) was then added and the mixture stirred 
until clear.  tert-Butyldimethylsilyl chloride (2.30 g, 15.2 mmol) was added, with 
TLC analysis showing that the reaction was complete after 10 min.  The mixture 
was diluted with diethyl ether (35 cm3) and quenched with water (50 cm3).  The 
organic layer was washed with water (4×100 cm3), dried over anhydrous sodium 
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sulphate, filtered and concentrated in vacuo, to afford silyl ether 504 (1.59 g, 
74%) as a colourless oil with no further purification, although excess, inseparable 
Si signals are seen in the NMR spectrum which equate to 570 mg, 26% of the 
obtained total mass of 2.16 g; Rf 0.80 (solvent B); δH(400 MHz; CDCl3) 0.00 (6 H, 
s, Si(CH3)2), 0.83 (9 H, s, SiC(CH3)3), 4.56 (2 H, s, CH2), 6.14 (1 H, d, J 3.1 Hz, 
CH=CO), 6.23 (1 H, dd, J 1.8 and 3.1, CHCO) and 7.28 (1 H, d, J 1.8, CHO).  The 
spectral data matches that reported in the literature.[207] 
(5-Allyl-furan-2-ylmethoxy)-tert-butyl-dimethyl-silane 506  
O
OTBS
 
A solution of crude silyl ether 504 (1.00 g, 4.70 mmol) in anhydrous 
tetrahydrofuran (23.5 cm3) was stirred for 10 min before being cooled down to 0 
oC and treated with nBuLi (2.25 cm3, 5.17 mmol).  The resulting mixture was 
stirred at 0 oC for 15 min and then it was allowed to warm up to room 
temperature.  The reaction was stirred at room temperature for 15 min and then 
cooled back down to 0 oC, where it was stirred for a further 15 min.  Freshly 
distilled allyl bromide (0.49 cm3, 5.65 mmol) was then added and the reaction 
allowed to warm up to room temperature.  After 18 h, the reaction mixture was 
diluted with diethyl ether (20 cm3) and quenched with water (30 cm3).  The 
layers were separated and the organic phase was dried over anhydrous sodium 
sulphate, filtered and concentrated in vacuo to afford diene 506 (1.07 g, 91%) 
with no need for further purification; Rf 0.66 (solvent F); νmax(film)/cm
-1 2929, 
2858, 1255 and 1078 (O-Si); δH(400 MHz; CDCl3) 0.00 (6 H, s, Si(CH3)2), 0.81 (9 H, 
s, SiC(CH3)3), 3.30 (2 H, dd, J 1.0 and 6.6, CH2CH=CH2), 4.51 (2 H, s, CH2), 5.02-
5.08 (2 H, m, CH=CH2), 5.79-5.90 (2 H, m, CH=CH2 and CH=CO) and 6.07 (1 H, d, 
J 3.1, CHCO); δC(100 MHz; CDCl3) -5.2 (Si(CH3)2), 18.4 (SiC(CH3)3), 25.8 
(SiC(CH3)3), 32.7 (CH2), 58.2 (CH2OTBS), 106.1 (CH), 108.1 (CH), 116.8 (H2C=CH), 
134.0 (H2C=CH), 152.0 (CO) and 154.0 (CCH2OTBS); MS (EI) m/z 121 [M-OTBS]
+; 
HRMS m/z 121.0656 (121.0653 calcd for C8H9O, M-OTBS
+). 
2-(5-Allyl)furyl methanol 509[207] 
O
OH
 
A solution of TBS ether 506 (2.73 g, 9.73 mmol) in anhydrous tetrahydrofuran 
(45 cm3) and pyridine (20 cm3) was treated with hydrogen fluoride in pyridine 
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(10 cm3) and the reaction stirred for 2 h at room temperature.  The reaction was 
quenched by the careful addition of saturated aqueous sodium hydrogen 
carbonate (350 cm3) with vigorous stirring.  The mixture was stirred until the 
fizzing had subsided.  After a further precautionary 30 min stirring, the reaction 
mixture was extracted with dichloromethane (2×70 cm3) and the combined 
organic layers washed with water (100 cm3), dried over anhydrous sodium 
sulphate, filtered and concentrated in vacuo.  Pyridine was azeotroped from the 
crude residue with toluene (3×10 cm3).  Purification by FCC of the crude residue 
[petroleum ether-ethyl acetate (85:15)] afforded alcohol 509 (0.812 g, 61%) as a 
yellow oil; Rf 0.13 (solvent A), δH(400 MHz; CDCl3) 2.00 (1 H, br s, OH), 3.42 (2 
H, dd, J 0.7 and 6.6, CH2CH=CH2), 4.58 (2 H, s, CH2), 5.12-5.22 (2 H, m, 
CH=CH2), 5.89-6.03 (2 H, m, CH=CH2 and CH=CO) and 6.20 (1 H, d, J 3.1, CHCO); 
MS(EI) m/z 138.1 [M]+, 121.1 [M-OH]+, 107.1 [M-CH2OH]
+; HRMS m/z 138.0685 
(138.0681 calcd for C8H10O2).  The spectral data matches that reported in the 
literature.[207] 
5-Allyl-furan-2-carbaldehyde 512[221] 
O
H
O
 
To a —78 oC solution of oxalyl chloride (0.17 cm3, 2.00 mmol) in dry 
dichloromethane (10 cm3) was added a solution of dimethylsulfoxide (0.28 cm3, 
4.00 mmol) in dichloromethane (1 cm3).  After 20 min at —78 oC, a solution of 
alcohol 509 (184.4 mg, 1.33 mmol) in dichloromethane (6.7 cm3) was added and 
the reaction was stirred at —78 oC for a further 1 h, whereafter triethylamine 
(0.93 cm3, 6.67 mmol) was added.  The reaction was warmed up to 0 oC and 
stirred for 30 min.  The reaction was then diluted with dichloromethane (10 cm3) 
and treated with 1 M hydrochloric acid (10 cm3).  The layers were separated and 
the organic layer was washed sequentially with saturated aqueous sodium 
chloride (20 cm3) and saturated aqueous sodium hydrogen carbonate (20 cm3).  
The solution was dried over anhydrous sodium sulphate, filtered and 
concentrated in vacuo to afford aldehyde 512 (158.3 mg, 87%) as a brown oil 
with no further purification carried out; Rf 0.69 (solvent C); δH(400 MHz; CDCl3) 
3.32 (2 H, d, J 7.2, CH2), 5.09-5.12 (2 H, m, CH2=CH), 5.82-5.90 (1 H, m, 
CH2=CH), 5.92 (1 H, d, J 3.3, CH=CO), 6.21 (1 H, d, J 3.3, CHCO) and 9.49 (1 H, 
s, CHO).  The spectral data matches that reported in the literature.[221] 
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1-(5-Allyl-furan-2-yl)-but-3-enylamine 513  
O
NH2
 
A mixture of allylboronic acid pinacol ester (0.14 cm3, 0.759 mmol) and 
dodecylbenzenesulfonic acid (20 µL, 63.2 µmol) in 25 wt% ammonia (1.3 cm3) 
was stirred at room temperature for 30 min before aldehyde 512 (86.2 mg, 
0.632 mmol) was added.  After stirring for 2 h, the reaction mixture was 
acidified to pH 1-2 with 3 N hydrochloric acid and extracted with 
dichloromethane (3×20 cm3).  The combined organic layers were dried over 
anhydrous sodium sulphate, filtered and concentrated in vacuo to afford the 
crude alcohol; Rf 0.84 (solvent B).  The aqueous layer was basified to pH 12-13 
with 6 N sodium hydroxide and extracted with dichloromethane (3×20 cm3).  
The combined organic layers were dried over anhydrous sodium sulphate, 
filtered and concentrated in vacuo to afford homoallylic amine 513 (86.1 mg, 
76%) as a pale yellow oil with no further purification required; Rf 0.09 (solvent 
B); νmax(film)/cm
-1 2999, 2931 and 1029; δH(400 MHz; CDCl3) 1.90 (2 H, br s, 
NH2), 2.29-2.35 (1 H, m, CH(NH2)CH2), 2.48-2.52 (1 H, m, CH(NH2)CH2), 3.28 (2 
H, d, J 6.5, CH2), 3.88 (1 H, dd, J 5.6 and 7.6, CHN), 5.00-5.11 (4 H, m, 
2×CH=CH2), 5.65-5.72 (1 H, m, CH(NH2)CH2CH=CH2), 5.81-5.91 (1 H, m, CH=CH2), 
5.85 (1 H, d, J 3.0, CH=CO) and 5.96 (1 H, d, J 3.0, CHCO); δC(100 MHz; CDCl3) 
29.1 (H2C=CHCH2), 41.0 (CH2), 49.3 (CHNH2), 104.4 (CH=CO), 110.0 (CHCO), 
118.0 (2×HC=CH2), 134.6 (2×HC=CH2), 141.5 (CCHN) and 158.5 (CHO); MS (CI) 
m/z 178 [M+H]+; HRMS m/z 178.1235 (178.1232 calcd for C11H16NO, M+H
+). 
N-[1-(5-Allyl-furan-2-yl)-but-3-enyl]-4-methyl-benzenesulfonamide 514  
O
NHTs
 
A solution of homoallylic amine 513 (26.5 mg, 0.149 mmol) in dry 
dichloromethane (1 cm3) was stirred at 0 oC for 30 min before triethylamine 
(0.05 cm3, 0.328 mmol), dimethylaminopyridine (11 mg, 0.0897 mmol) and p-
toluenesulfonyl chloride (43 mg, 0.224 mmol) were sequentially added.  After 30 
min at 0 oC, the reaction was allowed to warm up to room temperature and 
stirred overnight.  The reaction mixture was diluted with diethyl ether (5 cm3) 
and H2O (10 cm
3) and the layers separated.  The organic layer was washed with 
water (2×10 cm3), saturated aqueous sodium hydrogen carbonate (2×10 cm3) 
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and dried over anhydrous sodium sulphate.  The solution was concentrated in 
vacuo to afford crude tosylate 514 (17.4 mg, 35%) with no further purification 
carried out; Rf 0.78 (solvent C); νmax(film)/cm
-1 2926, 1371, 1172 and 1010; 
δH(400 MHz; CDCl3) 2.35 (3 H, s, CH3), 2.50-2.60 (1 H, m, CH(NHTs)CH2), 2.63-
2.72 (1 H, m, CH(NHTs)CH2), 3.50 (1 H, dd, J 7.1 and 16.4, H2C=CHCH2), 3.71 (1 
H, dd, J 5.4 and 16.4, H2C=CHCH2), 4.88-5.09 (5 H, m, CH=CH2, CH2=CH, 
HC(NHTs)), 5.47-5.57 (1 H, m, CH2=CHCH2), 5.60-5.72 (1 H, m, 
(NHTs)CH2CH=CH2), 6.02 (1 H, dd, J 0.6 and 3.2, CH=CO), 6.17 (1 H, dd, J 1.8 
and 3.2, CHCO), 7.18 (2 H, d, J 8.3, 2×CH) and 7.64 (2 H, d, J 8.3, 2×CH); 
δC(100 MHz; CDCl3) 21.4 (CH3), 29.5 (H2C=CHCH2), 39.0 (CH2), 51.0 (CHN), 107.3 
(CH=CO), 110.0 (CHCO), 119.3 (CH=CH2), 118.5 (H2C=CH), 127.0 (CH), 129.4 
(CH), 132.8 (CH=CH2), 133.9 (H2C=CH), 137.5 (CCHN), 141.9 (CHO), 143.1 (C) and 
152.8 (C)  MS (CI) m/z 332.2 [M+H]+; HRMS m/z 332.1323 (332.1321 calcd for 
C18H22O3NS, M+H
+).    
tert-Butyl-dimethyl-(5-pent-4-enyl-furan-2-ylmethoxy)-silane 507 
O
OTBS
 
A solution of furan 504 (322.2 mg, 1.52 mmol) in anhydrous tetrahydrofuran (8 
cm3) at 0 oC was treated with nBuLi (0.73 cm3, 1.67 mmol).  After 15 min at 0 oC 
the reaction mixture was allowed to warm to room temperature where it was 
stirred for a further 15 min.  The solution was recooled to 0 oC and 5-bromo-1-
pentene (0.22 cm3, 1.82 mmol) was added.  After 15 min at 0 oC, the reaction 
mixture was allowed to warm up to room temperature and stirred for 18 hours.  
The reaction was diluted with diethyl ether (10 cm3) and partitioned with water 
(10 cm3).  The layers were separated and the organic layer was dried over 
anhydrous sodium sulphate, filtered and concentrated in vacuo to afford alkene 
507 (337 mg, 79%) as an oil; Rf 0.72 (solvent F); νmax(film)/cm
-1 2929, 2858, 
1701, 1253 and 1078 (O-Si); δH(400 MHz; CDCl3) 0.02 (6 H, s, Si(CH3)2), 0.83 (9 H, 
s, SiC(CH3)3), 1.63-1.66 (2 H, m, CH2CH2CH2), 2.05-2.10 (2 H, m, CH2CH2CH2), 
2.54-2.56 (2 H, m, CH2CH2CH2), 4.51 (2 H, s, CH2OTBS), 4.90-4.99 (2 H, m, 
CH2=CH), 5.70-5.75 (1 H, m, CH2=CH), 5.80 (1 H, d, J 3.0, CH=CO) and 6.02 (1 H, 
d, J 3.0, CHCO); δC(100 MHz; CDCl3) -5.9 (Si(CH3)2), 17.9 (SiC(CH3)3), 25.8 
(SiC(CH3)3), 27.1 (CH2CH2CH2), 28.9 (CH2CH2CH2), 37.2 (CH2CH2CH2), 60.7 
(CH2OTBS), 106.6 (HC), 109.6 (HC), 115.0 (H2C=CH), 137.6 (H2C=CH), 152.2 
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(CCH2OH) and 156.5 (C); MS (CI) m/z 149.1 [M-OTBS]
+; HRMS m/z 149.0965 
(149.0966 calcd for C10H13O, M-OTBS
+). 
(5-Pent-4-enyl-furan-2-yl)-methanol 510 
O
OH
 
A 0 oC solution of silyl ether 507 (337 mg, 1.20 mmol) in tetrahydrofuran (10 
cm3) was added tetra-butylammonium fluoride (2.4 cm3, 2.40 mmol) and the 
reaction was stirred at 0 oC for 15 min before allowing it to warm up to room 
temperature.  After 1.5 h at room temperature the reaction mixture was diluted 
with diethyl ether (20 cm3) and quenched with water (20 cm3).  The organic 
layer was separated, dried over anhydrous sodium sulphate, filtered and 
concentrated in vacuo.  Purification by FCC [petroleum ether-ethyl acetate 
(80:20)→(75:25)] of the crude residue afforded alcohol 510  (60.4 mg, 30%) as a 
yellow oil; Rf 0.09 (solvent F); νmax(film)/cm
-1 3470 (OH), 2852, 1260; δH(400 
MHz; CDCl3) 1.71-1.80 (2 H, m, CH2CH2CH2), 2.13-2.20 (2 H, m, CH2CH2CH2),  
2.65 (2 H, t, J 7.6, CH2CH2CH2), 4.59 (2 H, d, J 5.8, CH2OH), 5.00-5.07 (2 H, m, 
CH2=CH), 5.80-5.89 (1 H, m, CH2=CH), 5.95 (1 H, d, J 3.0, CH=CO) and 6.21 (1 H, 
d, J 3.0, CHCO); δC(100 MHz; CDCl3) 27.1 (CH2CH2CH2), 27.5 (CH2CH2CH2), 33.2 
(CH2CH2CH2), 57.7 (CH2OH), 105.6 (HC), 108.6 (HCCCH2OH), 115.0 (H2C=CH), 
138.2 (H2C=CH), 152.2 (HCCCH2OH) and 156.5 (HCC); MS (EI) m/z 82.96 [M-
CH2OH-CH2=CHCH2CH2]
+, 111.07 [M-CH2OH-CH2CH], 124.08 [M-CH2OH-CH2]
+, 
135.11 [M-CH2OH]
+; HRMS m/z 166.0996 (166.2170 calcd for C10H14O2, M
+). 
tert-Butyl-(5-hex-5-enyl-furan-2-ylmethoxy)-dimethyl-silane 508  
O
OTBS
 
A 0 oC solution of silyl ether 504 (266.2 mg, 1.25 mmol) in anhydrous 
tetrahydrofuran (6.5 cm3) was treated with nBuLi (0.73 cm3, 1.67 mmol).  After 
15 min at 0 oC, the reaction mixture was allowed to warm up to room 
temperature and was stirred for a further 15 min, before being recooled back to 
0 oC.  5-Bromo-1-hexene (0.2 cm3, 1.50 mmol) was then added and the reaction 
was stirred for 15 min.  The reaction mixture was allowed to warm up to room 
temperature and stirred for 18 h.  The reaction was diluted with diethyl ether 
(10 cm3) and quenched with water (10 cm3).  The layers were separated and the 
organic layer was dried over anhydrous sodium sulphate, filtered and 
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concentrated in vacuo to afford alkene 508 (231 mg, 63%) as a colourless oil 
with no further purification required; Rf 0.69 (solvent F); νmax(film)/cm
-1 2934, 
2860, 1699, 1258, 1159 and 1111; δH(400 MHz; CDCl3) 0.00 (6 H, s, (Si(CH3)2), 
0.83 (9 H, s, SiC(CH3)3), 1.33-1.62 (4 H, m, CH2CH2CH2CH2), 2.00 (2 H, qn, J 6.7 
and 13.8, CH2=CHCH2), 3.33 (2 H, t, J 6.8, (CH2)3CH2), 4.51 (2 H, s, CH2OTBS), 
4.85-4.94 (2 H, m, CH2=CH), 5.67-5.75 (1 H, m, CH2=CH), 5.82 (1 H, d, J 2.9, 
CH=CO) and 6.02 (1 H, d, J 2.9 Hz, CHCO); δC(100 MHz, CDCl3) -5.0 (Si(CH3)2), 
15.5 (SiC(CH3)3), 25.9 (SiC(CH3)3), 25.9 (CH2CH2CH2CH2), 27.6 (CH2CH2CH2CH2), 
32.4 (CH2CH2CH2CH2), 33.1 (CH2CH2CH2CH2), 68.2 (CH2OTBS), 105.6 (HC), 108.2 
(HCCCH2OTBS), 115.3 (H2C=CH), 138.3 (H2C=CH), 152.7 (HCCCH2OTBS) and 156.2 
(HCC); MS (CI) m/z 163 [M-OTBS]+; HRMS m/z  163.1120 (163.1123 calcd for 
C11H15O, M-OTBS
+). 
(5-Hex-5-enyl-furan-2-yl)-methanol 511  
O
OH
 
A 0 oC solution of silyl ether 508 (231.8 mg, 0.787 mmol) in tetrahydrofuran (5 
cm3) was treated with tetra-butylammonium fluoride (1.57 cm3, 1.57 mmol) and 
the resulting reaction was stirred at 0 oC for 15 min, before being warmed up to 
room temperature.  After 1.5 h at room temperature, the reaction mixture was 
diluted with diethyl ether (20 cm3) and quenched with water (20 cm3).  The 
organic layer was separated, dried over anhydrous sodium sulphate, filtered and 
concentrated in vacuo.  Purification by FCC [petroleum ether-ethyl acetate 
(80:20)→(75:25)] of the crude residue afforded alcohol 511 (89.1 mg, 63%) as a 
yellow oil; Rf 0.50 (solvent C); δH(400 MHz; CDCl3) 1.32-1.38 (2 H, m, 
CH2=CH(CH2)CH2), 1.53-1.61 (2 H, m, CH2=CHCH2CH2), 1.95-2.01 (2 H, m, 
CH2=CHCH2), 2.51 (2 H, t, J 7.5, CH2=CH(CH2)3CH2), 4.45 (2 H, d, J 5.9, CH2OH), 
4.82-4.90 (2 H, m, CH2=CH), 5.66-5.73 (1 H, m, CH2=CH), 5.82 (1 H, d, J 3.1, 
CH=CO) and 6.08 (1 H, d, J 3.1 Hz, CHCO); δC(100 MHz, CDCl3) 25.9 
(CH2CH2CH2CH2), 26.2 (CH2CH2CH2CH2), 32.7 (CH2CH2CH2CH2), 33.2 
(CH2CH2CH2CH2), 60.2 (CH2OH), 105.6 (HC), 108.2 (HC), 115.3 (H2C=CH), 138.3 
(H2C=CH), 152.2 (CCH2OH) and 156.2 (C); MS (CI) m/z 163.2 [M-OH]
+; HRMS m/z 
163.1126 (163.1123 calcd for C11H15O, M-OH
+). 
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1-(5-Methyl-furan-2-yl)-but-3-enylamine 540  
O
NH2
 
A mixture of allylboronic acid pinacol ester (2.04 cm3, 10.8 mmol) and 
dodecylbenzenesulfonic acid (0.3 cm3, 0.90 mmol) in 25% aqueous ammonia (18 
cm3) was stirred for 30 min, before being treated with 5-methylfuraldehyde 539 
(0.90 cm3, 9.08 mmol) at room temperature.  After 2 h, the reaction mixture 
was acidified to pH 1-2 with 3 N hydrochloric acid and extracted with 
dichlormethane (3×30 cm3).  The combined organic phases were dried over 
anhydrous sodium sulphate, filtered and concentrated in vacuo to afford the 
crude alcohol; Rf 0.68 (solvent A).  The aqueous layer was basified to pH 12-13 
with 6 N sodium hydroxide and extracted with dichloromethane (3×40 cm3).  
The combined organic phases were dried over anhydrous sodium sulphate, 
filtered and concentrated in vacuo to yield amine 540 (1.05 g, 77%) as yellow oil 
with no need for further purification; Rf 0.16 (solvent A); δH(400 MHz; CDCl3) 
2.20 (3 H, s, CH3), 2.33-2.40 (1 H, m, CH2), 2.51-2.56 (1 H, m, CH2), 3.90 (1 H, t, 
J 6.1, CHN), 5.03-5.10 (2 H, m, CH=CH2), 5.68-5.79 (1 H, m, CH=CH2), 5.82 (1 H, 
d, J 2.4, CH=CO) and 5.96 (1 H, d, J 2.4, CHCO); δC(100 MHz; CDCl3) 13.5 (CH3), 
40.9 (CH2), 49.2 (CHN), 105.1 (CH), 105.8 (CH), 117.8 (CH=CH2), 134.9 (CH=CH2), 
150.8 (CCHN) and 156.6 (CCH3); MS (CI) m/z 152.23 [M + H]
+; HRMS m/z 152.1074 
(152.1075 calcd for C9H14NO, M+ H
+). 
4-Methyl-N-[(1-(5-methyl-furan-2-yl)-but-3-enyl)]-benzenesulfonamide 541 
O
NHTs
 
A solution of homoallylic amine 540 (200 mg, 1.32 mmol) in dichloromethane (7 
cm3) was cooled to 0 oC and treated with dimethylaminopyridine (97 mg, 0.79 
mmol) and triethylamine (0.41 cm3, 2.90 mmol).  After stirring for 10 min, p-
toluenesulfonyl chloride (265 mg, 1.38 mmol) was added to the reaction mixture 
and the ice-water bath removed after a further 10 min.  After 1 h, the reaction 
mixture was diluted with dichloromethane (10 cm3) and quenched with water 
(10 cm3).  The phases were separated and the organic layer was washed with 
saturated aqueous sodium hydrogen carbonate (2×10 cm3), dried over anhydrous 
sodium sulphate, filtered and concentrated in vacuo.  The crude residue was 
passed through a pad of silica gel (eluting with solvent C) to afford tosyl amine 
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541 (376 mg, 93%) as a yellow oil; νmax(film)/cm
-1 3054, 2986, 1598, 1265 and 
1160; δH(400 MHz; CDCl3) 2.00 (3 H, s, CH3), 2.31 (3 H, s, CH3(Ar)), 2.35-2.50 (2 
H, m, CH2), 4.36 (1 H, q, J 6.9, CHNH), 5.00-5.02 (2 H, m, CH=CH2), 5.49-5.58 (1 
H, m, CH=CH2), 5.62 (1 H, dd, J 1.0 and 3.1, CH=CO), 5.78 (1 H, d, J 3.1, CHCO), 
7.12 (2 H, d, J 8.0, 2×CH) and 7.57 (2 H, d, J 8.0, 2×CH); δC(100 MHz; CDCl3) 
13.3 (CH3CO), 21.5 (CH3), 39.1 (CH2), 51.2 (CHN), 105.8 (CH), 108.0 (CH), 119.1 
(CH=CH2), 127.1 (2×CH), 129.3 (2×CH), 133.0 (CH=CH2), 137.7 (CCH3), 143.0 
(CS), 150.6 (CCHN) and 151.6 (CH3CO); MS (CI) m/z 306.3 [M+H]
+; HRMS 306.1165 
(306.1164 calcd for C16H20NO3S, M+H
+). 
2-Allyl-6-hydroxy-6-methyl-1-(toluene-4-sulfonyl)-1,6-dihydro-2H-pyridin-3-
one 542  
NTs
O
H3C OH  
To a room temperature solution of tosyl amine 541 (103 mg, 0.337 mmol) in 
dichloromethane (1.7 cm3) was added meta-chloroperoxybenzoic acid (mCPBA) 
(91 mg, 0.404 mmol).  After stirring for 2 h, 10% aqueous sodium hydrogen 
carbonate (5 cm3) was added to the pale yellow solution and the resulting 
mixture was stirred for 40 min.  The biphasic mixture was transferred to a 
separating funnel and dichloromethane (10 cm3) was added.  The phases were 
separated and the organic layer was washed with saturated aqueous sodium 
hydrogen carbonate (4×15 cm3), dried over anhydrous sodium sulphate, filtered 
and concentrated in vacuo to afford hemi-aminal 542 (107 mg, 99%) as a pale 
yellow oil; Rf 0.10 (solvent A); νmax(film)/cm
-1 2254, 1701, 1265 and 1164; δH(400 
MHz; CDCl3) 2.12 (3 H, s, CH3), 2.43-2.50 (2 H, m, CH2), 2.45 (3 H, s, CH3(Ar)), 
4.02-4.05 (1 H, m, CH(N)), 4.89-4.99 (2 H, m, CH=CH2), 5.21 (1 H, d, J 7.6, 
CH=CH(C=O)), 5.41-5.51 (1 H, m, CH=CH2), 6.30 (1 H, app. s, CH=CH(C=O)) and 
7.21 (2 H, d, J 8.0, 2×CH) and 7.62 (2 H, d, J 8.0, 2×CH); δC(100 MHz; CDCl3) 
21.6 (CH3(Ar)), 29.6 (CH3), 36.0 (CH2), 60.6 (CH(N)), 119.9 (CH=CH2), 127.2 
(2×CH), 129.8 (2×CH), 131.5 (CH=CH2), 132.6 (CH=CH(CO)), 137.0 (C), 138.4 
(C), 143.8 (CH=CH(CO)), 199.3 (C=O), plus one unresolved carbon; MS (CI) m/z 
322.2 [M+H]+; HRMS m/z 322.1114 (322.1114 calcd for C16H20NO4S, M+H
+). 
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[1-(5-Methyl-furan-2-yl)-but-3-enyl]-carbamic acid tert-butyl ester 543  
O
NHBoc
 
To a stirred, room temperature solution of homoallylic amine 540 (200 mg, 1.32 
mmol) in water (1.5 cm3) was added di-tert-butyl dicarbonate ((Boc)2O) (317 mg, 
1.45 mmol).  The pale yellow solution was stirred at for 30 min after which 
water (5 cm3) was added and the mixture extracted with ethyl acetate (2×10 
cm3).  The combined organic phases were dried over anhydrous sodium sulphate, 
filtered and concentrated in vacuo to afford Boc amine 543 (269 mg, 81%) as a 
colourless oil with further purification needed; Rf 0.67 (solvent A); νmax-
(film)/cm-1 1709, 1498, 1265 and 1168; δH(400 MHz; CDCl3) 1.45 (9 H, s, 3×CH3), 
2.27 (3 H, s, CH3), 2.53-2.57 (2 H, m, CH2), 4.80-4.83 (1 H, m, CHN), 5.05-5.12 (2 
H, m, CH=CH2), 5.65-5.73 (1 H, m, CH=CH2), 5.88 (1 H, dd, J 1.0 and 3.0, 
CH=CO) and 6.03 (1 H, d, J 3.0, CHCO); δC(100 MHz; CDCl3) 13.6 (CH3), 28.4 
(3×CH3), 38.7 (CH2), 48.3 (CHN), 85.2 (C(CH3)3), 105.9 (CH), 106.6 (CH), 118.1 
(CH=CH2), 133.9 (CH=CH2), 146.7 (CCHN), 151.3 (CH3C) and 155.2 (C=O); MS (CI) 
m/z 252.2 [M+H]+; HRMS m/z 252.1602 (252.1599 calcd for C14H22NO3, M+H
+). 
2-Allyl-6-hydroxy-6-methyl-3-oxo-3,6-dihydro-2H-pyridine-1-carboxylic acid 
tert-butyl ester 544  
NBoc
O
H3C OH  
To a solution of Boc amine 543 (102 mg, 0.405 mmol) in dichloromethane (2 
cm3) at room temperature, was added meta-chloroperoxybenzoic acid (mCPBA) 
(109 mg, 0.486 mmol) at room temperature.  After stirring for 1 h, 10% aqueous 
sodium hydrogen carbonate (5 cm3) was added and the pale yellow biphasic 
solution was stirred for 1 h before being transferred to a separating funnel.   
Dichloromethane (10 cm3) was added and the organic layer separated.  The 
organic layer was washed with saturated aqueous sodium hydrogen carbonate 
(4×15 cm3), dried over anhydrous sodium sulphate, filtered and concentrated in 
vacuo to afford Boc aminal 544 (94.6 mg, 88%) as a white oil; Rf 0.18 (solvent A); 
νmax(film)/cm
-1 3431 (OH), 2983, 2254, 1702 (C=O), 1165 and 907; δH(400 MHz; 
CDCl3) 1.44 (9 H, s, 3×CH3), 2.21 (3 H, s, CH3), 2.37-2.42 (1 H, m, CH2), 2.58-
2.64 (1 H, m, CH2), 4.37-4.41 (1 H, m, NCH), 5.02-5.09 (2 H, m, CH=CH2), 5.60-
5.71 (1 H, m, CH=CH2), 6.32 (2 H, m, CH=CH); δC(100 MHz; CDCl3) 28.2 (3×CH3), 
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29.7 (CH3), 35.5 (CH2), 58.5 (NCH), 80.0 (COH), 85.2 (C(CH3)3), 119.6 (CH=CH2), 
130.1 (CH=CH(C=O)), 133.2 (CH=CH2), 146.7 (CH=CH(C=O)), 155.5 (N(C=O)O
tBu) 
and 200.6 (C=O); MS (CI) m/z 268.3 [M+H]+;  HRMS m/z 268.1548 (268.1549 calcd 
for C14H22NO4, M+H
+). 
N-Furan-2-ylmethyl-4-methyl-benzenesulfonamide 525[222,223] 
O
NHTs
 
To a stirred solution of furfurylamine (500 mg, 5.14 mmol) in dichloromethane 
(25 cm3) at 0 oC, was added triethylamine (1.6 cm3, 11.3 mmol) and 
dimethylaminopyridine (377 mg, 3.08 mmol).  After 10 min, p-toluenesulfonyl 
chloride (1.03 g, 5.40 mmol) was added, following which, an immediate colour 
change from colourless to yellow was observed.  The ice-water bath was then 
removed after 10 min and the reaction mixture was allowed to warm up to room 
temperature.  After 1 h, the reaction was diluted with dichloromethane (20 
cm3), washed with water (2×20 cm3) followed by saturated aqueous sodium 
hydrogen carbonate (2×20 cm3).  The solution was then dried over anhydrous 
sodium sulphate, filtered and concentrated in vacuo to afford tosyl amine 525 
(1.29 g, 100%) as a yellow solid; Rf 0.35; mp 110-112 
oC (from dichloromethane) 
(lit.,12 111-112 oC); δH(400 MHz; CDCl3) 2.35 (3 H, s, CH3), 4.09 (2 H, s, CH2), 
6.02 (1 H, dd, J 0.8 and 3.3, CH=CO), 6.15 (1 H, dd, J 1.9 and 3.3, CHCO), 7.18 
(1 H, dd, J 0.8 and 1.9, CHO), 7.20 (2 H, d, J 8.3, 2×CH) and 7.65 (2 H, d, J 8.3, 
2×CH).  The spectral data matches that reported in the literature.[222,223] 
N-((5-allylfuran-2-yl)methyl)-4-methylbenzenesulfonamide 524  
O
NHTs
 
A solution of tosyl amine 525 (259 mg, 1.02 mmol) in tetrahydrofuran (5 cm3) 
was stirred for 10 min and then cooled to 0 oC before being treated with nBuLi 
(0.49 cm3, 1.13 mmol).  The resulting light brown solution was stirred at 0 oC for 
15 min before being allowed to warm up to room temperature and stirred for 15 
min.  The solution was recooled down to 0 oC and allyl bromide (0.11 cm3, 1.23 
mmol) was added.  The reaction was stirred for 10 min and the ice-water bath 
was removed to allow the reaction mixture to warm up to room temperature.  
After 20 h, the reaction mixture was diluted with diethyl ether (10 cm3) and 
quenched with water (10 cm3).  The organic layer was separated, dried over 
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anhydrous sodium sulphate, filtered and concentrated in vacuo to afford alkene 
524 (264 mg, 88%) as a dark brown thick oil; Rf 0.52 (solvent A); νmax(film)/cm
-1 
2253, 1159, 1093 and 908; δH(400 MHz; CDCl3) 2.28 (3 H, s, CH3), 3.62 (2 H, d, J 
6.4, CH2CH=CH2), 4.25 (2 H, s, CH2), 4.98-5.03 (2 H, m, CH=CH2), 5.45-5.57 (1 H, 
m, CH=CH2), 6.00 (1 H, dd, J 0.6 and 3.2, CH=CO), 6.12 (1 H, dd, J 1.8 and 3.2, 
CHCO), 7.11 (2 H, d, J 8.2, 2×CH) and 7.53 (2 H, d, 2×CH); δC(100 MHz; CDCl3) 
21.5 (CH3), 42.7 (CH2=CHCH2), 49.6 (CH2N), 109.5 (CH), 110.3 (CH), 119.2 
(CH2=CH), 127.3 (2×CH), 129.5 (2×CH), 132.5 (CH2=CH), 137.6 (CCH3), 142.4 
(CS), 143.1 (CH2=CHCH2C) and 149.7 (CCH2); MS (CI) m/z 292.2 [M+H]
+; HRMS 
m/z 292.1006 (292.1007 calcd for C15H18NO3S, M+H
+). 
4-Methyl-N-((5-propylfuran-2-yl)methyl)benzenesulfonamide 528  
O
NHTs
 
A solution of alkene 524 (174 mg, 0.598 mmol) in methanol (3 cm3) was treated 
with a catalytic amount of 10% palladium on activated carbon.  The flask was 
evacuated and after purging three times with hydrogen gas via a balloon, the 
mixture was stirred under an atmosphere of hydrogen for 45 min at room 
temperature.  TLC analysis deemed the reaction complete and the solution was 
filtered through a pad of Celite® to remove the catalyst and the solvent 
concentrated in vacuo to afford tosyl amine 528 (161 mg, 92%) as a thick, 
orange oil; Rf 0.52 (solvent A); νmax(film)/cm
-1 2254, 1334, 1158 and 908; δH(400 
MHz; CDCl3) 0.72 (3 H, t, J 7.4, CH2CH3), 1.49 (2 H, sext., J 7.4, CH2CH3), 2.35 (3 
H, s, CH3), 3.00 (2 H, dd, J 7.4 and 9.2, CH2CH2CH3), 4.31 (2 H, s, CH2), 6.07 (1 
H, dd, J 0.6 and 3.2, CH=CO), 6.18 (1 H, dd, J 1.9 and 3.2, CHCO), 7.17 (2 H, d, 
J 8.1, 2×CH) and 7.57 (2 H, d, J 8.1, 2×CH); δC(100 MHz; CDCl3) 11.0 (CH3), 21.3 
(CH3(Ar)), 21.5 (CH3CH2), 43.7 (CH3CH2CH2), 49.2 (CH2), 109.3 (CH), 110.4 (CH), 
127.2 (2×CH), 129.5 (2×CH), 137.0 (CCH3), 142.4 (CS), 143.0 (CHCH2) and 149.9 
(CH2CH); MS (CI) m/z 294.3 [M+H]
+; HRMS m/z 294.1161 (296.1164 calcd for 
C15H20NO3S, M+H
+).   
N-((5-(But-3-enyl)furan-2-yl)methyl)-4-methylbenzenesulfonamide 530  
O
NHTs
 
A solution of amine 525 (650 mg, 2.58 mmol) in tetrahydrofuran (10 cm3) was 
stirred for 10 min, then cooled to 0 oC and treated with nBuLi (1.19 cm3, 2.84 
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mmol).  The resulting dark orange solution was stirred at this temperature for 15 
min before being warmed up to room temperature and stirred for 15 min.  The 
solution was recooled to 0 oC and 4-bromobutene (0.32 cm3, 3.10 mmol) was 
added.  After 10 min, the ice-water bath was removed to allow the reaction 
mixture to warm up to room temperature.  After 20 h, TLC analysis showed 
there to be considerable remaining starting material, so the above procedure 
was repeated to add the same amount of reagents for a second time.  After 8 h, 
the reaction had not proceeded, so the reaction mixture was diluted with 
diethyl ether (20 cm3) and water (20 cm3).  The organic layer was separated, 
dried over anhydrous sodium sulphate, filtered and concentrated in vacuo.  
Purification by FCC [petroleum ether-ethyl acetate (70:30)] of the residue 
afforded alkene  530 (340 mg, 43%) as an orange oil; νmax(film)/cm
-1 913; δH(400 
MHz; CDCl3) 2.05 (2 H, q, J 7.2, CH2=CHCH2), 2.25 (3 H, s, CH3), 3.03 (2 H, t, J 
7.2, CH2=CHCH2CH2), 4.22 (2 H, s, CH2), 4.82-4.88 (2 H, m, CH2=CH), 5.51-5.62 (1 
H, m, CH2=CH), 6.00 (1 H, dd, J 0.6 and 3.2, CH=CO), 6.12 (1 H, dd, J 1.9 and 
3.2, CHCO), 7.10 (2 H, d, J 8.4, 2×CH) and 7.51 (2 H, d, J 8.4, 2×CH); δC(100 
MHz; CDCl3) 21.5 (CH3), 32.8 (CH2CH2), 43.9 (CH2CH2), 46.9 (CH2), 109.4 (CH), 
110.4 (CH), 117.0 (CH2=CH), 127.3 (2×CH), 129.5 (2×CH), 134.7 (CCH3), 142.4 
(CH2=CH), 143.0 (CS), 149.8 (CCH2), plus one unresolved carbon; MS (CI) m/z 
306.2 [M+H]+; HRMS m/z 306.1165 (306.1164 calcd for C16H20NO3S, M+H
+). 
4-Methyl-N-(5-methylfuran-2-ylmethyl)-benzenesulfonamide 535[224] 
O
NHTs
 
To a stirred solution of methylfurfurylamine 534 (300 mg, 2.69 mmol) in 
dichloromethane (13 cm3) at 0 oC was added triethylamine (0.83 cm3, 5.93 
mmol) and dimethylaminopyridine (198 mg, 1.61 mmol).  After 10 min, p-
toluenesulfonyl chloride (540 mg, 2.83 mmol) was added, following which an 
immediate colour change from colourless to yellow was observed.  The cooling 
bath was removed after 10 min and the reaction mixture allowed to warm up to 
room temperature.  After 1 h, the reaction was diluted with dichloromethane 
(20 cm3), washed with water (2×20 cm3) followed by saturated aqueous sodium 
hydrogen carbonate (2×20 cm3).  The organic phase was dried over anhydrous 
sodium sulphate, filtered and concentrated in vacuo.  The residue was passed 
through a pad of silica gel to afford tosyl amine 535 (715 mg, 100%) as a yellow 
solid; Rf 0.31; mp 85-86 
oC (from dichloromethane) (lit.,[224] 82-83 oC); δH(400 
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MHz; CDCl3) 2.16 (3 H, s, CH3), 2.46 (3 H, s, CH3(Ph)), 4.13 (2 H, s, CH2), 5.80 (1 
H, d, J 3.0, CH=CO), 5.99 (1 H, d, J 3.0, CHCO), 7.30 (2 H, d, J 8.0, 2×CH) and 
7.74 (2 H, d, J 8.0, 2×CH); δC(100 MHz; CDCl3) 13.4 (CH3), 21.5 (CH3(Ph)), 40.3 
(CH2), 106.2 (CH), 109.1 (CH), 127.2 (2×CH), 129.6 (2×CH), 136.9 (CCH3), 143.4 
(CS), 147.5 (CCH2) and 152.3 (OC(CH3)); MS (CI) m/z 266.2 [M+H]
+; HRMS m/z 
266.0850 (266.0852 calcd for C13H16NO3S, M+H
+).  The spectral data matches that 
reported in the literature.[224] 
6-Hydroxy-6-methyl-1-(toluene-4-sulfonyl)-1,6-dihydro-2H-pyridin-3-one 536  
NTs
O
H3C OH  
To a 0 oC solution of amine 535 (360 mg, 1.35 mmol) in dichloromethane (7 cm3) 
was added meta-chloroperoxybenzoic acid (mCPBA) (365 mg, 1.62 mmol) and 
the ice-water bath was removed after 10 min.  The yellow reaction mixture was 
allowed to warm up to room temperature and quenched after 4 h with water (10 
cm3).  The solution was transferred to a separating funnel and dichloromethane 
(15 cm3) and water (10 cm3) were added.  The phases were separated and the 
organic layer was washed with water (10 cm3) and saturated aqueous sodium 
hydrogen carbonate (4×15 cm3), dried over anhydrous sodium sulphate, filtered 
and concentrated in vacuo to afford 536 (381 mg, 100%) as a pale yellow oil; Rf 
0.13 (solvent G); νmax(film)/cm
-1 2253, 1160, 1090 and 910; δH(400 MHz; CDCl3) 
2.19 (3 H, s, CH3), 2.36 (3 H, s, CH3), 3.90 (2 H, s, J 5.2, CH2), 5.23 (1 H, t, J 
5.1, OH), 6.15 (1 H, d, J 11.9, CH=CH(C=O)), 6.35 (1 H, d, J 11.9, CH=CH(C=O)), 
7.23 (2 H, d, J 8.2, 2×CH) and 7.66 (2 H, d, 2×CH); δC(100 MHz; CDCl3) 21.6 
(CH3), 29.7 (CH3COH), 51.5 (CH2), 77.0 (COH), 127.1 (2×CH), 129.8 (2×CH), 
133.2 (CH=CH(C=O)), 136.2 (CS), 137.3 (CCH3), 143.9 CH=CH(C=O)) and 196.9 
(C=O); MS (CI) m/z 282.2 [M+H]+; HRMS 282.0807 (282.0800 calcd for C13H16NO4S, 
M+H+). 
Furan-2-ylmethyl-carbamic acid tert-butyl ester 532[225] 
O
NHBoc
 
To a stirred mixture of furfuryl amine 526 (0.36 cm3, 4.11 mmol) in water (4.2 
cm3) was added di-tert-butyl dicarbonate ((Boc)2O) (988 mg, 4.43 mmol) at room 
temperature.  After 40 min, the reaction was complete and was diluted with 
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water (10 cm3) and extracted with ethyl acetate (2×10 cm3).  The combined 
organic layers were dried over anhydrous sodium sulphate, filtered and 
concentrated in vacuo to afford Boc amine 532 (785 mg, 97%) as a clear oil; Rf 
0.71; δH(400 MHz; CDCl3) 1.45 (9 H, s, 3×CH3), 4.30 (2 H, d, J 5.4, CH2), 6.20 (1 
H, d, J 2.8, CH=CO), 6.31 (1 H, dd, J 1.8 and 2.8, CHCO) and 7.32 (1 H, dd, J 0.8 
and 1.8, CHO); δC(100 MHz; CDCl3) 28.4 (3×CH3), 37.7 (CH2), 79.6 (CCH3), 110.3 
(2×CH), 142.0 (CHO), 146.7 (CCH2) and 155.6 (C=O).  The spectral data matches 
that reported in the literature.[225] 
(5-Methyl-furan-2-ylmethyl)-carbamic acid tert-butyl ester 537 
O
NHBoc
 
To a stirred mixture of methylfurfurylamine 534 (150 mg, 1.34 mmol) in water 
(1.35 cm3) was added di-tert-butyl dicarbonate ((Boc)2O) (324 mg, 1.48 mmol) at 
room temperature.  Soon after, transparent liquid droplets were observed on the 
walls of the reaction vessel.  After 40 min, water (5 cm3) was added to the pale 
yellow solution and the reaction mixture extracted with ethyl acetate (2×5 
cm3).  The combined organic layers were dried over anhydrous sodium sulphate, 
filtered and concentrated in vacuo to yield Boc amine 537 (233 mg, 82%) as a 
yellow oil; Rf 0.53 (solvent A); νmax(film)/cm
-1 1701 and 1110; δH(400 MHz; CDCl3) 
1.48 (9 H, s, 3×CH3), 2.27 (3 H, s, CH3), 4.23 (2 H, d, J 5.2, CH2), 5.88 (1 H, dd, 
J 0.8 and 2.9, CH=CO) and 6.08 (1 H, d, J 2.9, CHCO); δC(100 MHz; CDCl3) 13.5 
(CH3), 28.4 (3×CH3), 37.8 (CH2), 79.5 (C(CH3)3), 106.1 (CH), 107.8 (CH), 150.0 
(CCH3), 151.7 (CCH2) and 155.6 (C=O); MS (EI) m/z 211 [M]
+; HRMS m/z 211.1210 
(211.2108 calcd for C11H17NO3, M
+). 
N-(1-furan-2-yl-butyl)-4-methyl-benzenesulfonamide 516  
O
NHTs
 
To a solution of homoallylic amine 492 (275 mg, 0.943 mmol) in methanol (5 
cm3) was treated with a catalytic amount of 10% palladium on activated carbon.  
The flask was evacuated and after purging three times with hydrogen gas via a 
balloon, the mixture was stirred under an atmosphere of hydrogen for 40 min at 
room temperature.  TLC analysis deemed the reaction complete and the solution 
was filtered through a pad of Celite® to remove the catalyst and the solvent 
concentrated in vacuo to afford alkane 516 (275 mg, 99%) as a white crystalline 
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solid; Rf 0.59 (solvent B); mp 94-96 
oC(from methanol); δH(400 MHz; CDCl3) 0.78 
(3 H, t, J 7.4, CH2CH3), 1.10-1.28 (2 H, m, CH2CH3), 1.67 (2 H, q, J 7.6, CH2CH2), 
2.30 (3 H, s, CH3(Ph)), 4.32 (1 H, t, J 7.6, CHN), 5.80 (1 H, d, J 3.2, CH=CO), 
6.03 (1 H, dd, J 1.8 and 3.2, CHCO), 7.06 (1 H, dd, J 0.6 and 1.8, CHO), 7.11 (2 
H, d, J 8.1, 2×CH) and 7.53 (2 H, d, J 8.1, 2×CH); δC(100 MHz, CDCl3) 13.5 
(CH2CH3), 18.9 (CH2CH3), 21.5 (CH3), 37.1 (CH2CH2), 51.5 (CHN), 106.8 (CH=CO), 
109.9 (CHCO), 127.0 (CH), 129.4 (CH), 137.7 (CCHN), 141.8 (CHO), 143.0 (C) and 
153.0 (C); MS (EI) m/z 293.1 [M]+, 250.1 [M-CH2CH2CH3]
+, 155.0 [M-
(HTs)CH2CH2CH3]
+; HRMS 293.1084 (293.1086 calcd for C15H19NO3S, M
+).     
N-[1-(5-Allyl-furan-2-yl)-butyl]-4-methyl-benzenesulfonamide 517  
O
NHTs
 
To a solution of amine 516 (704.8 mg, 2.40 mmol) in tetrahydrofuran (10 cm3) at 
0 oC, was added nBuLi (1.2 cm3, 2.88 mmol).  After stirring for 10 min at 0 oC 
and then 15 min at room temperature, the now yellow solution was recooled to 
0 oC and allyl bromide (0.25 cm3, 2.88 mmol) was added.  After 15 min at 0 oC, 
the reaction mixture was allowed to warm up to room temperature once again 
and stirred for 16 h.  The reaction was diluted with diethyl ether (10 cm3) and 
water (10 cm3) was added to separate the layers.  The organic layer was dried 
over anhydrous sodium sulphate, filtered and concentrated in vacuo.  
Purification by FCC [petroleum ether-ethyl acetate (85:15)→(80:20)] of the 
crude residue afforded alkene 517 (294 mg, 66% based on starting material 
consumed); Rf 0.65 (solvent A); νmax(film)/cm
-1 2910, 2849, 1699 (C=C), 1455, 
1262 and 1090; δH(400 MHz; CDCl3) 0.85 (3 H, t, J 7.4, CH3), 1.22-1.39 (2 H, m, 
CH2CH3), 1.71-1.87 (2 H, m, CH2CH2), 2.34 (3 H, s, CH3), 3.46 (1 H, dd, J 7.6 and 
16.4, CH2), 3.65-3.70 (1 H, m, CH2), 4.87-5.00 (3 H, m, CH2=CH and CHN), 5.47-
5.55 (1 H, m, CH2=CH), 5.98 (1 H, dd, J 0.6 and 3.2, CH=CO), 6.15 (1 H, dd, J 1.8 
and 3.2, CHCO), 7.18 (2 H, d, J 8.4, 2×CH) and 7.63 (2 H, d, J 8.4, 2×CH); 
δC(100 MHz; CDCl3) 13.7 (CH3), 19.5 (CH2CH3), 21.5 (CH3), 33.9 (CH2CH2), 47.1 
(CH2=CHCH2), 55.1 (CHN), 108.5 (CH=CO), 110.1 (CHCO), 116.8 (CH2=CH), 127.5 
(2×CH), 129.2 (2×CH), 135.6 (CHN), 137.9 (CCHN), 141.8 (CH2=CH), 142.9 (C) 
and 152.8 (C); MS (CI) m/z 290.2 [M-CH2CH2CH3]
+, 334.3 [M+H]+; HRMS m/z 
334.1481 (334.1478 calcd for C18H24O3NS, M+H
+). 
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4-Methyl-N-[(1-(5-propylfuran-2-yl)butyl)]benzenesulfonamide 519  
O
NHTs
 
To a solution of amine 517 (106 mg, 0.31 mmol) in methanol (2 cm3) was treated 
with a catalytic amount of 10% palladium on activated carbon.  The flask was 
evacuated and after purging three times with hydrogen gas via a balloon, the 
mixture was stirred under an atmosphere of hydrogen for 45 min at room 
temperature.  TLC analysis deemed the reaction complete and the solution was 
filtered through a pad of Celite® to remove the catalyst and the solvent 
concentrated in vacuo to afford alkane 519 (104 mg, 98%) as an orange oil with 
no further purification performed; Rf 0.58 (solvent A); νmax(film)/cm
-1 2254, 1160 
and 908; δH(400 MHz; CDCl3) 0.64 (3 H, t, J 7.4, CH3), 0.84 (3 H, t, J 7.4, CH3), 
1.20–1.40 (4 H, m, 2×CH2CH3), 1.63-1.71 (1 H, m, NCHCH2), 1.83-1.91 (1 H, m, 
NCHCH2), 2.43 (3 H, s, CH3), 2.75-2.80 (1 H, m, CH2), 2.88-2.97 (1 H, m, CH2), 
4.90 (1 H, t, J 7.7, NCH), 5.92 (1 H, d, J 3.3, CH=CO), 6.13 (1 H, dd, J 1.9 and 
3.3, CHCO), 7.17 (2 H, d, J 8.0, 2×CH) and 7.61 (2 H, d, J 8.0, 2×CH); δC(100 
MHz; CDCl3) 11.3 (CH3), 13.8 (HNCHCH2CH2CH3), 19.7 (HNCHCH2CH2CH3), 21.5 
(PhCH3), 23.8 (H3CCH2), 34.2 (H3CCH2CH2), 46.5 (HNCHCH2CH2CH3), 55.0 
(HNCHCH2CH2CH3), 108.2 (CH), 110.1 (CH), 127.4 (2×CH), 129.2 (2×CH), 138.2 
(CCH3), 141.8 (SO2C), 142.7 (CCHNH) and 153.0 (CH3CH2CH2C); MS (CI) m/z 336.4 
[M+H]+; HRMS m/z 336.1637 (336.1634 calcd for C18H26NO3S, M+H
+). 
N-(1-Furan-2-yl-but-3-enyl)acrylamide 551[226]  
O
HN
O
 
To a stirring, room temperature, solution of acryloyl chloride (70 µL, 0.801 
mmol) and diisopropylethylamine (0.14 cm3, 0.801 mmol) in dry 
dichloromethane (4 cm3) under argon, was added a solution of amine 490 (100 
mg, 0.729 mmol) and diisopropylethylamine (0.13 cm3, 0.729 mmol) in dry 
dichloromethane (7 cm3).  The resulting bright yellow solution was stirred for 2 
h, whereafter it was quenched with saturated aqueous ammonium chloride (15 
cm3) and diluted with dichloromethane (15 cm3).  The organic layer was 
separated and dried over anhydrous sodium sulphate, filtered and concentrated 
in vacuo.  Purification by FCC [petroleum ether-ethyl acetate, (60:40)] of the 
crude residue afforded amide 551 (139 mg, 100%) as a pale yellow oil; Rf 0.52 
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(solvent I); δH(400 MHz; CDCl3) 2.61 (2 H, t, J 6.9, CH2), 5.06-5.13 (2 H, m, 
CH=CH2), 5.26-5.30 (1 H, m, CHN), 5.62-5.76 (2 H, m, CH2CH=CH2 and 
COCH=CH2), 6.09-6.14 (1 H, m, COCH=CH2), 6.20 (1 H, dd, J 0.6 and 3.0, 
CH=CO), 6.28 (1 H, d, J 1.4, CHCO), 6.31 (1 H, dd, J 1.4 and 3.0, COCH=CH2) and 
7.33 (1 H, d, J 0.9, CHO).  The spectral data matches that reported in the 
literature.[226]    
6-Furan-2-yl-5,6-dihydro-1H-pyridin-2-one 550  
O
HN
O
 
A solution of amide 551 (316 mg, 1.65 mmol) in dry dichloromethane (17 cm3) 
under argon was treated with Grubbs first generation catalyst (136 mg, 0.165 
mmol).  The reaction mixture was heated under reflux in the dark for 18 h, then 
concentrated under reduced pressure and the residue passed through a short 
column of silica gel, eluting with ethyl acetate, to give cyclic amide 550 (226 
mg, 84%) as a brown solid with no further purification necessary; Rf 0.07 (solvent 
C); mp 96-98 oC (from ethyl acetate) (lit.,[226] 98-99 oC); δH(400 MHz; CDCl3) 
2.68-2.71 (2 H, m, CH2), 4.80 (1 H, t, J 7.5, CHN), 5.97 (1 H, d, J 10.0, 
CH=CHCH2), 6.25 (1 H, d, J 3.2, CH=CO), 6.34 (1 H, dd, J 1.8 and 3.2, CHCO), 
6.61 (1 H, dt, J 4.2 and 10.0, CH=CHCH2) and 7.39 (1 H, s, CHO); δC(100 MHz; 
CDCl3) 27.6 (CH2), 47.2 (CHN), 104.8 (CH), 108.9 (CH), 122.8 (CH=CHCH2), 138.1 
(CH=CHCH2), 140.7 (CHO), 151.6 (C) and 164.2 (C=O); MS (CI) m/z 164.2 [M+H]
+; 
HRMS 164.0710 (164.0712 calcd for C9H10NO2, M+H
+).  The spectral data matches 
that reported in the literature.[226] 
6-Furan-2-yl-piperidin-2-one 552[186] 
O
HN
O
 
To a solution of amide 550 (56 mg, 0.345 mmol) in methanol (2 cm3) was treated 
with a catalytic amount of 10% palladium on activated carbon.  The flask was 
evacuated and after purging three times with hydrogen gas via a balloon, the 
mixture was stirred under an atmosphere of hydrogen for 35 min at room 
temperature.  TLC analysis deemed the reaction complete and the solution was 
filtered through a pad of Celite® to remove the catalyst and the solvent 
Suzannah J. Harnor, 2010  278 
concentrated in vacuo.  Purification by FCC [petroleum ether-ethyl acetate, 
(20:80)] of the crude residue afforded lactam 552 (40 mg, 79%) as a white solid; 
Rf 0.24 (ethyl acetate); δH(400 MHz; CDCl3) 1.76-1.87 (1 H, m, OCCH2CH2), 1.91-
2.02 (2 H, m, OCCH2CH2 and OCCH2CH2CH2), 2.11-2.20 (1 H, m, OCCH2CH2CH2), 
2.42-2.48 (2 H, m, OCCH2), 4.67 (1 H, t, J 6.0, CHNH), 6.25 (1 H, d, J 3.2, 
CH=CO), 6.38 (1 H, dd, J 1.9 and 3.2, CHCO) and 7.40 (1 H, d, J 1.9, CHO); MS 
(CI) m/z 166.25 [M+H]+; HRMS m/z 166.0864 (166.0868 calcd for C9H12NO2, 
M+H+).  The spectral data matches that reported in the literature.[186].   
4-Hydroxy-9,9a-dihydro-4H-quinolizine-1,6-dione 549  
N
O
OH O  
A solution of lactam 550 (46 mg, 0.218 mmol) in chloroform (10 cm3) was 
treated with meta-chloroperoxybenzoic acid (mCPBA) (139 mg, 0.620 mmol) in 
one portion at room temperature.  The reaction mixture was heated to 60 oC for 
3.5 h, then cooled down to room temperature and stirred overnight.  The 
reaction mixture was diluted with dichloromethane (10 cm3) and saturated 
aqueous sodium hydrogen carbonate (10 cm3) added.  The organic layer was 
washed with a further amount of saturated aqueous sodium hydrogen carbonate 
(15 cm3), water (15 cm3) and saturated aqueous sodium chloride (15 cm3).  The 
organic phase was dried over anhydrous sodium sulphate, filtered and 
concentrated in vacuo.  Purification by FCC [petroleum ether-ethyl acetate, 
(30:70)] of the crude residue afforded the bicyclic lactam 549 (40 mg, 70%) as a 
yellow oil; Rf 0.40 (solvent J); δH(400 MHz; CDCl3) 2.70-2.75 (2 H, m, H2CCH=CH), 
4.44 (1 H, t, J 8.1, HCN), 5.90 (1 H, dt, J 1.9 and 10.0, H2CCH=CH), 6.09 (1 H, d, 
J 10.1, O=CCH=CHCHOH), 6.14 (1 H, d, J 4.9, O=CCH=CHCHOH), 6.55-6.60 (1 H, 
m, H2CCH=CH) and 6.99 (1 H, dd, J 4.9 and 10.1, O=CCH=CHCHOH); δC(100 MHz; 
CDCl3) 22.7 (CH2), 56.6 (CHN), 74.8 (HOCH), 122.9 (CH2CH=CH), 126.9 
(HOCHCH=CH), 138.5 (CH2CH), 142.8 (HOCHCH), 157.9 (NCO) and 192.7 (C=O); 
MS (CI) m/z 162.19 [M-OH]+, 180.21 [M+H]+; HRMS 180.0675 (180.0660 calcd for 
C9H10NO3, M+H
+). 
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1-Furan-2-yl-2-methyl-propan-1-ol 554[207]   
O
OH
 
To a solution of furan (5.0 g, 73.4 mmol) in diethyl ether (150 cm3) at 0 oC, was 
added N,N,N’,N’-tetramethylethylenediamine (11.0 cm3, 73.4 mmol), followed 
by nBuLi (32.3 cm3, 80.7 mmol).  The reaction mixture was stirred at 0 oC for 1 
h, then warmed up to room temperature and stirred for a further 1 h.  After this 
time, the reaction mixture was cooled to –78 oC and isobutyraldehyde (7.33 cm3, 
80.7 mmol) was added.  After 3 h at –78 oC, the reaction was diluted with diethyl 
ether (50 cm3) and quenched with water (50 cm3).  The organic layer was 
separated, washed with water (3×50 cm3), dried over anhydrous sodium 
sulphate, filtered and concentrated in vacuo.  Purification by FCC [diethyl ether-
petroleum ether (30:70)] of the crude residue afforded furfuryl alcohol 554 
(9.82 g, 96%) as a pale yellow oil; δH(400 MHz; CDCl3) 0.86 (3 H, d, J 6.8, CH3), 
1.02 (3 H, d, J 6.8, CH3), 1.94 (1 H, br s, OH), 2.10-2.13 (1 H, m, CH(CH3)2), 4.37 
(1 H, d, J 6.8, CHOH), 6.27 (1 H, d, J 3.2, CH=CO), 6.33 (1 H, dd, J 1.8 and 3.2, 
CHCO) and 7.30 (1 H, d, J 1.8, CHO).  The spectral data matches that reported 
in the literature.[207] 
tert-Butyl-(1-furan-2-yl-2-methyl-propoxy)-dimethyl-silane 452   
O
OTBS
 
To a solution of furfuryl alcohol 554 (5.90 g, 42.1 mmol) in dichloromethane 
(210 cm3) at 0 oC, was added triethylamine (17.6 cm3, 126.3 mmol) and the 
reaction mixture was stirred for 10 min.  tert-Butyldimethylsilyl chloride (9.52 g, 
63.1 mmol) and dimethylaminopyridine (2.57 g, 21.1 mmol) were added 
successively and the reaction was warmed up to room temperature.  After 16 h, 
further portions of triethylamine (17.6 cm3, 126.3 mmol), dimethylaminopyridine 
(2.57 g, 21.1 mmol) and tert-butyldimethylsilyl chloride (9.52 g, 63.1 mmol) 
were added and the mixture stirred for a further 24 h.  The reaction was 
quenched with 1% hydrochloric acid (40 cm3) and extracted with 
dichloromethane (50 cm3).  The organic layer was separated, washed with 
saturated aqueous sodium hydrogen carbonate (50 cm3), water (2×50 cm3) and 
saturated aqueous sodium chloride (50 cm3).  The solution was then dried over 
anhydrous magnesium sulfate, filtered and concentrated in vacuo.  Purification 
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by FCC [diethyl ether-petroleum ether (20:80) then (5:95) then (0:100)] of the 
crude residue afforded silyl ether 452 (8.97 g, 84%) as a colourless oil; Rf 0.62 
(solvent L); δH(400 MHz; CDCl3) -0.18 (3 H, s, Si(CH3)2), 0.00 (3 H, s, Si(CH3)2), 
0.77 (3 H, d, J 6.7, CH3), 0.85 (9 H, s, SiC(CH3)3), 0.93 (3 H, d, J 6.7, CH3), 1.98-
2.01 (1 H, m, CH), 4.29 (1 H, d, J 6.8, OCH), 6.11 (1 H, d, J 3.1, CH=CO), 6.27 (1 
H, dd, J 1.8 and 3.1, CHCO) and 7.30 (1 H, d, J 1.8, CHO); δC(100 MHz; CDCl3) -
5.9 (Si(CH3)2), 18.0 (SiC(CH3)3, 18.5 (CHCH3), 19.0 (CHCH3), 25.9 (SiC(CH3)3), 35.2 
(CH(CH3)2), 76.8 (CHOTBS), 108.8 (CH=CO), 109.7 (CHCO), 152.5 (CCHOTBS) and 
155.5 (C); MS (EI) m/z 123.1 [M-OTBS]+; HRMS m/z 123.0813 (123.0810 calcd for 
C8H11O, M-OTBS
+). 
[1-(5-Allyl-furan-2-yl)-2-methyl-propoxy]-tert-butyl-dimethyl-silane 555   
O
OTBS
 
To a solution of silyl ether 452 (1.0 g, 3.93 mmol) in anhydrous tetrahydrofuran 
(20 cm3) at 0 oC was added nBuLi (2.36 cm3, 5.89 mmol).  The resulting yellow 
solution was stirred at 0 oC for 15 min and then allowed to warm up to room 
temperature and stirred for 15 min.  After recooling down to 0 oC, allyl bromide 
(0.41 cm3, 4.71 mmol) was added and the mixture was stirred for 15 min.  The 
reaction was allowed to warm up to room temperature and after 16 h, the 
reaction was diluted with diethyl ether (30 cm3) and quenched with water (50 
cm3).  The phases were separated and the organic phase was dried over 
anhydrous sodium sulfate, filtered and concentrated in vacuo to afford alkene 
555 (1.06 g, 92%) as a yellow oil with further purification necessary; Rf 0.70 
(solvent L); νmax(film)/cm
-1 2981, 1610 (C=C) and 1145 (O-Si); δH(400 MHz; CDCl3) 
-0.16 (3 H, s, Si(CH3)2), 0.00 (3 H, s, Si(CH3)2), 0.77 (3 H, d, J 6.7, CHCH3), 0.88 
(9 H, s, SiC(CH3)3), 0.93 (3 H, d, J 6.7, CHCH3), 1.94-2.02 (1 H, m, CH(CH3)2), 
3.33 (2 H, d, J 6.4, CH2), 4.22 (1 H, d, J 6.9, CHOTBS), 5.05-5.12 (2 H, m, 
CH2=CH), 5.85-5.95 (1 H, m, CH=CH2), 5.89 (1 H, d, J 3.1, CH=CO) and 6.02 (1 H, 
d, J 3.1, CHCO); δC(100 MHz; CDCl3) -5.2 (Si(CH3)2), -4.9 (Si(CH3)2), 18.2 
(SiC(CH3)3), 18.4 (CHCH3), 18.9 (CHCH3), 25.8 (SiC(CH3)3), 32.6 (CH2), 34.2 
(CH(CH3)2), 74.2 (CHOTBS), 105.8 (CH=CO), 107.0 (CHCO), 116.5 (CH2=CH), 134.3 
(CH2=CH), 152.3 (CCHOTBS) and 155.5 (CH2=CHCH2C); MS (CI) m/z 163 [M-
OTBS]+; HRMS m/z 163.1119 (163.1123 calcd for C11H15O, M-OTBS
+).   
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1-(5-Allyl-furan-2-yl)-2-methyl-propan-1-ol 558[157]  
O
OH
 
To a solution of silyl ether 555 (1.06 g, 4.19 mmol) in anhydrous tetrahydrofuran 
(20 cm3) at 0 oC, was added tetra-butylammonium fluoride (8.4 cm3, 8.38 
mmol).  The ice-water bath was removed after 10 min and the reaction was left 
to stir overnight.  The reaction mixture was then diluted with diethyl ether (30 
cm3) and water (30 cm3) was added.  The organic layer was separated, dried 
over anhydrous sodium sulfate, filtered and concentrated in vacuo.  Purification 
by FCC [petroleum ether-ethyl acetate (80:20)] of the crude residue afforded 
alcohol 558 (513 mg, 87%) as a colourless oil; Rf 0.26 (solvent D); νmax(film)/cm
-1 
3550 (OH), 2968, 2940 and 1459; δH(400 MHz; CDCl3) 0.75 (3 H, d, J 6.7, CHCH3), 
0.91 (3 H, d, J 6.7, CHCH3), 1.71 (1 H, d, J 5.2, OH), 1.98 (1 H, oct., J 6.8, 
CH(CH3)2), 3.28 (2 H, dd, J 0.7 and 6.5, CH2=CHCH2), 4.19 (1H, dd, J 5.2 and 7.0, 
CHOH), 4.98-5.06 (2 H, m, CH2=CH), 5.78-5.89 (1 H, m, CH2=CH), 5.85 (1 H, d, J 
3.1, CH=CO) and 6.03 (1 H, d, J 3.1, CHCO); MS (EI) m/z 163 [M-OH]+; HRMS m/z 
181.1225 (181.1229 calcd for C11H17O2, M+H
+).  The spectral data matches that 
reported in the literature.[157] 
[1-(5-But-3-enyl-furan-2-yl)-2-methyl-propoxy]-tert-butyl-dimethyl-silane 
451   
O
OTBS
 
To a solution of silyl ether 452 (1.2 g, 4.71 mmol) in anhydrous tetrahydrofuran 
(25 cm3) at 0 oC, was added nBuLi (2.82 cm3, 7.06 mmol).  The resulting yellow 
solution was stirred at 0 oC for 15 min and then allowed to warm up to room 
temperature.  The solution was stirred at room temperature for 15 min and then 
recooled back down to 0 oC, before 4-bromo-1-butene (0.59 cm3, 5.65 mmol) 
was added.  The reaction was stirred for 15 min at 0 oC and then allowed to 
warm up to room temperature.  After 16 h, the reaction was diluted with diethyl 
ether (40 cm3) and water (60 cm3), the organic layers were separated and dried 
over anhydrous sodium sulfate, filtered and concentrated in vacuo to afford 
alkene 451 (1.32 g, 91%) as a yellow oil; Rf 0.72 (solvent L); νmax(film)/cm
-1 
2969, 1621 and 1152 (O-Si); δH(400 MHz; CDCl3) -0.14 (3 H, s, Si(CH3)2), 0.00 (3 
H, s, Si(CH3)2), 0.79 (3 H, d, J 6.7, CHCH3), 0.86 (9 H, s, SiC(CH3)3), 0.93 (3 H, d, 
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J 6.7, CHCH3), 1.97-2.01 (1 H, m, CH(CH3)2), 2.28-2.32 (2 H, m, CH2=CHCH2), 
2.93-2.95 (2 H, m, CH2=CHCH2CH2), 4.20 (1 H, d, J 6.9, CHOTBS), 5.03-5.12 (2 H, 
m, CH2=CH), 5.85-5.90 (1 H, m, CH2=CH), 5.89 (1 H, d, J 3.2, CH=CO) and 6.02 (1 
H, d, J 3.2, CHCO); δC(100 MHz; CDCl3) -5.1 (Si(CH3)2), -4.8 (Si(CH3)2), 18.3 
(SiC(CH3)3), 18.5 (CHCH3), 19.0 (CHCH3), 25.5 (C(CH3)3), 30.3 (CH2CH2), 32.6 
(CH2CH2), 34.2 (CH(CH3)2), 74.0 (CHOTBS), 105.5 (CH=CO), 107.2 (CHCO), 116.6 
(CH2=CH), 134.5 (CH2=CH), 152.1 (CCHOTBS) and 155.4 (CH2=CHCH2C); MS (CI) 
m/z 177 [M-OTBS]+; HRMS m/z 177.1281 (177.1279 calcd for C12H17O, M-OTBS
+). 
1-(5-But-3-enyl-furan-2-yl)-2-methyl-propan-1-ol 450[157] 
O
OH
 
To a solution of silyl ether 451 (1.3 g, 4.21 mmol) in anhydrous tetrahydrofuran 
(20 cm3) was added tetra-butylammonium fluoride (8.4 cm3, 8.42 mmol) at 0 oC.  
The ice-water bath was removed after 10 min and the reaction was left to stir 
overnight at room temperature.  The reaction mixture was then diluted with 
diethyl ether (30 cm3) and water (30 cm3) was added.  The organic layer was 
separated, dried over anhydrous sodium sulfate, filtered and concentrated in 
vacuo.  Purification by FCC [petroleum ether-ethyl acetate (80:20)] of the crude 
residue afforded alcohol 450 (818 mg, 81%) as a colourless oil; Rf 0.26 (solvent 
D); δH(400 MHz; CDCl3) 0.71 (3 H, d, J 6.7, CHCH3), 0.89 (3 H, d, J 6.7, CHCH3), 
1.67 (1 H, d, J 5.1, OH), 1.96 (1 H, oct., J 6.8, CH(CH3)2), 2.25 (2 H, q, J 7.6, 
CH2=CHCH2), 2.58 (2 H, t, J 7.6, CH2=CHCH2CH2), 4.16 (1 H, dd, J 5.2 and 7.1, 
CHOH), 4.82-4.94 (2 H, m, CH2=CH), 5.65-5.75 (1 H, m, CH2=CH), 5.80 (1 H, d, J 
3.0, CH=CO) and 6.02 (1 H, d, J 3.0, CHCO); δC(100 MHz; CDCl3) 18.4 (CHCH3), 
18.8 (CHCH3), 27.6 (CH2=CHCH2), 32.1 (CH2=CHCH2CH2), 33.3 (CH(CH3)2), 73.6 
(CHOH), 105.4 (CH=CO), 107.1 (CHCO), 115.3 (CH2=CH), 137.5 (CH2=CH), 154.3 
(CCHOH) and 154.9 (CH2=CHCH2CH2C); MS (EI) m/z 177.0 [M-OH]
+; HRMS m/z 
177.1281 (177.1279 calcd for C12H17O, M-OH
+).  The spectral data matches that 
reported in the literature.[157] 
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[1-(5-Pent-4-enyl-furan-2-yl)-2-methyl-propoxy]-tert-butyl-dimethyl-silane 
556  
O
OTBS
 
To a solution of silyl ether 452 (1.0 g, 3.93 mmol) in anhydrous tetrahydrofuran 
(20 cm3) at 0 oC, was added nBuLi (2.35 cm3, 5.89 mmol).  The resulting yellow 
solution was stirred at 0 oC for 15 min and then allowed to warm up to room 
temperature.  The solution was stirred at room temperature for 15 min and then 
recooled back down to 0 oC, before 5-bromo-1-pentene (0.56 cm3, 4.71 mmol) 
was added.  The reaction was stirred for 15 min at 0 oC and then allowed to 
warm up to room temperature.  After 16 h, the reaction was diluted with diethyl 
ether (40 cm3) and water (50 cm3), the organic layers were separated and dried 
over anhydrous sodium sulfate, filtered and concentrated in vacuo to afford 
alkene 556 (1.09 g, 86%) as a yellow oil with no further purification carried out; 
Rf 0.71 (solvent L); δH(400 MHz; CDCl3) -0.12 (3 H, s, Si(CH3)2), 0.00 (3 H, s, 
Si(CH3)2), 0.79 (3 H, d, J 6.7, CHCH3), 0.86 (9 H, s, SiC(CH3)3), 0.93 (3 H, d, J 
6.7, CHCH3), 1.87-1.92 (2 H, m, CH2=CHCH2CH2), 1.97-2.03 (1 H, m, CH(CH3)2), 
2.18-2.21 (2 H, m, CH2=CHCH2), 2.92-2.97 (2 H, m, CH2=CHCH2CH2CH2), 4.20 (1 
H, d, J 7.0, CHOTBS), 5.03-5.12 (2 H, m, CH2=CH), 5.85-5.90 (1 H, m, CH2=CH), 
5.88 (1 H, d, J 3.2, CH=CO) and 6.02 (1 H, d, J 3.2, CHCO); δC(100 MHz; CDCl3) -
5.1 (Si(CH3)2), -4.8 (Si(CH3)2), 18.3 (SiC(CH3)3), 18.5 (CHCH3), 19.0 (CHCH3), 25.5 
(C(CH3)3), 29.9 (CH2CH2CH2), 32.6 (CH2CH2CH2), 34.2 (CH(CH3)2), 38.4 
(CH2CH2CH2), 74.0 (CHOTBS), 105.5 (CH=CO), 107.2 (CHCO), 116.6 (CH2=CH), 
134.5 (CH2=CH), 152.1 (CCHOTBS) and 155.4 (CH2=CHCH2C); MS (CI) m/z 191 [M-
OTBS]+; HRMS m/z 191.1433 (191.1436 calcd for C13H19O, M-OTBS
+). 
2-Methyl-1-(5-pent-4-enyl-furan-2-yl)-propan-1-ol 559   
O
OH
 
To a solution of silyl ether 556 (1.0 g, 3.10 mmol) in anhydrous tetrahydrofuran 
(15 cm3) was added tetra-butylammonium fluoride (6.2 cm3, 6.20 mmol) at 0 oC.  
The ice-water bath was removed after 10 min and the reaction left to stir 
overnight at room temperature.  The reaction mixture was then diluted with 
diethyl ether (25 cm3) and water (25 cm3) was added.  The organic layer was 
separated, dried over anhydrous sodium sulfate, filtered and concentrated in 
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vacuo.  Purification by FCC [petroleum ether-ethyl acetate (90:10)→(85:15)] of 
the crude residue afforded alcohol 559 (514 mg, 80%) as a pale yellow oil; Rf 
0.45 (solvent A).  Also obtained was a mixture of alcohol 559 and silyl ether 452 
of which approximately 15% was silyl ether 452; δH(400 MHz; CDCl3) 0.75 (3 H, d, 
J 6.8, CHCH3), 0.93 (3 H, d, J 6.8, CHCH3), 1.64 (2 H, q, J 7.6, CH2=CHCH2CH2), 
1.93-2.06 (3 H, m, CH2=CHCH2 and CH(CH3)2), 2.51 (2 H, t, J 7.6, 
CH2=CHCH2CH2CH2), 4.19 (1 H, dd, J 3.6 and 6.4, CHOH), 4.86-4.97 (2 H, m, 
CH2=CH), 5.68-5.76 (1 H, m, CH2=CH), 5.81 (1 H, d, J 3.0, CH=CO) and 6.00 (1 H, 
d, J 3.0, CHCO); δC(100 MHz; CDCl3) 18.4 (CHCH3), 18.8 (CHCH3), 27.2 
(CH2=CHCH2CH2), 27.4 (CH2=CHCH2), 33.2 (CH(CH3)2), 33.3 (CH2=CHCH2CH2CH2), 
73.6 (CHOH), 105.3 (CH=CO), 107.1 (CHCO), 115.0 (CH2=CH), 138.2 (CH2=CH), 
154.3 (CCHOH) and 155.3 (CH2=CHCH2CH2CH2C); MS (EI) m/z 191 [M-OH]
+; HRMS 
m/z 191.1433 (191.1436 calcd for C13H19O, M-OH
+).   
[1-(5-Hex-5-enyl-furan-2-yl)-2-methyl-propoxy]-tert-butyl-dimethylsilane 
557  
O
OTBS
 
To a solution of silyl ether 452 (1.0 g, 3.93 mmol) in anhydrous tetrahydrofuran 
(20 cm3) at 0 oC, was added nBuLi (2.36 cm3, 5.89 mmol).  The resulting yellow 
solution was stirred at 0 oC for 15 min and then allowed to warm up to room 
temperature.  The solution was stirred at room temperature for 15 min and then 
recooled back down to 0 oC, before 6-bromo-1-pentene (0.63 cm3, 4.71 mmol) 
was added.  The reaction was stirred for 15 min at 0 oC and then allowed to 
warm up to room temperature.  After 16 h, the reaction was diluted with diethyl 
ether (30 cm3) and water (40 cm3), the organic layers were separated and dried 
over anhydrous sodium sulfate, filtered and concentrated in vacuo to afford 
alkene 557.  1H NMR spectroscopy of the crude residue showed that 
approximately 19% of starting material 452 remained, which was inseparable 
from the product (Rf 0.58 (solvent L)) by FCC.  Therefore alkene 557 was taken 
on crude to the next step; νmax(film)/cm
-1 2929, 2857, 2251, 1676 (C=C), 1254 
and 1068 (O-Si); δH(400 MHz; CDCl3) -0.17 (3 H, s, Si(CH3)2), -0.09 (3 H, s, 
Si(CH3)2), 0.76 (3 H, d, J 6.8, CH3), 0.82 (9 H, s, SiC(CH3)3), 0.94 (3 H, d, J 6.8, 
CH3), 1.40 (1 H, dt, J 7.5 and 15.1, CH2=CHCH2CH2), 1.60 (1 H, dt, J 7.5 and 
15.1, CH2=CHCH2CH2CH2), 1.95-2.10 (3 H, m, CH(CH3)2 and CH2=CHCH2), 2.57 (2 
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H, t, J 7.5, CH2=CHCH2CH2CH2CH2), 4.20 (1 H, d, J 7.1, CHOTBS), 4.88-5.01 (2 H, 
m, CH2=CH), 5.72-5.80 (1 H, m, CH2=CH), 5.83 (1 H, d, J 3.0, CH=CO) and 5.97 (1 
H, d, J 3.0, CHCO); δC(100 MHz; CDCl3) -5.3 (Si(CH3)2), -4.9 (Si(CH3)2), 18.3 
(CH3), 18.6 (CH3), 18.8 (SiC(CH3)3), 25.7 (CH2=CHCH2CH2), 25.8 
(CH2=CHCH2CH2CH2), 25.8 (SiC(CH3)3), 28.3 (CH2=CHCH2), 33.5 
(CH2=CHCH2CH2CH2CH2), 34.2 (CH(CH3)2), 74.3 (CHOTBS), 104.9 (CH=CO), 106.9 
(CHCO), 114.4 (CH2=CH), 138.8 (CH2=CH), 154.8 (CCHOTBS) and 154.9 
(CH2=CH(CH2)4C); MS (CI) m/z 205 [M-OTBS]
+, 221 [M-TBS]+; HRMS m/z 221.1546 
(221.1542 calcd for C14H21O2, M-TBS
+). 
1-(5-Hex-5-enyl-furan-2-yl)-2-methyl-propan-1-ol 560   
O
OH
 
To a stirred solution of silyl ether 557 (1.32 g, 3.91 mmol) in anhydrous 
tetrahydrofuran (20 cm3) at 0 oC, was added tetra-butylammonium fluoride (7.82 
cm3, 7.82 mmol).  The ice-water bath was removed after 10 min and the 
reaction allowed to warm up to room temperature, whereafter it was stirred for 
16 h.  Due to the remainder of some starting material, further tetra-
butylammonium fluoride (1.10 cm3, 1.10 mmol, 0.3 eq.) was added at 0 oC.  
After a further 4 h, there was still incomplete consumption of starting material 
so work up was carried out.  The reaction was diluted with diethyl ether (30 
cm3) and water (30 cm3), the organic layer was separated and dried over 
anhydrous sodium sulfate, filtered and concentrated in vacuo.  Purification by 
FCC [petroleum ether-diethyl ether (90:10)→(85:15)] of the crude residue 
afforded 560 (494 mg, 57%) as a colourless oil; Rf 0.25 (solvent D); 
νmax(film)/cm
-1 3387 (OH), 2931, 2870, 1643 (C=C), 1180, 1010 and 910; δH(400 
MHz; CDCl3) 0.74 (3 H, d, J 6.8, CHCH3), 0.92 (3 H, d, J 6.8, CHCH3), 1.33 (2 H, 
qn, J 7.6, CH2=CH(CH2)2CH2)), 1.52 (2 H, qn, J 7.6, CH2=CHCH2CH2), 1.69 (1 H, d, 
J 5.1, CH(CH3)2), 1.98 (2 H, q, J 7.5, CH2=CHCH2), 2.50 (2 H, t, J 7.6, 
CH2=CH(CH2)3CH2), 4.19 (1 H, dd, J 5.3 and 7.2, CHOH), 4.81-4.92 (2 H, m, 
CH2=CH), 5.64-5.75 (1 H, m, CH2=CH), 5.80 (1 H, d, J 3.0, CH=CO) and 6.00 (1 H, 
d, J 3.0, CHCO); δC(100 MHz; CDCl3) 18.4 (CHCH3), 18.8 (CHCH3), 24.5 
(CH2=CHCH2CH2), 27.9 (CH2=CH(CH2)2CH2), 28.4 (CH2=CHCH2), 33.3 (CH(CH3)2), 
33.5 (CH2=CH(CH2)3CH2), 73.6 (CHOH), 105.1 (CH=CO), 107.1 (CHCO), 114.5 
(CH2=CH), 138.7 (CH2=CH), 154.1 (CCHOH) and 155.7 (CH2=CH(CH2)4C); MS (EI) 
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m/z 222.1 [M]+; HRMS m/z 222.1618 (222.1620 calcd for C14H22O2, M
+).  The 
spectral data matches that reported in the literature.[157] 
(E/Z)-2-Methyl-1-(5-(4-(trimethylsilyl)but-2-enyl)furan-2-yl)propan-1-ol 561 
O
OH
TMS
 
Anhydrous dichloromethane (5 cm3) was added to a mixture of alkene 558 (107 
mg, 0.764 mmol) and allyltrimethylsilane (0.36 cm3, 2.29 mmol).  The reaction 
mixture was heated to reflux under an argon atmosphere after which Grubbs 
second generation catalyst (32 mg, 0.0382 mmol) was added.  The reaction 
mixture was heated under reflux in the dark for 48 h, cooled to room 
temperature and the solvent concentrated in vacuo.  Purification by FCC 
[petroleum ether-ethyl acetate (90:10)] of the crude residue afforded allylsilane 
561 (72 mg, 36%) as a yellow oil and as an inseparable E:Z-mixture (7:2); Rf 
0.61; νmax(film)/cm
-1 3433 (OH), 2962, 1681 (C=C), 1249 and 1018 (O-Si); δH (400 
MHz; CDCl3) (E isomer) 0.01 (9 H, s, Si(CCH3)3), 0.86 (3 H, d, J 6.8, CHCH3), 1.03 
(3 H, d, J 6.8, CHCH3), 1.46 (2 H, dd, J 1.2 and 8.0, CH2TMS), 1.78 (1 H, d, J 5.2, 
OH), 2.05-2.15 (1 H, m, CH(CH3)2), 3.32 (2 H, dd, J 6.8 and 11.8, CH2), 4.30 (1 H, 
dd, J 5.2 and 7.2, CHOH), 5.30-5.60 (2 H, m, Jtrans 15.1, CH=CH), 5.99 (1 H, d, J 
3.3, CH=CO) and 6.12 (1 H, d, J 3.3, CHCO); δC(100 MHz; CDCl3) -1.5 (3×CH3), 
15.5 (2×CH3), 24.3 (TMSCH2), 31.8 (CH2), 35.0 (HC(CH3)2), 74.5 (HCOH), 106.8 
(CH), 109.1 (CH), 127.8 (CH=CH), 144.5 (CH2C) and 151.1 (CHCOH); MS (FAB) m/z 
249 [M-OH]+; HRMS m/z 249.1670 (249.1675 calcd for C15H25OSi, M-OH
+). 
2-Methyl-1-[5-((E/Z)-5-trimethylsilanyl-pent-3-enyl)-furan-2-yl]-propan-1-ol 
449  
O
OH
TMS
 
Anhydrous dichloromethane (5 cm3) was added to a mixture of alkene 450 (123 
mg, 0.632 mmol) and allyltrimethylsilane (0.30 cm3, 1.89 mmol) and the 
reaction heated to reflux after which Grubbs second generation catalyst (27 mg, 
0.0316 mmol) was added.  The reaction mixture was heated under reflux in the 
dark for 48 h, cooled and the solvent concentrated in vacuo.  Purification by FCC 
[petroleum ether-ethyl acetate (90:10)] of the crude residue afforded allylsilane 
449 (92 mg, 52%) as a yellow oil and as an inseparable mixture E:Z-mixture 
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(6.15:1); νmax(film)/cm
-1 3441 (OH), 2955, 1689 (C=C), 1250 and 1041 (O-Si); 
δH(400 MHz; CDCl3) 0.04 (9 H, s, (Si(CH3)3), 0.88 (3 H, d, J 6.8, CHCH3), 1.07 (3 
H, d, J 6.8, CHCH3), 1.42 (2 H, d, J 7.9, CH2TMS), 2.12 (1 H, sext., J 6.8, 
CH(CH3)2), 2.34 (2 H, q, J 7.0, CH2CH2), 2.67 (2 H, t, J 7.0, CH2CH2), 4.32-4.34 (1 
H, m, CHOH), 5.24-5.50 (2 H, m, Jtrans 15.0, CH=CH), 5.94 (1 H, d, J 3.1, CH=CO) 
and 6.13 (1 H, d, J 3.1, CHCO); δC(100 MHz; CDCl3) -1.7 (3×CH3), 15.8 (2×CH3), 
24.3 (TMSCH2), 28.5 (CH2CH2), 31.9 (CH2CH2), 35.0 (HC(CH3)2), 74.5 (HCOH), 
106.8 (CH), 109.1 (CH), 127.8 (CH=CH), 149.5 (CH2C) and 151.6 (CHCOH); MS (CI) 
m/z 263.3 [M-OH]+, 279.3 [M-H]+; HRMS m/z 280.1763 (280.1859 calcd for 
C16H28O2Si, M
+). 
2-Methyl-1-[5-((E/Z)-6-trimethylsilanyl-hex-4-enyl)-furan-2-yl]-propan-1-ol 
562 
O
OH
TMS
 
Anhydrous dichloromethane (5 cm3) was added to 559 (200 mg, 0.960 mmol) and 
allyltrimethylsilane (0.53 cm3, 3.36 mmol) and the reaction heated to reflux 
after which Grubbs second generation catalyst (41 mg, 0.048 mmol) was added.  
The reaction mixture was heated under reflux in the dark for 48 h, cooled and 
the solvent concentrated in vacuo.  Purification by FCC [petroleum ether-ethyl 
acetate (90:10)] of the crude residue afforded 562 (127 mg, 45%) as a yellow oil 
and as an inseparable E:Z-mixture (2:1); Rf 0.52 (Solvent A); νmax(film)/cm
-1 3394 
(OH), 2955, 1249, 1010 (O-Si) and 964; δH(400 MHz; CDCl3) 0.00 (9 H, s, 
(Si(CH3)3), 0.86 (3 H, d, J 6.8, CH(CH3)), 1.03 (3 H, d, J 6.8, CH(CH3)), 1.42 (2 H, 
t, J 7.0, CH2), 1.62-1.79 and 2.00-2.20 (6 H, 2×m, 3×CH2), 2.59-2.65 (1 H, m, 
CH(CH3)2), 4.27-4.32 (1 H, m, CHOH), 5.20-5.29 (1 H, m, CH=CH), 5.38-5.44 (1 H, 
m, CH=CH), 5.91 (1 H, d, J 3.0, CH=CO) and 6.10 (1 H, d, J 3.0, CHCO); δC(100 
MHz; CDCl3) -1.7 (3×CH3), 16.0 (2×CH3), 24.4 (TMSCH2), 28.6 (CH2CH2CH2), 29.4 
(CH2CH2CH2), 34.8 (HC(CH3)2), 38.6 (CH2CH2CH2), 74.8 (HCOH), 106.6 (CH), 109.0 
(CH), 127.8 (CH=CH), 149.4 (CH2C) and 151.6 (CHCOH); MS (CI) m/z 207 [M-
CH2TMS]
+, 277 [M-OH]+; HRMS m/z 277.1984 (277.1988 calcd for C17H29OSi, M-
OH+). 
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6-Hydroxy-2-isopropyl-6-((E)-5-trimethylsilanyl-pent-3-enyl)-6H-pyran-3-one 
448   
O
O
OH
TMS  
Procedure A 
To a solution of alcohol 449 (64 mg, 0.228 mmol) in anhydrous dichloromethane 
(5 cm3) was added meta-chloroperoxybenzoic acid (mCPBA) (56 mg, 0.251 mmol) 
at 0 oC.  The reaction was allowed to warm up to room temperature and left to 
stir overnight.  An extra portion of meta-chloroperoxybenzoic acid (mCPBA) (28 
mg, 0.125 mmol) was added and the solution was stirred overnight.  The 
reaction mixture was diluted with dichloromethane (5 cm3) and saturated 
aqueous sodium hydrogen carbonate (5 cm3).  The organic layer was separated 
and washed with water (5 cm3), brine (5 cm3) and dried over anhydrous sodium 
sulfate.  The solution was then filtered and concentrated in vacuo.  Purification 
by FCC [petroleum ether-ethyl acetate (80:20)] of the crude residue caused 
product degradation.  Product 448 seen at Rf 0.34 (Solvent B). 
Procedure B 
To a solution of alcohol 449 (44.4 mg, 0.158 mmol) in dry dichloromethane (1.5 
cm3) at 0 oC, was added vanadyl acetylacetonate (VO(acac)2) (4.2 mg, 0.0158 
mmol).  The solution turned instantly green and tert-butyl hydroperoxide (TBHP) 
(40 µL, 0.237 mmol) was then added dropwise.  The now dark red reaction 
mixture was stirred for 2 h at 0 oC, then filtered through a pad of Celite® and the 
filtrate concentrated in vacuo.  Purification of the crude residue by FCC 
[petroleum ether-ethyl acetate (80:20)] afforded pyrone 448 (4.1 mg, 8.7%); Rf 
0.42 (Solvent A); νmax(film)/cm
-1 3423, 2960, 1686, 1248 and 841; δH (400 MHz, 
CDCl3) 0.00 (9 H, s, Si(CH3)3), 0.82 (3 H, d, J 6.7, CH(CH3)), 1.05 (3 H, d, J 6.7, 
CH(CH3)), 1.42-1.44 (2 H, m, CH2), 1.90 (2 H, t, J 2.8, CH=CHCH2CH2), 2.42-2.50 
(2 H, m, CH=CHCH2CH2), 4.33-4.38 (1 H, m, (CO)CH), 5.32-5.40 (1 H, m, CH=CH), 
5.49-5.53 (1 H, m, CH=CH), 6.03-6.08 (1 H, m, CH=CH(CO)) and 6.74-6.80 (1 H, 
m, CH=CH(CO)); δC(100 MHz; CDCl3) -1.5 (3×CH3), 18.5 (2×CH3), 21.6 
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(HC=CHCH2CH2), 25.2 (CH2), 28.6 (C(CH3)2), 45.0 (HC=CHCH2CH2), 90.5 (HCO), 
93.4 (COH), 126.0 (HC=CH and HC=CHCO), 144.3 (HC=CHCO) and 196.9 (C=O); MS 
(CI) m/z 297.3 [M+H]+; HRMS m/z 297.1888 (297.1886 calcd for C16H29O3Si, 
M+H+). 
7-Isopropyl-1-vinyl-6-oxa-spiro[4.5]dec-9-en-8-one 447   
O
OH
TMS O
O
OH
TMS
O
O
 
To a stirred solution of allylsilane 449 (90 mg, 0.321 mmol) in dry 
dichloromethane (3 cm3) was added vanadyl acetylacetonate (VO(acac)2) (8.5 
mg, 0.0321 mmol) at 0 oC.  The solution turned instantly green and tert-butyl 
hydroperoxide (TBHP) (0.08 cm3, 0.481 mmol) was added dropwise.  The dark 
red solution was stirred for 1.5 h at 0 oC then allowed to warm up to room 
temperature and filtered through Celite®.  The solvent was concentrated in 
vacuo to ~1 cm3 and then dry dichloromethane (2 cm3) was added and the 
solution cooled down to —78 oC.  Boron trifluorodiethyletherate (BF3OEt2) (0.12 
cm3, 0.962 mmol) was added slowly and stirring continued for 30 min at —78 oC.  
The reaction mixture was allowed to warm up to room temperature and was 
then quenched with saturated aqueous ammonium chloride (5 cm3) and 
extracted with dichloromethane (2×7 cm3).  The combined organic extracts 
were washed with saturated aqueous sodium hydrogen carbonate (10 cm3), 
water (10 cm3) and saturated aqueous ammonium chloride (10 cm3), then dried 
over anhydrous sodium sulfate, filtered and concentrated in vacuo.  Purification 
by FCC [petroleum ether-ethyl acetate (95:5) then (50:50)] of the crude residue 
afforded bicyclic pyran 447 (5.4 mg, ~1%); νmax(film)/cm
-1 2973, 2253, 1737, 
1265 and 1095; δH(400 MHz; CDCl3) 0.76 (3 H, d, J 6.8, CH3), 1.10 (3 H, d, J 6.8, 
CH3), 0.80-1.04 and 1.16-1.76 (6 H, 2×m, 3×CH2), 2.12-2.64 (2 H, m, CH(CH3)2 
and HCCH=CH2), 4.05 (1 H, dd, J 2.8 and 4.4, (OCH), 5.04 (2 H, dd, J 7.7 and 
13.5, CH=CH2), 5.60-5.68 (1 H, m, CH=CH2), 5.91 (1 H, d, J 10.0, CH=CH(CO)) 
and 6.70 (1 H, d, J 10.0, CH=CH(CO)); δC(100 MHz; CDCl3) 18.4 ((CH3)2), 23.6 
(CH2CH2CH2), 28.4 (CH2CH2CH2), 28.9 (C(CH3)2), 39.2 (CH2CH2CH2), 51.5 
(CCH=CH), 80.9 (C), 94.1 (CC(CH3)2), 116.9 (CH=CH), 132.6 (HC=CHCO), 138.0 
(CH=CH), 147.1 (HC=CHCO) and 196.1 (C=O). 
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